---
title: 'Selective serotonin reuptake inhibitors for amblyopia treatment: a systematic
  review and meta-analysis of randomized controlled trials.**DOI:** 10.3389/fneur.2025.1639913'
authors:
- EhteshamShamsher
- LuisaSaccaro
- Victor BarreirosPungirum
- Nghi BaoTran
- Omar A H AAlghaith
- FatemehKhabazianzadeh
- HollyBridge
- I BetinaIp
journal: Frontiers in neurology
doi: 10.3389/fneur.2025.1639913
publication_date: ''
source: Processed from scraped content
processing_date: '2025-10-21T22:15:05.551227'
content_type: research_paper
conditions:
- related_disorders
topics:
- neurochemistry
categories:
- related-disorders
- neurochemistry
reading_level: academic
audience:
- professional
- researcher
patient_friendly: false
search_priority: standard
keywords:
- clinical
- therapy
- treatment
search_tags:
- peer-reviewed
- related_disorders
- academic
- research
- neurochemistry
---

# Selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials.**DOI:** 10.3389/fneur.2025.1639913

**Authors:** EhteshamShamsher, LuisaSaccaro, Victor BarreirosPungirum, Nghi BaoTran, Omar A H AAlghaith, FatemehKhabazianzadeh, HollyBridge, I BetinaIp

**Journal:** Frontiers in neurology

**DOI:** 10.3389/fneur.2025.1639913

## Abstract

Amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. After early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. Selective serotonin reuptake inhibitors (SSRIs) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. We aimed to perform a systematic review and meta-analysis evaluating the effect of SSRIs on patients with amblyopia.
We systematically searched Pubmed, EMBASE, and Cochrane Central for randomized controlled trials (RCTs) and controlled observational studies comparing an SSRI with placebo in patients with amblyopia. Outcomes of interest were visual acuity (VA) change and visual evoked potential (VEP) change (P100 amplitude and latency). Statistical analysis was performed using the web version of RevMan by calculating the mean difference between groups (MD). Heterogeneity was assessed with Cochrane Q test and I
Four RCTs and 139 patients were included. 55% patients received SSRIs. Three studies used fluoxetine and one study used citalopram as the intervention. While SSRIs use statistically improved VA (MD 0.09 logMAR, 95% CI 0.04-0.14,
While SSRIs significantly improved VA in patients, the increase was not clinically significant as it represents less than one line of improvement on the Snellen chart. Given the minimal change in VA, it may be necessary to combine SSRIs with other modalities of intervention to demonstrate a clinically significant effect. Secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.
CRD42025633077, https://www.crd.york.ac.uk/PROSPERO/view/CRD42025633077.

We systematically searched Pubmed, EMBASE, and Cochrane Central for randomized controlled trials (RCTs) and controlled observational studies comparing an SSRI with placebo in patients with amblyopia. Outcomes of interest were visual acuity (VA) change and visual evoked potential (VEP) change (P100 amplitude and latency). Statistical analysis was performed using the web version of RevMan by calculating the mean difference between groups (MD). Heterogeneity was assessed with Cochrane Q test and I
Four RCTs and 139 patients were included. 55% patients received SSRIs. Three studies used fluoxetine and one study used citalopram as the intervention. While SSRIs use statistically improved VA (MD 0.09 logMAR, 95% CI 0.04-0.14,
While SSRIs significantly improved VA in patients, the increase was not clinically significant as it represents less than one line of improvement on the Snellen chart. Given the minimal change in VA, it may be necessary to combine SSRIs with other modalities of intervention to demonstrate a clinically significant effect. Secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.
CRD42025633077, https://www.crd.york.ac.uk/PROSPERO/view/CRD42025633077.## Full Text## Abstract
| crossref full text | google scholar 2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. rom j ophthalmol . (2020) 64:342–55. doi: 10.22336/rjo.2020.56 pubmed abstract | crossref full text | google scholar 3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. cereb cortex . (2006) 16:1750–8. doi: 10.1093/cercor/bhj110 pubmed abstract | crossref full text | google scholar 4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. j neurosci . (1994) 14:6855–71. doi: 10.1523/jneurosci.14-11-06855.1994 pubmed abstract | crossref full text | google scholar 5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. eye . (1996) 10:250–8. google scholar 6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. bmc ophthalmol . (2020) 20:203. doi: 10.1186/s12886-020-01442-9 pubmed abstract | crossref full text | google scholar 7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. optom vis sci . (2009) 86:629–33. doi: 10.1097/opx.0b013e3181a7b3e5 pubmed abstract | crossref full text | google scholar 8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. curr biol . (2014) 24:r936–40. doi: 10.1016/j.cub.2014.05.063 pubmed abstract | crossref full text | google scholar 9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. sci rep . (2018) 8:12830. doi: 10.1038/s41598-018-31169-z pubmed abstract | crossref full text | google scholar 10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. j neurosci . (2010) 30:14964–71. doi: 10.1523/jneurosci.4812-10.2010 pubmed abstract | crossref full text | google scholar 11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. science . (2008) 320:385–8. doi: 10.1126/science.1150516 crossref full text | google scholar 12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. eye . (2019) 33:1060–7. doi: 10.1038/s41433-019-0360-z pubmed abstract | crossref full text | google scholar 13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. j aapos . (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 pubmed abstract | crossref full text | google scholar 14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. neural plast . (2019) 2019:5857243. doi: 10.1155/2019/5857243 crossref full text | google scholar 15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. bmj . (2009) 339:b2535. doi: 10.1136/bmj.b2535 pubmed abstract | crossref full text | google scholar 16. sterne, jac, savović, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. bmj . (2019) 366:l4898. doi: 10.1136/bmj.l4898 pubmed abstract | crossref full text | google scholar 17. higgins, jpt, altman, dg, gøtzsche, pc, jüni, p, moher, d, oxman, ad, et al. the cochrane collaboration’s tool for assessing risk of bias in randomised trials. bmj . (2011) 343:d5928. doi: 10.1136/bmj.d5928 pubmed abstract | crossref full text | google scholar 18. feighner, jp. mechanism of action of antidepressant medications. j clin psychiatry . (1999) 60:4–11. google scholar 19. morishita, h, and hensch, tk. critical period revisited: impact on vision. curr opin neurobiol . (2008) 18:101–7. doi: 10.1016/j.conb.2008.05.009 pubmed abstract | crossref full text | google scholar 20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. ophthalmology . (2015) 122:874–81. doi: 10.1016/j.ophtha.2015.01.002 pubmed abstract | crossref full text | google scholar 21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. sci rep . (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 pubmed abstract | crossref full text | google scholar 22. mitchell, d, and sengpiel, f. animal models of amblyopia. vis neurosci . (2018) 35:e017. doi: 10.1017/s0952523817000244 pubmed abstract | crossref full text | google scholar 23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). doc ophthalmol . (2016) 133:1–9. doi: 10.1007/s10633-016-9553-y pubmed abstract | crossref full text | google scholar 24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. brain struct funct . (2022) 227:1491–505. doi: 10.1007/s00429-021-02273-0 pubmed abstract | crossref full text | google scholar 25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. imaging neurosci. (2024) 2:1–18. doi: 10.1162/imag_a_00256 pubmed abstract | crossref full text | google scholar 26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. perception . (2023) 52:441–58. doi: 10.1177/03010066231178664 pubmed abstract | crossref full text | google scholar 27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical γ−aminobutyric acid and perceptual suppression in amblyopia. front hum neurosci . (2022) 16:949395. doi: 10.3389/fnhum.2022.949395 crossref full text | google scholar 28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: https://pubmed.ncbi.nlm.nih.gov/26004760/ google scholar 29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. strabismus . (2025) 1–11:1–11. doi: 10.1080/09273972.2025.2478078 pubmed abstract | crossref full text | google scholar 30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. j vis . (2023) 23:14. doi: 10.1167/jov.23.1.14 pubmed abstract | crossref full text | google scholar 31. lunghi, c, and sale, a. a cycling lane for brain rewiring. curr biol . (2015) 25:r1122–3. doi: 10.1016/j.cub.2015.10.026 pubmed abstract | crossref full text | google scholar 32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. annal. clin. transl. neurol. (2019) 6:274–84. doi: 10.1002/acn3.698 pubmed abstract | crossref full text | google scholar keywords: amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity citation: shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. front. neurol . 16:1639913. doi: 10.3389/fneur.2025.1639913 received: 03 june 2025; accepted: 31 july 2025; published: 21 august 2025. edited by: gordon plant , university college london, united kingdom reviewed by: sara samadzadeh , charité university medicine berlin, germany alistair r. fielder , city university of london, united kingdom copyright © 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the creative commons attribution license (cc by) . the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. *correspondence: i. betina ip, ymv0aw5hlmlwqg5ky24ub3guywmudws= † these authors share senior authorship disclaimer: all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. download article download pdf readcube epub xml share on export citation endnote reference manager simple text file bibtex 1,812 total views 250 downloads citation numbers are available from dimensions view article impact view altmetric score share on edited by g p gordon plant reviewed by a r alistair r fielder s s sara samadzadeh table of contents abstract introduction methods results discussion conclusion data availability statement author contributions funding conflict of interest generative ai statement publisher’s note author disclaimer references export citation endnote reference manager simple text file bibtex check for updates frontiers' impact articles published with frontiers have received 12 million total citations your research is the real superpower - learn how we maximise its impact through our leading community journals explore our impact metrics supplementary material download article download download pdf readcube epub xml guidelines author guidelines services for authors policies and publication ethics editor guidelines fee policy explore articles research topics journals how we publish outreach frontiers forum frontiers policy labs frontiers for young minds frontiers planet prize connect help center emails and alerts contact us submit career opportunities follow us © 2025 frontiers media s.a. all rights reserved privacy policy | terms and conditions [["shallowreactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverrendered":13,"path":14,"pinia":15},["shallowreactive",3],{},["reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","frontiers articles","https://article-pages-2024.frontiersin.org/",["set"],["shallowreactive",12],{},true,"/journals/neurology/articles/10.3389/fneur.2025.1639913/full",["reactive",16],{"main":17,"user":579,"article":580,"articlehub":881,"mainheader":885},{"ibar":18,"footer":296,"newslettercomponent":-1,"snackbaritem":378,"toggleshowsnackbar":379,"contentfuljournal":380,"graphjournal":480,"settingsfeaturesswitchers":484,"templatetogglebanner":485,"tenantconfig":544},{"tenantlogo":19,"journallogo":19,"aboutus":20,"submiturl":113,"showsubmitbutton":13,"journal":114,"sectionterm":227,"aboutjournal":228,"mainlinks":277,"journallinks":284,"helpcenterlink":293},"",[21,38,47,71,87],{"title":22,"links":23},"who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"arialabel":28},"mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"arialabel":28},"history","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"arialabel":28},"leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"arialabel":28},"awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"impact and progress",[41,44],{"text":42,"url":43,"target":27,"arialabel":28},"frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"arialabel":28},"our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"arialabel":28},"how we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"arialabel":28},"open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"arialabel":28},"peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"arialabel":28},"research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"arialabel":28},"research topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"arialabel":28},"fair² data management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"arialabel":28},"fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"services",[74,78,81,84],{"text":75,"url":76,"target":77,"arialabel":28},"societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"arialabel":28},"national consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"arialabel":28},"institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"arialabel":28},"collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"more from frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"arialabel":93},"frontiers forum","https://forum.frontiersin.org/","this link will take you to the frontiers forum website",{"text":95,"url":96,"target":27,"arialabel":28},"frontiers planet prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"arialabel":100},"press office","https://pressoffice.frontiersin.org/","this link will take you to the frontiers press office website",{"text":102,"url":103,"target":27,"arialabel":104},"sustainability","https://www.frontiersin.org/about/sustainability","link to information about frontiers' sustainability",{"text":106,"url":107,"target":77,"arialabel":108},"career opportunities","https://careers.frontiersin.org/","this link will take you to the frontiers careers website",{"text":110,"url":111,"target":27,"arialabel":112},"contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=54&specialtyid=0&entitytype=2&entityid=141",{"id":115,"name":116,"slug":117,"sections":118},141,"frontiers in neurology","neurology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223],{"id":120,"name":121,"slug":122},156,"applied neuroimaging","applied-neuroimaging",{"id":124,"name":125,"slug":126},3712,"artificial intelligence in neurology","artificial-intelligence-in-neurology",{"id":128,"name":129,"slug":130},3023,"autonomic disorders","autonomic-disorders",{"id":132,"name":133,"slug":134},3740,"cognitive and behavioral neurology","cognitive-and-behavioral-neurology",{"id":136,"name":137,"slug":138},1439,"dementia and neurodegenerative diseases","dementia-and-neurodegenerative-diseases",{"id":140,"name":141,"slug":142},2038,"diagnostic neuropathology","diagnostic-neuropathology",{"id":144,"name":145,"slug":146},143,"endovascular and interventional neurology","endovascular-and-interventional-neurology",{"id":148,"name":149,"slug":150},144,"epilepsy","epilepsy",{"id":152,"name":153,"slug":154},1784,"experimental therapeutics","experimental-therapeutics",{"id":156,"name":157,"slug":158},153,"headache and neurogenic pain","headache-and-neurogenic-pain",{"id":160,"name":161,"slug":162},145,"movement disorders","movement-disorders",{"id":164,"name":165,"slug":166},147,"multiple sclerosis and neuroimmunology","multiple-sclerosis-and-neuroimmunology",{"id":168,"name":169,"slug":170},150,"neuro-oncology and neurosurgical oncology","neuro-oncology-and-neurosurgical-oncology",{"id":172,"name":173,"slug":174},154,"neuro-ophthalmology","neuro-ophthalmology",{"id":176,"name":177,"slug":178},155,"neuro-otology","neuro-otology",{"id":180,"name":181,"slug":182},159,"neurocritical and neurohospitalist care","neurocritical-and-neurohospitalist-care",{"id":184,"name":185,"slug":186},1339,"neuroepidemiology","neuroepidemiology",{"id":188,"name":189,"slug":190},160,"neurogenetics","neurogenetics",{"id":192,"name":193,"slug":194},1334,"neuroinfectious diseases","neuroinfectious-diseases",{"id":196,"name":197,"slug":198},2345,"neurological biomarkers","neurological-biomarkers",{"id":200,"name":201,"slug":202},146,"neuromuscular disorders and peripheral neuropathies","neuromuscular-disorders-and-peripheral-neuropathies",{"id":204,"name":205,"slug":206},547,"neurorehabilitation","neurorehabilitation",{"id":208,"name":209,"slug":210},3418,"neurotechnology","neurotechnology",{"id":212,"name":213,"slug":214},163,"neurotrauma","neurotrauma",{"id":216,"name":217,"slug":218},161,"pediatric neurology","pediatric-neurology",{"id":220,"name":221,"slug":222},151,"sleep disorders","sleep-disorders",{"id":224,"name":225,"slug":226},142,"stroke","stroke","sections",[229,253],{"title":230,"links":231},"scope",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"arialabel":28},"field chief editors","https://www.frontiersin.org/journals/neurology/about#about-editors",{"text":236,"url":237,"target":27,"arialabel":28},"mission & scope","https://www.frontiersin.org/journals/neurology/about#about-scope",{"text":239,"url":240,"target":27,"arialabel":28},"facts","https://www.frontiersin.org/journals/neurology/about#about-facts",{"text":242,"url":243,"target":27,"arialabel":28},"journal sections","https://www.frontiersin.org/journals/neurology/about#about-submission",{"text":245,"url":246,"target":27,"arialabel":28},"open access statement","https://www.frontiersin.org/journals/neurology/about#about-open",{"text":248,"url":249,"target":27,"arialabel":28},"copyright statement","https://www.frontiersin.org/journals/neurology/about#copyright-statement",{"text":251,"url":252,"target":27,"arialabel":28},"quality","https://www.frontiersin.org/journals/neurology/about#about-quality",{"title":254,"links":255},"for authors",[256,259,262,265,268,271,274],{"text":257,"url":258,"target":27,"arialabel":28},"why submit?","https://www.frontiersin.org/journals/neurology/for-authors/why-submit",{"text":260,"url":261,"target":27,"arialabel":28},"article types","https://www.frontiersin.org/journals/neurology/for-authors/article-types",{"text":263,"url":264,"target":27,"arialabel":28},"author guidelines","https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines",{"text":266,"url":267,"target":27,"arialabel":28},"editor guidelines","https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines",{"text":269,"url":270,"target":27,"arialabel":28},"publishing fees","https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees",{"text":272,"url":273,"target":27,"arialabel":28},"submission checklist","https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist",{"text":275,"url":276,"target":27,"arialabel":28},"contact editorial office","https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office",[278,281],{"text":279,"url":280,"target":27,"arialabel":28},"all journals","https://www.frontiersin.org/journals",{"text":282,"url":283,"target":27,"arialabel":28},"all articles","https://www.frontiersin.org/articles",[285,288,290],{"text":286,"url":287,"target":27,"arialabel":28},"articles","articles",{"text":63,"url":289,"target":27,"arialabel":28},"research-topics",{"text":291,"url":292,"target":27,"arialabel":28},"editorial board","editors",{"text":294,"url":295,"target":77,"arialabel":294},"help center","https://helpcenter.frontiersin.org",{"blocks":297,"sociallinks":351,"copyright":375,"termsandconditionsurl":376,"privacypolicyurl":377},[298,312,322,336],{"title":299,"links":300},"guidelines",[301,303,306,309,311],{"text":263,"url":302,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":304,"url":305,"target":27,"arialabel":28},"services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":307,"url":308,"target":27,"arialabel":28},"policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":266,"url":310,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"arialabel":28},{"title":313,"links":314},"explore",[315,316,319,321],{"text":286,"url":283,"target":27,"arialabel":28},{"text":317,"url":318,"target":27,"arialabel":28},"research topics ","https://www.frontiersin.org/research-topics",{"text":320,"url":280,"target":27,"arialabel":28},"journals",{"text":51,"url":52,"target":27,"arialabel":28},{"title":323,"links":324},"outreach",[325,328,331,335],{"text":326,"url":92,"target":77,"arialabel":327},"frontiers forum ","frontiers forum website",{"text":329,"url":330,"target":77,"arialabel":28},"frontiers policy labs ","https://policylabs.frontiersin.org/",{"text":332,"url":333,"target":77,"arialabel":334},"frontiers for young minds","https://kids.frontiersin.org/","frontiers for young minds journal",{"text":95,"url":96,"target":27,"arialabel":28},{"title":337,"links":338},"connect",[339,340,344,347,350],{"text":294,"url":295,"target":77,"arialabel":294},{"text":341,"url":342,"target":77,"arialabel":343},"emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","subscribe to frontiers emails",{"text":345,"url":111,"target":27,"arialabel":346},"contact us ","subscribe to newsletter",{"text":348,"url":349,"target":27,"arialabel":28},"submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"arialabel":28},[352,360,365,370],{"link":353,"type":356,"color":357,"icon":358,"size":359,"hiddentext":13},{"text":354,"url":355,"target":77,"arialabel":354},"frontiers facebook","https://www.facebook.com/frontiersin","link","grey","facebook","medium",{"link":361,"type":356,"color":357,"icon":364,"size":359,"hiddentext":13},{"text":362,"url":363,"target":77,"arialabel":28},"frontiers twitter","https://twitter.com/frontiersin","twitter",{"link":366,"type":356,"color":357,"icon":369,"size":359,"hiddentext":13},{"text":367,"url":368,"target":77,"arialabel":28},"frontiers linkedin","https://www.linkedin.com/company/frontiers","linkedin",{"link":371,"type":356,"color":357,"icon":374,"size":359,"hiddentext":13},{"text":372,"url":373,"target":77,"arialabel":28},"frontiers instagram","https://www.instagram.com/frontiersin_","instagram","frontiers media s.a. all rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":381,"identifier":115,"name":116,"slug":117,"banner":382,"description":473,"mission":474,"palette":475,"impactfactor":476,"citescore":477,"citations":478,"showtagline":28,"twitter":479},"journal",[383],{"id":384,"src":385,"name":386,"tags":387,"type":432,"width":433,"height":434,"idhash":435,"archive":436,"brandid":437,"limited":436,"filesize":438,"ispublic":439,"original":440,"copyright":19,"extension":441,"thumbnails":443,"datecreated":451,"description":452,"orientation":453,"usercreated":454,"watermarked":436,"datemodified":451,"datepublished":455,"ecsarchivefiles":456,"propertyoptions":457,"property_channel":462,"property_sub-type":464,"property_asset_type":466,"activeoriginalfocuspoint":468,"property_office_department":471},"d315adb2-2967-48b6-be3b61009343d69e","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/webimage-810a1e19-163c-4fd0-bfd3d50a4721b642.png","fneur_main visual_cyan_website",[388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,117,430,431],"professional","device","medical","close up","technology","wires","brain waves","record","digital","selective focus","laboratory","brain","health","electrodes","computer","examination","electroencephalography","scan","study","oncology","examine","electroencephalogram","neurosurgery","science","doctor","diagnose","magnetic","patient","modern","electroencephalograph","equipment","office","healthcare","scanning","instrument","eeg","hospital","ct","technician","medicine","ultrasound","radiology","diagnostic","lab","image",5052,3368,"62463d527f6ddd4d",0,"22c10171-81b3-4da6-99342f272a32e8bb",5758943,1,"https://brand.frontiersin.org/m/62463d527f6ddd4d/original/fneur_main-visual_cyan_website.jpg",[442],"jpg",{"mini":444,"thul":445,"webimage":385,"guidelines":446,"websitejpg_xl":447,"websitewebp_l":448,"websitewebp_m":449,"websitewebp_xl":450},"https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/mini-a927c1b7-02f8-4d29-94320f509270457d.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/thul-fcd9f16d-d1a9-4535-a7e4c140224266b9.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/guidelines-fneur_main visual_cyan_website.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitejpg_xl-fneur_main visual_cyan_website.jpg","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_l-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_m-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_xl-fneur_main visual_cyan_website.webp","2022-06-27t10:00:23z","charming young woman undergoing electroencephalography; shutterstock id 695951221; purchase_order: main visual; job: ; client: ; other:","landscape","caroline sutter","2022-06-27t06:08:46z",[],[458,459,460,461],"414fb2d4-2283-43fd-be14e534eca67928","6c18119b-14bd-4951-b437696f4357bd33","7c692885-db25-4858-b1fb4ff47b241e9b","d88c0047-ec30-4506-a7df28a4d765e1cf",[463],"frontiersin_org",[465],"main_visual",[467],"photography",{"x":469,"y":470},2526,1684,[472],"publishing","the world's most cited clinical neurology journal, exploring the diagnosis, causes, treatment, and public health aspects of neurological illnesses to improve patient care.","\u003cp>frontiers in neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. it is indexed in pubmed central (pmc), scopus, and the doaj.\u003c/p>\n\n\u003cp>led by field chief editor prof. irene litvan (university of california, san diego, usa), frontiers in neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.\u003c/p>\n\n\u003cp>the journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:\u003c/p>\n\n\u003cul>\n \u003cli>artificial intelligence in neurology\u003c/li>\n \u003cli>applied neuroimaging\u003c/li>\n \u003cli>autonomic disorders\u003c/li>\n \u003cli>cognitive behavioural neurology\u003c/li>\n \u003cli>dementia and neurodegenerative diseases\u003c/li>\n \u003cli>diagnostic and forensic neuropathology\u003c/li>\n \u003cli>endovascular and interventional neurology\u003c/li>\n \u003cli>epilepsy\u003c/li>\n \u003cli>experimental therapeutics\u003c/li>\n \u003cli>headache and neurogenic pain\u003c/li>\n \u003cli>movement disorders\u003c/li>\n \u003cli>multiple sclerosis and neuroimmunology\u003c/li>\n \u003cli>neuro-oncology and neurosurgical oncology\u003c/li>\n \u003cli>neuro-ophthalmology\u003c/li>\n \u003cli>neuro-otology\u003c/li>\n \u003cli>neurocritical and neurohospitalist care\u003c/li>\n \u003cli>neuroepidemiology\u003c/li>\n \u003cli>neurogenetics\u003c/li>\n \u003cli>neuroinfectious diseases\u003c/li>\n \u003cli>neurological biomarkers\u003c/li>\n \u003cli>neuromuscular disorders and peripheral neuropathies\u003c/li>\n \u003cli>neurorehabilitation\u003c/li>\n \u003cli>neurotechnology\u003c/li>\n \u003cli>neurotrauma\u003c/li>\n \u003cli>pediatric neurology\u003c/li>\n \u003cli>sleep disorders\u003c/li>\n \u003cli>stroke\u003c/li>\n\u003c/ul>\n\n\u003cp>in particular, the journal welcomes submissions that support and advance the un’s \u003ca href=https://globalgoals.org/goals/>sustainable development goals\u003c/a> (sdgs), notably \u003ca href=https://globalgoals.org/goals/3-good-health-and-well-being/>sdg 3: good health and well-being\u003c/a>.\u003c/p>\n\n\u003cp>manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.\u003c/p>\n\n\u003cp>the journal no longer accepts papers concerning simple bibliometric studies. authors are still welcome to submit systematic reviews using publicly available data, but these must adhere to the \u003ca href=https://www.prisma-statement.org/>prisma guidelines\u003c/a> and have a conclusion related to neurological research. studies without this primary focus will be transferred to a more applicable journal.\u003c/p>\n\n\u003cp>frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as nhanes or mendelian randomization studies, must include appropriate validation. please refer to the \u003ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,standards%20for%20research%20methodology,-experiments\">frontiers standards for research methodology policy\u003c/a> for more information. manuscripts not adhering to these standards will not be considered.\u003cp>\n\n\u003cp>frontiers in neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.\u003c/p>","cyan","3.4","4.8","273537","@frontneurol",{"id":115,"name":116,"slug":117,"abbreviation":481,"isonline":13,"isopenforsubmissions":13,"citescore":482,"impactfactor":483},"fneur",5.2,2.8,{"displaytitlepilllabels":13,"displayrelatedarticlesbox":13,"showeditors":13,"showreviewers":13,"showloopimpactlink":13,"enablefigshare":379,"usexmlimages":13},{"ispublic":13,"allowcompanyusers":379,"whitelistemails":486,"enablealljournals":13,"whitelistjournals":508},[487,488,489,490,491,492,493,494,495,492,496,497,498,499,500,501,502,503,504,505,506,507],"y2fybg9zlmxvcmnhqgzyb250awvyc2lulm9yzw==","zgfuawvslmx1ekbmcm9udgllcnnpbi5vcmc=","bgf1cmeudgvuyubmcm9udgllcnnpbi5vcmc=","cmfmywvslnjpyw5jag9aznjvbnrpzxjzaw4ub3jn","amftzxmuc21hbgxib25lqgzyb250awvyc2lulm9yzw==","znjhbi5tb3jlbm9aznjvbnrpzxjzaw4ub3jn","c2ftdwvslmzlcm5hbmrlekbmcm9udgllcnnpbi5vcmc=","ymfyymfyys5jyxjjyw5naxvaznjvbnrpzxjzaw4ub3jn","axzhbi5zyw50yw1hcmlhqgzyb250awvyc2lulm9yzw==","ahvllnryyw5aznjvbnrpzxjzaw4ub3jn","z29uy2fsby52yxjnyxnaznjvbnrpzxjzaw4ub3jn","bhvjawuuc2vubkbmcm9udgllcnnpbi5vcmc=","bg9ybi5mcmfzzxjaznjvbnrpzxjzaw4ub3jn","zwxzys5jyxjyb25aznjvbnrpzxjzaw4ub3jn","bwfhcnrlbi52yw5kawpja0bmcm9udgllcnnpbi5vcmc=","ymluzgh1lmtyaxnobmfuqgzyb250awvyc2lulm9yzw==","bwf0dghldy5hdhr3yxrlcnnaznjvbnrpzxjzaw4ub3jn","z2l1bglhlnzhbhnly2noaubmcm9udgllcnnpbi5vcmc=","zmfiawfulmrlbgxhbw9ydgvaznjvbnrpzxjzaw4ub3jn","dmlqyxlhbi5wcebwaxrzb2x1dglvbnmuy29t","z3vpbgxhdw1llnnldxjhdebmcm9udgllcnnpbi5vcmc=",[509,510,511,512,513,514,439,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,115,530,531,532,533,534,535,536,537,538,539,540,541,542,543],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceid":439,"name":439,"availablejournalpages":545,"announcement":549},[287,292,289,546,547,548],"volumes","about","community-reviewers",{"__typename":550,"sys":551,"preheader":42,"title":553,"description":554,"image":555,"link":577},"announcement",{"id":552},"5ittnttqgazppgh6rx0alm","articles published with frontiers have received 12 million total citations","your research is the real superpower - learn how we maximise its impact through our leading community journals",[556],{"archive":436,"brandid":437,"copyright":28,"datecreated":557,"datemodified":558,"datepublished":559,"description":28,"extension":560,"filesize":562,"height":563,"id":564,"ispublic":436,"limited":436,"name":565,"orientation":453,"original":28,"thumbnails":566,"type":432,"watermarked":436,"width":573,"videopreviewurls":574,"tags":575,"textmetaproperties":576,"src":567},"2025-06-18t12:58:01z","2025-06-18t14:15:34z","2025-06-18t12:57:32z",[561],"png",1365026,920,"7c5269c4-3c83-4591-951a74d15b95daea","impact metrics banner for article pages",{"webimage":567,"thul":568,"mini":569,"websitewebp_l":570,"websitewebp_m":571,"guidelines":572},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_l/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_m/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/guidelines/impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":578,"url":43,"target":27,"arialabel":28},"explore our impact metrics",{"loggeduserinfo":-1},{"currentarticle":581,"ispreviewpage":379,"hassupplementaldata":379,"showcrossmarkwidget":13,"articletemplate":738,"currentarticlepagemetainfo":739,"xmlparsedarticlecontent":-1,"xmlparsingerror":-1},{"id":582,"doi":583,"title":584,"acceptancedate":585,"receptiondate":586,"publicationdate":587,"lastmodifieddate":588,"ispublished":13,"abstract":589,"researchtopic":590,"articletype":596,"stage":599,"keywords":601,"authors":609,"editors":675,"reviewers":683,"journal":699,"section":707,"impactmetrics":709,"volume":712,"articlevolume":713,"relatedarticles":714,"ispublishedv2":13,"contents":715,"files":718},1639913,"10.3389/fneur.2025.1639913","selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials","2025-07-31t18:15:51.000z","2025-06-03t00:38:20.000z","2025-08-21t00:00:00.000z","2025-10-21t02:26:11.259z","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.methodswe systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i2 statistics.resultsfour rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04–0.14, p = 0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.conclusionwhile ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.systematic review registrationcrd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077.",{"id":591,"title":592,"articlescount":593,"ismagazinepage":379,"slug":594,"isopenforsubmission":13,"views":595},61549,"advances in understanding visual disorders linked to cortical dysfunction",10,"advances-in-understanding-visual-disorders-linked-to-cortical-dysfunction",15702,{"id":597,"name":598},136,"systematic review",{"id":600,"name":19},18,[602,603,604,605,606,607,608],"strabismus","neuroplasticity","amblyopia","fluoxetine","ssris","anisometropia","citalopram",[610,619,627,636,645,652,660,668],{"id":611,"firstname":612,"middlename":19,"lastname":613,"givennames":614,"iscorresponding":379,"isprofilepublic":13,"userid":611,"email":-1,"affiliations":615},3083093,"ehtesham","shamsher","ehtesham ",[616],{"organizationname":617,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust","united kingdom",{"id":436,"firstname":620,"middlename":19,"lastname":621,"givennames":622,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":623},"luisa","saccaro","luisa ",[624],{"organizationname":625,"countryname":626,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, universidade de mogi das cruzes","brazil",{"id":628,"firstname":629,"middlename":19,"lastname":630,"givennames":631,"iscorresponding":379,"isprofilepublic":13,"userid":628,"email":-1,"affiliations":632},3089392,"victor barreiros","pungirum","victor barreiros ",[633],{"organizationname":634,"countryname":635,"cityname":19,"statename":19,"zipcode":19},"faculty of medical sciences, university of buenos aires","argentina",{"id":637,"firstname":638,"middlename":19,"lastname":639,"givennames":640,"iscorresponding":379,"isprofilepublic":13,"userid":637,"email":-1,"affiliations":641},3162299,"nghi bao","tran","nghi bao ",[642],{"organizationname":643,"countryname":644,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, university of debrecen","hungary",{"id":436,"firstname":646,"middlename":19,"lastname":647,"givennames":648,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":649},"omar a. h. a.","alghaith","omar a. h. a. ",[650],{"organizationname":651,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"institute of ophthalmology, university college london",{"id":436,"firstname":653,"middlename":19,"lastname":654,"givennames":655,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":656},"fatemeh","khabazianzadeh","fatemeh ",[657],{"organizationname":658,"countryname":659,"cityname":19,"statename":19,"zipcode":19},"eye research center, khatam-al-anbia hospital, mashad university of medical sciences","iran",{"id":661,"firstname":662,"middlename":19,"lastname":663,"givennames":664,"iscorresponding":379,"isprofilepublic":13,"userid":661,"email":-1,"affiliations":665},30975,"holly","bridge","holly ",[666],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging",{"id":669,"firstname":670,"middlename":19,"lastname":671,"givennames":672,"iscorresponding":379,"isprofilepublic":13,"userid":669,"email":-1,"affiliations":673},318592,"i. betina","ip","i. betina ",[674],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},[676],{"id":677,"firstname":678,"middlename":19,"lastname":679,"givennames":680,"iscorresponding":379,"isprofilepublic":13,"userid":677,"email":-1,"affiliations":681},2271562,"gordon","plant","gordon ",[682],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},[684,692],{"id":685,"firstname":686,"middlename":687,"lastname":688,"givennames":689,"iscorresponding":379,"isprofilepublic":13,"userid":685,"email":-1,"affiliations":690},870962,"alistair","r","fielder","alistair r",[691],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":693,"firstname":694,"middlename":19,"lastname":695,"givennames":696,"iscorresponding":379,"isprofilepublic":13,"userid":693,"email":-1,"affiliations":697},1863925,"sara","samadzadeh","sara ",[698],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":115,"slug":117,"name":116,"shortname":700,"electronicissn":701,"field":702,"specialtyid":28,"journalsectionpaths":705},"front. neurol.","1664-2295",{"id":703,"domainid":704},54,2,[706],{"section":707},{"id":172,"name":173,"slug":174,"specialtyid":708},758,{"views":710,"downloads":711,"citations":436},1812,250,16,"volume 16 - 2025",[],{"titlehtml":584,"fulltexthtml":716,"menuhtml":717},"\u003cdiv class=\"journalabstract\"> \u003ca id=\"h1\" name=\"h1\">\u003c/a>\n \u003cdiv class=\"authors\">\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3083093\" class=\"user-id-3083093\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3083093/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"ehtesham shamsher\">ehtesham shamsher\u003c/a>\u003csup>1\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"luisa saccaro\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">luisa saccaro\u003csup>2\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3089392\" class=\"user-id-3089392\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3089392/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"victor barreiros pungirum\">victor barreiros pungirum\u003c/a>\u003csup>3\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3162299\" class=\"user-id-3162299\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3162299/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"nghi bao tran\">nghi bao tran\u003c/a>\u003csup>4\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"omar a. h. a. alghaith\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">omar a. h. a. alghaith\u003csup>5\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"fatemeh khabazianzadeh\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">fatemeh khabazianzadeh\u003csup>6\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/30975\" class=\"user-id-30975\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/30975/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"holly bridge&#x;\">holly bridge\u003c/a>\u003csup>7\u003c/sup>\u003csup>†\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/318592\" class=\"user-id-318592\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/318592/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"i. betina ip
&#x;\">i. betina ip\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x0002a;\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003c/div> \u003cul class=\"notes\"> \u003cli>\u003cspan>\u003csup>1\u003c/sup>\u003c/span>oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, oxford, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>2\u003c/sup>\u003c/span>faculty of medicine, universidade de mogi das cruzes, mogi das cruzes, brazil\u003c/li> \u003cli>\u003cspan>\u003csup>3\u003c/sup>\u003c/span>faculty of medical sciences, university of buenos aires, buenos aires, argentina\u003c/li> \u003cli>\u003cspan>\u003csup>4\u003c/sup>\u003c/span>faculty of medicine, university of debrecen, debrecen, hungary\u003c/li> \u003cli>\u003cspan>\u003csup>5\u003c/sup>\u003c/span>institute of ophthalmology, university college london, london, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>6\u003c/sup>\u003c/span>eye research center, khatam-al-anbia hospital, mashad university of medical sciences, mashhad, iran\u003c/li> \u003cli>\u003cspan>\u003csup>7\u003c/sup>\u003c/span>nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, oxford, united kingdom\u003c/li> \u003c/ul>\n\u003cp class=\"mb15\">\u003cb>introduction:\u003c/b> amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>methods:\u003c/b> we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i\u003csup>2\u003c/sup> statistics.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>results:\u003c/b> four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>conclusion:\u003c/b> while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.\u003c/p>\n\u003cp class=\"mb0\">\u003cb>systematic review registration:\u003c/b> crd42025633077, \u003ca href=\"https://www.crd.york.ac.uk/prospero/view/crd42025633077\">https://www.crd.york.ac.uk/prospero/view/crd42025633077\u003c/a>.\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div> \u003cdiv class=\"journalfulltext\"> \u003ca id=\"h2\" name=\"h2\">\u003c/a>\n\u003ch2>introduction\u003c/h2>\n\u003cp class=\"mb15\">amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children (\u003ca href=\"#ref1\">1\u003c/a>, \u003ca href=\"#ref2\">2\u003c/a>). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye (\u003ca href=\"#ref3\">3\u003c/a>&#x2013;\u003ca href=\"#ref5\">5\u003c/a>). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye (\u003ca href=\"#ref5\">5\u003c/a>). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) (\u003ca href=\"#ref6\">6\u003c/a>). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function (\u003ca href=\"#ref6\">6\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children (\u003ca href=\"#ref7\">7\u003c/a>). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed (\u003ca href=\"#ref6\">6\u003c/a>). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old (\u003ca href=\"#ref8\">8\u003c/a>). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity (\u003ca href=\"#ref6\">6\u003c/a>, \u003ca href=\"#ref9\">9\u003c/a>). therefore, novel treatment paradigms are needed to treat amblyopia in adults.\u003c/p>\n\u003cp class=\"mb0\">selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy (\u003ca href=\"#ref10\">10\u003c/a>). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex (\u003ca href=\"#ref11\">11\u003c/a>). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>), while others fail to demonstrate efficacy (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information.\u003c/p> \u003ca id=\"h3\" name=\"h3\">\u003c/a>\n\u003ch2>methods\u003c/h2>\n\u003ch3>search strategy and eligibility criteria\u003c/h3>\n\u003cp class=\"mb15\">this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement (\u003ca href=\"#ref15\">15\u003c/a>). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus.\u003c/p>\n\u003cp class=\"mb0\">we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations.\u003c/p>\n\u003ch3>data extraction\u003c/h3>\n\u003cp class=\"mb0\">data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus.\u003c/p>\n\u003ch3>endpoints\u003c/h3>\n\u003cp class=\"mb0\">the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation.\u003c/p>\n\u003ch3>quality assessment (risk of bias)\u003c/h3>\n\u003cp class=\"mb0\">the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) (\u003ca href=\"#ref16\">16\u003c/a>). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed (\u003ca href=\"#ref17\">17\u003c/a>). discrepancies were resolved through consensus following a discussion of the reasons for the differences.\u003c/p>\n\u003ch3>statistical analysis\u003c/h3>\n\u003cp class=\"mb0\">statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student \u003ci>t\u003c/i>-test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i\u003csup>2\u003c/sup> statistics, with \u003ci>p\u003c/i>&#x202f;&#x0003c;&#x202f;0.10 and i\u003csup>2\u003c/sup>&#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it.\u003c/p> \u003ca id=\"h4\" name=\"h4\">\u003c/a>\n\u003ch2>results\u003c/h2>\n\u003cp class=\"mb0\">the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) were included, encompassing 139 patients from four rcts (\u003ca href=\"#fig1\">figure 1\u003c/a>). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in \u003ca href=\"#tab1\">table 1\u003c/a>. three studies had fluoxetine and one citalopram as the intervention group.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" name=\"figure1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" alt=\"flowchart detailing a study selection process: identification phase shows pubmed with fifty-five results, embase with three hundred ninety-six results, cochrane with thirty results, totaling four hundred eighty-one. screening phase removes four hundred seventy-two as duplicates or non-criteria matches. eligibility phase reviews nine full-text studies; discards one conference abstract and four from the manuscript registry. four studies remain included.\" id=\"fig1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 1\u003c/b>. prisma flow diagram of study screening and selection.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">table 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" name=\"table1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" alt=\"www.frontiersin.org\" id=\"tab1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 1\u003c/b>. baseline characteristics of included studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004, i\u003csup>2\u003c/sup> =&#x202f;23%, \u003ca href=\"#fig2\">figure 2\u003c/a>). only three studies (\u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.76, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3a\u003c/a>) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.48, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3b\u003c/a>) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" name=\"figure2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" alt=\"forest plot showing the mean differences from four studies comparing the effects of ssri to placebo. each study is represented by a red square with horizontal lines indicating confidence intervals. the total effect is represented by a black diamond indicating a mean difference of 0.09 with a confidence interval of 0.04 to 0.14, favoring ssri. heterogeneity measures show tau-squared equals zero, chi-squared equals 3.90 with a p-value of 0.27, and i-squared equals 23%.\" id=\"fig2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 2\u003c/b>. visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 3\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" name=\"figure3\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" alt=\"forest plots a and b compare mean differences for several studies on ssri effectiveness. plot a shows a total mean difference of 0.34, favoring placebo, with no heterogeneity. plot b shows a total mean difference of 1.76, still favoring placebo, with no heterogeneity. each plot displays individual study results with confidence intervals and weight distributions.\" id=\"fig3\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 3\u003c/b>. visual evoked potential (vep) did not improve with ssri. \u003cb>(a)\u003c/b> p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. \u003cb>(b)\u003c/b> p100 latency improvement was not statistically significantly different between the ssri and placebo group.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all studies were evaluated as having a low risk of bias (\u003ca href=\"#tab2\">table 2\u003c/a>). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial (\u003ca href=\"#fig4\">figure 4\u003c/a>).\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">table 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" name=\"table2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" alt=\"www.frontiersin.org\" id=\"tab2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 2\u003c/b>. risk of bias summary for randomized studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 4\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" name=\"figure4\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" alt=\"funnel plot depicting standard error of mean difference (se[md]) on the y-axis versus mean difference (md) on the x-axis. points representing studies are scattered around a central vertical line, with dashed lines forming an inverted triangle indicating data distribution.\" id=\"fig4\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 4\u003c/b>. funnel plot for visual acuity improvement. there is no publication bias.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div> \u003ca id=\"h5\" name=\"h5\">\u003c/a>\n\u003ch2>discussion\u003c/h2>\n\u003cp class=\"mb15\">this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency.\u003c/p>\n\u003cp class=\"mb15\">current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic.\u003c/p>\n\u003cp class=\"mb15\">ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation (\u003ca href=\"#ref18\">18\u003c/a>). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia (\u003ca href=\"#ref19\">19\u003c/a>). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye (\u003ca href=\"#ref19\">19\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit (\u003ca href=\"#ref20\">20\u003c/a>). donepezil showed an improvement of the va in an open-label pilot study (\u003ca href=\"#ref21\">21\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods (\u003ca href=\"#ref11\">11\u003c/a>). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) whereas others did not (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans (\u003ca href=\"#ref22\">22\u003c/a>). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans (\u003ca href=\"#ref22\">22\u003c/a>). similarly, measuring of visual acuity in rodents and humans cannot be standardized (\u003ca href=\"#ref22\">22\u003c/a>). mitchell et al. (\u003ca href=\"#ref22\">22\u003c/a>) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans (\u003ca href=\"#ref22\">22\u003c/a>). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes (\u003ca href=\"#ref23\">23\u003c/a>). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) (\u003ca href=\"#ref24\">24\u003c/a>) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials (\u003ca href=\"#ref25\">25\u003c/a>&#x2013;\u003ca href=\"#ref27\">27\u003c/a>). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba (\u003ca href=\"#ref28\">28\u003c/a>), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes.\u003c/p>\n\u003cp class=\"mb15\">given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy (\u003ca href=\"#ref29\">29\u003c/a>), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven.\u003c/p>\n\u003cp class=\"mb15\">heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings.\u003c/p>\n\u003cp class=\"mb15\">to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature.\u003c/p>\n\u003cp class=\"mb15\">other modalities of treatment are also currently under research. extended-reality (xr) devices (\u003ca href=\"#ref30\">30\u003c/a>), physical activity (cycling) (\u003ca href=\"#ref31\">31\u003c/a>) and more recently the occlusion of the amblyopic eye combined with physical activity (\u003ca href=\"#ref32\">32\u003c/a>) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects.\u003c/p>\n\u003cp class=\"mb0\">in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial (\u003ca href=\"#ref16\">16\u003c/a>) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks.\u003c/p> \u003ca id=\"h6\" name=\"h6\">\u003c/a>\n\u003ch2>conclusion\u003c/h2>\n\u003cp class=\"mb0\">this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes.\u003c/p> \u003ca id=\"h7\" name=\"h7\">\u003c/a>\n\u003ch2>data availability statement\u003c/h2>\n\u003cp class=\"mb0\">the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.\u003c/p> \u003ca id=\"h8\" name=\"h8\">\u003c/a>\n\u003ch2>author contributions\u003c/h2>\n\u003cp class=\"mb0\">es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology.\u003c/p> \u003ca id=\"h9\" name=\"h9\">\u003c/a>\n\u003ch2>funding\u003c/h2>\n\u003cp class=\"mb0\">the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\\r1\\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z).\u003c/p> \u003ca id=\"h10\" name=\"h10\">\u003c/a>\n\u003ch2>conflict of interest\u003c/h2>\n\u003cp class=\"mb15\">the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003c/p>\n\u003cp class=\"mb15\">the handling editor gp declared a shared parent affiliation with the author oa at the time of review.\u003c/p>\n\u003cp class=\"mb0\">the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision.\u003c/p> \u003ca id=\"h11\" name=\"h11\">\u003c/a>\n\u003ch2>generative ai statement\u003c/h2>\n\u003cp class=\"mb0\">the authors declare that no gen ai was used in the creation of this manuscript.\u003c/p> \u003ca id=\"h12\" name=\"h12\">\u003c/a>\n\u003ch2>publisher&#x2019;s note\u003c/h2>\n\u003cp class=\"mb0\">all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003c/p> \u003ca id=\"h13\" name=\"h13\">\u003c/a>\n\u003ch2>author disclaimer\u003c/h2>\n\u003cp class=\"mb0\">the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care.\u003c/p> \u003ca id=\"h14\" name=\"h14\">\u003c/a>\n\u003ch2>references\u003c/h2>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref1\" id=\"ref1\">\u003c/a>1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. \u003ci>front pediatr\u003c/i>. (2022) 10:819998. doi: 10.3389/fped.2022.819998 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/35601430\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.3389/fped.2022.819998\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=b+hu&#x00026;author=z+liu&#x00026;author=j+zhao&#x00026;author=l+zeng&#x00026;author=g+hao&#x00026;author=d+shui&#x00026;publication_year=2022&#x00026;title=the+global+prevalence+of+amblyopia+in+children:+a+systematic+review+and+meta-analysis&#x00026;journal=front+pediatr&#x00026;volume=10&#x00026;pages=819998\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref2\" id=\"ref2\">\u003c/a>2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. \u003ci>rom j ophthalmol\u003c/i>. (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33367172\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.22336/rjo.2020.56\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mostafaie&#x00026;author=m+ghojazadeh&#x00026;author=h+hosseinifard&#x00026;author=h+manaflouyan&#x00026;author=f+farhadi&#x00026;author=n+taheri&#x00026;publication_year=2020&#x00026;title=a+systematic+review+of+amblyopia+prevalence+among+the+children+of+the+world&#x00026;journal=rom+j+ophthalmol&#x00026;volume=64&#x00026;pages=342-55\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref3\" id=\"ref3\">\u003c/a>3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. \u003ci>cereb cortex\u003c/i>. (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/16400161\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1093/cercor/bhj110\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=ku+jirmann&#x00026;author=v+vorobyov&#x00026;author=ut+eysel&#x00026;publication_year=2006&#x00026;title=strabismic+suppression+is+mediated+by+inhibitory+interactions+in+the+primary+visual+cortex&#x00026;journal=cereb+cortex&#x00026;volume=16&#x00026;pages=1750-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref4\" id=\"ref4\">\u003c/a>4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. \u003ci>j neurosci\u003c/i>. (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/7965083\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.14-11-06855.1994\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;author=pc+kind&#x00026;author=r+harrad&#x00026;publication_year=1994&#x00026;title=interocular+suppression+in+the+visual+cortex+of+strabismic+cats&#x00026;journal=j+neurosci&#x00026;volume=14&#x00026;pages=6855-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref5\" id=\"ref5\">\u003c/a>5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. \u003ci>eye\u003c/i>. (1996) 10:250&#x2013;8.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;publication_year=1996&#x00026;title=the+neural+basis+of+suppression+and+amblyopia+in+strabismus&#x00026;journal=eye&#x00026;volume=10&#x00026;pages=250-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref6\" id=\"ref6\">\u003c/a>6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. \u003ci>bmc ophthalmol\u003c/i>. (2020) 20:203. doi: 10.1186/s12886-020-01442-9 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/32450849\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1186/s12886-020-01442-9\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=y+li&#x00026;author=h+sun&#x00026;author=x+zhu&#x00026;author=y+su&#x00026;author=t+yu&#x00026;author=x+wu&#x00026;publication_year=2020&#x00026;title=efficacy+of+interventions+for+amblyopia:+a+systematic+review+and+network+meta-analysis&#x00026;journal=bmc+ophthalmol&#x00026;volume=20&#x00026;pages=203\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref7\" id=\"ref7\">\u003c/a>7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. \u003ci>optom vis sci\u003c/i>. (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19417699\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1097/opx.0b013e3181a7b3e5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mj+moseley&#x00026;author=ar+fielder&#x00026;author=ce+stewart&#x00026;publication_year=2009&#x00026;title=the+optical+treatment+of+amblyopia&#x00026;journal=optom+vis+sci&#x00026;volume=86&#x00026;pages=629-33\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref8\" id=\"ref8\">\u003c/a>8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. \u003ci>curr biol\u003c/i>. (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25247373\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2014.05.063\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;publication_year=2014&#x00026;title=plasticity+of+the+visual+cortex+and+treatment+of+amblyopia&#x00026;journal=curr+biol&#x00026;volume=24&#x00026;pages=r936-40\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref9\" id=\"ref9\">\u003c/a>9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. \u003ci>sci rep\u003c/i>. (2018) 8:12830. doi: 10.1038/s41598-018-31169-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30150750\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-018-31169-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=hj+huttunen&#x00026;author=jm+palva&#x00026;author=l+lindberg&#x00026;author=s+palva&#x00026;author=v+saarela&#x00026;author=e+karvonen&#x00026;publication_year=2018&#x00026;title=fluoxetine+does+not+enhance+the+effect+of+perceptual+learning+on+visual+function+in+adults+with+amblyopia&#x00026;journal=sci+rep&#x00026;volume=8&#x00026;pages=12830\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref10\" id=\"ref10\">\u003c/a>10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. \u003ci>j neurosci\u003c/i>. (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/21068299\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.4812-10.2010\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+bavelier&#x00026;author=dm+levi&#x00026;author=rw+li&#x00026;author=y+dan&#x00026;author=tk+hensch&#x00026;publication_year=2010&#x00026;title=removing+brakes+on+adult+brain+plasticity:+from+molecular+to+behavioral+interventions&#x00026;journal=j+neurosci&#x00026;volume=30&#x00026;pages=14964-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref11\" id=\"ref11\">\u003c/a>11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. \u003ci>science\u003c/i>. (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1126/science.1150516\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=m+vetencourt&#x00026;author=v+jf&#x00026;author=a+sale&#x00026;author=a+viegi&#x00026;author=l+baroncelli&#x00026;author=r+de+pasquale&#x00026;publication_year=2008&#x00026;title=the+antidepressant+fluoxetine+restores+plasticity+in+the+adult+visual+cortex&#x00026;journal=science&#x00026;volume=320&#x00026;pages=385-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref12\" id=\"ref12\">\u003c/a>12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. \u003ci>eye\u003c/i>. (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30783259\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41433-019-0360-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mh+sharif&#x00026;author=mr+talebnejad&#x00026;author=k+rastegar&#x00026;author=mr+khalili&#x00026;author=mh+nowroozzadeh&#x00026;publication_year=2019&#x00026;title=oral+fluoxetine+in+the+management+of+amblyopic+patients+aged+between+10+and+40+years+old:+a+randomized+clinical+trial&#x00026;journal=eye&#x00026;volume=33&#x00026;pages=1060-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref13\" id=\"ref13\">\u003c/a>13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. \u003ci>j aapos\u003c/i>. (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/39304030\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.jaapos.2024.104009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mirmohammadsadeghi&#x00026;author=a+mousavi&#x00026;author=mr+akbari&#x00026;author=h+khojasteh&#x00026;author=b+masoomian&#x00026;author=m+sadeghi&#x00026;publication_year=2024&#x00026;title=fluoxetine+as+a+possible+treatment+for+adult+amblyopia:+results+of+a+double-blind+randomized+placebo-controlled+trial&#x00026;journal=j+aapos&#x00026;volume=28&#x00026;pages=104009\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref14\" id=\"ref14\">\u003c/a>14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. \u003ci>neural plast\u003c/i>. (2019) 2019:5857243. doi: 10.1155/2019/5857243\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1155/2019/5857243\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ak+lagas&#x00026;author=jm+black&#x00026;author=br+russell&#x00026;author=rr+kydd&#x00026;author=b+thompson&#x00026;publication_year=2019&#x00026;title=the+effect+of+combined+patching+and+citalopram+on+visual+acuity+in+adults+with+amblyopia:+a+randomized+crossover+placebo-controlled+trial&#x00026;journal=neural+plast&#x00026;volume=2019&#x00026;pages=5857243\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref15\" id=\"ref15\">\u003c/a>15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. \u003ci>bmj\u003c/i>. (2009) 339:b2535. doi: 10.1136/bmj.b2535 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19622551\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.b2535\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+moher&#x00026;author=a+liberati&#x00026;author=j+tetzlaff&#x00026;author=dg+altman&#x00026;publication_year=2009&#x00026;title=preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+the+prisma+statement&#x00026;journal=bmj&#x00026;volume=339&#x00026;pages=b2535\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref16\" id=\"ref16\">\u003c/a>16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2019) 366:l4898. doi: 10.1136/bmj.l4898 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/31462531\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.l4898\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jac+sterne&#x00026;author=j+savovi&#x0107;&#x00026;author=mj+page&#x00026;author=rg+elbers&#x00026;author=ns+blencowe&#x00026;author=i+boutron&#x00026;publication_year=2019&#x00026;title=rob+2:+a+revised+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=366&#x00026;pages=l4898\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref17\" id=\"ref17\">\u003c/a>17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2011) 343:d5928. doi: 10.1136/bmj.d5928 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/22008217\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.d5928\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jpt+higgins&#x00026;author=dg+altman&#x00026;author=pc+g&#x000f8;tzsche&#x00026;author=p+j&#x000fc;ni&#x00026;author=d+moher&#x00026;author=ad+oxman&#x00026;publication_year=2011&#x00026;title=the+cochrane+collaboration&#x2019;s+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=343&#x00026;pages=d5928\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref18\" id=\"ref18\">\u003c/a>18. feighner, jp. mechanism of action of antidepressant medications. \u003ci>j clin psychiatry\u003c/i>. (1999) 60:4&#x2013;11.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=jp+feighner&#x00026;publication_year=1999&#x00026;title=mechanism+of+action+of+antidepressant+medications&#x00026;journal=j+clin+psychiatry&#x00026;volume=60&#x00026;pages=4-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref19\" id=\"ref19\">\u003c/a>19. morishita, h, and hensch, tk. critical period revisited: impact on vision. \u003ci>curr opin neurobiol\u003c/i>. (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/18534841\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.conb.2008.05.009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+morishita&#x00026;author=tk+hensch&#x00026;publication_year=2008&#x00026;title=critical+period+revisited:+impact+on+vision&#x00026;journal=curr+opin+neurobiol&#x00026;volume=18&#x00026;pages=101-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref20\" id=\"ref20\">\u003c/a>20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. \u003ci>ophthalmology\u003c/i>. (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25676904\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.ophtha.2015.01.002\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mx+repka&#x00026;author=rt+kraker&#x00026;author=tw+dean&#x00026;author=rw+beck&#x00026;author=rm+siatkowski&#x00026;publication_year=2015&#x00026;title=a+randomized+trial+of+levodopa+as+treatment+for+residual+amblyopia+in+older+children&#x00026;journal=ophthalmology&#x00026;volume=122&#x00026;pages=874-81\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref21\" id=\"ref21\">\u003c/a>21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. \u003ci>sci rep\u003c/i>. (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37349338\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-023-34891-5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+wu&#x00026;author=ed+gaier&#x00026;author=br+nihalani&#x00026;author=s+whitecross&#x00026;author=tk+hensch&#x00026;author=dg+hunter&#x00026;publication_year=2023&#x00026;title=durable+recovery+from+amblyopia+with+donepezil&#x00026;journal=sci+rep&#x00026;volume=13&#x00026;pages=10161\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref22\" id=\"ref22\">\u003c/a>22. mitchell, d, and sengpiel, f. animal models of amblyopia. \u003ci>vis neurosci\u003c/i>. (2018) 35:e017. doi: 10.1017/s0952523817000244 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/29905121\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1017/s0952523817000244\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+mitchell&#x00026;author=f+sengpiel&#x00026;publication_year=2018&#x00026;title=animal+models+of+amblyopia&#x00026;journal=vis+neurosci&#x00026;volume=35&#x00026;pages=e017\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref23\" id=\"ref23\">\u003c/a>23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). \u003ci>doc ophthalmol\u003c/i>. (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/27443562\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s10633-016-9553-y\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jv+odom&#x00026;author=m+bach&#x00026;author=m+brigell&#x00026;author=ge+holder&#x00026;author=dl+mcculloch&#x00026;author=a+mizota&#x00026;publication_year=2016&#x00026;title=iscev+standard+for+clinical+visual+evoked+potentials:+(2016+update)&#x00026;journal=doc+ophthalmol&#x00026;volume=133&#x00026;pages=1-9\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref24\" id=\"ref24\">\u003c/a>24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. \u003ci>brain struct funct\u003c/i>. (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33900453\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s00429-021-02273-0\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=h+bridge&#x00026;publication_year=2022&#x00026;title=investigating+the+neurochemistry+of+the+human+visual+system+using+magnetic+resonance+spectroscopy&#x00026;journal=brain+struct+funct&#x00026;volume=227&#x00026;pages=1491-505\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref25\" id=\"ref25\">\u003c/a>25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. \u003ci>imaging neurosci.\u003c/i> (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40110226\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1162/imag_a_00256\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=wt+clarke&#x00026;author=a+wyllie&#x00026;author=k+tracey&#x00026;author=j+matuszewski&#x00026;author=s+jbabdi&#x00026;publication_year=2024&#x00026;title=the+relationship+between+visual+acuity+loss+and+gabaergic+inhibition+in+amblyopia&#x00026;journal=imaging+neurosci.&#x00026;volume=2&#x00026;pages=1-18\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref26\" id=\"ref26\">\u003c/a>26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. \u003ci>perception\u003c/i>. (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37272064\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1177/03010066231178664\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+bridge&#x00026;author=ib+ip&#x00026;author=aj+parker&#x00026;publication_year=2023&#x00026;title=investigating+the+human+binocular+visual+system+using+multi-modal+magnetic+resonance+imaging&#x00026;journal=perception&#x00026;volume=52&#x00026;pages=441-58\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref27\" id=\"ref27\">\u003c/a>27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. \u003ci>front hum neurosci\u003c/i>. (2022) 16:949395. doi: 10.3389/fnhum.2022.949395\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.3389/fnhum.2022.949395\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mukerji&#x00026;author=kn+byrne&#x00026;author=e+yang&#x00026;author=dm+levi&#x00026;author=ma+silver&#x00026;publication_year=2022&#x00026;title=visual+cortical+&#x03b3;&#x02212;aminobutyric+acid+and+perceptual+suppression+in+amblyopia&#x00026;journal=front+hum+neurosci&#x00026;volume=16&#x00026;pages=949395\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref28\" id=\"ref28\">\u003c/a>28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: \u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26004760/\">https://pubmed.ncbi.nlm.nih.gov/26004760/\u003c/a>\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?publication_year=2025&#x00026;\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref29\" id=\"ref29\">\u003c/a>29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. \u003ci>strabismus\u003c/i>. (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40226898\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1080/09273972.2025.2478078\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+chedid&#x00026;author=m+fronius&#x00026;author=y+wenner&#x00026;author=l+cirina&#x00026;author=t+kohnen&#x00026;author=c+kuhli-hattenbach&#x00026;publication_year=2025&#x00026;title=optical+coherence+tomography+(oct)+parameters+in+amblyopia&#x00026;journal=strabismus&#x00026;volume=1&#x2013;11&#x00026;pages=1-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref30\" id=\"ref30\">\u003c/a>30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. \u003ci>j vis\u003c/i>. (2023) 23:14. doi: 10.1167/jov.23.1.14 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/36662501\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1167/jov.23.1.14\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=dm+levi&#x00026;publication_year=2023&#x00026;title=applications+and+implications+for+extended+reality+to+improve+binocular+vision+and+stereopsis&#x00026;journal=j+vis&#x00026;volume=23&#x00026;pages=14\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref31\" id=\"ref31\">\u003c/a>31. lunghi, c, and sale, a. a cycling lane for brain rewiring. \u003ci>curr biol\u003c/i>. (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26654367\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2015.10.026\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=a+sale&#x00026;publication_year=2015&#x00026;title=a+cycling+lane+for+brain+rewiring&#x00026;journal=curr+biol&#x00026;volume=25&#x00026;pages=r1122-3\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref32\" id=\"ref32\">\u003c/a>32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. \u003ci>annal. clin. transl. neurol.\u003c/i> (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30847360\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1002/acn3.698\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=at+sframeli&#x00026;author=a+lepri&#x00026;author=m+lepri&#x00026;author=d+lisi&#x00026;author=a+sale&#x00026;publication_year=2019&#x00026;title=a+new+counterintuitive+training+for+adult+amblyopia&#x00026;journal=annal.+clin.+transl.+neurol.&#x00026;volume=6&#x00026;pages=274-84\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003c/div> \u003cdiv class=\"thinlinem20\">\u003c/div> \u003cdiv class=\"abstractsummary\">\n\u003cp>\u003cspan>keywords:\u003c/span> amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity\u003c/p>\n\u003cp>\u003cspan>citation:\u003c/span> shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. \u003ci>front. neurol\u003c/i>. 16:1639913. doi: 10.3389/fneur.2025.1639913\u003c/p>\n\u003cp class=\"timestamps\">\u003cspan>received:\u003c/span> 03 june 2025; \u003cspan>accepted:\u003c/span> 31 july 2025;\u003cbr> \u003cspan>published:\u003c/span> 21 august 2025.\u003c/p> \u003cdiv>\n\u003cp>edited by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/2271562/overview\">gordon plant\u003c/a>, university college london, united kingdom\u003c/div> \u003cdiv>\n\u003cp>reviewed by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/1863925/overview\">sara samadzadeh\u003c/a>, charit&#x00e9; university medicine berlin, germany\u003cbr> \u003ca href=\"https://loop.frontiersin.org/people/870962/overview\">alistair r. fielder\u003c/a>, city university of london, united kingdom\u003c/div>\n\u003cp>\u003cspan>copyright\u003c/span> &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">creative commons attribution license (cc by)\u003c/a>. the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms.\u003c/p>\n\u003cp>\u003cspan>&#x0002a;correspondence:\u003c/span> i. betina ip, \u003ca id=\"encmail\">ymv0aw5hlmlwqg5ky24ub3guywmudws=\u003c/a>\u003c/p>\n\u003cp>\u003cspan>\u003csup>&#x2020;\u003c/sup>\u003c/span>these authors share senior authorship\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div>","\u003cul class=\"flyoutjournal\"> \u003cli>\u003ca href=\"#h1\">abstract\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h2\">introduction\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h3\">methods\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h4\">results\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h5\">discussion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h6\">conclusion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h7\">data availability statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h8\">author contributions\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h9\">funding\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h10\">conflict of interest\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h11\">generative ai statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h12\">publisher&#x2019;s note\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h13\">author disclaimer\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h14\">references\u003c/a>\u003c/li> \u003c/ul>",[719,725,731],{"name":720,"fileserverpackageentryid":19,"fileserverid":721,"fileserverversionnumber":439,"type":722},"epub.epub","1639913/epub",{"code":723,"name":724},"epub","epub",{"name":726,"fileserverpackageentryid":19,"fileserverid":727,"fileserverversionnumber":439,"type":728},"publishers-proof.pdf","1639913/publishers-proof",{"code":729,"name":730},"pdf","pdf",{"name":732,"fileserverpackageentryid":733,"fileserverid":734,"fileserverversionnumber":439,"type":735},"fneur-16-1639913.xml","fneur-16-1639913/fneur-16-1639913.xml","1639913/xml",{"code":736,"name":737},"nlm_xml","xml","v3",{"title":740,"link":741,"meta":745,"script":869},"frontiers | selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials",[742],{"rel":743,"href":744},"canonical","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/full",[746,749,752,754,757,761,764,768,771,774,777,779,781,783,785,787,790,793,795,798,800,802,805,808,811,814,817,821,825,828,831,834,837,840,843,846,849,852,855,858,861,864,866],{"hid":747,"property":747,"name":747,"content":748},"description","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in ea...",{"hid":750,"property":750,"name":751,"content":740},"og:title","title",{"hid":753,"property":753,"name":747,"content":748},"og:description",{"hid":755,"name":755,"content":756},"keywords","strabismus,neuroplasticity,amblyopia,fluoxetine,ssris,anisometropia,citalopram",{"hid":758,"property":758,"name":759,"content":760},"og:site_name","site_name","frontiers",{"hid":762,"property":762,"name":432,"content":763},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg",{"hid":765,"property":765,"name":766,"content":767},"og:type","type","article",{"hid":769,"property":769,"name":770,"content":744},"og:url","url",{"hid":772,"name":772,"content":773},"twitter:card","summary_large_image",{"hid":775,"name":775,"content":776},"citation_volume","16",{"hid":778,"name":778,"content":116},"citation_journal_title",{"hid":780,"name":780,"content":760},"citation_publisher",{"hid":782,"name":782,"content":700},"citation_journal_abbrev",{"hid":784,"name":784,"content":701},"citation_issn",{"hid":786,"name":786,"content":583},"citation_doi",{"hid":788,"name":788,"content":789},"citation_firstpage","1639913",{"hid":791,"name":791,"content":792},"citation_language","english",{"hid":794,"name":794,"content":584},"citation_title",{"hid":796,"name":796,"content":797},"citation_keywords","strabismus; neuroplasticity; amblyopia; fluoxetine; ssris; anisometropia; citalopram",{"hid":799,"name":799,"content":589},"citation_abstract",{"hid":801,"name":801,"content":598},"citation_article_type",{"hid":803,"name":803,"content":804},"citation_pdf_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/pdf",{"hid":806,"name":806,"content":807},"citation_xml_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/xml",{"hid":809,"name":809,"content":810},"citation_fulltext_world_readable","yes",{"hid":812,"name":812,"content":813},"citation_online_date","2025/07/31",{"hid":815,"name":815,"content":816},"citation_publication_date","2025/08/21",{"hid":818,"name":819,"content":820},"citation_author_0","citation_author","shamsher, ehtesham ",{"hid":822,"name":823,"content":824},"citation_author_institution_0","citation_author_institution","oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, united kingdom",{"hid":826,"name":819,"content":827},"citation_author_1","saccaro, luisa ",{"hid":829,"name":823,"content":830},"citation_author_institution_1","faculty of medicine, universidade de mogi das cruzes, brazil",{"hid":832,"name":819,"content":833},"citation_author_2","pungirum, victor barreiros ",{"hid":835,"name":823,"content":836},"citation_author_institution_2","faculty of medical sciences, university of buenos aires, argentina",{"hid":838,"name":819,"content":839},"citation_author_3","tran, nghi bao ",{"hid":841,"name":823,"content":842},"citation_author_institution_3","faculty of medicine, university of debrecen, hungary",{"hid":844,"name":819,"content":845},"citation_author_4","alghaith, omar a. h. a. ",{"hid":847,"name":823,"content":848},"citation_author_institution_4","institute of ophthalmology, university college london, united kingdom",{"hid":850,"name":819,"content":851},"citation_author_5","khabazianzadeh, fatemeh ",{"hid":853,"name":823,"content":854},"citation_author_institution_5","eye research center, khatam-al-anbia hospital, mashad university of medical sciences, iran",{"hid":856,"name":819,"content":857},"citation_author_6","bridge, holly ",{"hid":859,"name":823,"content":860},"citation_author_institution_6","nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, united kingdom",{"hid":862,"name":819,"content":863},"citation_author_7","ip, i. betina ",{"hid":865,"name":823,"content":860},"citation_author_institution_7",{"hid":867,"name":867,"content":868},"dc.identifier","doi:10.3389/fneur.2025.1639913",[870,873,875,877,879],{"src":871,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":874,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/mathjax.js?config=tex-mml-am_chtml",{"src":876,"body":13,"type":872,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":878,"body":13,"type":872,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1639913?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":880,"body":13,"type":872,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articlehubslug":19,"articlehubpage":882,"articlehubarticleslist":883,"canjournalhasarticlehub":379,"articledoilist":884},{},[],[],{"title":19,"image":-1,"breadcrumbs":886,"linkscollection":887,"metricscollection":889},[],{"total":436,"items":888},[],{"total":436,"items":890},[]] window.__nuxt__={};window.__nuxt__.config={public:{isdevmode:false,appname:"article-pages-2024",baseurl:"https://www.frontiersin.org",domain:"frontiersin.org",loopurl:"https://loop.frontiersin.org",ssmaindomain:"frontiersin.org",contentfulurl:"https://graphql.contentful.com/content/v1/spaces",spaceid:1,spacename:"frontiers",livespaceid:1,tenantlogourl:"",frontiersgraphurl:"https://apollo-federation-gateway.frontiersin.org",registrationapiurl:"https://onboarding-ui.frontiersin.org",emaildigestapiurl:"https://api-email-digest.frontiersin.org",journalfilesapiurl:"https://files-journal-api.frontiersin.org",searchapiurl:"https://search-api.frontiersin.org",productionforumapiurl:"https://production-forum-api-v2.frontiersin.org",gtmserverurl:"https://tag-manager.frontiersin.org",gtmid:"gtm-m322fv2",gtmauth:"owvbwxfajr21yqv1fe1caq",gtmpreview:"env-1",figsharepluginurl:"https://widgets.figshare.com/static/figshare.js",figshareapiurl:"https://api.figshare.com/v2/collections/search",figsharetimeout:3000,crossmarkpublisheddate:"2015/08/24",googlerecaptchasitekey:"6ldg3i0uaaaaaoc4quh35ubhgjotehp_stxhgr_v",googlerecaptchakeyname:"frontiersrecaptchav2",faviconsize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantfavicon-frontiers.png",faviconsize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantfavicon-frontiers.png",faviconsize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantfavicon-frontiers.png",faviconsize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantfavicon-frontiers.png",faviconsize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantfavicon-frontiers.png",socialmediaimg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/guidelines-frontiers_logo_1200x628_1-91to1.png",linkedarticlecopytext:"'{\"articletypecopytext\":[{\"articletypeid\":0,\"originalarticlecopytext\":\"part of this article's content has been mentioned in:\",\"linkedarticlecopytext\":\"this article mentions parts of:\"},{\"articletypeid\":122,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an erratum on:\"},{\"articletypeid\":129,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an addendum to:\"},{\"articletypeid\":128,\"originalarticlecopytext\":\"a correction has been applied to this article in:\",\"linkedarticlecopytext\":\"this article is a correction to:\"},{\"articletypeid\":134,\"originalarticlecopytext\":\"a retraction of this article was approved in:\",\"linkedarticlecopytext\":\"this article is a retraction of:\"},{\"articletypeid\":29,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"},{\"articletypeid\":30,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"}],\"articleidcopytext\":[]}'\n",acceptedarticleexcludedjournalids:"'[2766,979]'\n",articletypeconfigurablelabel:"\u003c\u003carticle-type:uppercase>> article",settingsfeaturesswitchers:"'{\"displaytitlepilllabels\":true,\"displayrelatedarticlesbox\":true,\"showeditors\":true,\"showreviewers\":true,\"showloopimpactlink\":true,\"enablefigshare\":false,\"usexmlimages\":true}'\n",journalswitharticlehub:"'{\"strings\":[\"science\"]}'\n",terminologysettings:"'{\"terms\":[{\"sequencenumber\":1,\"key\":\"frontiers\",\"tenantterm\":\"frontiers\",\"frontiersdefaultterm\":\"frontiers\",\"category\":\"customer\"},{\"sequencenumber\":2,\"key\":\"submission_system\",\"tenantterm\":\"submission system\",\"frontiersdefaultterm\":\"submission system\",\"category\":\"product\"},{\"sequencenumber\":3,\"key\":\"public_pages\",\"tenantterm\":\"public pages\",\"frontiersdefaultterm\":\"public pages\",\"category\":\"product\"},{\"sequencenumber\":4,\"key\":\"my_frontiers\",\"tenantterm\":\"my frontiers\",\"frontiersdefaultterm\":\"my frontiers\",\"category\":\"product\"},{\"sequencenumber\":5,\"key\":\"digital_editorial_office\",\"tenantterm\":\"digital editorial office\",\"frontiersdefaultterm\":\"digital editorial office\",\"category\":\"product\"},{\"sequencenumber\":6,\"key\":\"deo\",\"tenantterm\":\"deo\",\"frontiersdefaultterm\":\"deo\",\"category\":\"product\"},{\"sequencenumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantterm\":\"digital editorial office for chiefs\",\"frontiersdefaultterm\":\"digital editorial office for chiefs\",\"category\":\"product\"},{\"sequencenumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantterm\":\"digital editorial office for eof\",\"frontiersdefaultterm\":\"digital editorial office for eof\",\"category\":\"product\"},{\"sequencenumber\":9,\"key\":\"editorial_office\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"product\"},{\"sequencenumber\":10,\"key\":\"eof\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"product\"},{\"sequencenumber\":11,\"key\":\"research_topic_management\",\"tenantterm\":\"research topic management\",\"frontiersdefaultterm\":\"research topic management\",\"category\":\"product\"},{\"sequencenumber\":12,\"key\":\"review_forum\",\"tenantterm\":\"review forum\",\"frontiersdefaultterm\":\"review forum\",\"category\":\"product\"},{\"sequencenumber\":13,\"key\":\"accounting_office\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"product\"},{\"sequencenumber\":14,\"key\":\"aof\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"product\"},{\"sequencenumber\":15,\"key\":\"publishing_office\",\"tenantterm\":\"publishing office\",\"frontiersdefaultterm\":\"publishing office\",\"category\":\"product\"},{\"sequencenumber\":16,\"key\":\"production_office\",\"tenantterm\":\"production office forum\",\"frontiersdefaultterm\":\"production office forum\",\"category\":\"product\"},{\"sequencenumber\":17,\"key\":\"pof\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"product\"},{\"sequencenumber\":18,\"key\":\"book_office_forum\",\"tenantterm\":\"book office forum\",\"frontiersdefaultterm\":\"book office forum\",\"category\":\"product\"},{\"sequencenumber\":19,\"key\":\"bof\",\"tenantterm\":\"bof\",\"frontiersdefaultterm\":\"bof\",\"category\":\"product\"},{\"sequencenumber\":20,\"key\":\"aira\",\"tenantterm\":\"aira\",\"frontiersdefaultterm\":\"aira\",\"category\":\"product\"},{\"sequencenumber\":21,\"key\":\"editorial_board_management\",\"tenantterm\":\"editorial board management\",\"frontiersdefaultterm\":\"editorial board management\",\"category\":\"product\"},{\"sequencenumber\":22,\"key\":\"ebm\",\"tenantterm\":\"ebm\",\"frontiersdefaultterm\":\"ebm\",\"category\":\"product\"},{\"sequencenumber\":23,\"key\":\"domain\",\"tenantterm\":\"domain\",\"frontiersdefaultterm\":\"domain\",\"category\":\"taxonomy\"},{\"sequencenumber\":24,\"key\":\"journal\",\"tenantterm\":\"journal\",\"frontiersdefaultterm\":\"journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":25,\"key\":\"section\",\"tenantterm\":\"section\",\"frontiersdefaultterm\":\"section\",\"category\":\"taxonomy\"},{\"sequencenumber\":26,\"key\":\"domains\",\"tenantterm\":\"domains\",\"frontiersdefaultterm\":\"domains\",\"category\":\"taxonomy\"},{\"sequencenumber\":27,\"key\":\"specialty_section\",\"tenantterm\":\"specialty section\",\"frontiersdefaultterm\":\"specialty section\",\"category\":\"taxonomy\"},{\"sequencenumber\":28,\"key\":\"specialty_journal\",\"tenantterm\":\"specialty journal\",\"frontiersdefaultterm\":\"specialty journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":29,\"key\":\"journals\",\"tenantterm\":\"journals\",\"frontiersdefaultterm\":\"journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":30,\"key\":\"sections\",\"tenantterm\":\"sections\",\"frontiersdefaultterm\":\"sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":31,\"key\":\"specialty_sections\",\"tenantterm\":\"specialty sections\",\"frontiersdefaultterm\":\"specialty sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":32,\"key\":\"specialty_journals\",\"tenantterm\":\"specialty journals\",\"frontiersdefaultterm\":\"specialty journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":33,\"key\":\"manuscript\",\"tenantterm\":\"manuscript\",\"frontiersdefaultterm\":\"manuscript\",\"category\":\"core\"},{\"sequencenumber\":34,\"key\":\"manuscripts\",\"tenantterm\":\"manuscripts\",\"frontiersdefaultterm\":\"manuscripts\",\"category\":\"core\"},{\"sequencenumber\":35,\"key\":\"article\",\"tenantterm\":\"article\",\"frontiersdefaultterm\":\"article\",\"category\":\"core\"},{\"sequencenumber\":36,\"key\":\"articles\",\"tenantterm\":\"articles\",\"frontiersdefaultterm\":\"articles\",\"category\":\"core\"},{\"sequencenumber\":37,\"key\":\"article_type\",\"tenantterm\":\"article type\",\"frontiersdefaultterm\":\"article type\",\"category\":\"core\"},{\"sequencenumber\":38,\"key\":\"article_types\",\"tenantterm\":\"article types\",\"frontiersdefaultterm\":\"article types\",\"category\":\"core\"},{\"sequencenumber\":39,\"key\":\"author\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":40,\"key\":\"authors\",\"tenantterm\":\"authors\",\"frontiersdefaultterm\":\"authors\",\"category\":\"label (role)\"},{\"sequencenumber\":41,\"key\":\"authoring\",\"tenantterm\":\"authoring\",\"frontiersdefaultterm\":\"authoring\",\"category\":\"core\"},{\"sequencenumber\":42,\"key\":\"authored\",\"tenantterm\":\"authored\",\"frontiersdefaultterm\":\"authored\",\"category\":\"core\"},{\"sequencenumber\":43,\"key\":\"accept\",\"tenantterm\":\"accept\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":44,\"key\":\"accepted\",\"tenantterm\":\"accepted\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"description\":\"an editorial role on a field journal that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantterm\":\"assistant specialty chief editors\",\"frontiersdefaultterm\":\"assistant specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":48,\"key\":\"associate_editor\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":49,\"key\":\"specialty_chief_editor\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":50,\"key\":\"specialty_chief_editors\",\"tenantterm\":\"specialty chief editors\",\"frontiersdefaultterm\":\"specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":51,\"key\":\"chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":52,\"key\":\"chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":53,\"key\":\"call_for_participation\",\"tenantterm\":\"call for participation\",\"frontiersdefaultterm\":\"call for participation\",\"category\":\"process\"},{\"sequencenumber\":54,\"key\":\"citation\",\"tenantterm\":\"citation\",\"frontiersdefaultterm\":\"citation\",\"category\":\"misc.\"},{\"sequencenumber\":55,\"key\":\"citations\",\"tenantterm\":\"citations\",\"frontiersdefaultterm\":\"citations\",\"category\":\"misc.\"},{\"sequencenumber\":56,\"key\":\"contributor\",\"tenantterm\":\"contributor\",\"frontiersdefaultterm\":\"contributor\",\"category\":\"label (role)\"},{\"sequencenumber\":57,\"key\":\"contributors\",\"tenantterm\":\"contributors\",\"frontiersdefaultterm\":\"contributors\",\"category\":\"label (role)\"},{\"sequencenumber\":58,\"key\":\"corresponding_author\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":59,\"key\":\"corresponding_authors\",\"tenantterm\":\"corresponding authors\",\"frontiersdefaultterm\":\"corresponding authors\",\"category\":\"label (role)\"},{\"sequencenumber\":60,\"key\":\"decline\",\"tenantterm\":\"decline\",\"frontiersdefaultterm\":\"decline\",\"category\":\"process\"},{\"sequencenumber\":61,\"key\":\"declined\",\"tenantterm\":\"declined\",\"frontiersdefaultterm\":\"declined\",\"category\":\"process\"},{\"sequencenumber\":62,\"key\":\"reject\",\"tenantterm\":\"reject\",\"frontiersdefaultterm\":\"reject\",\"category\":\"process\"},{\"sequencenumber\":63,\"key\":\"rejected\",\"tenantterm\":\"rejected\",\"frontiersdefaultterm\":\"rejected\",\"category\":\"process\"},{\"sequencenumber\":64,\"key\":\"publish\",\"tenantterm\":\"publish\",\"frontiersdefaultterm\":\"publish\",\"category\":\"core\"},{\"sequencenumber\":65,\"key\":\"published\",\"tenantterm\":\"published\",\"frontiersdefaultterm\":\"published\",\"category\":\"core\"},{\"sequencenumber\":66,\"key\":\"publication\",\"tenantterm\":\"publication\",\"frontiersdefaultterm\":\"publication\",\"category\":\"core\"},{\"sequencenumber\":67,\"key\":\"peer_review\",\"tenantterm\":\"peer review\",\"frontiersdefaultterm\":\"peer review\",\"category\":\"peer review process\"},{\"sequencenumber\":68,\"key\":\"peer_reviewed\",\"tenantterm\":\"peer reviewed\",\"frontiersdefaultterm\":\"peer reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":69,\"key\":\"initial_validation\",\"tenantterm\":\"initial validation\",\"frontiersdefaultterm\":\"initial validation\",\"category\":\"peer review process\"},{\"sequencenumber\":70,\"key\":\"editorial_assignment\",\"tenantterm\":\"editorial assignment\",\"frontiersdefaultterm\":\"editorial assignment\",\"category\":\"peer review process\"},{\"sequencenumber\":71,\"key\":\"independent_review\",\"tenantterm\":\"independent review\",\"frontiersdefaultterm\":\"independent review\",\"category\":\"peer review process\"},{\"sequencenumber\":72,\"key\":\"interactive_review\",\"tenantterm\":\"interactive review\",\"frontiersdefaultterm\":\"interactive review\",\"category\":\"peer review process\"},{\"sequencenumber\":73,\"key\":\"review\",\"tenantterm\":\"review\",\"frontiersdefaultterm\":\"review\",\"category\":\"peer review process\"},{\"sequencenumber\":74,\"key\":\"reviewing\",\"tenantterm\":\"reviewing\",\"frontiersdefaultterm\":\"reviewing\",\"category\":\"peer review process\"},{\"sequencenumber\":75,\"key\":\"reviewer\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":76,\"key\":\"reviewers\",\"tenantterm\":\"reviewers\",\"frontiersdefaultterm\":\"reviewers\",\"category\":\"label (role)\"},{\"sequencenumber\":77,\"key\":\"review_finalized\",\"tenantterm\":\"review finalized\",\"frontiersdefaultterm\":\"review finalized\",\"category\":\"peer review process\"},{\"sequencenumber\":78,\"key\":\"final_decision\",\"tenantterm\":\"final decision\",\"frontiersdefaultterm\":\"final decision\",\"category\":\"peer review process\"},{\"sequencenumber\":79,\"key\":\"final_validation\",\"tenantterm\":\"final validation\",\"frontiersdefaultterm\":\"final validation\",\"category\":\"peer review process\"},{\"sequencenumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantterm\":\"recommend to accept manuscript\",\"frontiersdefaultterm\":\"accept manuscript\",\"category\":\"process\"},{\"sequencenumber\":81,\"key\":\"fee\",\"tenantterm\":\"fee\",\"frontiersdefaultterm\":\"fee\",\"category\":\"accounting\"},{\"sequencenumber\":82,\"key\":\"fees\",\"tenantterm\":\"fees\",\"frontiersdefaultterm\":\"fees\",\"category\":\"accounting\"},{\"sequencenumber\":83,\"key\":\"guest_associate_editor\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":84,\"key\":\"guest_associate_editors\",\"tenantterm\":\"guest associate editors\",\"frontiersdefaultterm\":\"guest associate editors\",\"category\":\"label (role)\"},{\"sequencenumber\":85,\"key\":\"in_review\",\"tenantterm\":\"in review\",\"frontiersdefaultterm\":\"in review\",\"category\":\"peer review process\"},{\"sequencenumber\":86,\"key\":\"institutional_member\",\"tenantterm\":\"institutional partner\",\"frontiersdefaultterm\":\"institutional partner\",\"category\":\"accounting\"},{\"sequencenumber\":87,\"key\":\"institutional_membership\",\"tenantterm\":\"institutional partnership\",\"frontiersdefaultterm\":\"institutional partnership\",\"category\":\"accounting\"},{\"sequencenumber\":88,\"key\":\"article_processing_charge\",\"tenantterm\":\"article processing charge\",\"frontiersdefaultterm\":\"article processing charge\",\"category\":\"accounting\"},{\"sequencenumber\":89,\"key\":\"article_processing_charges\",\"tenantterm\":\"article processing charges\",\"frontiersdefaultterm\":\"article processing charges\",\"category\":\"accounting\"},{\"sequencenumber\":90,\"key\":\"apcs\",\"tenantterm\":\"apcs\",\"frontiersdefaultterm\":\"apcs\",\"category\":\"accounting\"},{\"sequencenumber\":91,\"key\":\"apc\",\"tenantterm\":\"apc\",\"frontiersdefaultterm\":\"apc\",\"category\":\"accounting\"},{\"sequencenumber\":92,\"key\":\"received\",\"tenantterm\":\"received\",\"frontiersdefaultterm\":\"received\",\"description\":\"date manuscript was received on.\",\"category\":\"core\"},{\"sequencenumber\":93,\"key\":\"transferred\",\"tenantterm\":\"transferred\",\"frontiersdefaultterm\":\"transferred\",\"category\":\"core\"},{\"sequencenumber\":94,\"key\":\"transfer\",\"tenantterm\":\"transfer\",\"frontiersdefaultterm\":\"transfer\",\"category\":\"core\"},{\"sequencenumber\":95,\"key\":\"research_topic\",\"tenantterm\":\"research topic\",\"frontiersdefaultterm\":\"research topic\",\"category\":\"core\"},{\"sequencenumber\":96,\"key\":\"research_topics\",\"tenantterm\":\"research topics\",\"frontiersdefaultterm\":\"research topics\",\"category\":\"core\"},{\"sequencenumber\":97,\"key\":\"topic_editor\",\"tenantterm\":\"topic editor\",\"frontiersdefaultterm\":\"topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":98,\"key\":\"review_editor\",\"tenantterm\":\"community reviewer\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":99,\"key\":\"title\",\"tenantterm\":\"title\",\"frontiersdefaultterm\":\"title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":100,\"key\":\"running_title\",\"tenantterm\":\"running title\",\"frontiersdefaultterm\":\"running title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":101,\"key\":\"submit\",\"tenantterm\":\"submit\",\"frontiersdefaultterm\":\"submit\",\"category\":\"process\"},{\"sequencenumber\":102,\"key\":\"submitted\",\"tenantterm\":\"submitted\",\"frontiersdefaultterm\":\"submitted\",\"category\":\"process\"},{\"sequencenumber\":103,\"key\":\"submitting\",\"tenantterm\":\"submitting\",\"frontiersdefaultterm\":\"submitting\",\"category\":\"process\"},{\"sequencenumber\":104,\"key\":\"t_e\",\"tenantterm\":\"te\",\"frontiersdefaultterm\":\"te\",\"category\":\"label (role)\"},{\"sequencenumber\":105,\"key\":\"topic\",\"tenantterm\":\"topic\",\"frontiersdefaultterm\":\"topic\",\"category\":\"process\"},{\"sequencenumber\":106,\"key\":\"topic_summary\",\"tenantterm\":\"topic summary\",\"frontiersdefaultterm\":\"topic summary\",\"category\":\"process\"},{\"sequencenumber\":107,\"key\":\"figure\",\"tenantterm\":\"figure\",\"frontiersdefaultterm\":\"figure\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":108,\"key\":\"figures\",\"tenantterm\":\"figures\",\"frontiersdefaultterm\":\"figures\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":109,\"key\":\"editorial_file\",\"tenantterm\":\"editorial file\",\"frontiersdefaultterm\":\"editorial file\",\"category\":\"core\"},{\"sequencenumber\":110,\"key\":\"editorial_files\",\"tenantterm\":\"editorial files\",\"frontiersdefaultterm\":\"editorial files\",\"category\":\"core\"},{\"sequencenumber\":111,\"key\":\"e_book\",\"tenantterm\":\"e-book\",\"frontiersdefaultterm\":\"e-book\",\"category\":\"core\"},{\"sequencenumber\":112,\"key\":\"organization\",\"tenantterm\":\"organization\",\"frontiersdefaultterm\":\"organization\",\"category\":\"core\"},{\"sequencenumber\":113,\"key\":\"institution\",\"tenantterm\":\"institution\",\"frontiersdefaultterm\":\"institution\",\"category\":\"core\"},{\"sequencenumber\":114,\"key\":\"reference\",\"tenantterm\":\"reference\",\"frontiersdefaultterm\":\"reference\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":115,\"key\":\"references\",\"tenantterm\":\"references\",\"frontiersdefaultterm\":\"references\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":116,\"key\":\"sce\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"description\":\"abbreviation for specialty chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":117,\"key\":\"submission\",\"tenantterm\":\"submission\",\"frontiersdefaultterm\":\"submission\",\"category\":\"process\"},{\"sequencenumber\":118,\"key\":\"submissions\",\"tenantterm\":\"submissions\",\"frontiersdefaultterm\":\"submissions\",\"category\":\"process\"},{\"sequencenumber\":119,\"key\":\"editing\",\"tenantterm\":\"editing\",\"frontiersdefaultterm\":\"editing\",\"category\":\"process\"},{\"sequencenumber\":120,\"key\":\"in_preparation\",\"tenantterm\":\"in preparation\",\"frontiersdefaultterm\":\"in preparation\",\"category\":\"process\"},{\"sequencenumber\":121,\"key\":\"country_region\",\"tenantterm\":\"country/region\",\"frontiersdefaultterm\":\"country/region\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":122,\"key\":\"countries_regions\",\"tenantterm\":\"countries/regions\",\"frontiersdefaultterm\":\"countries/regions\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":123,\"key\":\"specialty\",\"tenantterm\":\"specialty\",\"frontiersdefaultterm\":\"specialty\",\"category\":\"core\"},{\"sequencenumber\":124,\"key\":\"specialties\",\"tenantterm\":\"specialties\",\"frontiersdefaultterm\":\"specialties\",\"category\":\"core\"},{\"sequencenumber\":125,\"key\":\"associate_editors\",\"tenantterm\":\"associate editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":126,\"key\":\"reviewed\",\"tenantterm\":\"reviewed\",\"frontiersdefaultterm\":\"reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":127,\"key\":\"institutional_members\",\"tenantterm\":\"institutional partners\",\"frontiersdefaultterm\":\"institutional partners\",\"category\":\"accounting\"},{\"sequencenumber\":128,\"key\":\"institutional_memberships\",\"tenantterm\":\"institutional partnerships\",\"frontiersdefaultterm\":\"institutional partnerships\",\"category\":\"accounting\"},{\"sequencenumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantterm\":\"assistant field chief editors\",\"frontiersdefaultterm\":\"assistant field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":130,\"key\":\"publications\",\"tenantterm\":\"publications\",\"frontiersdefaultterm\":\"publications\",\"category\":\"process\"},{\"sequencenumber\":131,\"key\":\"ae_accepted\",\"tenantterm\":\"recommended acceptance\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":132,\"key\":\"field_journal\",\"tenantterm\":\"field journal\",\"frontiersdefaultterm\":\"field journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":133,\"key\":\"field_journals\",\"tenantterm\":\"field journals\",\"frontiersdefaultterm\":\"field journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":134,\"key\":\"program_manager\",\"tenantterm\":\"program manager\",\"frontiersdefaultterm\":\"program manager\",\"category\":\"label (role)\"},{\"sequencenumber\":135,\"key\":\"journal_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":136,\"key\":\"journal_specialist\",\"tenantterm\":\"journal specialist\",\"frontiersdefaultterm\":\"journal specialist\",\"category\":\"label (role)\"},{\"sequencenumber\":137,\"key\":\"program_managers\",\"tenantterm\":\"program managers\",\"frontiersdefaultterm\":\"program managers\",\"category\":\"label (role)\"},{\"sequencenumber\":138,\"key\":\"journal_managers\",\"tenantterm\":\"journal managers\",\"frontiersdefaultterm\":\"journal managers\",\"category\":\"label (role)\"},{\"sequencenumber\":139,\"key\":\"journal_specialists\",\"tenantterm\":\"journal specialists\",\"frontiersdefaultterm\":\"journal specialists\",\"category\":\"label (role)\"},{\"sequencenumber\":140,\"key\":\"cover_letter\",\"tenantterm\":\"manuscript contribution to the field\",\"frontiersdefaultterm\":\"manuscript contribution to the field\",\"category\":\"process\"},{\"sequencenumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantterm\":\"recommended to accept manuscript\",\"frontiersdefaultterm\":\"accepted manuscript\",\"category\":\"process\"},{\"sequencenumber\":142,\"key\":\"recommend_for_rejection\",\"tenantterm\":\"recommend for rejection\",\"frontiersdefaultterm\":\"recommend for rejection\",\"category\":\"process\"},{\"sequencenumber\":143,\"key\":\"recommended_for_rejection\",\"tenantterm\":\"recommended for rejection\",\"frontiersdefaultterm\":\"recommended for rejection\",\"category\":\"process\"},{\"sequencenumber\":144,\"key\":\"ae\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"description\":\"associate editor - board member\",\"category\":\"label (role)\"},{\"sequencenumber\":145,\"key\":\"re\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"description\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":146,\"key\":\"rev\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"description\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":147,\"key\":\"aut\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"description\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":148,\"key\":\"coraut\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"description\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":149,\"key\":\"saut\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"description\":\"submitting author\",\"category\":\"label (role)\"},{\"sequencenumber\":150,\"key\":\"coaut\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"description\":\"co-author\",\"category\":\"label (role)\"},{\"sequencenumber\":151,\"key\":\"tsof\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"description\":\"typesetter\",\"category\":\"label (role)\"},{\"sequencenumber\":152,\"key\":\"typesetting_office\",\"tenantterm\":\"typesetting office\",\"frontiersdefaultterm\":\"typesetting office\",\"category\":\"product\"},{\"sequencenumber\":153,\"key\":\"config\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"description\":\"configuration office role\",\"category\":\"label (role)\"},{\"sequencenumber\":154,\"key\":\"jm\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"description\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":155,\"key\":\"rte\",\"tenantterm\":\"rte\",\"frontiersdefaultterm\":\"rte\",\"description\":\"research topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":156,\"key\":\"organizations\",\"tenantterm\":\"organizations\",\"frontiersdefaultterm\":\"organizations\",\"category\":\"core\"},{\"sequencenumber\":157,\"key\":\"publishing\",\"tenantterm\":\"publishing\",\"frontiersdefaultterm\":\"publishing\",\"category\":\"core\"},{\"sequencenumber\":158,\"key\":\"acceptance\",\"tenantterm\":\"acceptance\",\"frontiersdefaultterm\":\"acceptance\",\"category\":\"process\"},{\"sequencenumber\":159,\"key\":\"preferred_associate_editor\",\"tenantterm\":\"preferred associate editor\",\"frontiersdefaultterm\":\"preferred associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":160,\"key\":\"topic_editors\",\"tenantterm\":\"topic editors\",\"frontiersdefaultterm\":\"topic editors\",\"category\":\"label (role)\"},{\"sequencenumber\":161,\"key\":\"institutions\",\"tenantterm\":\"institutions\",\"frontiersdefaultterm\":\"institutions\",\"category\":\"core\"},{\"sequencenumber\":162,\"key\":\"author(s)\",\"tenantterm\":\"author(s)\",\"frontiersdefaultterm\":\"author(s)\",\"category\":\"label (role)\"},{\"sequencenumber\":163,\"key\":\"figure(s)\",\"tenantterm\":\"figure(s)\",\"frontiersdefaultterm\":\"figure(s)\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":164,\"key\":\"co-authors\",\"tenantterm\":\"co-authors\",\"frontiersdefaultterm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"label (role)\"},{\"sequencenumber\":165,\"key\":\"editorial_board_members\",\"tenantterm\":\"editorial board members\",\"frontiersdefaultterm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"label (role)\"},{\"sequencenumber\":166,\"key\":\"editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"product\"},{\"sequencenumber\":167,\"key\":\"co-authorship\",\"tenantterm\":\"co-authorship\",\"frontiersdefaultterm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"misc.\"},{\"sequencenumber\":168,\"key\":\"role_id_1\",\"tenantterm\":\"registration office\",\"frontiersdefaultterm\":\"registration office\",\"category\":\"user role\"},{\"sequencenumber\":169,\"key\":\"role_id_2\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"user role\"},{\"sequencenumber\":170,\"key\":\"role_id_7\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":171,\"key\":\"role_id_8\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":172,\"key\":\"role_id_9\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":173,\"key\":\"role_id_10\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":174,\"key\":\"role_id_11\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"category\":\"user role\"},{\"sequencenumber\":175,\"key\":\"role_id_12\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"user role\"},{\"sequencenumber\":176,\"key\":\"role_id_13\",\"tenantterm\":\"review editor\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"user role\"},{\"sequencenumber\":177,\"key\":\"role_id_14\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"user role\"},{\"sequencenumber\":178,\"key\":\"role_id_15\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"user role\"},{\"sequencenumber\":179,\"key\":\"role_id_16\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"user role\"},{\"sequencenumber\":180,\"key\":\"role_id_17\",\"tenantterm\":\"submitting author\",\"frontiersdefaultterm\":\"submitting author\",\"category\":\"user role\"},{\"sequencenumber\":181,\"key\":\"role_id_18\",\"tenantterm\":\"co-author\",\"frontiersdefaultterm\":\"co-author\",\"category\":\"user role\"},{\"sequencenumber\":182,\"key\":\"role_id_20\",\"tenantterm\":\"production office\",\"frontiersdefaultterm\":\"production office\",\"category\":\"user role\"},{\"sequencenumber\":183,\"key\":\"role_id_22\",\"tenantterm\":\"typesetting office (typesetter)\",\"frontiersdefaultterm\":\"typesetting office (typesetter)\",\"category\":\"user role\"},{\"sequencenumber\":184,\"key\":\"role_id_24\",\"tenantterm\":\"registered user\",\"frontiersdefaultterm\":\"registered user\",\"category\":\"user role\"},{\"sequencenumber\":185,\"key\":\"role_id_35\",\"tenantterm\":\"job office\",\"frontiersdefaultterm\":\"job office\",\"category\":\"user role\"},{\"sequencenumber\":186,\"key\":\"role_id_41\",\"tenantterm\":\"special event administrator\",\"frontiersdefaultterm\":\"special event administrator\",\"category\":\"user role\"},{\"sequencenumber\":187,\"key\":\"role_id_42\",\"tenantterm\":\"special event reviewer\",\"frontiersdefaultterm\":\"special event reviewer\",\"category\":\"user role\"},{\"sequencenumber\":188,\"key\":\"role_id_43\",\"tenantterm\":\"submit abstract\",\"frontiersdefaultterm\":\"submit abstract\",\"category\":\"user role\"},{\"sequencenumber\":189,\"key\":\"role_id_52\",\"tenantterm\":\"events office\",\"frontiersdefaultterm\":\"events office\",\"category\":\"user role\"},{\"sequencenumber\":190,\"key\":\"role_id_53\",\"tenantterm\":\"event administrator\",\"frontiersdefaultterm\":\"event administrator\",\"category\":\"user role\"},{\"sequencenumber\":191,\"key\":\"role_id_89\",\"tenantterm\":\"content management office\",\"frontiersdefaultterm\":\"content management office\",\"category\":\"user role\"},{\"sequencenumber\":192,\"key\":\"role_id_98\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"user role\"},{\"sequencenumber\":193,\"key\":\"role_id_99\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":194,\"key\":\"role_id_103\",\"tenantterm\":\"configuration office\",\"frontiersdefaultterm\":\"configuration office\",\"category\":\"user role\"},{\"sequencenumber\":195,\"key\":\"role_id_104\",\"tenantterm\":\"beta user\",\"frontiersdefaultterm\":\"beta user\",\"category\":\"user role\"},{\"sequencenumber\":196,\"key\":\"role_id_106\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":197,\"key\":\"role_id_107\",\"tenantterm\":\"rt management beta user\",\"frontiersdefaultterm\":\"rt management beta user\",\"category\":\"user role\"},{\"sequencenumber\":198,\"key\":\"role_id_108\",\"tenantterm\":\"deo beta user\",\"frontiersdefaultterm\":\"deo beta user\",\"category\":\"user role\"},{\"sequencenumber\":199,\"key\":\"role_id_109\",\"tenantterm\":\"search beta user\",\"frontiersdefaultterm\":\"search beta user\",\"category\":\"user role\"},{\"sequencenumber\":200,\"key\":\"role_id_110\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"user role\"},{\"sequencenumber\":201,\"key\":\"role_id_111\",\"tenantterm\":\"myfrontiers beta user\",\"frontiersdefaultterm\":\"myfrontiers beta user\",\"category\":\"user role\"},{\"sequencenumber\":202,\"key\":\"role_id_21\",\"tenantterm\":\"copy editor\",\"frontiersdefaultterm\":\"copy editor\",\"category\":\"user role\"},{\"sequencenumber\":203,\"key\":\"role_id_1_abr\",\"tenantterm\":\"rof\",\"frontiersdefaultterm\":\"rof\",\"category\":\"user role\"},{\"sequencenumber\":204,\"key\":\"role_id_2_abr\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"user role\"},{\"sequencenumber\":205,\"key\":\"role_id_7_abr\",\"tenantterm\":\"fce\",\"frontiersdefaultterm\":\"fce\",\"category\":\"user role\"},{\"sequencenumber\":206,\"key\":\"role_id_8_abr\",\"tenantterm\":\"afce\",\"frontiersdefaultterm\":\"afce\",\"category\":\"user role\"},{\"sequencenumber\":207,\"key\":\"role_id_9_abr\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"category\":\"user role\"},{\"sequencenumber\":208,\"key\":\"role_id_10_abr\",\"tenantterm\":\"asce\",\"frontiersdefaultterm\":\"asce\",\"category\":\"user role\"},{\"sequencenumber\":209,\"key\":\"role_id_11_abr\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"category\":\"user role\"},{\"sequencenumber\":210,\"key\":\"role_id_12_abr\",\"tenantterm\":\"gae\",\"frontiersdefaultterm\":\"gae\",\"category\":\"user role\"},{\"sequencenumber\":211,\"key\":\"role_id_13_abr\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"category\":\"user role\"},{\"sequencenumber\":212,\"key\":\"role_id_14_abr\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"category\":\"user role\"},{\"sequencenumber\":213,\"key\":\"role_id_15_abr\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"category\":\"user role\"},{\"sequencenumber\":214,\"key\":\"role_id_16_abr\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"category\":\"user role\"},{\"sequencenumber\":215,\"key\":\"role_id_17_abr\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"category\":\"user role\"},{\"sequencenumber\":216,\"key\":\"role_id_18_abr\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"category\":\"user role\"},{\"sequencenumber\":217,\"key\":\"role_id_20_abr\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"user role\"},{\"sequencenumber\":218,\"key\":\"role_id_22_abr\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"category\":\"user role\"},{\"sequencenumber\":219,\"key\":\"role_id_24_abr\",\"tenantterm\":\"ru\",\"frontiersdefaultterm\":\"ru\",\"category\":\"user role\"},{\"sequencenumber\":220,\"key\":\"role_id_35_abr\",\"tenantterm\":\"jof\",\"frontiersdefaultterm\":\"jof\",\"category\":\"user role\"},{\"sequencenumber\":221,\"key\":\"role_id_41_abr\",\"tenantterm\":\"se-adm\",\"frontiersdefaultterm\":\"se-adm\",\"category\":\"user role\"},{\"sequencenumber\":222,\"key\":\"role_id_42_abr\",\"tenantterm\":\"se-rev\",\"frontiersdefaultterm\":\"se-rev\",\"category\":\"user role\"},{\"sequencenumber\":223,\"key\":\"role_id_43_abr\",\"tenantterm\":\"se-aut\",\"frontiersdefaultterm\":\"se-aut\",\"category\":\"user role\"},{\"sequencenumber\":224,\"key\":\"role_id_52_abr\",\"tenantterm\":\"evof\",\"frontiersdefaultterm\":\"evof\",\"category\":\"user role\"},{\"sequencenumber\":225,\"key\":\"role_id_53_abr\",\"tenantterm\":\"ev-adm\",\"frontiersdefaultterm\":\"ev-adm\",\"category\":\"user role\"},{\"sequencenumber\":226,\"key\":\"role_id_89_abr\",\"tenantterm\":\"comof\",\"frontiersdefaultterm\":\"comof\",\"category\":\"user role\"},{\"sequencenumber\":227,\"key\":\"role_id_98_abr\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"user role\"},{\"sequencenumber\":228,\"key\":\"role_id_99_abr\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":229,\"key\":\"role_id_103_abr\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"category\":\"user role\"},{\"sequencenumber\":230,\"key\":\"role_id_104_abr\",\"tenantterm\":\"beta\",\"frontiersdefaultterm\":\"beta\",\"category\":\"user role\"},{\"sequencenumber\":231,\"key\":\"role_id_106_abr\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":232,\"key\":\"role_id_107_abr\",\"tenantterm\":\"rtbeta\",\"frontiersdefaultterm\":\"rtbeta\",\"category\":\"user role\"},{\"sequencenumber\":233,\"key\":\"role_id_108_abr\",\"tenantterm\":\"deobeta\",\"frontiersdefaultterm\":\"deobeta\",\"category\":\"user role\"},{\"sequencenumber\":234,\"key\":\"role_id_109_abr\",\"tenantterm\":\"searchbeta\",\"frontiersdefaultterm\":\"searchbeta\",\"category\":\"user role\"},{\"sequencenumber\":235,\"key\":\"role_id_110_abr\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"category\":\"user role\"},{\"sequencenumber\":236,\"key\":\"role_id_111_abr\",\"tenantterm\":\"mfbeta\",\"frontiersdefaultterm\":\"mfbeta\",\"category\":\"user role\"},{\"sequencenumber\":237,\"key\":\"role_id_21_abr\",\"tenantterm\":\"coped\",\"frontiersdefaultterm\":\"coped\",\"category\":\"user role\"},{\"sequencenumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"this is the label for the review editorial board\",\"category\":\"label\"},{\"sequencenumber\":239,\"key\":\"field_chief_editor\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":240,\"key\":\"field_chief_editors\",\"tenantterm\":\"field chief editors\",\"frontiersdefaultterm\":\"field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":241,\"key\":\"editor\",\"tenantterm\":\"editor\",\"frontiersdefaultterm\":\"editor\",\"category\":\"label (role)\"},{\"sequencenumber\":242,\"key\":\"editors\",\"tenantterm\":\"editors\",\"frontiersdefaultterm\":\"editors\",\"category\":\"label (role)\"},{\"sequencenumber\":243,\"key\":\"board\",\"tenantterm\":\"board\",\"frontiersdefaultterm\":\"board\",\"category\":\"label\"},{\"sequencenumber\":244,\"key\":\"boards\",\"tenantterm\":\"boards\",\"frontiersdefaultterm\":\"boards\",\"category\":\"label\"},{\"sequencenumber\":245,\"key\":\"article_collection\",\"tenantterm\":\"article collection\",\"frontiersdefaultterm\":\"article collection\",\"category\":\"label\"},{\"sequencenumber\":246,\"key\":\"article_collections\",\"tenantterm\":\"article collections\",\"frontiersdefaultterm\":\"article collections\",\"category\":\"label\"},{\"sequencenumber\":247,\"key\":\"handling_editor\",\"tenantterm\":\"handling editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":248,\"key\":\"handling_editors\",\"tenantterm\":\"handling editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":249,\"key\":\"ae_accept\",\"tenantterm\":\"recommend acceptance\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":250,\"key\":\"rtm\",\"tenantterm\":\"rtm\",\"frontiersdefaultterm\":\"rtm\",\"category\":\"product\"},{\"sequencenumber\":251,\"key\":\"frontiers_media_sa\",\"tenantterm\":\"frontiers media s.a\",\"frontiersdefaultterm\":\"frontiers media s.a\",\"category\":\"customer\"},{\"sequencenumber\":252,\"key\":\"review_editors\",\"tenantterm\":\"community reviewers\",\"frontiersdefaultterm\":\"review editors\",\"category\":\"label (role)\"},{\"sequencenumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":255,\"key\":\"call_for_papers\",\"tenantterm\":\"call for papers\",\"frontiersdefaultterm\":\"call for papers\",\"category\":\"label\"},{\"sequencenumber\":256,\"key\":\"calls_for_papers\",\"tenantterm\":\"calls for papers\",\"frontiersdefaultterm\":\"calls for papers\",\"category\":\"label\"},{\"sequencenumber\":257,\"key\":\"supervising_editor\",\"tenantterm\":\"supervising editor\",\"frontiersdefaultterm\":\"supervising editor\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editor\"},{\"sequencenumber\":258,\"key\":\"supervising_editors\",\"tenantterm\":\"supervising editors\",\"frontiersdefaultterm\":\"supervising editors\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editors\"},{\"sequencenumber\":259,\"key\":\"reviewer_endorse\",\"tenantterm\":\"endorse\",\"frontiersdefaultterm\":\"endorse\",\"category\":\"label\"},{\"sequencenumber\":260,\"key\":\"reviewer_endorsed\",\"tenantterm\":\"endorsed\",\"frontiersdefaultterm\":\"endorsed\",\"category\":\"label\"},{\"sequencenumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantterm\":\"endorse publication\",\"frontiersdefaultterm\":\"endorse publication\",\"category\":\"label\"},{\"sequencenumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantterm\":\"endorsed publication\",\"frontiersdefaultterm\":\"endorsed publication\",\"category\":\"label\"},{\"sequencenumber\":263,\"key\":\"editor_role\",\"tenantterm\":\"editor role\",\"frontiersdefaultterm\":\"editor role\",\"category\":\"label\"},{\"sequencenumber\":264,\"key\":\"editor_roles\",\"tenantterm\":\"editor roles\",\"frontiersdefaultterm\":\"editor roles\",\"category\":\"label\"},{\"sequencenumber\":265,\"key\":\"editorial_role\",\"tenantterm\":\"editorial role\",\"frontiersdefaultterm\":\"editorial role\",\"category\":\"label\"},{\"sequencenumber\":266,\"key\":\"editorial_roles\",\"tenantterm\":\"editorial roles\",\"frontiersdefaultterm\":\"editorial roles\",\"category\":\"label\"},{\"sequencenumber\":267,\"key\":\"call_for_paper\",\"tenantterm\":\"call for paper\",\"frontiersdefaultterm\":\"call for paper\",\"category\":\"label\"},{\"sequencenumber\":268,\"key\":\"research_topic_abstract\",\"tenantterm\":\"manuscript summary\",\"frontiersdefaultterm\":\"manuscript summary\",\"category\":\"process\"},{\"sequencenumber\":269,\"key\":\"research_topic_abstracts\",\"tenantterm\":\"manuscript summaries\",\"frontiersdefaultterm\":\"manuscript summaries\",\"category\":\"process\"},{\"sequencenumber\":270,\"key\":\"submissions_team_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"content manager\",\"category\":\"process\"},{\"sequencenumber\":271,\"key\":\"submissions_team\",\"tenantterm\":\"journal team\",\"frontiersdefaultterm\":\"content team\",\"category\":\"process\"},{\"sequencenumber\":272,\"key\":\"topic_coordinator\",\"tenantterm\":\"topic coordinator\",\"frontiersdefaultterm\":\"topic coordinator\",\"category\":\"process\"},{\"sequencenumber\":273,\"key\":\"topic_coordinators\",\"tenantterm\":\"topic coordinators\",\"frontiersdefaultterm\":\"topic coordinators\",\"category\":\"process\"},{\"sequencenumber\":274,\"key\":\"frontiers_journal_team\",\"tenantterm\":\"frontiers journal team\",\"frontiersdefaultterm\":\"frontiers journal team\",\"category\":\"label (role)\"},{\"sequencenumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantterm\":\"rt:ic submission\",\"frontiersdefaultterm\":\"rt:ic submission\",\"category\":\"label (role)\"},{\"sequencenumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantterm\":\"rt:ic submission participant\",\"frontiersdefaultterm\":\"rt:ic submission participant\",\"category\":\"label (role)\"}]}'\n",impactgtmid:"gtm-njf2ml9b",impactgtmauth:"fyo-7nodm9w37qgfms03sa",impactgtmpreview:"env-1",impactgooglemapsapikey:"aizasyctehx2eu8pwfi86gw9fi00ftcykk6ifr8",qualtricsv4tov3:"'{\"enabled\":true,\"interceptid\":\"si_er0e2ze69oz8yn4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricsumux:"'{\"enabled\":false,\"interceptid\":\"si_89fphy3etxqbwtu\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricscontinuousbrand:"'{\"enabled\":true,\"interceptid\":\"si_9zut94ut81fcrh4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",defaultarticletemplate:"v3"},app:{baseurl:"/",buildid:"f2d5b6d8-d01c-4534-90b9-d659f10f17ca",buildassetsdir:"ap-2024/_nuxt",cdnurl:""}}## Introduction
amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia. methods: we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i 2 statistics. results: four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps. conclusion: while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies. systematic review registration: crd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077 . introduction amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children ( 1 , 2 ). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye ( 3 &#x2013; 5 ). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye ( 5 ). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) ( 6 ). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function ( 6 ). the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children ( 7 ). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed ( 6 ). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old ( 8 ). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity ( 6 , 9 ). therefore, novel treatment paradigms are needed to treat amblyopia in adults. selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy ( 10 ). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex ( 11 ). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes ( 12 , 13 ), while others fail to demonstrate efficacy ( 9 , 14 ). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information. methods search strategy and eligibility criteria this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement ( 15 ). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus. we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations. data extraction data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus. endpoints the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation. quality assessment (risk of bias) the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) ( 16 ). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed ( 17 ). discrepancies were resolved through consensus following a discussion of the reasons for the differences. statistical analysis statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student t -test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i 2 statistics, with p &#x202f;&#x0003c;&#x202f;0.10 and i 2 &#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it. results the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies ( 9 , 12 &#x2013; 14 ) were included, encompassing 139 patients from four rcts ( figure 1 ). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in table 1 . three studies had fluoxetine and one citalopram as the intervention group. figure 1 figure 1 . prisma flow diagram of study screening and selection. table 1 table 1 . baseline characteristics of included studies. all four studies ( 9 , 12 &#x2013; 14 ) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004, i 2 =&#x202f;23%, figure 2 ). only three studies ( 12 &#x2013; 14 ) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, p &#x202f;=&#x202f;0.76, i 2 =&#x202f;0%, figure 3a ) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, p &#x202f;=&#x202f;0.48, i 2 =&#x202f;0%, figure 3b ) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size. figure 2 figure 2 . visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo. figure 3 figure 3 . visual evoked potential (vep) did not improve with ssri. (a) p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. (b) p100 latency improvement was not statistically significantly different between the ssri and placebo group. all studies were evaluated as having a low risk of bias ( table 2 ). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial ( figure 4 ). table 2 table 2 . risk of bias summary for randomized studies. figure 4 figure 4 . funnel plot for visual acuity improvement. there is no publication bias. discussion this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency. current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants ( 9 , 12 &#x2013; 14 ) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic. ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation ( 18 ). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia ( 19 ). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye ( 19 ). in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit ( 20 ). donepezil showed an improvement of the va in an open-label pilot study ( 21 ). across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods ( 11 ). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment ( 12 , 13 ) whereas others did not ( 9 , 14 ). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans ( 22 ). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans ( 22 ). similarly, measuring of visual acuity in rodents and humans cannot be standardized ( 22 ). mitchell et al. ( 22 ) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans ( 22 ). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies ( 12 , 13 ) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes ( 23 ). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) ( 24 ) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials ( 25 &#x2013; 27 ). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba ( 28 ), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes. given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy ( 29 ), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven. heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings. to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature. other modalities of treatment are also currently under research. extended-reality (xr) devices ( 30 ), physical activity (cycling) ( 31 ) and more recently the occlusion of the amblyopic eye combined with physical activity ( 32 ) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects. in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial ( 16 ) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks. conclusion this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes. data availability statement the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author. author contributions es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology. funding the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\r1\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z). conflict of interest the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the handling editor gp declared a shared parent affiliation with the author oa at the time of review. the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision. generative ai statement the authors declare that no gen ai was used in the creation of this manuscript. publisher&#x2019;s note all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. author disclaimer the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care. references 1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. front pediatr . (2022) 10:819998. doi: 10.3389/fped.2022.819998 pubmed abstract | crossref full text | google scholar 2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. rom j ophthalmol . (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 pubmed abstract | crossref full text | google scholar 3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. cereb cortex . (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 pubmed abstract | crossref full text | google scholar 4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. j neurosci . (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 pubmed abstract | crossref full text | google scholar 5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. eye . (1996) 10:250&#x2013;8. google scholar 6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. bmc ophthalmol . (2020) 20:203. doi: 10.1186/s12886-020-01442-9 pubmed abstract | crossref full text | google scholar 7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. optom vis sci . (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 pubmed abstract | crossref full text | google scholar 8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. curr biol . (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 pubmed abstract | crossref full text | google scholar 9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. sci rep . (2018) 8:12830. doi: 10.1038/s41598-018-31169-z pubmed abstract | crossref full text | google scholar 10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. j neurosci . (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 pubmed abstract | crossref full text | google scholar 11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. science . (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516 crossref full text | google scholar 12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. eye . (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z pubmed abstract | crossref full text | google scholar 13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. j aapos . (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 pubmed abstract | crossref full text | google scholar 14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. neural plast . (2019) 2019:5857243. doi: 10.1155/2019/5857243 crossref full text | google scholar 15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. bmj . (2009) 339:b2535. doi: 10.1136/bmj.b2535 pubmed abstract | crossref full text | google scholar 16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. bmj . (2019) 366:l4898. doi: 10.1136/bmj.l4898 pubmed abstract | crossref full text | google scholar 17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. bmj . (2011) 343:d5928. doi: 10.1136/bmj.d5928 pubmed abstract | crossref full text | google scholar 18. feighner, jp. mechanism of action of antidepressant medications. j clin psychiatry . (1999) 60:4&#x2013;11. google scholar 19. morishita, h, and hensch, tk. critical period revisited: impact on vision. curr opin neurobiol . (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 pubmed abstract | crossref full text | google scholar 20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. ophthalmology . (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 pubmed abstract | crossref full text | google scholar 21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. sci rep . (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 pubmed abstract | crossref full text | google scholar 22. mitchell, d, and sengpiel, f. animal models of amblyopia. vis neurosci . (2018) 35:e017. doi: 10.1017/s0952523817000244 pubmed abstract | crossref full text | google scholar 23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). doc ophthalmol . (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y pubmed abstract | crossref full text | google scholar 24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. brain struct funct . (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 pubmed abstract | crossref full text | google scholar 25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. imaging neurosci. (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 pubmed abstract | crossref full text | google scholar 26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. perception . (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 pubmed abstract | crossref full text | google scholar 27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. front hum neurosci . (2022) 16:949395. doi: 10.3389/fnhum.2022.949395 crossref full text | google scholar 28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: https://pubmed.ncbi.nlm.nih.gov/26004760/ google scholar 29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. strabismus . (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 pubmed abstract | crossref full text | google scholar 30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. j vis . (2023) 23:14. doi: 10.1167/jov.23.1.14 pubmed abstract | crossref full text | google scholar 31. lunghi, c, and sale, a. a cycling lane for brain rewiring. curr biol . (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 pubmed abstract | crossref full text | google scholar 32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. annal. clin. transl. neurol. (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 pubmed abstract | crossref full text | google scholar keywords: amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity citation: shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. front. neurol . 16:1639913. doi: 10.3389/fneur.2025.1639913 received: 03 june 2025; accepted: 31 july 2025; published: 21 august 2025. edited by: gordon plant , university college london, united kingdom reviewed by: sara samadzadeh , charit&#x00e9; university medicine berlin, germany alistair r. fielder , city university of london, united kingdom copyright &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the creative commons attribution license (cc by) . the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. &#x0002a;correspondence: i. betina ip, ymv0aw5hlmlwqg5ky24ub3guywmudws= &#x2020; these authors share senior authorship disclaimer: all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. download article download pdf readcube epub xml share on export citation endnote reference manager simple text file bibtex 1,812 total views 250 downloads citation numbers are available from dimensions view article impact view altmetric score share on edited by g p gordon plant reviewed by a r alistair r fielder s s sara samadzadeh table of contents abstract introduction methods results discussion conclusion data availability statement author contributions funding conflict of interest generative ai statement publisher&#x2019;s note author disclaimer references export citation endnote reference manager simple text file bibtex check for updates frontiers&#39; impact articles published with frontiers have received 12 million total citations your research is the real superpower - learn how we maximise its impact through our leading community journals explore our impact metrics supplementary material download article download download pdf readcube epub xml guidelines author guidelines services for authors policies and publication ethics editor guidelines fee policy explore articles research topics journals how we publish outreach frontiers forum frontiers policy labs frontiers for young minds frontiers planet prize connect help center emails and alerts contact us submit career opportunities follow us © 2025 frontiers media s.a. all rights reserved privacy policy | terms and conditions [["shallowreactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverrendered":13,"path":14,"pinia":15},["shallowreactive",3],{},["reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","frontiers articles","https://article-pages-2024.frontiersin.org/",["set"],["shallowreactive",12],{},true,"/journals/neurology/articles/10.3389/fneur.2025.1639913/full",["reactive",16],{"main":17,"user":579,"article":580,"articlehub":881,"mainheader":885},{"ibar":18,"footer":296,"newslettercomponent":-1,"snackbaritem":378,"toggleshowsnackbar":379,"contentfuljournal":380,"graphjournal":480,"settingsfeaturesswitchers":484,"templatetogglebanner":485,"tenantconfig":544},{"tenantlogo":19,"journallogo":19,"aboutus":20,"submiturl":113,"showsubmitbutton":13,"journal":114,"sectionterm":227,"aboutjournal":228,"mainlinks":277,"journallinks":284,"helpcenterlink":293},"",[21,38,47,71,87],{"title":22,"links":23},"who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"arialabel":28},"mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"arialabel":28},"history","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"arialabel":28},"leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"arialabel":28},"awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"impact and progress",[41,44],{"text":42,"url":43,"target":27,"arialabel":28},"frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"arialabel":28},"our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"arialabel":28},"how we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"arialabel":28},"open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"arialabel":28},"peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"arialabel":28},"research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"arialabel":28},"research topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"arialabel":28},"fair² data management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"arialabel":28},"fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"services",[74,78,81,84],{"text":75,"url":76,"target":77,"arialabel":28},"societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"arialabel":28},"national consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"arialabel":28},"institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"arialabel":28},"collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"more from frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"arialabel":93},"frontiers forum","https://forum.frontiersin.org/","this link will take you to the frontiers forum website",{"text":95,"url":96,"target":27,"arialabel":28},"frontiers planet prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"arialabel":100},"press office","https://pressoffice.frontiersin.org/","this link will take you to the frontiers press office website",{"text":102,"url":103,"target":27,"arialabel":104},"sustainability","https://www.frontiersin.org/about/sustainability","link to information about frontiers' sustainability",{"text":106,"url":107,"target":77,"arialabel":108},"career opportunities","https://careers.frontiersin.org/","this link will take you to the frontiers careers website",{"text":110,"url":111,"target":27,"arialabel":112},"contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=54&specialtyid=0&entitytype=2&entityid=141",{"id":115,"name":116,"slug":117,"sections":118},141,"frontiers in neurology","neurology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223],{"id":120,"name":121,"slug":122},156,"applied neuroimaging","applied-neuroimaging",{"id":124,"name":125,"slug":126},3712,"artificial intelligence in neurology","artificial-intelligence-in-neurology",{"id":128,"name":129,"slug":130},3023,"autonomic disorders","autonomic-disorders",{"id":132,"name":133,"slug":134},3740,"cognitive and behavioral neurology","cognitive-and-behavioral-neurology",{"id":136,"name":137,"slug":138},1439,"dementia and neurodegenerative diseases","dementia-and-neurodegenerative-diseases",{"id":140,"name":141,"slug":142},2038,"diagnostic neuropathology","diagnostic-neuropathology",{"id":144,"name":145,"slug":146},143,"endovascular and interventional neurology","endovascular-and-interventional-neurology",{"id":148,"name":149,"slug":150},144,"epilepsy","epilepsy",{"id":152,"name":153,"slug":154},1784,"experimental therapeutics","experimental-therapeutics",{"id":156,"name":157,"slug":158},153,"headache and neurogenic pain","headache-and-neurogenic-pain",{"id":160,"name":161,"slug":162},145,"movement disorders","movement-disorders",{"id":164,"name":165,"slug":166},147,"multiple sclerosis and neuroimmunology","multiple-sclerosis-and-neuroimmunology",{"id":168,"name":169,"slug":170},150,"neuro-oncology and neurosurgical oncology","neuro-oncology-and-neurosurgical-oncology",{"id":172,"name":173,"slug":174},154,"neuro-ophthalmology","neuro-ophthalmology",{"id":176,"name":177,"slug":178},155,"neuro-otology","neuro-otology",{"id":180,"name":181,"slug":182},159,"neurocritical and neurohospitalist care","neurocritical-and-neurohospitalist-care",{"id":184,"name":185,"slug":186},1339,"neuroepidemiology","neuroepidemiology",{"id":188,"name":189,"slug":190},160,"neurogenetics","neurogenetics",{"id":192,"name":193,"slug":194},1334,"neuroinfectious diseases","neuroinfectious-diseases",{"id":196,"name":197,"slug":198},2345,"neurological biomarkers","neurological-biomarkers",{"id":200,"name":201,"slug":202},146,"neuromuscular disorders and peripheral neuropathies","neuromuscular-disorders-and-peripheral-neuropathies",{"id":204,"name":205,"slug":206},547,"neurorehabilitation","neurorehabilitation",{"id":208,"name":209,"slug":210},3418,"neurotechnology","neurotechnology",{"id":212,"name":213,"slug":214},163,"neurotrauma","neurotrauma",{"id":216,"name":217,"slug":218},161,"pediatric neurology","pediatric-neurology",{"id":220,"name":221,"slug":222},151,"sleep disorders","sleep-disorders",{"id":224,"name":225,"slug":226},142,"stroke","stroke","sections",[229,253],{"title":230,"links":231},"scope",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"arialabel":28},"field chief editors","https://www.frontiersin.org/journals/neurology/about#about-editors",{"text":236,"url":237,"target":27,"arialabel":28},"mission & scope","https://www.frontiersin.org/journals/neurology/about#about-scope",{"text":239,"url":240,"target":27,"arialabel":28},"facts","https://www.frontiersin.org/journals/neurology/about#about-facts",{"text":242,"url":243,"target":27,"arialabel":28},"journal sections","https://www.frontiersin.org/journals/neurology/about#about-submission",{"text":245,"url":246,"target":27,"arialabel":28},"open access statement","https://www.frontiersin.org/journals/neurology/about#about-open",{"text":248,"url":249,"target":27,"arialabel":28},"copyright statement","https://www.frontiersin.org/journals/neurology/about#copyright-statement",{"text":251,"url":252,"target":27,"arialabel":28},"quality","https://www.frontiersin.org/journals/neurology/about#about-quality",{"title":254,"links":255},"for authors",[256,259,262,265,268,271,274],{"text":257,"url":258,"target":27,"arialabel":28},"why submit?","https://www.frontiersin.org/journals/neurology/for-authors/why-submit",{"text":260,"url":261,"target":27,"arialabel":28},"article types","https://www.frontiersin.org/journals/neurology/for-authors/article-types",{"text":263,"url":264,"target":27,"arialabel":28},"author guidelines","https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines",{"text":266,"url":267,"target":27,"arialabel":28},"editor guidelines","https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines",{"text":269,"url":270,"target":27,"arialabel":28},"publishing fees","https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees",{"text":272,"url":273,"target":27,"arialabel":28},"submission checklist","https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist",{"text":275,"url":276,"target":27,"arialabel":28},"contact editorial office","https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office",[278,281],{"text":279,"url":280,"target":27,"arialabel":28},"all journals","https://www.frontiersin.org/journals",{"text":282,"url":283,"target":27,"arialabel":28},"all articles","https://www.frontiersin.org/articles",[285,288,290],{"text":286,"url":287,"target":27,"arialabel":28},"articles","articles",{"text":63,"url":289,"target":27,"arialabel":28},"research-topics",{"text":291,"url":292,"target":27,"arialabel":28},"editorial board","editors",{"text":294,"url":295,"target":77,"arialabel":294},"help center","https://helpcenter.frontiersin.org",{"blocks":297,"sociallinks":351,"copyright":375,"termsandconditionsurl":376,"privacypolicyurl":377},[298,312,322,336],{"title":299,"links":300},"guidelines",[301,303,306,309,311],{"text":263,"url":302,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":304,"url":305,"target":27,"arialabel":28},"services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":307,"url":308,"target":27,"arialabel":28},"policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":266,"url":310,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"arialabel":28},{"title":313,"links":314},"explore",[315,316,319,321],{"text":286,"url":283,"target":27,"arialabel":28},{"text":317,"url":318,"target":27,"arialabel":28},"research topics ","https://www.frontiersin.org/research-topics",{"text":320,"url":280,"target":27,"arialabel":28},"journals",{"text":51,"url":52,"target":27,"arialabel":28},{"title":323,"links":324},"outreach",[325,328,331,335],{"text":326,"url":92,"target":77,"arialabel":327},"frontiers forum ","frontiers forum website",{"text":329,"url":330,"target":77,"arialabel":28},"frontiers policy labs ","https://policylabs.frontiersin.org/",{"text":332,"url":333,"target":77,"arialabel":334},"frontiers for young minds","https://kids.frontiersin.org/","frontiers for young minds journal",{"text":95,"url":96,"target":27,"arialabel":28},{"title":337,"links":338},"connect",[339,340,344,347,350],{"text":294,"url":295,"target":77,"arialabel":294},{"text":341,"url":342,"target":77,"arialabel":343},"emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","subscribe to frontiers emails",{"text":345,"url":111,"target":27,"arialabel":346},"contact us ","subscribe to newsletter",{"text":348,"url":349,"target":27,"arialabel":28},"submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"arialabel":28},[352,360,365,370],{"link":353,"type":356,"color":357,"icon":358,"size":359,"hiddentext":13},{"text":354,"url":355,"target":77,"arialabel":354},"frontiers facebook","https://www.facebook.com/frontiersin","link","grey","facebook","medium",{"link":361,"type":356,"color":357,"icon":364,"size":359,"hiddentext":13},{"text":362,"url":363,"target":77,"arialabel":28},"frontiers twitter","https://twitter.com/frontiersin","twitter",{"link":366,"type":356,"color":357,"icon":369,"size":359,"hiddentext":13},{"text":367,"url":368,"target":77,"arialabel":28},"frontiers linkedin","https://www.linkedin.com/company/frontiers","linkedin",{"link":371,"type":356,"color":357,"icon":374,"size":359,"hiddentext":13},{"text":372,"url":373,"target":77,"arialabel":28},"frontiers instagram","https://www.instagram.com/frontiersin_","instagram","frontiers media s.a. all rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":381,"identifier":115,"name":116,"slug":117,"banner":382,"description":473,"mission":474,"palette":475,"impactfactor":476,"citescore":477,"citations":478,"showtagline":28,"twitter":479},"journal",[383],{"id":384,"src":385,"name":386,"tags":387,"type":432,"width":433,"height":434,"idhash":435,"archive":436,"brandid":437,"limited":436,"filesize":438,"ispublic":439,"original":440,"copyright":19,"extension":441,"thumbnails":443,"datecreated":451,"description":452,"orientation":453,"usercreated":454,"watermarked":436,"datemodified":451,"datepublished":455,"ecsarchivefiles":456,"propertyoptions":457,"property_channel":462,"property_sub-type":464,"property_asset_type":466,"activeoriginalfocuspoint":468,"property_office_department":471},"d315adb2-2967-48b6-be3b61009343d69e","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/webimage-810a1e19-163c-4fd0-bfd3d50a4721b642.png","fneur_main visual_cyan_website",[388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,117,430,431],"professional","device","medical","close up","technology","wires","brain waves","record","digital","selective focus","laboratory","brain","health","electrodes","computer","examination","electroencephalography","scan","study","oncology","examine","electroencephalogram","neurosurgery","science","doctor","diagnose","magnetic","patient","modern","electroencephalograph","equipment","office","healthcare","scanning","instrument","eeg","hospital","ct","technician","medicine","ultrasound","radiology","diagnostic","lab","image",5052,3368,"62463d527f6ddd4d",0,"22c10171-81b3-4da6-99342f272a32e8bb",5758943,1,"https://brand.frontiersin.org/m/62463d527f6ddd4d/original/fneur_main-visual_cyan_website.jpg",[442],"jpg",{"mini":444,"thul":445,"webimage":385,"guidelines":446,"websitejpg_xl":447,"websitewebp_l":448,"websitewebp_m":449,"websitewebp_xl":450},"https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/mini-a927c1b7-02f8-4d29-94320f509270457d.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/thul-fcd9f16d-d1a9-4535-a7e4c140224266b9.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/guidelines-fneur_main visual_cyan_website.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitejpg_xl-fneur_main visual_cyan_website.jpg","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_l-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_m-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_xl-fneur_main visual_cyan_website.webp","2022-06-27t10:00:23z","charming young woman undergoing electroencephalography; shutterstock id 695951221; purchase_order: main visual; job: ; client: ; other:","landscape","caroline sutter","2022-06-27t06:08:46z",[],[458,459,460,461],"414fb2d4-2283-43fd-be14e534eca67928","6c18119b-14bd-4951-b437696f4357bd33","7c692885-db25-4858-b1fb4ff47b241e9b","d88c0047-ec30-4506-a7df28a4d765e1cf",[463],"frontiersin_org",[465],"main_visual",[467],"photography",{"x":469,"y":470},2526,1684,[472],"publishing","the world's most cited clinical neurology journal, exploring the diagnosis, causes, treatment, and public health aspects of neurological illnesses to improve patient care.","\u003cp>frontiers in neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. it is indexed in pubmed central (pmc), scopus, and the doaj.\u003c/p>\n\n\u003cp>led by field chief editor prof. irene litvan (university of california, san diego, usa), frontiers in neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.\u003c/p>\n\n\u003cp>the journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:\u003c/p>\n\n\u003cul>\n \u003cli>artificial intelligence in neurology\u003c/li>\n \u003cli>applied neuroimaging\u003c/li>\n \u003cli>autonomic disorders\u003c/li>\n \u003cli>cognitive behavioural neurology\u003c/li>\n \u003cli>dementia and neurodegenerative diseases\u003c/li>\n \u003cli>diagnostic and forensic neuropathology\u003c/li>\n \u003cli>endovascular and interventional neurology\u003c/li>\n \u003cli>epilepsy\u003c/li>\n \u003cli>experimental therapeutics\u003c/li>\n \u003cli>headache and neurogenic pain\u003c/li>\n \u003cli>movement disorders\u003c/li>\n \u003cli>multiple sclerosis and neuroimmunology\u003c/li>\n \u003cli>neuro-oncology and neurosurgical oncology\u003c/li>\n \u003cli>neuro-ophthalmology\u003c/li>\n \u003cli>neuro-otology\u003c/li>\n \u003cli>neurocritical and neurohospitalist care\u003c/li>\n \u003cli>neuroepidemiology\u003c/li>\n \u003cli>neurogenetics\u003c/li>\n \u003cli>neuroinfectious diseases\u003c/li>\n \u003cli>neurological biomarkers\u003c/li>\n \u003cli>neuromuscular disorders and peripheral neuropathies\u003c/li>\n \u003cli>neurorehabilitation\u003c/li>\n \u003cli>neurotechnology\u003c/li>\n \u003cli>neurotrauma\u003c/li>\n \u003cli>pediatric neurology\u003c/li>\n \u003cli>sleep disorders\u003c/li>\n \u003cli>stroke\u003c/li>\n\u003c/ul>\n\n\u003cp>in particular, the journal welcomes submissions that support and advance the un’s \u003ca href=https://globalgoals.org/goals/>sustainable development goals\u003c/a> (sdgs), notably \u003ca href=https://globalgoals.org/goals/3-good-health-and-well-being/>sdg 3: good health and well-being\u003c/a>.\u003c/p>\n\n\u003cp>manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.\u003c/p>\n\n\u003cp>the journal no longer accepts papers concerning simple bibliometric studies. authors are still welcome to submit systematic reviews using publicly available data, but these must adhere to the \u003ca href=https://www.prisma-statement.org/>prisma guidelines\u003c/a> and have a conclusion related to neurological research. studies without this primary focus will be transferred to a more applicable journal.\u003c/p>\n\n\u003cp>frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as nhanes or mendelian randomization studies, must include appropriate validation. please refer to the \u003ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,standards%20for%20research%20methodology,-experiments\">frontiers standards for research methodology policy\u003c/a> for more information. manuscripts not adhering to these standards will not be considered.\u003cp>\n\n\u003cp>frontiers in neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.\u003c/p>","cyan","3.4","4.8","273537","@frontneurol",{"id":115,"name":116,"slug":117,"abbreviation":481,"isonline":13,"isopenforsubmissions":13,"citescore":482,"impactfactor":483},"fneur",5.2,2.8,{"displaytitlepilllabels":13,"displayrelatedarticlesbox":13,"showeditors":13,"showreviewers":13,"showloopimpactlink":13,"enablefigshare":379,"usexmlimages":13},{"ispublic":13,"allowcompanyusers":379,"whitelistemails":486,"enablealljournals":13,"whitelistjournals":508},[487,488,489,490,491,492,493,494,495,492,496,497,498,499,500,501,502,503,504,505,506,507],"y2fybg9zlmxvcmnhqgzyb250awvyc2lulm9yzw==","zgfuawvslmx1ekbmcm9udgllcnnpbi5vcmc=","bgf1cmeudgvuyubmcm9udgllcnnpbi5vcmc=","cmfmywvslnjpyw5jag9aznjvbnrpzxjzaw4ub3jn","amftzxmuc21hbgxib25lqgzyb250awvyc2lulm9yzw==","znjhbi5tb3jlbm9aznjvbnrpzxjzaw4ub3jn","c2ftdwvslmzlcm5hbmrlekbmcm9udgllcnnpbi5vcmc=","ymfyymfyys5jyxjjyw5naxvaznjvbnrpzxjzaw4ub3jn","axzhbi5zyw50yw1hcmlhqgzyb250awvyc2lulm9yzw==","ahvllnryyw5aznjvbnrpzxjzaw4ub3jn","z29uy2fsby52yxjnyxnaznjvbnrpzxjzaw4ub3jn","bhvjawuuc2vubkbmcm9udgllcnnpbi5vcmc=","bg9ybi5mcmfzzxjaznjvbnrpzxjzaw4ub3jn","zwxzys5jyxjyb25aznjvbnrpzxjzaw4ub3jn","bwfhcnrlbi52yw5kawpja0bmcm9udgllcnnpbi5vcmc=","ymluzgh1lmtyaxnobmfuqgzyb250awvyc2lulm9yzw==","bwf0dghldy5hdhr3yxrlcnnaznjvbnrpzxjzaw4ub3jn","z2l1bglhlnzhbhnly2noaubmcm9udgllcnnpbi5vcmc=","zmfiawfulmrlbgxhbw9ydgvaznjvbnrpzxjzaw4ub3jn","dmlqyxlhbi5wcebwaxrzb2x1dglvbnmuy29t","z3vpbgxhdw1llnnldxjhdebmcm9udgllcnnpbi5vcmc=",[509,510,511,512,513,514,439,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,115,530,531,532,533,534,535,536,537,538,539,540,541,542,543],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceid":439,"name":439,"availablejournalpages":545,"announcement":549},[287,292,289,546,547,548],"volumes","about","community-reviewers",{"__typename":550,"sys":551,"preheader":42,"title":553,"description":554,"image":555,"link":577},"announcement",{"id":552},"5ittnttqgazppgh6rx0alm","articles published with frontiers have received 12 million total citations","your research is the real superpower - learn how we maximise its impact through our leading community journals",[556],{"archive":436,"brandid":437,"copyright":28,"datecreated":557,"datemodified":558,"datepublished":559,"description":28,"extension":560,"filesize":562,"height":563,"id":564,"ispublic":436,"limited":436,"name":565,"orientation":453,"original":28,"thumbnails":566,"type":432,"watermarked":436,"width":573,"videopreviewurls":574,"tags":575,"textmetaproperties":576,"src":567},"2025-06-18t12:58:01z","2025-06-18t14:15:34z","2025-06-18t12:57:32z",[561],"png",1365026,920,"7c5269c4-3c83-4591-951a74d15b95daea","impact metrics banner for article pages",{"webimage":567,"thul":568,"mini":569,"websitewebp_l":570,"websitewebp_m":571,"guidelines":572},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_l/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_m/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/guidelines/impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":578,"url":43,"target":27,"arialabel":28},"explore our impact metrics",{"loggeduserinfo":-1},{"currentarticle":581,"ispreviewpage":379,"hassupplementaldata":379,"showcrossmarkwidget":13,"articletemplate":738,"currentarticlepagemetainfo":739,"xmlparsedarticlecontent":-1,"xmlparsingerror":-1},{"id":582,"doi":583,"title":584,"acceptancedate":585,"receptiondate":586,"publicationdate":587,"lastmodifieddate":588,"ispublished":13,"abstract":589,"researchtopic":590,"articletype":596,"stage":599,"keywords":601,"authors":609,"editors":675,"reviewers":683,"journal":699,"section":707,"impactmetrics":709,"volume":712,"articlevolume":713,"relatedarticles":714,"ispublishedv2":13,"contents":715,"files":718},1639913,"10.3389/fneur.2025.1639913","selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials","2025-07-31t18:15:51.000z","2025-06-03t00:38:20.000z","2025-08-21t00:00:00.000z","2025-10-21t02:26:11.259z","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.methodswe systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i2 statistics.resultsfour rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04–0.14, p = 0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.conclusionwhile ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.systematic review registrationcrd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077.",{"id":591,"title":592,"articlescount":593,"ismagazinepage":379,"slug":594,"isopenforsubmission":13,"views":595},61549,"advances in understanding visual disorders linked to cortical dysfunction",10,"advances-in-understanding-visual-disorders-linked-to-cortical-dysfunction",15702,{"id":597,"name":598},136,"systematic review",{"id":600,"name":19},18,[602,603,604,605,606,607,608],"strabismus","neuroplasticity","amblyopia","fluoxetine","ssris","anisometropia","citalopram",[610,619,627,636,645,652,660,668],{"id":611,"firstname":612,"middlename":19,"lastname":613,"givennames":614,"iscorresponding":379,"isprofilepublic":13,"userid":611,"email":-1,"affiliations":615},3083093,"ehtesham","shamsher","ehtesham ",[616],{"organizationname":617,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust","united kingdom",{"id":436,"firstname":620,"middlename":19,"lastname":621,"givennames":622,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":623},"luisa","saccaro","luisa ",[624],{"organizationname":625,"countryname":626,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, universidade de mogi das cruzes","brazil",{"id":628,"firstname":629,"middlename":19,"lastname":630,"givennames":631,"iscorresponding":379,"isprofilepublic":13,"userid":628,"email":-1,"affiliations":632},3089392,"victor barreiros","pungirum","victor barreiros ",[633],{"organizationname":634,"countryname":635,"cityname":19,"statename":19,"zipcode":19},"faculty of medical sciences, university of buenos aires","argentina",{"id":637,"firstname":638,"middlename":19,"lastname":639,"givennames":640,"iscorresponding":379,"isprofilepublic":13,"userid":637,"email":-1,"affiliations":641},3162299,"nghi bao","tran","nghi bao ",[642],{"organizationname":643,"countryname":644,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, university of debrecen","hungary",{"id":436,"firstname":646,"middlename":19,"lastname":647,"givennames":648,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":649},"omar a. h. a.","alghaith","omar a. h. a. ",[650],{"organizationname":651,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"institute of ophthalmology, university college london",{"id":436,"firstname":653,"middlename":19,"lastname":654,"givennames":655,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":656},"fatemeh","khabazianzadeh","fatemeh ",[657],{"organizationname":658,"countryname":659,"cityname":19,"statename":19,"zipcode":19},"eye research center, khatam-al-anbia hospital, mashad university of medical sciences","iran",{"id":661,"firstname":662,"middlename":19,"lastname":663,"givennames":664,"iscorresponding":379,"isprofilepublic":13,"userid":661,"email":-1,"affiliations":665},30975,"holly","bridge","holly ",[666],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging",{"id":669,"firstname":670,"middlename":19,"lastname":671,"givennames":672,"iscorresponding":379,"isprofilepublic":13,"userid":669,"email":-1,"affiliations":673},318592,"i. betina","ip","i. betina ",[674],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},[676],{"id":677,"firstname":678,"middlename":19,"lastname":679,"givennames":680,"iscorresponding":379,"isprofilepublic":13,"userid":677,"email":-1,"affiliations":681},2271562,"gordon","plant","gordon ",[682],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},[684,692],{"id":685,"firstname":686,"middlename":687,"lastname":688,"givennames":689,"iscorresponding":379,"isprofilepublic":13,"userid":685,"email":-1,"affiliations":690},870962,"alistair","r","fielder","alistair r",[691],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":693,"firstname":694,"middlename":19,"lastname":695,"givennames":696,"iscorresponding":379,"isprofilepublic":13,"userid":693,"email":-1,"affiliations":697},1863925,"sara","samadzadeh","sara ",[698],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":115,"slug":117,"name":116,"shortname":700,"electronicissn":701,"field":702,"specialtyid":28,"journalsectionpaths":705},"front. neurol.","1664-2295",{"id":703,"domainid":704},54,2,[706],{"section":707},{"id":172,"name":173,"slug":174,"specialtyid":708},758,{"views":710,"downloads":711,"citations":436},1812,250,16,"volume 16 - 2025",[],{"titlehtml":584,"fulltexthtml":716,"menuhtml":717},"\u003cdiv class=\"journalabstract\"> \u003ca id=\"h1\" name=\"h1\">\u003c/a>\n \u003cdiv class=\"authors\">\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3083093\" class=\"user-id-3083093\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3083093/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"ehtesham shamsher\">ehtesham shamsher\u003c/a>\u003csup>1\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"luisa saccaro\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">luisa saccaro\u003csup>2\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3089392\" class=\"user-id-3089392\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3089392/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"victor barreiros pungirum\">victor barreiros pungirum\u003c/a>\u003csup>3\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3162299\" class=\"user-id-3162299\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3162299/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"nghi bao tran\">nghi bao tran\u003c/a>\u003csup>4\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"omar a. h. a. alghaith\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">omar a. h. a. alghaith\u003csup>5\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"fatemeh khabazianzadeh\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">fatemeh khabazianzadeh\u003csup>6\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/30975\" class=\"user-id-30975\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/30975/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"holly bridge&#x;\">holly bridge\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/318592\" class=\"user-id-318592\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/318592/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"i. betina ip&#xa;&#x;\">i. betina ip\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x0002a;\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003c/div> \u003cul class=\"notes\"> \u003cli>\u003cspan>\u003csup>1\u003c/sup>\u003c/span>oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, oxford, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>2\u003c/sup>\u003c/span>faculty of medicine, universidade de mogi das cruzes, mogi das cruzes, brazil\u003c/li> \u003cli>\u003cspan>\u003csup>3\u003c/sup>\u003c/span>faculty of medical sciences, university of buenos aires, buenos aires, argentina\u003c/li> \u003cli>\u003cspan>\u003csup>4\u003c/sup>\u003c/span>faculty of medicine, university of debrecen, debrecen, hungary\u003c/li> \u003cli>\u003cspan>\u003csup>5\u003c/sup>\u003c/span>institute of ophthalmology, university college london, london, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>6\u003c/sup>\u003c/span>eye research center, khatam-al-anbia hospital, mashad university of medical sciences, mashhad, iran\u003c/li> \u003cli>\u003cspan>\u003csup>7\u003c/sup>\u003c/span>nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, oxford, united kingdom\u003c/li> \u003c/ul>\n\u003cp class=\"mb15\">\u003cb>introduction:\u003c/b> amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>methods:\u003c/b> we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i\u003csup>2\u003c/sup> statistics.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>results:\u003c/b> four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>conclusion:\u003c/b> while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.\u003c/p>\n\u003cp class=\"mb0\">\u003cb>systematic review registration:\u003c/b> crd42025633077, \u003ca href=\"https://www.crd.york.ac.uk/prospero/view/crd42025633077\">https://www.crd.york.ac.uk/prospero/view/crd42025633077\u003c/a>.\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div> \u003cdiv class=\"journalfulltext\"> \u003ca id=\"h2\" name=\"h2\">\u003c/a>\n\u003ch2>introduction\u003c/h2>\n\u003cp class=\"mb15\">amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children (\u003ca href=\"#ref1\">1\u003c/a>, \u003ca href=\"#ref2\">2\u003c/a>). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye (\u003ca href=\"#ref3\">3\u003c/a>&#x2013;\u003ca href=\"#ref5\">5\u003c/a>). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye (\u003ca href=\"#ref5\">5\u003c/a>). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) (\u003ca href=\"#ref6\">6\u003c/a>). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function (\u003ca href=\"#ref6\">6\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children (\u003ca href=\"#ref7\">7\u003c/a>). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed (\u003ca href=\"#ref6\">6\u003c/a>). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old (\u003ca href=\"#ref8\">8\u003c/a>). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity (\u003ca href=\"#ref6\">6\u003c/a>, \u003ca href=\"#ref9\">9\u003c/a>). therefore, novel treatment paradigms are needed to treat amblyopia in adults.\u003c/p>\n\u003cp class=\"mb0\">selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy (\u003ca href=\"#ref10\">10\u003c/a>). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex (\u003ca href=\"#ref11\">11\u003c/a>). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>), while others fail to demonstrate efficacy (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information.\u003c/p> \u003ca id=\"h3\" name=\"h3\">\u003c/a>\n\u003ch2>methods\u003c/h2>\n\u003ch3>search strategy and eligibility criteria\u003c/h3>\n\u003cp class=\"mb15\">this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement (\u003ca href=\"#ref15\">15\u003c/a>). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus.\u003c/p>\n\u003cp class=\"mb0\">we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations.\u003c/p>\n\u003ch3>data extraction\u003c/h3>\n\u003cp class=\"mb0\">data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus.\u003c/p>\n\u003ch3>endpoints\u003c/h3>\n\u003cp class=\"mb0\">the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation.\u003c/p>\n\u003ch3>quality assessment (risk of bias)\u003c/h3>\n\u003cp class=\"mb0\">the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) (\u003ca href=\"#ref16\">16\u003c/a>). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed (\u003ca href=\"#ref17\">17\u003c/a>). discrepancies were resolved through consensus following a discussion of the reasons for the differences.\u003c/p>\n\u003ch3>statistical analysis\u003c/h3>\n\u003cp class=\"mb0\">statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student \u003ci>t\u003c/i>-test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i\u003csup>2\u003c/sup> statistics, with \u003ci>p\u003c/i>&#x202f;&#x0003c;&#x202f;0.10 and i\u003csup>2\u003c/sup>&#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it.\u003c/p> \u003ca id=\"h4\" name=\"h4\">\u003c/a>\n\u003ch2>results\u003c/h2>\n\u003cp class=\"mb0\">the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) were included, encompassing 139 patients from four rcts (\u003ca href=\"#fig1\">figure 1\u003c/a>). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in \u003ca href=\"#tab1\">table 1\u003c/a>. three studies had fluoxetine and one citalopram as the intervention group.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" name=\"figure1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" alt=\"flowchart detailing a study selection process: identification phase shows pubmed with fifty-five results, embase with three hundred ninety-six results, cochrane with thirty results, totaling four hundred eighty-one. screening phase removes four hundred seventy-two as duplicates or non-criteria matches. eligibility phase reviews nine full-text studies; discards one conference abstract and four from the manuscript registry. four studies remain included.\" id=\"fig1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 1\u003c/b>. prisma flow diagram of study screening and selection.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">table 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" name=\"table1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" alt=\"www.frontiersin.org\" id=\"tab1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 1\u003c/b>. baseline characteristics of included studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004, i\u003csup>2\u003c/sup> =&#x202f;23%, \u003ca href=\"#fig2\">figure 2\u003c/a>). only three studies (\u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.76, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3a\u003c/a>) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.48, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3b\u003c/a>) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" name=\"figure2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" alt=\"forest plot showing the mean differences from four studies comparing the effects of ssri to placebo. each study is represented by a red square with horizontal lines indicating confidence intervals. the total effect is represented by a black diamond indicating a mean difference of 0.09 with a confidence interval of 0.04 to 0.14, favoring ssri. heterogeneity measures show tau-squared equals zero, chi-squared equals 3.90 with a p-value of 0.27, and i-squared equals 23%.\" id=\"fig2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 2\u003c/b>. visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 3\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" name=\"figure3\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" alt=\"forest plots a and b compare mean differences for several studies on ssri effectiveness. plot a shows a total mean difference of 0.34, favoring placebo, with no heterogeneity. plot b shows a total mean difference of 1.76, still favoring placebo, with no heterogeneity. each plot displays individual study results with confidence intervals and weight distributions.\" id=\"fig3\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 3\u003c/b>. visual evoked potential (vep) did not improve with ssri. \u003cb>(a)\u003c/b> p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. \u003cb>(b)\u003c/b> p100 latency improvement was not statistically significantly different between the ssri and placebo group.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all studies were evaluated as having a low risk of bias (\u003ca href=\"#tab2\">table 2\u003c/a>). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial (\u003ca href=\"#fig4\">figure 4\u003c/a>).\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">table 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" name=\"table2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" alt=\"www.frontiersin.org\" id=\"tab2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 2\u003c/b>. risk of bias summary for randomized studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 4\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" name=\"figure4\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" alt=\"funnel plot depicting standard error of mean difference (se[md]) on the y-axis versus mean difference (md) on the x-axis. points representing studies are scattered around a central vertical line, with dashed lines forming an inverted triangle indicating data distribution.\" id=\"fig4\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 4\u003c/b>. funnel plot for visual acuity improvement. there is no publication bias.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div> \u003ca id=\"h5\" name=\"h5\">\u003c/a>\n\u003ch2>discussion\u003c/h2>\n\u003cp class=\"mb15\">this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency.\u003c/p>\n\u003cp class=\"mb15\">current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic.\u003c/p>\n\u003cp class=\"mb15\">ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation (\u003ca href=\"#ref18\">18\u003c/a>). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia (\u003ca href=\"#ref19\">19\u003c/a>). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye (\u003ca href=\"#ref19\">19\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit (\u003ca href=\"#ref20\">20\u003c/a>). donepezil showed an improvement of the va in an open-label pilot study (\u003ca href=\"#ref21\">21\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods (\u003ca href=\"#ref11\">11\u003c/a>). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) whereas others did not (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans (\u003ca href=\"#ref22\">22\u003c/a>). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans (\u003ca href=\"#ref22\">22\u003c/a>). similarly, measuring of visual acuity in rodents and humans cannot be standardized (\u003ca href=\"#ref22\">22\u003c/a>). mitchell et al. (\u003ca href=\"#ref22\">22\u003c/a>) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans (\u003ca href=\"#ref22\">22\u003c/a>). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes (\u003ca href=\"#ref23\">23\u003c/a>). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) (\u003ca href=\"#ref24\">24\u003c/a>) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials (\u003ca href=\"#ref25\">25\u003c/a>&#x2013;\u003ca href=\"#ref27\">27\u003c/a>). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba (\u003ca href=\"#ref28\">28\u003c/a>), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes.\u003c/p>\n\u003cp class=\"mb15\">given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy (\u003ca href=\"#ref29\">29\u003c/a>), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven.\u003c/p>\n\u003cp class=\"mb15\">heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings.\u003c/p>\n\u003cp class=\"mb15\">to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature.\u003c/p>\n\u003cp class=\"mb15\">other modalities of treatment are also currently under research. extended-reality (xr) devices (\u003ca href=\"#ref30\">30\u003c/a>), physical activity (cycling) (\u003ca href=\"#ref31\">31\u003c/a>) and more recently the occlusion of the amblyopic eye combined with physical activity (\u003ca href=\"#ref32\">32\u003c/a>) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects.\u003c/p>\n\u003cp class=\"mb0\">in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial (\u003ca href=\"#ref16\">16\u003c/a>) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks.\u003c/p> \u003ca id=\"h6\" name=\"h6\">\u003c/a>\n\u003ch2>conclusion\u003c/h2>\n\u003cp class=\"mb0\">this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes.\u003c/p> \u003ca id=\"h7\" name=\"h7\">\u003c/a>\n\u003ch2>data availability statement\u003c/h2>\n\u003cp class=\"mb0\">the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.\u003c/p> \u003ca id=\"h8\" name=\"h8\">\u003c/a>\n\u003ch2>author contributions\u003c/h2>\n\u003cp class=\"mb0\">es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology.\u003c/p> \u003ca id=\"h9\" name=\"h9\">\u003c/a>\n\u003ch2>funding\u003c/h2>\n\u003cp class=\"mb0\">the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\\r1\\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z).\u003c/p> \u003ca id=\"h10\" name=\"h10\">\u003c/a>\n\u003ch2>conflict of interest\u003c/h2>\n\u003cp class=\"mb15\">the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003c/p>\n\u003cp class=\"mb15\">the handling editor gp declared a shared parent affiliation with the author oa at the time of review.\u003c/p>\n\u003cp class=\"mb0\">the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision.\u003c/p> \u003ca id=\"h11\" name=\"h11\">\u003c/a>\n\u003ch2>generative ai statement\u003c/h2>\n\u003cp class=\"mb0\">the authors declare that no gen ai was used in the creation of this manuscript.\u003c/p> \u003ca id=\"h12\" name=\"h12\">\u003c/a>\n\u003ch2>publisher&#x2019;s note\u003c/h2>\n\u003cp class=\"mb0\">all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003c/p> \u003ca id=\"h13\" name=\"h13\">\u003c/a>\n\u003ch2>author disclaimer\u003c/h2>\n\u003cp class=\"mb0\">the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care.\u003c/p> \u003ca id=\"h14\" name=\"h14\">\u003c/a>\n\u003ch2>references\u003c/h2>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref1\" id=\"ref1\">\u003c/a>1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. \u003ci>front pediatr\u003c/i>. (2022) 10:819998. doi: 10.3389/fped.2022.819998 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/35601430\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.3389/fped.2022.819998\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=b+hu&#x00026;author=z+liu&#x00026;author=j+zhao&#x00026;author=l+zeng&#x00026;author=g+hao&#x00026;author=d+shui&#x00026;publication_year=2022&#x00026;title=the+global+prevalence+of+amblyopia+in+children:+a+systematic+review+and+meta-analysis&#x00026;journal=front+pediatr&#x00026;volume=10&#x00026;pages=819998\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref2\" id=\"ref2\">\u003c/a>2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. \u003ci>rom j ophthalmol\u003c/i>. (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33367172\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.22336/rjo.2020.56\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mostafaie&#x00026;author=m+ghojazadeh&#x00026;author=h+hosseinifard&#x00026;author=h+manaflouyan&#x00026;author=f+farhadi&#x00026;author=n+taheri&#x00026;publication_year=2020&#x00026;title=a+systematic+review+of+amblyopia+prevalence+among+the+children+of+the+world&#x00026;journal=rom+j+ophthalmol&#x00026;volume=64&#x00026;pages=342-55\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref3\" id=\"ref3\">\u003c/a>3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. \u003ci>cereb cortex\u003c/i>. (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/16400161\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1093/cercor/bhj110\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=ku+jirmann&#x00026;author=v+vorobyov&#x00026;author=ut+eysel&#x00026;publication_year=2006&#x00026;title=strabismic+suppression+is+mediated+by+inhibitory+interactions+in+the+primary+visual+cortex&#x00026;journal=cereb+cortex&#x00026;volume=16&#x00026;pages=1750-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref4\" id=\"ref4\">\u003c/a>4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. \u003ci>j neurosci\u003c/i>. (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/7965083\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.14-11-06855.1994\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;author=pc+kind&#x00026;author=r+harrad&#x00026;publication_year=1994&#x00026;title=interocular+suppression+in+the+visual+cortex+of+strabismic+cats&#x00026;journal=j+neurosci&#x00026;volume=14&#x00026;pages=6855-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref5\" id=\"ref5\">\u003c/a>5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. \u003ci>eye\u003c/i>. (1996) 10:250&#x2013;8.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;publication_year=1996&#x00026;title=the+neural+basis+of+suppression+and+amblyopia+in+strabismus&#x00026;journal=eye&#x00026;volume=10&#x00026;pages=250-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref6\" id=\"ref6\">\u003c/a>6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. \u003ci>bmc ophthalmol\u003c/i>. (2020) 20:203. doi: 10.1186/s12886-020-01442-9 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/32450849\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1186/s12886-020-01442-9\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=y+li&#x00026;author=h+sun&#x00026;author=x+zhu&#x00026;author=y+su&#x00026;author=t+yu&#x00026;author=x+wu&#x00026;publication_year=2020&#x00026;title=efficacy+of+interventions+for+amblyopia:+a+systematic+review+and+network+meta-analysis&#x00026;journal=bmc+ophthalmol&#x00026;volume=20&#x00026;pages=203\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref7\" id=\"ref7\">\u003c/a>7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. \u003ci>optom vis sci\u003c/i>. (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19417699\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1097/opx.0b013e3181a7b3e5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mj+moseley&#x00026;author=ar+fielder&#x00026;author=ce+stewart&#x00026;publication_year=2009&#x00026;title=the+optical+treatment+of+amblyopia&#x00026;journal=optom+vis+sci&#x00026;volume=86&#x00026;pages=629-33\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref8\" id=\"ref8\">\u003c/a>8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. \u003ci>curr biol\u003c/i>. (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25247373\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2014.05.063\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;publication_year=2014&#x00026;title=plasticity+of+the+visual+cortex+and+treatment+of+amblyopia&#x00026;journal=curr+biol&#x00026;volume=24&#x00026;pages=r936-40\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref9\" id=\"ref9\">\u003c/a>9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. \u003ci>sci rep\u003c/i>. (2018) 8:12830. doi: 10.1038/s41598-018-31169-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30150750\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-018-31169-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=hj+huttunen&#x00026;author=jm+palva&#x00026;author=l+lindberg&#x00026;author=s+palva&#x00026;author=v+saarela&#x00026;author=e+karvonen&#x00026;publication_year=2018&#x00026;title=fluoxetine+does+not+enhance+the+effect+of+perceptual+learning+on+visual+function+in+adults+with+amblyopia&#x00026;journal=sci+rep&#x00026;volume=8&#x00026;pages=12830\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref10\" id=\"ref10\">\u003c/a>10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. \u003ci>j neurosci\u003c/i>. (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/21068299\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.4812-10.2010\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+bavelier&#x00026;author=dm+levi&#x00026;author=rw+li&#x00026;author=y+dan&#x00026;author=tk+hensch&#x00026;publication_year=2010&#x00026;title=removing+brakes+on+adult+brain+plasticity:+from+molecular+to+behavioral+interventions&#x00026;journal=j+neurosci&#x00026;volume=30&#x00026;pages=14964-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref11\" id=\"ref11\">\u003c/a>11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. \u003ci>science\u003c/i>. (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1126/science.1150516\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=m+vetencourt&#x00026;author=v+jf&#x00026;author=a+sale&#x00026;author=a+viegi&#x00026;author=l+baroncelli&#x00026;author=r+de+pasquale&#x00026;publication_year=2008&#x00026;title=the+antidepressant+fluoxetine+restores+plasticity+in+the+adult+visual+cortex&#x00026;journal=science&#x00026;volume=320&#x00026;pages=385-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref12\" id=\"ref12\">\u003c/a>12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. \u003ci>eye\u003c/i>. (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30783259\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41433-019-0360-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mh+sharif&#x00026;author=mr+talebnejad&#x00026;author=k+rastegar&#x00026;author=mr+khalili&#x00026;author=mh+nowroozzadeh&#x00026;publication_year=2019&#x00026;title=oral+fluoxetine+in+the+management+of+amblyopic+patients+aged+between+10+and+40+years+old:+a+randomized+clinical+trial&#x00026;journal=eye&#x00026;volume=33&#x00026;pages=1060-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref13\" id=\"ref13\">\u003c/a>13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. \u003ci>j aapos\u003c/i>. (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/39304030\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.jaapos.2024.104009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mirmohammadsadeghi&#x00026;author=a+mousavi&#x00026;author=mr+akbari&#x00026;author=h+khojasteh&#x00026;author=b+masoomian&#x00026;author=m+sadeghi&#x00026;publication_year=2024&#x00026;title=fluoxetine+as+a+possible+treatment+for+adult+amblyopia:+results+of+a+double-blind+randomized+placebo-controlled+trial&#x00026;journal=j+aapos&#x00026;volume=28&#x00026;pages=104009\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref14\" id=\"ref14\">\u003c/a>14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. \u003ci>neural plast\u003c/i>. (2019) 2019:5857243. doi: 10.1155/2019/5857243\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1155/2019/5857243\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ak+lagas&#x00026;author=jm+black&#x00026;author=br+russell&#x00026;author=rr+kydd&#x00026;author=b+thompson&#x00026;publication_year=2019&#x00026;title=the+effect+of+combined+patching+and+citalopram+on+visual+acuity+in+adults+with+amblyopia:+a+randomized+crossover+placebo-controlled+trial&#x00026;journal=neural+plast&#x00026;volume=2019&#x00026;pages=5857243\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref15\" id=\"ref15\">\u003c/a>15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. \u003ci>bmj\u003c/i>. (2009) 339:b2535. doi: 10.1136/bmj.b2535 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19622551\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.b2535\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+moher&#x00026;author=a+liberati&#x00026;author=j+tetzlaff&#x00026;author=dg+altman&#x00026;publication_year=2009&#x00026;title=preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+the+prisma+statement&#x00026;journal=bmj&#x00026;volume=339&#x00026;pages=b2535\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref16\" id=\"ref16\">\u003c/a>16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2019) 366:l4898. doi: 10.1136/bmj.l4898 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/31462531\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.l4898\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jac+sterne&#x00026;author=j+savovi&#x0107;&#x00026;author=mj+page&#x00026;author=rg+elbers&#x00026;author=ns+blencowe&#x00026;author=i+boutron&#x00026;publication_year=2019&#x00026;title=rob+2:+a+revised+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=366&#x00026;pages=l4898\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref17\" id=\"ref17\">\u003c/a>17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2011) 343:d5928. doi: 10.1136/bmj.d5928 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/22008217\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.d5928\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jpt+higgins&#x00026;author=dg+altman&#x00026;author=pc+g&#x000f8;tzsche&#x00026;author=p+j&#x000fc;ni&#x00026;author=d+moher&#x00026;author=ad+oxman&#x00026;publication_year=2011&#x00026;title=the+cochrane+collaboration&#x2019;s+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=343&#x00026;pages=d5928\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref18\" id=\"ref18\">\u003c/a>18. feighner, jp. mechanism of action of antidepressant medications. \u003ci>j clin psychiatry\u003c/i>. (1999) 60:4&#x2013;11.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=jp+feighner&#x00026;publication_year=1999&#x00026;title=mechanism+of+action+of+antidepressant+medications&#x00026;journal=j+clin+psychiatry&#x00026;volume=60&#x00026;pages=4-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref19\" id=\"ref19\">\u003c/a>19. morishita, h, and hensch, tk. critical period revisited: impact on vision. \u003ci>curr opin neurobiol\u003c/i>. (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/18534841\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.conb.2008.05.009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+morishita&#x00026;author=tk+hensch&#x00026;publication_year=2008&#x00026;title=critical+period+revisited:+impact+on+vision&#x00026;journal=curr+opin+neurobiol&#x00026;volume=18&#x00026;pages=101-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref20\" id=\"ref20\">\u003c/a>20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. \u003ci>ophthalmology\u003c/i>. (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25676904\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.ophtha.2015.01.002\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mx+repka&#x00026;author=rt+kraker&#x00026;author=tw+dean&#x00026;author=rw+beck&#x00026;author=rm+siatkowski&#x00026;publication_year=2015&#x00026;title=a+randomized+trial+of+levodopa+as+treatment+for+residual+amblyopia+in+older+children&#x00026;journal=ophthalmology&#x00026;volume=122&#x00026;pages=874-81\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref21\" id=\"ref21\">\u003c/a>21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. \u003ci>sci rep\u003c/i>. (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37349338\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-023-34891-5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+wu&#x00026;author=ed+gaier&#x00026;author=br+nihalani&#x00026;author=s+whitecross&#x00026;author=tk+hensch&#x00026;author=dg+hunter&#x00026;publication_year=2023&#x00026;title=durable+recovery+from+amblyopia+with+donepezil&#x00026;journal=sci+rep&#x00026;volume=13&#x00026;pages=10161\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref22\" id=\"ref22\">\u003c/a>22. mitchell, d, and sengpiel, f. animal models of amblyopia. \u003ci>vis neurosci\u003c/i>. (2018) 35:e017. doi: 10.1017/s0952523817000244 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/29905121\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1017/s0952523817000244\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+mitchell&#x00026;author=f+sengpiel&#x00026;publication_year=2018&#x00026;title=animal+models+of+amblyopia&#x00026;journal=vis+neurosci&#x00026;volume=35&#x00026;pages=e017\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref23\" id=\"ref23\">\u003c/a>23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). \u003ci>doc ophthalmol\u003c/i>. (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/27443562\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s10633-016-9553-y\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jv+odom&#x00026;author=m+bach&#x00026;author=m+brigell&#x00026;author=ge+holder&#x00026;author=dl+mcculloch&#x00026;author=a+mizota&#x00026;publication_year=2016&#x00026;title=iscev+standard+for+clinical+visual+evoked+potentials:+(2016+update)&#x00026;journal=doc+ophthalmol&#x00026;volume=133&#x00026;pages=1-9\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref24\" id=\"ref24\">\u003c/a>24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. \u003ci>brain struct funct\u003c/i>. (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33900453\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s00429-021-02273-0\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=h+bridge&#x00026;publication_year=2022&#x00026;title=investigating+the+neurochemistry+of+the+human+visual+system+using+magnetic+resonance+spectroscopy&#x00026;journal=brain+struct+funct&#x00026;volume=227&#x00026;pages=1491-505\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref25\" id=\"ref25\">\u003c/a>25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. \u003ci>imaging neurosci.\u003c/i> (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40110226\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1162/imag_a_00256\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=wt+clarke&#x00026;author=a+wyllie&#x00026;author=k+tracey&#x00026;author=j+matuszewski&#x00026;author=s+jbabdi&#x00026;publication_year=2024&#x00026;title=the+relationship+between+visual+acuity+loss+and+gabaergic+inhibition+in+amblyopia&#x00026;journal=imaging+neurosci.&#x00026;volume=2&#x00026;pages=1-18\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref26\" id=\"ref26\">\u003c/a>26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. \u003ci>perception\u003c/i>. (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37272064\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1177/03010066231178664\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+bridge&#x00026;author=ib+ip&#x00026;author=aj+parker&#x00026;publication_year=2023&#x00026;title=investigating+the+human+binocular+visual+system+using+multi-modal+magnetic+resonance+imaging&#x00026;journal=perception&#x00026;volume=52&#x00026;pages=441-58\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref27\" id=\"ref27\">\u003c/a>27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. \u003ci>front hum neurosci\u003c/i>. (2022) 16:949395. doi: 10.3389/fnhum.2022.949395\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.3389/fnhum.2022.949395\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mukerji&#x00026;author=kn+byrne&#x00026;author=e+yang&#x00026;author=dm+levi&#x00026;author=ma+silver&#x00026;publication_year=2022&#x00026;title=visual+cortical+&#x03b3;&#x02212;aminobutyric+acid+and+perceptual+suppression+in+amblyopia&#x00026;journal=front+hum+neurosci&#x00026;volume=16&#x00026;pages=949395\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref28\" id=\"ref28\">\u003c/a>28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: \u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26004760/\">https://pubmed.ncbi.nlm.nih.gov/26004760/\u003c/a>\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?publication_year=2025&#x00026;\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref29\" id=\"ref29\">\u003c/a>29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. \u003ci>strabismus\u003c/i>. (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40226898\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1080/09273972.2025.2478078\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+chedid&#x00026;author=m+fronius&#x00026;author=y+wenner&#x00026;author=l+cirina&#x00026;author=t+kohnen&#x00026;author=c+kuhli-hattenbach&#x00026;publication_year=2025&#x00026;title=optical+coherence+tomography+(oct)+parameters+in+amblyopia&#x00026;journal=strabismus&#x00026;volume=1&#x2013;11&#x00026;pages=1-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref30\" id=\"ref30\">\u003c/a>30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. \u003ci>j vis\u003c/i>. (2023) 23:14. doi: 10.1167/jov.23.1.14 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/36662501\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1167/jov.23.1.14\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=dm+levi&#x00026;publication_year=2023&#x00026;title=applications+and+implications+for+extended+reality+to+improve+binocular+vision+and+stereopsis&#x00026;journal=j+vis&#x00026;volume=23&#x00026;pages=14\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref31\" id=\"ref31\">\u003c/a>31. lunghi, c, and sale, a. a cycling lane for brain rewiring. \u003ci>curr biol\u003c/i>. (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26654367\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2015.10.026\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=a+sale&#x00026;publication_year=2015&#x00026;title=a+cycling+lane+for+brain+rewiring&#x00026;journal=curr+biol&#x00026;volume=25&#x00026;pages=r1122-3\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref32\" id=\"ref32\">\u003c/a>32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. \u003ci>annal. clin. transl. neurol.\u003c/i> (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30847360\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1002/acn3.698\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=at+sframeli&#x00026;author=a+lepri&#x00026;author=m+lepri&#x00026;author=d+lisi&#x00026;author=a+sale&#x00026;publication_year=2019&#x00026;title=a+new+counterintuitive+training+for+adult+amblyopia&#x00026;journal=annal.+clin.+transl.+neurol.&#x00026;volume=6&#x00026;pages=274-84\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003c/div> \u003cdiv class=\"thinlinem20\">\u003c/div> \u003cdiv class=\"abstractsummary\">\n\u003cp>\u003cspan>keywords:\u003c/span> amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity\u003c/p>\n\u003cp>\u003cspan>citation:\u003c/span> shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. \u003ci>front. neurol\u003c/i>. 16:1639913. doi: 10.3389/fneur.2025.1639913\u003c/p>\n\u003cp class=\"timestamps\">\u003cspan>received:\u003c/span> 03 june 2025; \u003cspan>accepted:\u003c/span> 31 july 2025;\u003cbr> \u003cspan>published:\u003c/span> 21 august 2025.\u003c/p> \u003cdiv>\n\u003cp>edited by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/2271562/overview\">gordon plant\u003c/a>, university college london, united kingdom\u003c/div> \u003cdiv>\n\u003cp>reviewed by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/1863925/overview\">sara samadzadeh\u003c/a>, charit&#x00e9; university medicine berlin, germany\u003cbr> \u003ca href=\"https://loop.frontiersin.org/people/870962/overview\">alistair r. fielder\u003c/a>, city university of london, united kingdom\u003c/div>\n\u003cp>\u003cspan>copyright\u003c/span> &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">creative commons attribution license (cc by)\u003c/a>. the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms.\u003c/p>\n\u003cp>\u003cspan>&#x0002a;correspondence:\u003c/span> i. betina ip, \u003ca id=\"encmail\">ymv0aw5hlmlwqg5ky24ub3guywmudws=\u003c/a>\u003c/p>\n\u003cp>\u003cspan>\u003csup>&#x2020;\u003c/sup>\u003c/span>these authors share senior authorship\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div>","\u003cul class=\"flyoutjournal\"> \u003cli>\u003ca href=\"#h1\">abstract\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h2\">introduction\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h3\">methods\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h4\">results\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h5\">discussion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h6\">conclusion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h7\">data availability statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h8\">author contributions\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h9\">funding\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h10\">conflict of interest\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h11\">generative ai statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h12\">publisher&#x2019;s note\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h13\">author disclaimer\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h14\">references\u003c/a>\u003c/li> \u003c/ul>",[719,725,731],{"name":720,"fileserverpackageentryid":19,"fileserverid":721,"fileserverversionnumber":439,"type":722},"epub.epub","1639913/epub",{"code":723,"name":724},"epub","epub",{"name":726,"fileserverpackageentryid":19,"fileserverid":727,"fileserverversionnumber":439,"type":728},"publishers-proof.pdf","1639913/publishers-proof",{"code":729,"name":730},"pdf","pdf",{"name":732,"fileserverpackageentryid":733,"fileserverid":734,"fileserverversionnumber":439,"type":735},"fneur-16-1639913.xml","fneur-16-1639913/fneur-16-1639913.xml","1639913/xml",{"code":736,"name":737},"nlm_xml","xml","v3",{"title":740,"link":741,"meta":745,"script":869},"frontiers | selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials",[742],{"rel":743,"href":744},"canonical","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/full",[746,749,752,754,757,761,764,768,771,774,777,779,781,783,785,787,790,793,795,798,800,802,805,808,811,814,817,821,825,828,831,834,837,840,843,846,849,852,855,858,861,864,866],{"hid":747,"property":747,"name":747,"content":748},"description","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in ea...",{"hid":750,"property":750,"name":751,"content":740},"og:title","title",{"hid":753,"property":753,"name":747,"content":748},"og:description",{"hid":755,"name":755,"content":756},"keywords","strabismus,neuroplasticity,amblyopia,fluoxetine,ssris,anisometropia,citalopram",{"hid":758,"property":758,"name":759,"content":760},"og:site_name","site_name","frontiers",{"hid":762,"property":762,"name":432,"content":763},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg",{"hid":765,"property":765,"name":766,"content":767},"og:type","type","article",{"hid":769,"property":769,"name":770,"content":744},"og:url","url",{"hid":772,"name":772,"content":773},"twitter:card","summary_large_image",{"hid":775,"name":775,"content":776},"citation_volume","16",{"hid":778,"name":778,"content":116},"citation_journal_title",{"hid":780,"name":780,"content":760},"citation_publisher",{"hid":782,"name":782,"content":700},"citation_journal_abbrev",{"hid":784,"name":784,"content":701},"citation_issn",{"hid":786,"name":786,"content":583},"citation_doi",{"hid":788,"name":788,"content":789},"citation_firstpage","1639913",{"hid":791,"name":791,"content":792},"citation_language","english",{"hid":794,"name":794,"content":584},"citation_title",{"hid":796,"name":796,"content":797},"citation_keywords","strabismus; neuroplasticity; amblyopia; fluoxetine; ssris; anisometropia; citalopram",{"hid":799,"name":799,"content":589},"citation_abstract",{"hid":801,"name":801,"content":598},"citation_article_type",{"hid":803,"name":803,"content":804},"citation_pdf_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/pdf",{"hid":806,"name":806,"content":807},"citation_xml_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/xml",{"hid":809,"name":809,"content":810},"citation_fulltext_world_readable","yes",{"hid":812,"name":812,"content":813},"citation_online_date","2025/07/31",{"hid":815,"name":815,"content":816},"citation_publication_date","2025/08/21",{"hid":818,"name":819,"content":820},"citation_author_0","citation_author","shamsher, ehtesham ",{"hid":822,"name":823,"content":824},"citation_author_institution_0","citation_author_institution","oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, united kingdom",{"hid":826,"name":819,"content":827},"citation_author_1","saccaro, luisa ",{"hid":829,"name":823,"content":830},"citation_author_institution_1","faculty of medicine, universidade de mogi das cruzes, brazil",{"hid":832,"name":819,"content":833},"citation_author_2","pungirum, victor barreiros ",{"hid":835,"name":823,"content":836},"citation_author_institution_2","faculty of medical sciences, university of buenos aires, argentina",{"hid":838,"name":819,"content":839},"citation_author_3","tran, nghi bao ",{"hid":841,"name":823,"content":842},"citation_author_institution_3","faculty of medicine, university of debrecen, hungary",{"hid":844,"name":819,"content":845},"citation_author_4","alghaith, omar a. h. a. ",{"hid":847,"name":823,"content":848},"citation_author_institution_4","institute of ophthalmology, university college london, united kingdom",{"hid":850,"name":819,"content":851},"citation_author_5","khabazianzadeh, fatemeh ",{"hid":853,"name":823,"content":854},"citation_author_institution_5","eye research center, khatam-al-anbia hospital, mashad university of medical sciences, iran",{"hid":856,"name":819,"content":857},"citation_author_6","bridge, holly ",{"hid":859,"name":823,"content":860},"citation_author_institution_6","nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, united kingdom",{"hid":862,"name":819,"content":863},"citation_author_7","ip, i. betina ",{"hid":865,"name":823,"content":860},"citation_author_institution_7",{"hid":867,"name":867,"content":868},"dc.identifier","doi:10.3389/fneur.2025.1639913",[870,873,875,877,879],{"src":871,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":874,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/mathjax.js?config=tex-mml-am_chtml",{"src":876,"body":13,"type":872,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":878,"body":13,"type":872,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1639913?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":880,"body":13,"type":872,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articlehubslug":19,"articlehubpage":882,"articlehubarticleslist":883,"canjournalhasarticlehub":379,"articledoilist":884},{},[],[],{"title":19,"image":-1,"breadcrumbs":886,"linkscollection":887,"metricscollection":889},[],{"total":436,"items":888},[],{"total":436,"items":890},[]] window.__nuxt__={};window.__nuxt__.config={public:{isdevmode:false,appname:"article-pages-2024",baseurl:"https://www.frontiersin.org",domain:"frontiersin.org",loopurl:"https://loop.frontiersin.org",ssmaindomain:"frontiersin.org",contentfulurl:"https://graphql.contentful.com/content/v1/spaces",spaceid:1,spacename:"frontiers",livespaceid:1,tenantlogourl:"",frontiersgraphurl:"https://apollo-federation-gateway.frontiersin.org",registrationapiurl:"https://onboarding-ui.frontiersin.org",emaildigestapiurl:"https://api-email-digest.frontiersin.org",journalfilesapiurl:"https://files-journal-api.frontiersin.org",searchapiurl:"https://search-api.frontiersin.org",productionforumapiurl:"https://production-forum-api-v2.frontiersin.org",gtmserverurl:"https://tag-manager.frontiersin.org",gtmid:"gtm-m322fv2",gtmauth:"owvbwxfajr21yqv1fe1caq",gtmpreview:"env-1",figsharepluginurl:"https://widgets.figshare.com/static/figshare.js",figshareapiurl:"https://api.figshare.com/v2/collections/search",figsharetimeout:3000,crossmarkpublisheddate:"2015/08/24",googlerecaptchasitekey:"6ldg3i0uaaaaaoc4quh35ubhgjotehp_stxhgr_v",googlerecaptchakeyname:"frontiersrecaptchav2",faviconsize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantfavicon-frontiers.png",faviconsize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantfavicon-frontiers.png",faviconsize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantfavicon-frontiers.png",faviconsize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantfavicon-frontiers.png",faviconsize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantfavicon-frontiers.png",socialmediaimg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/guidelines-frontiers_logo_1200x628_1-91to1.png",linkedarticlecopytext:"'{\"articletypecopytext\":[{\"articletypeid\":0,\"originalarticlecopytext\":\"part of this article's content has been mentioned in:\",\"linkedarticlecopytext\":\"this article mentions parts of:\"},{\"articletypeid\":122,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an erratum on:\"},{\"articletypeid\":129,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an addendum to:\"},{\"articletypeid\":128,\"originalarticlecopytext\":\"a correction has been applied to this article in:\",\"linkedarticlecopytext\":\"this article is a correction to:\"},{\"articletypeid\":134,\"originalarticlecopytext\":\"a retraction of this article was approved in:\",\"linkedarticlecopytext\":\"this article is a retraction of:\"},{\"articletypeid\":29,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"},{\"articletypeid\":30,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"}],\"articleidcopytext\":[]}'\n",acceptedarticleexcludedjournalids:"'[2766,979]'\n",articletypeconfigurablelabel:"\u003c\u003carticle-type:uppercase>> article",settingsfeaturesswitchers:"'{\"displaytitlepilllabels\":true,\"displayrelatedarticlesbox\":true,\"showeditors\":true,\"showreviewers\":true,\"showloopimpactlink\":true,\"enablefigshare\":false,\"usexmlimages\":true}'\n",journalswitharticlehub:"'{\"strings\":[\"science\"]}'\n",terminologysettings:"'{\"terms\":[{\"sequencenumber\":1,\"key\":\"frontiers\",\"tenantterm\":\"frontiers\",\"frontiersdefaultterm\":\"frontiers\",\"category\":\"customer\"},{\"sequencenumber\":2,\"key\":\"submission_system\",\"tenantterm\":\"submission system\",\"frontiersdefaultterm\":\"submission system\",\"category\":\"product\"},{\"sequencenumber\":3,\"key\":\"public_pages\",\"tenantterm\":\"public pages\",\"frontiersdefaultterm\":\"public pages\",\"category\":\"product\"},{\"sequencenumber\":4,\"key\":\"my_frontiers\",\"tenantterm\":\"my frontiers\",\"frontiersdefaultterm\":\"my frontiers\",\"category\":\"product\"},{\"sequencenumber\":5,\"key\":\"digital_editorial_office\",\"tenantterm\":\"digital editorial office\",\"frontiersdefaultterm\":\"digital editorial office\",\"category\":\"product\"},{\"sequencenumber\":6,\"key\":\"deo\",\"tenantterm\":\"deo\",\"frontiersdefaultterm\":\"deo\",\"category\":\"product\"},{\"sequencenumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantterm\":\"digital editorial office for chiefs\",\"frontiersdefaultterm\":\"digital editorial office for chiefs\",\"category\":\"product\"},{\"sequencenumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantterm\":\"digital editorial office for eof\",\"frontiersdefaultterm\":\"digital editorial office for eof\",\"category\":\"product\"},{\"sequencenumber\":9,\"key\":\"editorial_office\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"product\"},{\"sequencenumber\":10,\"key\":\"eof\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"product\"},{\"sequencenumber\":11,\"key\":\"research_topic_management\",\"tenantterm\":\"research topic management\",\"frontiersdefaultterm\":\"research topic management\",\"category\":\"product\"},{\"sequencenumber\":12,\"key\":\"review_forum\",\"tenantterm\":\"review forum\",\"frontiersdefaultterm\":\"review forum\",\"category\":\"product\"},{\"sequencenumber\":13,\"key\":\"accounting_office\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"product\"},{\"sequencenumber\":14,\"key\":\"aof\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"product\"},{\"sequencenumber\":15,\"key\":\"publishing_office\",\"tenantterm\":\"publishing office\",\"frontiersdefaultterm\":\"publishing office\",\"category\":\"product\"},{\"sequencenumber\":16,\"key\":\"production_office\",\"tenantterm\":\"production office forum\",\"frontiersdefaultterm\":\"production office forum\",\"category\":\"product\"},{\"sequencenumber\":17,\"key\":\"pof\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"product\"},{\"sequencenumber\":18,\"key\":\"book_office_forum\",\"tenantterm\":\"book office forum\",\"frontiersdefaultterm\":\"book office forum\",\"category\":\"product\"},{\"sequencenumber\":19,\"key\":\"bof\",\"tenantterm\":\"bof\",\"frontiersdefaultterm\":\"bof\",\"category\":\"product\"},{\"sequencenumber\":20,\"key\":\"aira\",\"tenantterm\":\"aira\",\"frontiersdefaultterm\":\"aira\",\"category\":\"product\"},{\"sequencenumber\":21,\"key\":\"editorial_board_management\",\"tenantterm\":\"editorial board management\",\"frontiersdefaultterm\":\"editorial board management\",\"category\":\"product\"},{\"sequencenumber\":22,\"key\":\"ebm\",\"tenantterm\":\"ebm\",\"frontiersdefaultterm\":\"ebm\",\"category\":\"product\"},{\"sequencenumber\":23,\"key\":\"domain\",\"tenantterm\":\"domain\",\"frontiersdefaultterm\":\"domain\",\"category\":\"taxonomy\"},{\"sequencenumber\":24,\"key\":\"journal\",\"tenantterm\":\"journal\",\"frontiersdefaultterm\":\"journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":25,\"key\":\"section\",\"tenantterm\":\"section\",\"frontiersdefaultterm\":\"section\",\"category\":\"taxonomy\"},{\"sequencenumber\":26,\"key\":\"domains\",\"tenantterm\":\"domains\",\"frontiersdefaultterm\":\"domains\",\"category\":\"taxonomy\"},{\"sequencenumber\":27,\"key\":\"specialty_section\",\"tenantterm\":\"specialty section\",\"frontiersdefaultterm\":\"specialty section\",\"category\":\"taxonomy\"},{\"sequencenumber\":28,\"key\":\"specialty_journal\",\"tenantterm\":\"specialty journal\",\"frontiersdefaultterm\":\"specialty journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":29,\"key\":\"journals\",\"tenantterm\":\"journals\",\"frontiersdefaultterm\":\"journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":30,\"key\":\"sections\",\"tenantterm\":\"sections\",\"frontiersdefaultterm\":\"sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":31,\"key\":\"specialty_sections\",\"tenantterm\":\"specialty sections\",\"frontiersdefaultterm\":\"specialty sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":32,\"key\":\"specialty_journals\",\"tenantterm\":\"specialty journals\",\"frontiersdefaultterm\":\"specialty journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":33,\"key\":\"manuscript\",\"tenantterm\":\"manuscript\",\"frontiersdefaultterm\":\"manuscript\",\"category\":\"core\"},{\"sequencenumber\":34,\"key\":\"manuscripts\",\"tenantterm\":\"manuscripts\",\"frontiersdefaultterm\":\"manuscripts\",\"category\":\"core\"},{\"sequencenumber\":35,\"key\":\"article\",\"tenantterm\":\"article\",\"frontiersdefaultterm\":\"article\",\"category\":\"core\"},{\"sequencenumber\":36,\"key\":\"articles\",\"tenantterm\":\"articles\",\"frontiersdefaultterm\":\"articles\",\"category\":\"core\"},{\"sequencenumber\":37,\"key\":\"article_type\",\"tenantterm\":\"article type\",\"frontiersdefaultterm\":\"article type\",\"category\":\"core\"},{\"sequencenumber\":38,\"key\":\"article_types\",\"tenantterm\":\"article types\",\"frontiersdefaultterm\":\"article types\",\"category\":\"core\"},{\"sequencenumber\":39,\"key\":\"author\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":40,\"key\":\"authors\",\"tenantterm\":\"authors\",\"frontiersdefaultterm\":\"authors\",\"category\":\"label (role)\"},{\"sequencenumber\":41,\"key\":\"authoring\",\"tenantterm\":\"authoring\",\"frontiersdefaultterm\":\"authoring\",\"category\":\"core\"},{\"sequencenumber\":42,\"key\":\"authored\",\"tenantterm\":\"authored\",\"frontiersdefaultterm\":\"authored\",\"category\":\"core\"},{\"sequencenumber\":43,\"key\":\"accept\",\"tenantterm\":\"accept\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":44,\"key\":\"accepted\",\"tenantterm\":\"accepted\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"description\":\"an editorial role on a field journal that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantterm\":\"assistant specialty chief editors\",\"frontiersdefaultterm\":\"assistant specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":48,\"key\":\"associate_editor\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":49,\"key\":\"specialty_chief_editor\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":50,\"key\":\"specialty_chief_editors\",\"tenantterm\":\"specialty chief editors\",\"frontiersdefaultterm\":\"specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":51,\"key\":\"chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":52,\"key\":\"chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":53,\"key\":\"call_for_participation\",\"tenantterm\":\"call for participation\",\"frontiersdefaultterm\":\"call for participation\",\"category\":\"process\"},{\"sequencenumber\":54,\"key\":\"citation\",\"tenantterm\":\"citation\",\"frontiersdefaultterm\":\"citation\",\"category\":\"misc.\"},{\"sequencenumber\":55,\"key\":\"citations\",\"tenantterm\":\"citations\",\"frontiersdefaultterm\":\"citations\",\"category\":\"misc.\"},{\"sequencenumber\":56,\"key\":\"contributor\",\"tenantterm\":\"contributor\",\"frontiersdefaultterm\":\"contributor\",\"category\":\"label (role)\"},{\"sequencenumber\":57,\"key\":\"contributors\",\"tenantterm\":\"contributors\",\"frontiersdefaultterm\":\"contributors\",\"category\":\"label (role)\"},{\"sequencenumber\":58,\"key\":\"corresponding_author\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":59,\"key\":\"corresponding_authors\",\"tenantterm\":\"corresponding authors\",\"frontiersdefaultterm\":\"corresponding authors\",\"category\":\"label (role)\"},{\"sequencenumber\":60,\"key\":\"decline\",\"tenantterm\":\"decline\",\"frontiersdefaultterm\":\"decline\",\"category\":\"process\"},{\"sequencenumber\":61,\"key\":\"declined\",\"tenantterm\":\"declined\",\"frontiersdefaultterm\":\"declined\",\"category\":\"process\"},{\"sequencenumber\":62,\"key\":\"reject\",\"tenantterm\":\"reject\",\"frontiersdefaultterm\":\"reject\",\"category\":\"process\"},{\"sequencenumber\":63,\"key\":\"rejected\",\"tenantterm\":\"rejected\",\"frontiersdefaultterm\":\"rejected\",\"category\":\"process\"},{\"sequencenumber\":64,\"key\":\"publish\",\"tenantterm\":\"publish\",\"frontiersdefaultterm\":\"publish\",\"category\":\"core\"},{\"sequencenumber\":65,\"key\":\"published\",\"tenantterm\":\"published\",\"frontiersdefaultterm\":\"published\",\"category\":\"core\"},{\"sequencenumber\":66,\"key\":\"publication\",\"tenantterm\":\"publication\",\"frontiersdefaultterm\":\"publication\",\"category\":\"core\"},{\"sequencenumber\":67,\"key\":\"peer_review\",\"tenantterm\":\"peer review\",\"frontiersdefaultterm\":\"peer review\",\"category\":\"peer review process\"},{\"sequencenumber\":68,\"key\":\"peer_reviewed\",\"tenantterm\":\"peer reviewed\",\"frontiersdefaultterm\":\"peer reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":69,\"key\":\"initial_validation\",\"tenantterm\":\"initial validation\",\"frontiersdefaultterm\":\"initial validation\",\"category\":\"peer review process\"},{\"sequencenumber\":70,\"key\":\"editorial_assignment\",\"tenantterm\":\"editorial assignment\",\"frontiersdefaultterm\":\"editorial assignment\",\"category\":\"peer review process\"},{\"sequencenumber\":71,\"key\":\"independent_review\",\"tenantterm\":\"independent review\",\"frontiersdefaultterm\":\"independent review\",\"category\":\"peer review process\"},{\"sequencenumber\":72,\"key\":\"interactive_review\",\"tenantterm\":\"interactive review\",\"frontiersdefaultterm\":\"interactive review\",\"category\":\"peer review process\"},{\"sequencenumber\":73,\"key\":\"review\",\"tenantterm\":\"review\",\"frontiersdefaultterm\":\"review\",\"category\":\"peer review process\"},{\"sequencenumber\":74,\"key\":\"reviewing\",\"tenantterm\":\"reviewing\",\"frontiersdefaultterm\":\"reviewing\",\"category\":\"peer review process\"},{\"sequencenumber\":75,\"key\":\"reviewer\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":76,\"key\":\"reviewers\",\"tenantterm\":\"reviewers\",\"frontiersdefaultterm\":\"reviewers\",\"category\":\"label (role)\"},{\"sequencenumber\":77,\"key\":\"review_finalized\",\"tenantterm\":\"review finalized\",\"frontiersdefaultterm\":\"review finalized\",\"category\":\"peer review process\"},{\"sequencenumber\":78,\"key\":\"final_decision\",\"tenantterm\":\"final decision\",\"frontiersdefaultterm\":\"final decision\",\"category\":\"peer review process\"},{\"sequencenumber\":79,\"key\":\"final_validation\",\"tenantterm\":\"final validation\",\"frontiersdefaultterm\":\"final validation\",\"category\":\"peer review process\"},{\"sequencenumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantterm\":\"recommend to accept manuscript\",\"frontiersdefaultterm\":\"accept manuscript\",\"category\":\"process\"},{\"sequencenumber\":81,\"key\":\"fee\",\"tenantterm\":\"fee\",\"frontiersdefaultterm\":\"fee\",\"category\":\"accounting\"},{\"sequencenumber\":82,\"key\":\"fees\",\"tenantterm\":\"fees\",\"frontiersdefaultterm\":\"fees\",\"category\":\"accounting\"},{\"sequencenumber\":83,\"key\":\"guest_associate_editor\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":84,\"key\":\"guest_associate_editors\",\"tenantterm\":\"guest associate editors\",\"frontiersdefaultterm\":\"guest associate editors\",\"category\":\"label (role)\"},{\"sequencenumber\":85,\"key\":\"in_review\",\"tenantterm\":\"in review\",\"frontiersdefaultterm\":\"in review\",\"category\":\"peer review process\"},{\"sequencenumber\":86,\"key\":\"institutional_member\",\"tenantterm\":\"institutional partner\",\"frontiersdefaultterm\":\"institutional partner\",\"category\":\"accounting\"},{\"sequencenumber\":87,\"key\":\"institutional_membership\",\"tenantterm\":\"institutional partnership\",\"frontiersdefaultterm\":\"institutional partnership\",\"category\":\"accounting\"},{\"sequencenumber\":88,\"key\":\"article_processing_charge\",\"tenantterm\":\"article processing charge\",\"frontiersdefaultterm\":\"article processing charge\",\"category\":\"accounting\"},{\"sequencenumber\":89,\"key\":\"article_processing_charges\",\"tenantterm\":\"article processing charges\",\"frontiersdefaultterm\":\"article processing charges\",\"category\":\"accounting\"},{\"sequencenumber\":90,\"key\":\"apcs\",\"tenantterm\":\"apcs\",\"frontiersdefaultterm\":\"apcs\",\"category\":\"accounting\"},{\"sequencenumber\":91,\"key\":\"apc\",\"tenantterm\":\"apc\",\"frontiersdefaultterm\":\"apc\",\"category\":\"accounting\"},{\"sequencenumber\":92,\"key\":\"received\",\"tenantterm\":\"received\",\"frontiersdefaultterm\":\"received\",\"description\":\"date manuscript was received on.\",\"category\":\"core\"},{\"sequencenumber\":93,\"key\":\"transferred\",\"tenantterm\":\"transferred\",\"frontiersdefaultterm\":\"transferred\",\"category\":\"core\"},{\"sequencenumber\":94,\"key\":\"transfer\",\"tenantterm\":\"transfer\",\"frontiersdefaultterm\":\"transfer\",\"category\":\"core\"},{\"sequencenumber\":95,\"key\":\"research_topic\",\"tenantterm\":\"research topic\",\"frontiersdefaultterm\":\"research topic\",\"category\":\"core\"},{\"sequencenumber\":96,\"key\":\"research_topics\",\"tenantterm\":\"research topics\",\"frontiersdefaultterm\":\"research topics\",\"category\":\"core\"},{\"sequencenumber\":97,\"key\":\"topic_editor\",\"tenantterm\":\"topic editor\",\"frontiersdefaultterm\":\"topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":98,\"key\":\"review_editor\",\"tenantterm\":\"community reviewer\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":99,\"key\":\"title\",\"tenantterm\":\"title\",\"frontiersdefaultterm\":\"title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":100,\"key\":\"running_title\",\"tenantterm\":\"running title\",\"frontiersdefaultterm\":\"running title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":101,\"key\":\"submit\",\"tenantterm\":\"submit\",\"frontiersdefaultterm\":\"submit\",\"category\":\"process\"},{\"sequencenumber\":102,\"key\":\"submitted\",\"tenantterm\":\"submitted\",\"frontiersdefaultterm\":\"submitted\",\"category\":\"process\"},{\"sequencenumber\":103,\"key\":\"submitting\",\"tenantterm\":\"submitting\",\"frontiersdefaultterm\":\"submitting\",\"category\":\"process\"},{\"sequencenumber\":104,\"key\":\"t_e\",\"tenantterm\":\"te\",\"frontiersdefaultterm\":\"te\",\"category\":\"label (role)\"},{\"sequencenumber\":105,\"key\":\"topic\",\"tenantterm\":\"topic\",\"frontiersdefaultterm\":\"topic\",\"category\":\"process\"},{\"sequencenumber\":106,\"key\":\"topic_summary\",\"tenantterm\":\"topic summary\",\"frontiersdefaultterm\":\"topic summary\",\"category\":\"process\"},{\"sequencenumber\":107,\"key\":\"figure\",\"tenantterm\":\"figure\",\"frontiersdefaultterm\":\"figure\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":108,\"key\":\"figures\",\"tenantterm\":\"figures\",\"frontiersdefaultterm\":\"figures\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":109,\"key\":\"editorial_file\",\"tenantterm\":\"editorial file\",\"frontiersdefaultterm\":\"editorial file\",\"category\":\"core\"},{\"sequencenumber\":110,\"key\":\"editorial_files\",\"tenantterm\":\"editorial files\",\"frontiersdefaultterm\":\"editorial files\",\"category\":\"core\"},{\"sequencenumber\":111,\"key\":\"e_book\",\"tenantterm\":\"e-book\",\"frontiersdefaultterm\":\"e-book\",\"category\":\"core\"},{\"sequencenumber\":112,\"key\":\"organization\",\"tenantterm\":\"organization\",\"frontiersdefaultterm\":\"organization\",\"category\":\"core\"},{\"sequencenumber\":113,\"key\":\"institution\",\"tenantterm\":\"institution\",\"frontiersdefaultterm\":\"institution\",\"category\":\"core\"},{\"sequencenumber\":114,\"key\":\"reference\",\"tenantterm\":\"reference\",\"frontiersdefaultterm\":\"reference\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":115,\"key\":\"references\",\"tenantterm\":\"references\",\"frontiersdefaultterm\":\"references\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":116,\"key\":\"sce\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"description\":\"abbreviation for specialty chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":117,\"key\":\"submission\",\"tenantterm\":\"submission\",\"frontiersdefaultterm\":\"submission\",\"category\":\"process\"},{\"sequencenumber\":118,\"key\":\"submissions\",\"tenantterm\":\"submissions\",\"frontiersdefaultterm\":\"submissions\",\"category\":\"process\"},{\"sequencenumber\":119,\"key\":\"editing\",\"tenantterm\":\"editing\",\"frontiersdefaultterm\":\"editing\",\"category\":\"process\"},{\"sequencenumber\":120,\"key\":\"in_preparation\",\"tenantterm\":\"in preparation\",\"frontiersdefaultterm\":\"in preparation\",\"category\":\"process\"},{\"sequencenumber\":121,\"key\":\"country_region\",\"tenantterm\":\"country/region\",\"frontiersdefaultterm\":\"country/region\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":122,\"key\":\"countries_regions\",\"tenantterm\":\"countries/regions\",\"frontiersdefaultterm\":\"countries/regions\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":123,\"key\":\"specialty\",\"tenantterm\":\"specialty\",\"frontiersdefaultterm\":\"specialty\",\"category\":\"core\"},{\"sequencenumber\":124,\"key\":\"specialties\",\"tenantterm\":\"specialties\",\"frontiersdefaultterm\":\"specialties\",\"category\":\"core\"},{\"sequencenumber\":125,\"key\":\"associate_editors\",\"tenantterm\":\"associate editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":126,\"key\":\"reviewed\",\"tenantterm\":\"reviewed\",\"frontiersdefaultterm\":\"reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":127,\"key\":\"institutional_members\",\"tenantterm\":\"institutional partners\",\"frontiersdefaultterm\":\"institutional partners\",\"category\":\"accounting\"},{\"sequencenumber\":128,\"key\":\"institutional_memberships\",\"tenantterm\":\"institutional partnerships\",\"frontiersdefaultterm\":\"institutional partnerships\",\"category\":\"accounting\"},{\"sequencenumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantterm\":\"assistant field chief editors\",\"frontiersdefaultterm\":\"assistant field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":130,\"key\":\"publications\",\"tenantterm\":\"publications\",\"frontiersdefaultterm\":\"publications\",\"category\":\"process\"},{\"sequencenumber\":131,\"key\":\"ae_accepted\",\"tenantterm\":\"recommended acceptance\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":132,\"key\":\"field_journal\",\"tenantterm\":\"field journal\",\"frontiersdefaultterm\":\"field journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":133,\"key\":\"field_journals\",\"tenantterm\":\"field journals\",\"frontiersdefaultterm\":\"field journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":134,\"key\":\"program_manager\",\"tenantterm\":\"program manager\",\"frontiersdefaultterm\":\"program manager\",\"category\":\"label (role)\"},{\"sequencenumber\":135,\"key\":\"journal_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":136,\"key\":\"journal_specialist\",\"tenantterm\":\"journal specialist\",\"frontiersdefaultterm\":\"journal specialist\",\"category\":\"label (role)\"},{\"sequencenumber\":137,\"key\":\"program_managers\",\"tenantterm\":\"program managers\",\"frontiersdefaultterm\":\"program managers\",\"category\":\"label (role)\"},{\"sequencenumber\":138,\"key\":\"journal_managers\",\"tenantterm\":\"journal managers\",\"frontiersdefaultterm\":\"journal managers\",\"category\":\"label (role)\"},{\"sequencenumber\":139,\"key\":\"journal_specialists\",\"tenantterm\":\"journal specialists\",\"frontiersdefaultterm\":\"journal specialists\",\"category\":\"label (role)\"},{\"sequencenumber\":140,\"key\":\"cover_letter\",\"tenantterm\":\"manuscript contribution to the field\",\"frontiersdefaultterm\":\"manuscript contribution to the field\",\"category\":\"process\"},{\"sequencenumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantterm\":\"recommended to accept manuscript\",\"frontiersdefaultterm\":\"accepted manuscript\",\"category\":\"process\"},{\"sequencenumber\":142,\"key\":\"recommend_for_rejection\",\"tenantterm\":\"recommend for rejection\",\"frontiersdefaultterm\":\"recommend for rejection\",\"category\":\"process\"},{\"sequencenumber\":143,\"key\":\"recommended_for_rejection\",\"tenantterm\":\"recommended for rejection\",\"frontiersdefaultterm\":\"recommended for rejection\",\"category\":\"process\"},{\"sequencenumber\":144,\"key\":\"ae\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"description\":\"associate editor - board member\",\"category\":\"label (role)\"},{\"sequencenumber\":145,\"key\":\"re\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"description\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":146,\"key\":\"rev\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"description\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":147,\"key\":\"aut\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"description\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":148,\"key\":\"coraut\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"description\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":149,\"key\":\"saut\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"description\":\"submitting author\",\"category\":\"label (role)\"},{\"sequencenumber\":150,\"key\":\"coaut\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"description\":\"co-author\",\"category\":\"label (role)\"},{\"sequencenumber\":151,\"key\":\"tsof\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"description\":\"typesetter\",\"category\":\"label (role)\"},{\"sequencenumber\":152,\"key\":\"typesetting_office\",\"tenantterm\":\"typesetting office\",\"frontiersdefaultterm\":\"typesetting office\",\"category\":\"product\"},{\"sequencenumber\":153,\"key\":\"config\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"description\":\"configuration office role\",\"category\":\"label (role)\"},{\"sequencenumber\":154,\"key\":\"jm\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"description\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":155,\"key\":\"rte\",\"tenantterm\":\"rte\",\"frontiersdefaultterm\":\"rte\",\"description\":\"research topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":156,\"key\":\"organizations\",\"tenantterm\":\"organizations\",\"frontiersdefaultterm\":\"organizations\",\"category\":\"core\"},{\"sequencenumber\":157,\"key\":\"publishing\",\"tenantterm\":\"publishing\",\"frontiersdefaultterm\":\"publishing\",\"category\":\"core\"},{\"sequencenumber\":158,\"key\":\"acceptance\",\"tenantterm\":\"acceptance\",\"frontiersdefaultterm\":\"acceptance\",\"category\":\"process\"},{\"sequencenumber\":159,\"key\":\"preferred_associate_editor\",\"tenantterm\":\"preferred associate editor\",\"frontiersdefaultterm\":\"preferred associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":160,\"key\":\"topic_editors\",\"tenantterm\":\"topic editors\",\"frontiersdefaultterm\":\"topic editors\",\"category\":\"label (role)\"},{\"sequencenumber\":161,\"key\":\"institutions\",\"tenantterm\":\"institutions\",\"frontiersdefaultterm\":\"institutions\",\"category\":\"core\"},{\"sequencenumber\":162,\"key\":\"author(s)\",\"tenantterm\":\"author(s)\",\"frontiersdefaultterm\":\"author(s)\",\"category\":\"label (role)\"},{\"sequencenumber\":163,\"key\":\"figure(s)\",\"tenantterm\":\"figure(s)\",\"frontiersdefaultterm\":\"figure(s)\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":164,\"key\":\"co-authors\",\"tenantterm\":\"co-authors\",\"frontiersdefaultterm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"label (role)\"},{\"sequencenumber\":165,\"key\":\"editorial_board_members\",\"tenantterm\":\"editorial board members\",\"frontiersdefaultterm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"label (role)\"},{\"sequencenumber\":166,\"key\":\"editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"product\"},{\"sequencenumber\":167,\"key\":\"co-authorship\",\"tenantterm\":\"co-authorship\",\"frontiersdefaultterm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"misc.\"},{\"sequencenumber\":168,\"key\":\"role_id_1\",\"tenantterm\":\"registration office\",\"frontiersdefaultterm\":\"registration office\",\"category\":\"user role\"},{\"sequencenumber\":169,\"key\":\"role_id_2\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"user role\"},{\"sequencenumber\":170,\"key\":\"role_id_7\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":171,\"key\":\"role_id_8\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":172,\"key\":\"role_id_9\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":173,\"key\":\"role_id_10\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":174,\"key\":\"role_id_11\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"category\":\"user role\"},{\"sequencenumber\":175,\"key\":\"role_id_12\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"user role\"},{\"sequencenumber\":176,\"key\":\"role_id_13\",\"tenantterm\":\"review editor\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"user role\"},{\"sequencenumber\":177,\"key\":\"role_id_14\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"user role\"},{\"sequencenumber\":178,\"key\":\"role_id_15\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"user role\"},{\"sequencenumber\":179,\"key\":\"role_id_16\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"user role\"},{\"sequencenumber\":180,\"key\":\"role_id_17\",\"tenantterm\":\"submitting author\",\"frontiersdefaultterm\":\"submitting author\",\"category\":\"user role\"},{\"sequencenumber\":181,\"key\":\"role_id_18\",\"tenantterm\":\"co-author\",\"frontiersdefaultterm\":\"co-author\",\"category\":\"user role\"},{\"sequencenumber\":182,\"key\":\"role_id_20\",\"tenantterm\":\"production office\",\"frontiersdefaultterm\":\"production office\",\"category\":\"user role\"},{\"sequencenumber\":183,\"key\":\"role_id_22\",\"tenantterm\":\"typesetting office (typesetter)\",\"frontiersdefaultterm\":\"typesetting office (typesetter)\",\"category\":\"user role\"},{\"sequencenumber\":184,\"key\":\"role_id_24\",\"tenantterm\":\"registered user\",\"frontiersdefaultterm\":\"registered user\",\"category\":\"user role\"},{\"sequencenumber\":185,\"key\":\"role_id_35\",\"tenantterm\":\"job office\",\"frontiersdefaultterm\":\"job office\",\"category\":\"user role\"},{\"sequencenumber\":186,\"key\":\"role_id_41\",\"tenantterm\":\"special event administrator\",\"frontiersdefaultterm\":\"special event administrator\",\"category\":\"user role\"},{\"sequencenumber\":187,\"key\":\"role_id_42\",\"tenantterm\":\"special event reviewer\",\"frontiersdefaultterm\":\"special event reviewer\",\"category\":\"user role\"},{\"sequencenumber\":188,\"key\":\"role_id_43\",\"tenantterm\":\"submit abstract\",\"frontiersdefaultterm\":\"submit abstract\",\"category\":\"user role\"},{\"sequencenumber\":189,\"key\":\"role_id_52\",\"tenantterm\":\"events office\",\"frontiersdefaultterm\":\"events office\",\"category\":\"user role\"},{\"sequencenumber\":190,\"key\":\"role_id_53\",\"tenantterm\":\"event administrator\",\"frontiersdefaultterm\":\"event administrator\",\"category\":\"user role\"},{\"sequencenumber\":191,\"key\":\"role_id_89\",\"tenantterm\":\"content management office\",\"frontiersdefaultterm\":\"content management office\",\"category\":\"user role\"},{\"sequencenumber\":192,\"key\":\"role_id_98\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"user role\"},{\"sequencenumber\":193,\"key\":\"role_id_99\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":194,\"key\":\"role_id_103\",\"tenantterm\":\"configuration office\",\"frontiersdefaultterm\":\"configuration office\",\"category\":\"user role\"},{\"sequencenumber\":195,\"key\":\"role_id_104\",\"tenantterm\":\"beta user\",\"frontiersdefaultterm\":\"beta user\",\"category\":\"user role\"},{\"sequencenumber\":196,\"key\":\"role_id_106\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":197,\"key\":\"role_id_107\",\"tenantterm\":\"rt management beta user\",\"frontiersdefaultterm\":\"rt management beta user\",\"category\":\"user role\"},{\"sequencenumber\":198,\"key\":\"role_id_108\",\"tenantterm\":\"deo beta user\",\"frontiersdefaultterm\":\"deo beta user\",\"category\":\"user role\"},{\"sequencenumber\":199,\"key\":\"role_id_109\",\"tenantterm\":\"search beta user\",\"frontiersdefaultterm\":\"search beta user\",\"category\":\"user role\"},{\"sequencenumber\":200,\"key\":\"role_id_110\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"user role\"},{\"sequencenumber\":201,\"key\":\"role_id_111\",\"tenantterm\":\"myfrontiers beta user\",\"frontiersdefaultterm\":\"myfrontiers beta user\",\"category\":\"user role\"},{\"sequencenumber\":202,\"key\":\"role_id_21\",\"tenantterm\":\"copy editor\",\"frontiersdefaultterm\":\"copy editor\",\"category\":\"user role\"},{\"sequencenumber\":203,\"key\":\"role_id_1_abr\",\"tenantterm\":\"rof\",\"frontiersdefaultterm\":\"rof\",\"category\":\"user role\"},{\"sequencenumber\":204,\"key\":\"role_id_2_abr\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"user role\"},{\"sequencenumber\":205,\"key\":\"role_id_7_abr\",\"tenantterm\":\"fce\",\"frontiersdefaultterm\":\"fce\",\"category\":\"user role\"},{\"sequencenumber\":206,\"key\":\"role_id_8_abr\",\"tenantterm\":\"afce\",\"frontiersdefaultterm\":\"afce\",\"category\":\"user role\"},{\"sequencenumber\":207,\"key\":\"role_id_9_abr\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"category\":\"user role\"},{\"sequencenumber\":208,\"key\":\"role_id_10_abr\",\"tenantterm\":\"asce\",\"frontiersdefaultterm\":\"asce\",\"category\":\"user role\"},{\"sequencenumber\":209,\"key\":\"role_id_11_abr\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"category\":\"user role\"},{\"sequencenumber\":210,\"key\":\"role_id_12_abr\",\"tenantterm\":\"gae\",\"frontiersdefaultterm\":\"gae\",\"category\":\"user role\"},{\"sequencenumber\":211,\"key\":\"role_id_13_abr\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"category\":\"user role\"},{\"sequencenumber\":212,\"key\":\"role_id_14_abr\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"category\":\"user role\"},{\"sequencenumber\":213,\"key\":\"role_id_15_abr\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"category\":\"user role\"},{\"sequencenumber\":214,\"key\":\"role_id_16_abr\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"category\":\"user role\"},{\"sequencenumber\":215,\"key\":\"role_id_17_abr\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"category\":\"user role\"},{\"sequencenumber\":216,\"key\":\"role_id_18_abr\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"category\":\"user role\"},{\"sequencenumber\":217,\"key\":\"role_id_20_abr\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"user role\"},{\"sequencenumber\":218,\"key\":\"role_id_22_abr\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"category\":\"user role\"},{\"sequencenumber\":219,\"key\":\"role_id_24_abr\",\"tenantterm\":\"ru\",\"frontiersdefaultterm\":\"ru\",\"category\":\"user role\"},{\"sequencenumber\":220,\"key\":\"role_id_35_abr\",\"tenantterm\":\"jof\",\"frontiersdefaultterm\":\"jof\",\"category\":\"user role\"},{\"sequencenumber\":221,\"key\":\"role_id_41_abr\",\"tenantterm\":\"se-adm\",\"frontiersdefaultterm\":\"se-adm\",\"category\":\"user role\"},{\"sequencenumber\":222,\"key\":\"role_id_42_abr\",\"tenantterm\":\"se-rev\",\"frontiersdefaultterm\":\"se-rev\",\"category\":\"user role\"},{\"sequencenumber\":223,\"key\":\"role_id_43_abr\",\"tenantterm\":\"se-aut\",\"frontiersdefaultterm\":\"se-aut\",\"category\":\"user role\"},{\"sequencenumber\":224,\"key\":\"role_id_52_abr\",\"tenantterm\":\"evof\",\"frontiersdefaultterm\":\"evof\",\"category\":\"user role\"},{\"sequencenumber\":225,\"key\":\"role_id_53_abr\",\"tenantterm\":\"ev-adm\",\"frontiersdefaultterm\":\"ev-adm\",\"category\":\"user role\"},{\"sequencenumber\":226,\"key\":\"role_id_89_abr\",\"tenantterm\":\"comof\",\"frontiersdefaultterm\":\"comof\",\"category\":\"user role\"},{\"sequencenumber\":227,\"key\":\"role_id_98_abr\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"user role\"},{\"sequencenumber\":228,\"key\":\"role_id_99_abr\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":229,\"key\":\"role_id_103_abr\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"category\":\"user role\"},{\"sequencenumber\":230,\"key\":\"role_id_104_abr\",\"tenantterm\":\"beta\",\"frontiersdefaultterm\":\"beta\",\"category\":\"user role\"},{\"sequencenumber\":231,\"key\":\"role_id_106_abr\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":232,\"key\":\"role_id_107_abr\",\"tenantterm\":\"rtbeta\",\"frontiersdefaultterm\":\"rtbeta\",\"category\":\"user role\"},{\"sequencenumber\":233,\"key\":\"role_id_108_abr\",\"tenantterm\":\"deobeta\",\"frontiersdefaultterm\":\"deobeta\",\"category\":\"user role\"},{\"sequencenumber\":234,\"key\":\"role_id_109_abr\",\"tenantterm\":\"searchbeta\",\"frontiersdefaultterm\":\"searchbeta\",\"category\":\"user role\"},{\"sequencenumber\":235,\"key\":\"role_id_110_abr\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"category\":\"user role\"},{\"sequencenumber\":236,\"key\":\"role_id_111_abr\",\"tenantterm\":\"mfbeta\",\"frontiersdefaultterm\":\"mfbeta\",\"category\":\"user role\"},{\"sequencenumber\":237,\"key\":\"role_id_21_abr\",\"tenantterm\":\"coped\",\"frontiersdefaultterm\":\"coped\",\"category\":\"user role\"},{\"sequencenumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"this is the label for the review editorial board\",\"category\":\"label\"},{\"sequencenumber\":239,\"key\":\"field_chief_editor\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":240,\"key\":\"field_chief_editors\",\"tenantterm\":\"field chief editors\",\"frontiersdefaultterm\":\"field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":241,\"key\":\"editor\",\"tenantterm\":\"editor\",\"frontiersdefaultterm\":\"editor\",\"category\":\"label (role)\"},{\"sequencenumber\":242,\"key\":\"editors\",\"tenantterm\":\"editors\",\"frontiersdefaultterm\":\"editors\",\"category\":\"label (role)\"},{\"sequencenumber\":243,\"key\":\"board\",\"tenantterm\":\"board\",\"frontiersdefaultterm\":\"board\",\"category\":\"label\"},{\"sequencenumber\":244,\"key\":\"boards\",\"tenantterm\":\"boards\",\"frontiersdefaultterm\":\"boards\",\"category\":\"label\"},{\"sequencenumber\":245,\"key\":\"article_collection\",\"tenantterm\":\"article collection\",\"frontiersdefaultterm\":\"article collection\",\"category\":\"label\"},{\"sequencenumber\":246,\"key\":\"article_collections\",\"tenantterm\":\"article collections\",\"frontiersdefaultterm\":\"article collections\",\"category\":\"label\"},{\"sequencenumber\":247,\"key\":\"handling_editor\",\"tenantterm\":\"handling editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":248,\"key\":\"handling_editors\",\"tenantterm\":\"handling editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":249,\"key\":\"ae_accept\",\"tenantterm\":\"recommend acceptance\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":250,\"key\":\"rtm\",\"tenantterm\":\"rtm\",\"frontiersdefaultterm\":\"rtm\",\"category\":\"product\"},{\"sequencenumber\":251,\"key\":\"frontiers_media_sa\",\"tenantterm\":\"frontiers media s.a\",\"frontiersdefaultterm\":\"frontiers media s.a\",\"category\":\"customer\"},{\"sequencenumber\":252,\"key\":\"review_editors\",\"tenantterm\":\"community reviewers\",\"frontiersdefaultterm\":\"review editors\",\"category\":\"label (role)\"},{\"sequencenumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":255,\"key\":\"call_for_papers\",\"tenantterm\":\"call for papers\",\"frontiersdefaultterm\":\"call for papers\",\"category\":\"label\"},{\"sequencenumber\":256,\"key\":\"calls_for_papers\",\"tenantterm\":\"calls for papers\",\"frontiersdefaultterm\":\"calls for papers\",\"category\":\"label\"},{\"sequencenumber\":257,\"key\":\"supervising_editor\",\"tenantterm\":\"supervising editor\",\"frontiersdefaultterm\":\"supervising editor\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editor\"},{\"sequencenumber\":258,\"key\":\"supervising_editors\",\"tenantterm\":\"supervising editors\",\"frontiersdefaultterm\":\"supervising editors\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editors\"},{\"sequencenumber\":259,\"key\":\"reviewer_endorse\",\"tenantterm\":\"endorse\",\"frontiersdefaultterm\":\"endorse\",\"category\":\"label\"},{\"sequencenumber\":260,\"key\":\"reviewer_endorsed\",\"tenantterm\":\"endorsed\",\"frontiersdefaultterm\":\"endorsed\",\"category\":\"label\"},{\"sequencenumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantterm\":\"endorse publication\",\"frontiersdefaultterm\":\"endorse publication\",\"category\":\"label\"},{\"sequencenumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantterm\":\"endorsed publication\",\"frontiersdefaultterm\":\"endorsed publication\",\"category\":\"label\"},{\"sequencenumber\":263,\"key\":\"editor_role\",\"tenantterm\":\"editor role\",\"frontiersdefaultterm\":\"editor role\",\"category\":\"label\"},{\"sequencenumber\":264,\"key\":\"editor_roles\",\"tenantterm\":\"editor roles\",\"frontiersdefaultterm\":\"editor roles\",\"category\":\"label\"},{\"sequencenumber\":265,\"key\":\"editorial_role\",\"tenantterm\":\"editorial role\",\"frontiersdefaultterm\":\"editorial role\",\"category\":\"label\"},{\"sequencenumber\":266,\"key\":\"editorial_roles\",\"tenantterm\":\"editorial roles\",\"frontiersdefaultterm\":\"editorial roles\",\"category\":\"label\"},{\"sequencenumber\":267,\"key\":\"call_for_paper\",\"tenantterm\":\"call for paper\",\"frontiersdefaultterm\":\"call for paper\",\"category\":\"label\"},{\"sequencenumber\":268,\"key\":\"research_topic_abstract\",\"tenantterm\":\"manuscript summary\",\"frontiersdefaultterm\":\"manuscript summary\",\"category\":\"process\"},{\"sequencenumber\":269,\"key\":\"research_topic_abstracts\",\"tenantterm\":\"manuscript summaries\",\"frontiersdefaultterm\":\"manuscript summaries\",\"category\":\"process\"},{\"sequencenumber\":270,\"key\":\"submissions_team_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"content manager\",\"category\":\"process\"},{\"sequencenumber\":271,\"key\":\"submissions_team\",\"tenantterm\":\"journal team\",\"frontiersdefaultterm\":\"content team\",\"category\":\"process\"},{\"sequencenumber\":272,\"key\":\"topic_coordinator\",\"tenantterm\":\"topic coordinator\",\"frontiersdefaultterm\":\"topic coordinator\",\"category\":\"process\"},{\"sequencenumber\":273,\"key\":\"topic_coordinators\",\"tenantterm\":\"topic coordinators\",\"frontiersdefaultterm\":\"topic coordinators\",\"category\":\"process\"},{\"sequencenumber\":274,\"key\":\"frontiers_journal_team\",\"tenantterm\":\"frontiers journal team\",\"frontiersdefaultterm\":\"frontiers journal team\",\"category\":\"label (role)\"},{\"sequencenumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantterm\":\"rt:ic submission\",\"frontiersdefaultterm\":\"rt:ic submission\",\"category\":\"label (role)\"},{\"sequencenumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantterm\":\"rt:ic submission participant\",\"frontiersdefaultterm\":\"rt:ic submission participant\",\"category\":\"label (role)\"}]}'\n",impactgtmid:"gtm-njf2ml9b",impactgtmauth:"fyo-7nodm9w37qgfms03sa",impactgtmpreview:"env-1",impactgooglemapsapikey:"aizasyctehx2eu8pwfi86gw9fi00ftcykk6ifr8",qualtricsv4tov3:"'{\"enabled\":true,\"interceptid\":\"si_er0e2ze69oz8yn4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricsumux:"'{\"enabled\":false,\"interceptid\":\"si_89fphy3etxqbwtu\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricscontinuousbrand:"'{\"enabled\":true,\"interceptid\":\"si_9zut94ut81fcrh4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",defaultarticletemplate:"v3"},app:{baseurl:"/",buildid:"f2d5b6d8-d01c-4534-90b9-d659f10f17ca",buildassetsdir:"ap-2024/_nuxt",cdnurl:""}}## Methods
we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i 2 statistics. results: four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps. conclusion: while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies. systematic review registration: crd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077 . introduction amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children ( 1 , 2 ). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye ( 3 &#x2013; 5 ). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye ( 5 ). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) ( 6 ). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function ( 6 ). the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children ( 7 ). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed ( 6 ). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old ( 8 ). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity ( 6 , 9 ). therefore, novel treatment paradigms are needed to treat amblyopia in adults. selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy ( 10 ). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex ( 11 ). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes ( 12 , 13 ), while others fail to demonstrate efficacy ( 9 , 14 ). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information. methods search strategy and eligibility criteria this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement ( 15 ). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus. we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations. data extraction data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus. endpoints the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation. quality assessment (risk of bias) the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) ( 16 ). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed ( 17 ). discrepancies were resolved through consensus following a discussion of the reasons for the differences. statistical analysis statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student t -test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i 2 statistics, with p &#x202f;&#x0003c;&#x202f;0.10 and i 2 &#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it. results the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies ( 9 , 12 &#x2013; 14 ) were included, encompassing 139 patients from four rcts ( figure 1 ). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in table 1 . three studies had fluoxetine and one citalopram as the intervention group. figure 1 figure 1 . prisma flow diagram of study screening and selection. table 1 table 1 . baseline characteristics of included studies. all four studies ( 9 , 12 &#x2013; 14 ) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004, i 2 =&#x202f;23%, figure 2 ). only three studies ( 12 &#x2013; 14 ) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, p &#x202f;=&#x202f;0.76, i 2 =&#x202f;0%, figure 3a ) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, p &#x202f;=&#x202f;0.48, i 2 =&#x202f;0%, figure 3b ) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size. figure 2 figure 2 . visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo. figure 3 figure 3 . visual evoked potential (vep) did not improve with ssri. (a) p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. (b) p100 latency improvement was not statistically significantly different between the ssri and placebo group. all studies were evaluated as having a low risk of bias ( table 2 ). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial ( figure 4 ). table 2 table 2 . risk of bias summary for randomized studies. figure 4 figure 4 . funnel plot for visual acuity improvement. there is no publication bias. discussion this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency. current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants ( 9 , 12 &#x2013; 14 ) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic. ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation ( 18 ). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia ( 19 ). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye ( 19 ). in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit ( 20 ). donepezil showed an improvement of the va in an open-label pilot study ( 21 ). across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods ( 11 ). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment ( 12 , 13 ) whereas others did not ( 9 , 14 ). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans ( 22 ). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans ( 22 ). similarly, measuring of visual acuity in rodents and humans cannot be standardized ( 22 ). mitchell et al. ( 22 ) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans ( 22 ). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies ( 12 , 13 ) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes ( 23 ). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) ( 24 ) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials ( 25 &#x2013; 27 ). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba ( 28 ), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes. given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy ( 29 ), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven. heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings. to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature. other modalities of treatment are also currently under research. extended-reality (xr) devices ( 30 ), physical activity (cycling) ( 31 ) and more recently the occlusion of the amblyopic eye combined with physical activity ( 32 ) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects. in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial ( 16 ) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks. conclusion this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes. data availability statement the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author. author contributions es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology. funding the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\r1\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z). conflict of interest the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the handling editor gp declared a shared parent affiliation with the author oa at the time of review. the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision. generative ai statement the authors declare that no gen ai was used in the creation of this manuscript. publisher&#x2019;s note all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. author disclaimer the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care. references 1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. front pediatr . (2022) 10:819998. doi: 10.3389/fped.2022.819998 pubmed abstract | crossref full text | google scholar 2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. rom j ophthalmol . (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 pubmed abstract | crossref full text | google scholar 3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. cereb cortex . (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 pubmed abstract | crossref full text | google scholar 4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. j neurosci . (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 pubmed abstract | crossref full text | google scholar 5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. eye . (1996) 10:250&#x2013;8. google scholar 6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. bmc ophthalmol . (2020) 20:203. doi: 10.1186/s12886-020-01442-9 pubmed abstract | crossref full text | google scholar 7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. optom vis sci . (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 pubmed abstract | crossref full text | google scholar 8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. curr biol . (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 pubmed abstract | crossref full text | google scholar 9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. sci rep . (2018) 8:12830. doi: 10.1038/s41598-018-31169-z pubmed abstract | crossref full text | google scholar 10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. j neurosci . (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 pubmed abstract | crossref full text | google scholar 11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. science . (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516 crossref full text | google scholar 12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. eye . (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z pubmed abstract | crossref full text | google scholar 13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. j aapos . (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 pubmed abstract | crossref full text | google scholar 14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. neural plast . (2019) 2019:5857243. doi: 10.1155/2019/5857243 crossref full text | google scholar 15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. bmj . (2009) 339:b2535. doi: 10.1136/bmj.b2535 pubmed abstract | crossref full text | google scholar 16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. bmj . (2019) 366:l4898. doi: 10.1136/bmj.l4898 pubmed abstract | crossref full text | google scholar 17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. bmj . (2011) 343:d5928. doi: 10.1136/bmj.d5928 pubmed abstract | crossref full text | google scholar 18. feighner, jp. mechanism of action of antidepressant medications. j clin psychiatry . (1999) 60:4&#x2013;11. google scholar 19. morishita, h, and hensch, tk. critical period revisited: impact on vision. curr opin neurobiol . (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 pubmed abstract | crossref full text | google scholar 20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. ophthalmology . (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 pubmed abstract | crossref full text | google scholar 21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. sci rep . (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 pubmed abstract | crossref full text | google scholar 22. mitchell, d, and sengpiel, f. animal models of amblyopia. vis neurosci . (2018) 35:e017. doi: 10.1017/s0952523817000244 pubmed abstract | crossref full text | google scholar 23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). doc ophthalmol . (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y pubmed abstract | crossref full text | google scholar 24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. brain struct funct . (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 pubmed abstract | crossref full text | google scholar 25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. imaging neurosci. (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 pubmed abstract | crossref full text | google scholar 26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. perception . (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 pubmed abstract | crossref full text | google scholar 27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. front hum neurosci . (2022) 16:949395. doi: 10.3389/fnhum.2022.949395 crossref full text | google scholar 28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: https://pubmed.ncbi.nlm.nih.gov/26004760/ google scholar 29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. strabismus . (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 pubmed abstract | crossref full text | google scholar 30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. j vis . (2023) 23:14. doi: 10.1167/jov.23.1.14 pubmed abstract | crossref full text | google scholar 31. lunghi, c, and sale, a. a cycling lane for brain rewiring. curr biol . (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 pubmed abstract | crossref full text | google scholar 32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. annal. clin. transl. neurol. (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 pubmed abstract | crossref full text | google scholar keywords: amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity citation: shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. front. neurol . 16:1639913. doi: 10.3389/fneur.2025.1639913 received: 03 june 2025; accepted: 31 july 2025; published: 21 august 2025. edited by: gordon plant , university college london, united kingdom reviewed by: sara samadzadeh , charit&#x00e9; university medicine berlin, germany alistair r. fielder , city university of london, united kingdom copyright &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the creative commons attribution license (cc by) . the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. &#x0002a;correspondence: i. betina ip, ymv0aw5hlmlwqg5ky24ub3guywmudws= &#x2020; these authors share senior authorship disclaimer: all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. download article download pdf readcube epub xml share on export citation endnote reference manager simple text file bibtex 1,812 total views 250 downloads citation numbers are available from dimensions view article impact view altmetric score share on edited by g p gordon plant reviewed by a r alistair r fielder s s sara samadzadeh table of contents abstract introduction methods results discussion conclusion data availability statement author contributions funding conflict of interest generative ai statement publisher&#x2019;s note author disclaimer references export citation endnote reference manager simple text file bibtex check for updates frontiers&#39; impact articles published with frontiers have received 12 million total citations your research is the real superpower - learn how we maximise its impact through our leading community journals explore our impact metrics supplementary material download article download download pdf readcube epub xml guidelines author guidelines services for authors policies and publication ethics editor guidelines fee policy explore articles research topics journals how we publish outreach frontiers forum frontiers policy labs frontiers for young minds frontiers planet prize connect help center emails and alerts contact us submit career opportunities follow us © 2025 frontiers media s.a. all rights reserved privacy policy | terms and conditions [["shallowreactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverrendered":13,"path":14,"pinia":15},["shallowreactive",3],{},["reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","frontiers articles","https://article-pages-2024.frontiersin.org/",["set"],["shallowreactive",12],{},true,"/journals/neurology/articles/10.3389/fneur.2025.1639913/full",["reactive",16],{"main":17,"user":579,"article":580,"articlehub":881,"mainheader":885},{"ibar":18,"footer":296,"newslettercomponent":-1,"snackbaritem":378,"toggleshowsnackbar":379,"contentfuljournal":380,"graphjournal":480,"settingsfeaturesswitchers":484,"templatetogglebanner":485,"tenantconfig":544},{"tenantlogo":19,"journallogo":19,"aboutus":20,"submiturl":113,"showsubmitbutton":13,"journal":114,"sectionterm":227,"aboutjournal":228,"mainlinks":277,"journallinks":284,"helpcenterlink":293},"",[21,38,47,71,87],{"title":22,"links":23},"who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"arialabel":28},"mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"arialabel":28},"history","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"arialabel":28},"leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"arialabel":28},"awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"impact and progress",[41,44],{"text":42,"url":43,"target":27,"arialabel":28},"frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"arialabel":28},"our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"arialabel":28},"how we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"arialabel":28},"open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"arialabel":28},"peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"arialabel":28},"research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"arialabel":28},"research topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"arialabel":28},"fair² data management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"arialabel":28},"fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"services",[74,78,81,84],{"text":75,"url":76,"target":77,"arialabel":28},"societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"arialabel":28},"national consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"arialabel":28},"institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"arialabel":28},"collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"more from frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"arialabel":93},"frontiers forum","https://forum.frontiersin.org/","this link will take you to the frontiers forum website",{"text":95,"url":96,"target":27,"arialabel":28},"frontiers planet prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"arialabel":100},"press office","https://pressoffice.frontiersin.org/","this link will take you to the frontiers press office website",{"text":102,"url":103,"target":27,"arialabel":104},"sustainability","https://www.frontiersin.org/about/sustainability","link to information about frontiers' sustainability",{"text":106,"url":107,"target":77,"arialabel":108},"career opportunities","https://careers.frontiersin.org/","this link will take you to the frontiers careers website",{"text":110,"url":111,"target":27,"arialabel":112},"contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=54&specialtyid=0&entitytype=2&entityid=141",{"id":115,"name":116,"slug":117,"sections":118},141,"frontiers in neurology","neurology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223],{"id":120,"name":121,"slug":122},156,"applied neuroimaging","applied-neuroimaging",{"id":124,"name":125,"slug":126},3712,"artificial intelligence in neurology","artificial-intelligence-in-neurology",{"id":128,"name":129,"slug":130},3023,"autonomic disorders","autonomic-disorders",{"id":132,"name":133,"slug":134},3740,"cognitive and behavioral neurology","cognitive-and-behavioral-neurology",{"id":136,"name":137,"slug":138},1439,"dementia and neurodegenerative diseases","dementia-and-neurodegenerative-diseases",{"id":140,"name":141,"slug":142},2038,"diagnostic neuropathology","diagnostic-neuropathology",{"id":144,"name":145,"slug":146},143,"endovascular and interventional neurology","endovascular-and-interventional-neurology",{"id":148,"name":149,"slug":150},144,"epilepsy","epilepsy",{"id":152,"name":153,"slug":154},1784,"experimental therapeutics","experimental-therapeutics",{"id":156,"name":157,"slug":158},153,"headache and neurogenic pain","headache-and-neurogenic-pain",{"id":160,"name":161,"slug":162},145,"movement disorders","movement-disorders",{"id":164,"name":165,"slug":166},147,"multiple sclerosis and neuroimmunology","multiple-sclerosis-and-neuroimmunology",{"id":168,"name":169,"slug":170},150,"neuro-oncology and neurosurgical oncology","neuro-oncology-and-neurosurgical-oncology",{"id":172,"name":173,"slug":174},154,"neuro-ophthalmology","neuro-ophthalmology",{"id":176,"name":177,"slug":178},155,"neuro-otology","neuro-otology",{"id":180,"name":181,"slug":182},159,"neurocritical and neurohospitalist care","neurocritical-and-neurohospitalist-care",{"id":184,"name":185,"slug":186},1339,"neuroepidemiology","neuroepidemiology",{"id":188,"name":189,"slug":190},160,"neurogenetics","neurogenetics",{"id":192,"name":193,"slug":194},1334,"neuroinfectious diseases","neuroinfectious-diseases",{"id":196,"name":197,"slug":198},2345,"neurological biomarkers","neurological-biomarkers",{"id":200,"name":201,"slug":202},146,"neuromuscular disorders and peripheral neuropathies","neuromuscular-disorders-and-peripheral-neuropathies",{"id":204,"name":205,"slug":206},547,"neurorehabilitation","neurorehabilitation",{"id":208,"name":209,"slug":210},3418,"neurotechnology","neurotechnology",{"id":212,"name":213,"slug":214},163,"neurotrauma","neurotrauma",{"id":216,"name":217,"slug":218},161,"pediatric neurology","pediatric-neurology",{"id":220,"name":221,"slug":222},151,"sleep disorders","sleep-disorders",{"id":224,"name":225,"slug":226},142,"stroke","stroke","sections",[229,253],{"title":230,"links":231},"scope",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"arialabel":28},"field chief editors","https://www.frontiersin.org/journals/neurology/about#about-editors",{"text":236,"url":237,"target":27,"arialabel":28},"mission & scope","https://www.frontiersin.org/journals/neurology/about#about-scope",{"text":239,"url":240,"target":27,"arialabel":28},"facts","https://www.frontiersin.org/journals/neurology/about#about-facts",{"text":242,"url":243,"target":27,"arialabel":28},"journal sections","https://www.frontiersin.org/journals/neurology/about#about-submission",{"text":245,"url":246,"target":27,"arialabel":28},"open access statement","https://www.frontiersin.org/journals/neurology/about#about-open",{"text":248,"url":249,"target":27,"arialabel":28},"copyright statement","https://www.frontiersin.org/journals/neurology/about#copyright-statement",{"text":251,"url":252,"target":27,"arialabel":28},"quality","https://www.frontiersin.org/journals/neurology/about#about-quality",{"title":254,"links":255},"for authors",[256,259,262,265,268,271,274],{"text":257,"url":258,"target":27,"arialabel":28},"why submit?","https://www.frontiersin.org/journals/neurology/for-authors/why-submit",{"text":260,"url":261,"target":27,"arialabel":28},"article types","https://www.frontiersin.org/journals/neurology/for-authors/article-types",{"text":263,"url":264,"target":27,"arialabel":28},"author guidelines","https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines",{"text":266,"url":267,"target":27,"arialabel":28},"editor guidelines","https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines",{"text":269,"url":270,"target":27,"arialabel":28},"publishing fees","https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees",{"text":272,"url":273,"target":27,"arialabel":28},"submission checklist","https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist",{"text":275,"url":276,"target":27,"arialabel":28},"contact editorial office","https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office",[278,281],{"text":279,"url":280,"target":27,"arialabel":28},"all journals","https://www.frontiersin.org/journals",{"text":282,"url":283,"target":27,"arialabel":28},"all articles","https://www.frontiersin.org/articles",[285,288,290],{"text":286,"url":287,"target":27,"arialabel":28},"articles","articles",{"text":63,"url":289,"target":27,"arialabel":28},"research-topics",{"text":291,"url":292,"target":27,"arialabel":28},"editorial board","editors",{"text":294,"url":295,"target":77,"arialabel":294},"help center","https://helpcenter.frontiersin.org",{"blocks":297,"sociallinks":351,"copyright":375,"termsandconditionsurl":376,"privacypolicyurl":377},[298,312,322,336],{"title":299,"links":300},"guidelines",[301,303,306,309,311],{"text":263,"url":302,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":304,"url":305,"target":27,"arialabel":28},"services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":307,"url":308,"target":27,"arialabel":28},"policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":266,"url":310,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"arialabel":28},{"title":313,"links":314},"explore",[315,316,319,321],{"text":286,"url":283,"target":27,"arialabel":28},{"text":317,"url":318,"target":27,"arialabel":28},"research topics ","https://www.frontiersin.org/research-topics",{"text":320,"url":280,"target":27,"arialabel":28},"journals",{"text":51,"url":52,"target":27,"arialabel":28},{"title":323,"links":324},"outreach",[325,328,331,335],{"text":326,"url":92,"target":77,"arialabel":327},"frontiers forum ","frontiers forum website",{"text":329,"url":330,"target":77,"arialabel":28},"frontiers policy labs ","https://policylabs.frontiersin.org/",{"text":332,"url":333,"target":77,"arialabel":334},"frontiers for young minds","https://kids.frontiersin.org/","frontiers for young minds journal",{"text":95,"url":96,"target":27,"arialabel":28},{"title":337,"links":338},"connect",[339,340,344,347,350],{"text":294,"url":295,"target":77,"arialabel":294},{"text":341,"url":342,"target":77,"arialabel":343},"emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","subscribe to frontiers emails",{"text":345,"url":111,"target":27,"arialabel":346},"contact us ","subscribe to newsletter",{"text":348,"url":349,"target":27,"arialabel":28},"submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"arialabel":28},[352,360,365,370],{"link":353,"type":356,"color":357,"icon":358,"size":359,"hiddentext":13},{"text":354,"url":355,"target":77,"arialabel":354},"frontiers facebook","https://www.facebook.com/frontiersin","link","grey","facebook","medium",{"link":361,"type":356,"color":357,"icon":364,"size":359,"hiddentext":13},{"text":362,"url":363,"target":77,"arialabel":28},"frontiers twitter","https://twitter.com/frontiersin","twitter",{"link":366,"type":356,"color":357,"icon":369,"size":359,"hiddentext":13},{"text":367,"url":368,"target":77,"arialabel":28},"frontiers linkedin","https://www.linkedin.com/company/frontiers","linkedin",{"link":371,"type":356,"color":357,"icon":374,"size":359,"hiddentext":13},{"text":372,"url":373,"target":77,"arialabel":28},"frontiers instagram","https://www.instagram.com/frontiersin_","instagram","frontiers media s.a. all rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":381,"identifier":115,"name":116,"slug":117,"banner":382,"description":473,"mission":474,"palette":475,"impactfactor":476,"citescore":477,"citations":478,"showtagline":28,"twitter":479},"journal",[383],{"id":384,"src":385,"name":386,"tags":387,"type":432,"width":433,"height":434,"idhash":435,"archive":436,"brandid":437,"limited":436,"filesize":438,"ispublic":439,"original":440,"copyright":19,"extension":441,"thumbnails":443,"datecreated":451,"description":452,"orientation":453,"usercreated":454,"watermarked":436,"datemodified":451,"datepublished":455,"ecsarchivefiles":456,"propertyoptions":457,"property_channel":462,"property_sub-type":464,"property_asset_type":466,"activeoriginalfocuspoint":468,"property_office_department":471},"d315adb2-2967-48b6-be3b61009343d69e","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/webimage-810a1e19-163c-4fd0-bfd3d50a4721b642.png","fneur_main visual_cyan_website",[388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,117,430,431],"professional","device","medical","close up","technology","wires","brain waves","record","digital","selective focus","laboratory","brain","health","electrodes","computer","examination","electroencephalography","scan","study","oncology","examine","electroencephalogram","neurosurgery","science","doctor","diagnose","magnetic","patient","modern","electroencephalograph","equipment","office","healthcare","scanning","instrument","eeg","hospital","ct","technician","medicine","ultrasound","radiology","diagnostic","lab","image",5052,3368,"62463d527f6ddd4d",0,"22c10171-81b3-4da6-99342f272a32e8bb",5758943,1,"https://brand.frontiersin.org/m/62463d527f6ddd4d/original/fneur_main-visual_cyan_website.jpg",[442],"jpg",{"mini":444,"thul":445,"webimage":385,"guidelines":446,"websitejpg_xl":447,"websitewebp_l":448,"websitewebp_m":449,"websitewebp_xl":450},"https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/mini-a927c1b7-02f8-4d29-94320f509270457d.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/thul-fcd9f16d-d1a9-4535-a7e4c140224266b9.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/guidelines-fneur_main visual_cyan_website.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitejpg_xl-fneur_main visual_cyan_website.jpg","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_l-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_m-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_xl-fneur_main visual_cyan_website.webp","2022-06-27t10:00:23z","charming young woman undergoing electroencephalography; shutterstock id 695951221; purchase_order: main visual; job: ; client: ; other:","landscape","caroline sutter","2022-06-27t06:08:46z",[],[458,459,460,461],"414fb2d4-2283-43fd-be14e534eca67928","6c18119b-14bd-4951-b437696f4357bd33","7c692885-db25-4858-b1fb4ff47b241e9b","d88c0047-ec30-4506-a7df28a4d765e1cf",[463],"frontiersin_org",[465],"main_visual",[467],"photography",{"x":469,"y":470},2526,1684,[472],"publishing","the world's most cited clinical neurology journal, exploring the diagnosis, causes, treatment, and public health aspects of neurological illnesses to improve patient care.","\u003cp>frontiers in neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. it is indexed in pubmed central (pmc), scopus, and the doaj.\u003c/p>\n\n\u003cp>led by field chief editor prof. irene litvan (university of california, san diego, usa), frontiers in neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.\u003c/p>\n\n\u003cp>the journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:\u003c/p>\n\n\u003cul>\n \u003cli>artificial intelligence in neurology\u003c/li>\n \u003cli>applied neuroimaging\u003c/li>\n \u003cli>autonomic disorders\u003c/li>\n \u003cli>cognitive behavioural neurology\u003c/li>\n \u003cli>dementia and neurodegenerative diseases\u003c/li>\n \u003cli>diagnostic and forensic neuropathology\u003c/li>\n \u003cli>endovascular and interventional neurology\u003c/li>\n \u003cli>epilepsy\u003c/li>\n \u003cli>experimental therapeutics\u003c/li>\n \u003cli>headache and neurogenic pain\u003c/li>\n \u003cli>movement disorders\u003c/li>\n \u003cli>multiple sclerosis and neuroimmunology\u003c/li>\n \u003cli>neuro-oncology and neurosurgical oncology\u003c/li>\n \u003cli>neuro-ophthalmology\u003c/li>\n \u003cli>neuro-otology\u003c/li>\n \u003cli>neurocritical and neurohospitalist care\u003c/li>\n \u003cli>neuroepidemiology\u003c/li>\n \u003cli>neurogenetics\u003c/li>\n \u003cli>neuroinfectious diseases\u003c/li>\n \u003cli>neurological biomarkers\u003c/li>\n \u003cli>neuromuscular disorders and peripheral neuropathies\u003c/li>\n \u003cli>neurorehabilitation\u003c/li>\n \u003cli>neurotechnology\u003c/li>\n \u003cli>neurotrauma\u003c/li>\n \u003cli>pediatric neurology\u003c/li>\n \u003cli>sleep disorders\u003c/li>\n \u003cli>stroke\u003c/li>\n\u003c/ul>\n\n\u003cp>in particular, the journal welcomes submissions that support and advance the un’s \u003ca href=https://globalgoals.org/goals/>sustainable development goals\u003c/a> (sdgs), notably \u003ca href=https://globalgoals.org/goals/3-good-health-and-well-being/>sdg 3: good health and well-being\u003c/a>.\u003c/p>\n\n\u003cp>manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.\u003c/p>\n\n\u003cp>the journal no longer accepts papers concerning simple bibliometric studies. authors are still welcome to submit systematic reviews using publicly available data, but these must adhere to the \u003ca href=https://www.prisma-statement.org/>prisma guidelines\u003c/a> and have a conclusion related to neurological research. studies without this primary focus will be transferred to a more applicable journal.\u003c/p>\n\n\u003cp>frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as nhanes or mendelian randomization studies, must include appropriate validation. please refer to the \u003ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,standards%20for%20research%20methodology,-experiments\">frontiers standards for research methodology policy\u003c/a> for more information. manuscripts not adhering to these standards will not be considered.\u003cp>\n\n\u003cp>frontiers in neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.\u003c/p>","cyan","3.4","4.8","273537","@frontneurol",{"id":115,"name":116,"slug":117,"abbreviation":481,"isonline":13,"isopenforsubmissions":13,"citescore":482,"impactfactor":483},"fneur",5.2,2.8,{"displaytitlepilllabels":13,"displayrelatedarticlesbox":13,"showeditors":13,"showreviewers":13,"showloopimpactlink":13,"enablefigshare":379,"usexmlimages":13},{"ispublic":13,"allowcompanyusers":379,"whitelistemails":486,"enablealljournals":13,"whitelistjournals":508},[487,488,489,490,491,492,493,494,495,492,496,497,498,499,500,501,502,503,504,505,506,507],"y2fybg9zlmxvcmnhqgzyb250awvyc2lulm9yzw==","zgfuawvslmx1ekbmcm9udgllcnnpbi5vcmc=","bgf1cmeudgvuyubmcm9udgllcnnpbi5vcmc=","cmfmywvslnjpyw5jag9aznjvbnrpzxjzaw4ub3jn","amftzxmuc21hbgxib25lqgzyb250awvyc2lulm9yzw==","znjhbi5tb3jlbm9aznjvbnrpzxjzaw4ub3jn","c2ftdwvslmzlcm5hbmrlekbmcm9udgllcnnpbi5vcmc=","ymfyymfyys5jyxjjyw5naxvaznjvbnrpzxjzaw4ub3jn","axzhbi5zyw50yw1hcmlhqgzyb250awvyc2lulm9yzw==","ahvllnryyw5aznjvbnrpzxjzaw4ub3jn","z29uy2fsby52yxjnyxnaznjvbnrpzxjzaw4ub3jn","bhvjawuuc2vubkbmcm9udgllcnnpbi5vcmc=","bg9ybi5mcmfzzxjaznjvbnrpzxjzaw4ub3jn","zwxzys5jyxjyb25aznjvbnrpzxjzaw4ub3jn","bwfhcnrlbi52yw5kawpja0bmcm9udgllcnnpbi5vcmc=","ymluzgh1lmtyaxnobmfuqgzyb250awvyc2lulm9yzw==","bwf0dghldy5hdhr3yxrlcnnaznjvbnrpzxjzaw4ub3jn","z2l1bglhlnzhbhnly2noaubmcm9udgllcnnpbi5vcmc=","zmfiawfulmrlbgxhbw9ydgvaznjvbnrpzxjzaw4ub3jn","dmlqyxlhbi5wcebwaxrzb2x1dglvbnmuy29t","z3vpbgxhdw1llnnldxjhdebmcm9udgllcnnpbi5vcmc=",[509,510,511,512,513,514,439,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,115,530,531,532,533,534,535,536,537,538,539,540,541,542,543],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceid":439,"name":439,"availablejournalpages":545,"announcement":549},[287,292,289,546,547,548],"volumes","about","community-reviewers",{"__typename":550,"sys":551,"preheader":42,"title":553,"description":554,"image":555,"link":577},"announcement",{"id":552},"5ittnttqgazppgh6rx0alm","articles published with frontiers have received 12 million total citations","your research is the real superpower - learn how we maximise its impact through our leading community journals",[556],{"archive":436,"brandid":437,"copyright":28,"datecreated":557,"datemodified":558,"datepublished":559,"description":28,"extension":560,"filesize":562,"height":563,"id":564,"ispublic":436,"limited":436,"name":565,"orientation":453,"original":28,"thumbnails":566,"type":432,"watermarked":436,"width":573,"videopreviewurls":574,"tags":575,"textmetaproperties":576,"src":567},"2025-06-18t12:58:01z","2025-06-18t14:15:34z","2025-06-18t12:57:32z",[561],"png",1365026,920,"7c5269c4-3c83-4591-951a74d15b95daea","impact metrics banner for article pages",{"webimage":567,"thul":568,"mini":569,"websitewebp_l":570,"websitewebp_m":571,"guidelines":572},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_l/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_m/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/guidelines/impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":578,"url":43,"target":27,"arialabel":28},"explore our impact metrics",{"loggeduserinfo":-1},{"currentarticle":581,"ispreviewpage":379,"hassupplementaldata":379,"showcrossmarkwidget":13,"articletemplate":738,"currentarticlepagemetainfo":739,"xmlparsedarticlecontent":-1,"xmlparsingerror":-1},{"id":582,"doi":583,"title":584,"acceptancedate":585,"receptiondate":586,"publicationdate":587,"lastmodifieddate":588,"ispublished":13,"abstract":589,"researchtopic":590,"articletype":596,"stage":599,"keywords":601,"authors":609,"editors":675,"reviewers":683,"journal":699,"section":707,"impactmetrics":709,"volume":712,"articlevolume":713,"relatedarticles":714,"ispublishedv2":13,"contents":715,"files":718},1639913,"10.3389/fneur.2025.1639913","selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials","2025-07-31t18:15:51.000z","2025-06-03t00:38:20.000z","2025-08-21t00:00:00.000z","2025-10-21t02:26:11.259z","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.methodswe systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i2 statistics.resultsfour rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04–0.14, p = 0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.conclusionwhile ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.systematic review registrationcrd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077.",{"id":591,"title":592,"articlescount":593,"ismagazinepage":379,"slug":594,"isopenforsubmission":13,"views":595},61549,"advances in understanding visual disorders linked to cortical dysfunction",10,"advances-in-understanding-visual-disorders-linked-to-cortical-dysfunction",15702,{"id":597,"name":598},136,"systematic review",{"id":600,"name":19},18,[602,603,604,605,606,607,608],"strabismus","neuroplasticity","amblyopia","fluoxetine","ssris","anisometropia","citalopram",[610,619,627,636,645,652,660,668],{"id":611,"firstname":612,"middlename":19,"lastname":613,"givennames":614,"iscorresponding":379,"isprofilepublic":13,"userid":611,"email":-1,"affiliations":615},3083093,"ehtesham","shamsher","ehtesham ",[616],{"organizationname":617,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust","united kingdom",{"id":436,"firstname":620,"middlename":19,"lastname":621,"givennames":622,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":623},"luisa","saccaro","luisa ",[624],{"organizationname":625,"countryname":626,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, universidade de mogi das cruzes","brazil",{"id":628,"firstname":629,"middlename":19,"lastname":630,"givennames":631,"iscorresponding":379,"isprofilepublic":13,"userid":628,"email":-1,"affiliations":632},3089392,"victor barreiros","pungirum","victor barreiros ",[633],{"organizationname":634,"countryname":635,"cityname":19,"statename":19,"zipcode":19},"faculty of medical sciences, university of buenos aires","argentina",{"id":637,"firstname":638,"middlename":19,"lastname":639,"givennames":640,"iscorresponding":379,"isprofilepublic":13,"userid":637,"email":-1,"affiliations":641},3162299,"nghi bao","tran","nghi bao ",[642],{"organizationname":643,"countryname":644,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, university of debrecen","hungary",{"id":436,"firstname":646,"middlename":19,"lastname":647,"givennames":648,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":649},"omar a. h. a.","alghaith","omar a. h. a. ",[650],{"organizationname":651,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"institute of ophthalmology, university college london",{"id":436,"firstname":653,"middlename":19,"lastname":654,"givennames":655,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":656},"fatemeh","khabazianzadeh","fatemeh ",[657],{"organizationname":658,"countryname":659,"cityname":19,"statename":19,"zipcode":19},"eye research center, khatam-al-anbia hospital, mashad university of medical sciences","iran",{"id":661,"firstname":662,"middlename":19,"lastname":663,"givennames":664,"iscorresponding":379,"isprofilepublic":13,"userid":661,"email":-1,"affiliations":665},30975,"holly","bridge","holly ",[666],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging",{"id":669,"firstname":670,"middlename":19,"lastname":671,"givennames":672,"iscorresponding":379,"isprofilepublic":13,"userid":669,"email":-1,"affiliations":673},318592,"i. betina","ip","i. betina ",[674],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},[676],{"id":677,"firstname":678,"middlename":19,"lastname":679,"givennames":680,"iscorresponding":379,"isprofilepublic":13,"userid":677,"email":-1,"affiliations":681},2271562,"gordon","plant","gordon ",[682],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},[684,692],{"id":685,"firstname":686,"middlename":687,"lastname":688,"givennames":689,"iscorresponding":379,"isprofilepublic":13,"userid":685,"email":-1,"affiliations":690},870962,"alistair","r","fielder","alistair r",[691],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":693,"firstname":694,"middlename":19,"lastname":695,"givennames":696,"iscorresponding":379,"isprofilepublic":13,"userid":693,"email":-1,"affiliations":697},1863925,"sara","samadzadeh","sara ",[698],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":115,"slug":117,"name":116,"shortname":700,"electronicissn":701,"field":702,"specialtyid":28,"journalsectionpaths":705},"front. neurol.","1664-2295",{"id":703,"domainid":704},54,2,[706],{"section":707},{"id":172,"name":173,"slug":174,"specialtyid":708},758,{"views":710,"downloads":711,"citations":436},1812,250,16,"volume 16 - 2025",[],{"titlehtml":584,"fulltexthtml":716,"menuhtml":717},"\u003cdiv class=\"journalabstract\"> \u003ca id=\"h1\" name=\"h1\">\u003c/a>\n \u003cdiv class=\"authors\">\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3083093\" class=\"user-id-3083093\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3083093/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"ehtesham shamsher\">ehtesham shamsher\u003c/a>\u003csup>1\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"luisa saccaro\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">luisa saccaro\u003csup>2\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3089392\" class=\"user-id-3089392\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3089392/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"victor barreiros pungirum\">victor barreiros pungirum\u003c/a>\u003csup>3\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3162299\" class=\"user-id-3162299\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3162299/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"nghi bao tran\">nghi bao tran\u003c/a>\u003csup>4\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"omar a. h. a. alghaith\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">omar a. h. a. alghaith\u003csup>5\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"fatemeh khabazianzadeh\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">fatemeh khabazianzadeh\u003csup>6\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/30975\" class=\"user-id-30975\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/30975/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"holly bridge&#x;\">holly bridge\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/318592\" class=\"user-id-318592\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/318592/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"i. betina ip&#xa;&#x;\">i. betina ip\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x0002a;\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003c/div> \u003cul class=\"notes\"> \u003cli>\u003cspan>\u003csup>1\u003c/sup>\u003c/span>oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, oxford, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>2\u003c/sup>\u003c/span>faculty of medicine, universidade de mogi das cruzes, mogi das cruzes, brazil\u003c/li> \u003cli>\u003cspan>\u003csup>3\u003c/sup>\u003c/span>faculty of medical sciences, university of buenos aires, buenos aires, argentina\u003c/li> \u003cli>\u003cspan>\u003csup>4\u003c/sup>\u003c/span>faculty of medicine, university of debrecen, debrecen, hungary\u003c/li> \u003cli>\u003cspan>\u003csup>5\u003c/sup>\u003c/span>institute of ophthalmology, university college london, london, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>6\u003c/sup>\u003c/span>eye research center, khatam-al-anbia hospital, mashad university of medical sciences, mashhad, iran\u003c/li> \u003cli>\u003cspan>\u003csup>7\u003c/sup>\u003c/span>nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, oxford, united kingdom\u003c/li> \u003c/ul>\n\u003cp class=\"mb15\">\u003cb>introduction:\u003c/b> amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>methods:\u003c/b> we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i\u003csup>2\u003c/sup> statistics.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>results:\u003c/b> four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>conclusion:\u003c/b> while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.\u003c/p>\n\u003cp class=\"mb0\">\u003cb>systematic review registration:\u003c/b> crd42025633077, \u003ca href=\"https://www.crd.york.ac.uk/prospero/view/crd42025633077\">https://www.crd.york.ac.uk/prospero/view/crd42025633077\u003c/a>.\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div> \u003cdiv class=\"journalfulltext\"> \u003ca id=\"h2\" name=\"h2\">\u003c/a>\n\u003ch2>introduction\u003c/h2>\n\u003cp class=\"mb15\">amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children (\u003ca href=\"#ref1\">1\u003c/a>, \u003ca href=\"#ref2\">2\u003c/a>). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye (\u003ca href=\"#ref3\">3\u003c/a>&#x2013;\u003ca href=\"#ref5\">5\u003c/a>). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye (\u003ca href=\"#ref5\">5\u003c/a>). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) (\u003ca href=\"#ref6\">6\u003c/a>). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function (\u003ca href=\"#ref6\">6\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children (\u003ca href=\"#ref7\">7\u003c/a>). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed (\u003ca href=\"#ref6\">6\u003c/a>). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old (\u003ca href=\"#ref8\">8\u003c/a>). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity (\u003ca href=\"#ref6\">6\u003c/a>, \u003ca href=\"#ref9\">9\u003c/a>). therefore, novel treatment paradigms are needed to treat amblyopia in adults.\u003c/p>\n\u003cp class=\"mb0\">selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy (\u003ca href=\"#ref10\">10\u003c/a>). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex (\u003ca href=\"#ref11\">11\u003c/a>). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>), while others fail to demonstrate efficacy (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information.\u003c/p> \u003ca id=\"h3\" name=\"h3\">\u003c/a>\n\u003ch2>methods\u003c/h2>\n\u003ch3>search strategy and eligibility criteria\u003c/h3>\n\u003cp class=\"mb15\">this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement (\u003ca href=\"#ref15\">15\u003c/a>). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus.\u003c/p>\n\u003cp class=\"mb0\">we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations.\u003c/p>\n\u003ch3>data extraction\u003c/h3>\n\u003cp class=\"mb0\">data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus.\u003c/p>\n\u003ch3>endpoints\u003c/h3>\n\u003cp class=\"mb0\">the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation.\u003c/p>\n\u003ch3>quality assessment (risk of bias)\u003c/h3>\n\u003cp class=\"mb0\">the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) (\u003ca href=\"#ref16\">16\u003c/a>). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed (\u003ca href=\"#ref17\">17\u003c/a>). discrepancies were resolved through consensus following a discussion of the reasons for the differences.\u003c/p>\n\u003ch3>statistical analysis\u003c/h3>\n\u003cp class=\"mb0\">statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student \u003ci>t\u003c/i>-test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i\u003csup>2\u003c/sup> statistics, with \u003ci>p\u003c/i>&#x202f;&#x0003c;&#x202f;0.10 and i\u003csup>2\u003c/sup>&#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it.\u003c/p> \u003ca id=\"h4\" name=\"h4\">\u003c/a>\n\u003ch2>results\u003c/h2>\n\u003cp class=\"mb0\">the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) were included, encompassing 139 patients from four rcts (\u003ca href=\"#fig1\">figure 1\u003c/a>). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in \u003ca href=\"#tab1\">table 1\u003c/a>. three studies had fluoxetine and one citalopram as the intervention group.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" name=\"figure1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" alt=\"flowchart detailing a study selection process: identification phase shows pubmed with fifty-five results, embase with three hundred ninety-six results, cochrane with thirty results, totaling four hundred eighty-one. screening phase removes four hundred seventy-two as duplicates or non-criteria matches. eligibility phase reviews nine full-text studies; discards one conference abstract and four from the manuscript registry. four studies remain included.\" id=\"fig1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 1\u003c/b>. prisma flow diagram of study screening and selection.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">table 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" name=\"table1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" alt=\"www.frontiersin.org\" id=\"tab1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 1\u003c/b>. baseline characteristics of included studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004, i\u003csup>2\u003c/sup> =&#x202f;23%, \u003ca href=\"#fig2\">figure 2\u003c/a>). only three studies (\u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.76, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3a\u003c/a>) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.48, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3b\u003c/a>) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" name=\"figure2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" alt=\"forest plot showing the mean differences from four studies comparing the effects of ssri to placebo. each study is represented by a red square with horizontal lines indicating confidence intervals. the total effect is represented by a black diamond indicating a mean difference of 0.09 with a confidence interval of 0.04 to 0.14, favoring ssri. heterogeneity measures show tau-squared equals zero, chi-squared equals 3.90 with a p-value of 0.27, and i-squared equals 23%.\" id=\"fig2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 2\u003c/b>. visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 3\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" name=\"figure3\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" alt=\"forest plots a and b compare mean differences for several studies on ssri effectiveness. plot a shows a total mean difference of 0.34, favoring placebo, with no heterogeneity. plot b shows a total mean difference of 1.76, still favoring placebo, with no heterogeneity. each plot displays individual study results with confidence intervals and weight distributions.\" id=\"fig3\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 3\u003c/b>. visual evoked potential (vep) did not improve with ssri. \u003cb>(a)\u003c/b> p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. \u003cb>(b)\u003c/b> p100 latency improvement was not statistically significantly different between the ssri and placebo group.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all studies were evaluated as having a low risk of bias (\u003ca href=\"#tab2\">table 2\u003c/a>). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial (\u003ca href=\"#fig4\">figure 4\u003c/a>).\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">table 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" name=\"table2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" alt=\"www.frontiersin.org\" id=\"tab2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 2\u003c/b>. risk of bias summary for randomized studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 4\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" name=\"figure4\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" alt=\"funnel plot depicting standard error of mean difference (se[md]) on the y-axis versus mean difference (md) on the x-axis. points representing studies are scattered around a central vertical line, with dashed lines forming an inverted triangle indicating data distribution.\" id=\"fig4\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 4\u003c/b>. funnel plot for visual acuity improvement. there is no publication bias.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div> \u003ca id=\"h5\" name=\"h5\">\u003c/a>\n\u003ch2>discussion\u003c/h2>\n\u003cp class=\"mb15\">this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency.\u003c/p>\n\u003cp class=\"mb15\">current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic.\u003c/p>\n\u003cp class=\"mb15\">ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation (\u003ca href=\"#ref18\">18\u003c/a>). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia (\u003ca href=\"#ref19\">19\u003c/a>). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye (\u003ca href=\"#ref19\">19\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit (\u003ca href=\"#ref20\">20\u003c/a>). donepezil showed an improvement of the va in an open-label pilot study (\u003ca href=\"#ref21\">21\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods (\u003ca href=\"#ref11\">11\u003c/a>). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) whereas others did not (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans (\u003ca href=\"#ref22\">22\u003c/a>). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans (\u003ca href=\"#ref22\">22\u003c/a>). similarly, measuring of visual acuity in rodents and humans cannot be standardized (\u003ca href=\"#ref22\">22\u003c/a>). mitchell et al. (\u003ca href=\"#ref22\">22\u003c/a>) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans (\u003ca href=\"#ref22\">22\u003c/a>). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes (\u003ca href=\"#ref23\">23\u003c/a>). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) (\u003ca href=\"#ref24\">24\u003c/a>) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials (\u003ca href=\"#ref25\">25\u003c/a>&#x2013;\u003ca href=\"#ref27\">27\u003c/a>). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba (\u003ca href=\"#ref28\">28\u003c/a>), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes.\u003c/p>\n\u003cp class=\"mb15\">given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy (\u003ca href=\"#ref29\">29\u003c/a>), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven.\u003c/p>\n\u003cp class=\"mb15\">heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings.\u003c/p>\n\u003cp class=\"mb15\">to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature.\u003c/p>\n\u003cp class=\"mb15\">other modalities of treatment are also currently under research. extended-reality (xr) devices (\u003ca href=\"#ref30\">30\u003c/a>), physical activity (cycling) (\u003ca href=\"#ref31\">31\u003c/a>) and more recently the occlusion of the amblyopic eye combined with physical activity (\u003ca href=\"#ref32\">32\u003c/a>) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects.\u003c/p>\n\u003cp class=\"mb0\">in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial (\u003ca href=\"#ref16\">16\u003c/a>) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks.\u003c/p> \u003ca id=\"h6\" name=\"h6\">\u003c/a>\n\u003ch2>conclusion\u003c/h2>\n\u003cp class=\"mb0\">this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes.\u003c/p> \u003ca id=\"h7\" name=\"h7\">\u003c/a>\n\u003ch2>data availability statement\u003c/h2>\n\u003cp class=\"mb0\">the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.\u003c/p> \u003ca id=\"h8\" name=\"h8\">\u003c/a>\n\u003ch2>author contributions\u003c/h2>\n\u003cp class=\"mb0\">es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology.\u003c/p> \u003ca id=\"h9\" name=\"h9\">\u003c/a>\n\u003ch2>funding\u003c/h2>\n\u003cp class=\"mb0\">the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\\r1\\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z).\u003c/p> \u003ca id=\"h10\" name=\"h10\">\u003c/a>\n\u003ch2>conflict of interest\u003c/h2>\n\u003cp class=\"mb15\">the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003c/p>\n\u003cp class=\"mb15\">the handling editor gp declared a shared parent affiliation with the author oa at the time of review.\u003c/p>\n\u003cp class=\"mb0\">the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision.\u003c/p> \u003ca id=\"h11\" name=\"h11\">\u003c/a>\n\u003ch2>generative ai statement\u003c/h2>\n\u003cp class=\"mb0\">the authors declare that no gen ai was used in the creation of this manuscript.\u003c/p> \u003ca id=\"h12\" name=\"h12\">\u003c/a>\n\u003ch2>publisher&#x2019;s note\u003c/h2>\n\u003cp class=\"mb0\">all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003c/p> \u003ca id=\"h13\" name=\"h13\">\u003c/a>\n\u003ch2>author disclaimer\u003c/h2>\n\u003cp class=\"mb0\">the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care.\u003c/p> \u003ca id=\"h14\" name=\"h14\">\u003c/a>\n\u003ch2>references\u003c/h2>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref1\" id=\"ref1\">\u003c/a>1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. \u003ci>front pediatr\u003c/i>. (2022) 10:819998. doi: 10.3389/fped.2022.819998 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/35601430\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.3389/fped.2022.819998\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=b+hu&#x00026;author=z+liu&#x00026;author=j+zhao&#x00026;author=l+zeng&#x00026;author=g+hao&#x00026;author=d+shui&#x00026;publication_year=2022&#x00026;title=the+global+prevalence+of+amblyopia+in+children:+a+systematic+review+and+meta-analysis&#x00026;journal=front+pediatr&#x00026;volume=10&#x00026;pages=819998\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref2\" id=\"ref2\">\u003c/a>2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. \u003ci>rom j ophthalmol\u003c/i>. (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33367172\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.22336/rjo.2020.56\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mostafaie&#x00026;author=m+ghojazadeh&#x00026;author=h+hosseinifard&#x00026;author=h+manaflouyan&#x00026;author=f+farhadi&#x00026;author=n+taheri&#x00026;publication_year=2020&#x00026;title=a+systematic+review+of+amblyopia+prevalence+among+the+children+of+the+world&#x00026;journal=rom+j+ophthalmol&#x00026;volume=64&#x00026;pages=342-55\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref3\" id=\"ref3\">\u003c/a>3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. \u003ci>cereb cortex\u003c/i>. (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/16400161\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1093/cercor/bhj110\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=ku+jirmann&#x00026;author=v+vorobyov&#x00026;author=ut+eysel&#x00026;publication_year=2006&#x00026;title=strabismic+suppression+is+mediated+by+inhibitory+interactions+in+the+primary+visual+cortex&#x00026;journal=cereb+cortex&#x00026;volume=16&#x00026;pages=1750-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref4\" id=\"ref4\">\u003c/a>4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. \u003ci>j neurosci\u003c/i>. (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/7965083\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.14-11-06855.1994\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;author=pc+kind&#x00026;author=r+harrad&#x00026;publication_year=1994&#x00026;title=interocular+suppression+in+the+visual+cortex+of+strabismic+cats&#x00026;journal=j+neurosci&#x00026;volume=14&#x00026;pages=6855-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref5\" id=\"ref5\">\u003c/a>5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. \u003ci>eye\u003c/i>. (1996) 10:250&#x2013;8.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;publication_year=1996&#x00026;title=the+neural+basis+of+suppression+and+amblyopia+in+strabismus&#x00026;journal=eye&#x00026;volume=10&#x00026;pages=250-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref6\" id=\"ref6\">\u003c/a>6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. \u003ci>bmc ophthalmol\u003c/i>. (2020) 20:203. doi: 10.1186/s12886-020-01442-9 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/32450849\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1186/s12886-020-01442-9\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=y+li&#x00026;author=h+sun&#x00026;author=x+zhu&#x00026;author=y+su&#x00026;author=t+yu&#x00026;author=x+wu&#x00026;publication_year=2020&#x00026;title=efficacy+of+interventions+for+amblyopia:+a+systematic+review+and+network+meta-analysis&#x00026;journal=bmc+ophthalmol&#x00026;volume=20&#x00026;pages=203\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref7\" id=\"ref7\">\u003c/a>7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. \u003ci>optom vis sci\u003c/i>. (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19417699\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1097/opx.0b013e3181a7b3e5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mj+moseley&#x00026;author=ar+fielder&#x00026;author=ce+stewart&#x00026;publication_year=2009&#x00026;title=the+optical+treatment+of+amblyopia&#x00026;journal=optom+vis+sci&#x00026;volume=86&#x00026;pages=629-33\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref8\" id=\"ref8\">\u003c/a>8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. \u003ci>curr biol\u003c/i>. (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25247373\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2014.05.063\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;publication_year=2014&#x00026;title=plasticity+of+the+visual+cortex+and+treatment+of+amblyopia&#x00026;journal=curr+biol&#x00026;volume=24&#x00026;pages=r936-40\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref9\" id=\"ref9\">\u003c/a>9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. \u003ci>sci rep\u003c/i>. (2018) 8:12830. doi: 10.1038/s41598-018-31169-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30150750\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-018-31169-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=hj+huttunen&#x00026;author=jm+palva&#x00026;author=l+lindberg&#x00026;author=s+palva&#x00026;author=v+saarela&#x00026;author=e+karvonen&#x00026;publication_year=2018&#x00026;title=fluoxetine+does+not+enhance+the+effect+of+perceptual+learning+on+visual+function+in+adults+with+amblyopia&#x00026;journal=sci+rep&#x00026;volume=8&#x00026;pages=12830\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref10\" id=\"ref10\">\u003c/a>10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. \u003ci>j neurosci\u003c/i>. (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/21068299\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.4812-10.2010\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+bavelier&#x00026;author=dm+levi&#x00026;author=rw+li&#x00026;author=y+dan&#x00026;author=tk+hensch&#x00026;publication_year=2010&#x00026;title=removing+brakes+on+adult+brain+plasticity:+from+molecular+to+behavioral+interventions&#x00026;journal=j+neurosci&#x00026;volume=30&#x00026;pages=14964-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref11\" id=\"ref11\">\u003c/a>11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. \u003ci>science\u003c/i>. (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1126/science.1150516\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=m+vetencourt&#x00026;author=v+jf&#x00026;author=a+sale&#x00026;author=a+viegi&#x00026;author=l+baroncelli&#x00026;author=r+de+pasquale&#x00026;publication_year=2008&#x00026;title=the+antidepressant+fluoxetine+restores+plasticity+in+the+adult+visual+cortex&#x00026;journal=science&#x00026;volume=320&#x00026;pages=385-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref12\" id=\"ref12\">\u003c/a>12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. \u003ci>eye\u003c/i>. (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30783259\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41433-019-0360-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mh+sharif&#x00026;author=mr+talebnejad&#x00026;author=k+rastegar&#x00026;author=mr+khalili&#x00026;author=mh+nowroozzadeh&#x00026;publication_year=2019&#x00026;title=oral+fluoxetine+in+the+management+of+amblyopic+patients+aged+between+10+and+40+years+old:+a+randomized+clinical+trial&#x00026;journal=eye&#x00026;volume=33&#x00026;pages=1060-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref13\" id=\"ref13\">\u003c/a>13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. \u003ci>j aapos\u003c/i>. (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/39304030\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.jaapos.2024.104009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mirmohammadsadeghi&#x00026;author=a+mousavi&#x00026;author=mr+akbari&#x00026;author=h+khojasteh&#x00026;author=b+masoomian&#x00026;author=m+sadeghi&#x00026;publication_year=2024&#x00026;title=fluoxetine+as+a+possible+treatment+for+adult+amblyopia:+results+of+a+double-blind+randomized+placebo-controlled+trial&#x00026;journal=j+aapos&#x00026;volume=28&#x00026;pages=104009\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref14\" id=\"ref14\">\u003c/a>14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. \u003ci>neural plast\u003c/i>. (2019) 2019:5857243. doi: 10.1155/2019/5857243\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1155/2019/5857243\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ak+lagas&#x00026;author=jm+black&#x00026;author=br+russell&#x00026;author=rr+kydd&#x00026;author=b+thompson&#x00026;publication_year=2019&#x00026;title=the+effect+of+combined+patching+and+citalopram+on+visual+acuity+in+adults+with+amblyopia:+a+randomized+crossover+placebo-controlled+trial&#x00026;journal=neural+plast&#x00026;volume=2019&#x00026;pages=5857243\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref15\" id=\"ref15\">\u003c/a>15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. \u003ci>bmj\u003c/i>. (2009) 339:b2535. doi: 10.1136/bmj.b2535 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19622551\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.b2535\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+moher&#x00026;author=a+liberati&#x00026;author=j+tetzlaff&#x00026;author=dg+altman&#x00026;publication_year=2009&#x00026;title=preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+the+prisma+statement&#x00026;journal=bmj&#x00026;volume=339&#x00026;pages=b2535\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref16\" id=\"ref16\">\u003c/a>16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2019) 366:l4898. doi: 10.1136/bmj.l4898 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/31462531\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.l4898\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jac+sterne&#x00026;author=j+savovi&#x0107;&#x00026;author=mj+page&#x00026;author=rg+elbers&#x00026;author=ns+blencowe&#x00026;author=i+boutron&#x00026;publication_year=2019&#x00026;title=rob+2:+a+revised+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=366&#x00026;pages=l4898\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref17\" id=\"ref17\">\u003c/a>17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2011) 343:d5928. doi: 10.1136/bmj.d5928 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/22008217\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.d5928\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jpt+higgins&#x00026;author=dg+altman&#x00026;author=pc+g&#x000f8;tzsche&#x00026;author=p+j&#x000fc;ni&#x00026;author=d+moher&#x00026;author=ad+oxman&#x00026;publication_year=2011&#x00026;title=the+cochrane+collaboration&#x2019;s+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=343&#x00026;pages=d5928\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref18\" id=\"ref18\">\u003c/a>18. feighner, jp. mechanism of action of antidepressant medications. \u003ci>j clin psychiatry\u003c/i>. (1999) 60:4&#x2013;11.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=jp+feighner&#x00026;publication_year=1999&#x00026;title=mechanism+of+action+of+antidepressant+medications&#x00026;journal=j+clin+psychiatry&#x00026;volume=60&#x00026;pages=4-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref19\" id=\"ref19\">\u003c/a>19. morishita, h, and hensch, tk. critical period revisited: impact on vision. \u003ci>curr opin neurobiol\u003c/i>. (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/18534841\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.conb.2008.05.009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+morishita&#x00026;author=tk+hensch&#x00026;publication_year=2008&#x00026;title=critical+period+revisited:+impact+on+vision&#x00026;journal=curr+opin+neurobiol&#x00026;volume=18&#x00026;pages=101-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref20\" id=\"ref20\">\u003c/a>20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. \u003ci>ophthalmology\u003c/i>. (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25676904\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.ophtha.2015.01.002\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mx+repka&#x00026;author=rt+kraker&#x00026;author=tw+dean&#x00026;author=rw+beck&#x00026;author=rm+siatkowski&#x00026;publication_year=2015&#x00026;title=a+randomized+trial+of+levodopa+as+treatment+for+residual+amblyopia+in+older+children&#x00026;journal=ophthalmology&#x00026;volume=122&#x00026;pages=874-81\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref21\" id=\"ref21\">\u003c/a>21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. \u003ci>sci rep\u003c/i>. (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37349338\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-023-34891-5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+wu&#x00026;author=ed+gaier&#x00026;author=br+nihalani&#x00026;author=s+whitecross&#x00026;author=tk+hensch&#x00026;author=dg+hunter&#x00026;publication_year=2023&#x00026;title=durable+recovery+from+amblyopia+with+donepezil&#x00026;journal=sci+rep&#x00026;volume=13&#x00026;pages=10161\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref22\" id=\"ref22\">\u003c/a>22. mitchell, d, and sengpiel, f. animal models of amblyopia. \u003ci>vis neurosci\u003c/i>. (2018) 35:e017. doi: 10.1017/s0952523817000244 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/29905121\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1017/s0952523817000244\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+mitchell&#x00026;author=f+sengpiel&#x00026;publication_year=2018&#x00026;title=animal+models+of+amblyopia&#x00026;journal=vis+neurosci&#x00026;volume=35&#x00026;pages=e017\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref23\" id=\"ref23\">\u003c/a>23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). \u003ci>doc ophthalmol\u003c/i>. (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/27443562\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s10633-016-9553-y\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jv+odom&#x00026;author=m+bach&#x00026;author=m+brigell&#x00026;author=ge+holder&#x00026;author=dl+mcculloch&#x00026;author=a+mizota&#x00026;publication_year=2016&#x00026;title=iscev+standard+for+clinical+visual+evoked+potentials:+(2016+update)&#x00026;journal=doc+ophthalmol&#x00026;volume=133&#x00026;pages=1-9\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref24\" id=\"ref24\">\u003c/a>24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. \u003ci>brain struct funct\u003c/i>. (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33900453\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s00429-021-02273-0\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=h+bridge&#x00026;publication_year=2022&#x00026;title=investigating+the+neurochemistry+of+the+human+visual+system+using+magnetic+resonance+spectroscopy&#x00026;journal=brain+struct+funct&#x00026;volume=227&#x00026;pages=1491-505\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref25\" id=\"ref25\">\u003c/a>25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. \u003ci>imaging neurosci.\u003c/i> (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40110226\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1162/imag_a_00256\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=wt+clarke&#x00026;author=a+wyllie&#x00026;author=k+tracey&#x00026;author=j+matuszewski&#x00026;author=s+jbabdi&#x00026;publication_year=2024&#x00026;title=the+relationship+between+visual+acuity+loss+and+gabaergic+inhibition+in+amblyopia&#x00026;journal=imaging+neurosci.&#x00026;volume=2&#x00026;pages=1-18\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref26\" id=\"ref26\">\u003c/a>26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. \u003ci>perception\u003c/i>. (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37272064\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1177/03010066231178664\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+bridge&#x00026;author=ib+ip&#x00026;author=aj+parker&#x00026;publication_year=2023&#x00026;title=investigating+the+human+binocular+visual+system+using+multi-modal+magnetic+resonance+imaging&#x00026;journal=perception&#x00026;volume=52&#x00026;pages=441-58\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref27\" id=\"ref27\">\u003c/a>27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. \u003ci>front hum neurosci\u003c/i>. (2022) 16:949395. doi: 10.3389/fnhum.2022.949395\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.3389/fnhum.2022.949395\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mukerji&#x00026;author=kn+byrne&#x00026;author=e+yang&#x00026;author=dm+levi&#x00026;author=ma+silver&#x00026;publication_year=2022&#x00026;title=visual+cortical+&#x03b3;&#x02212;aminobutyric+acid+and+perceptual+suppression+in+amblyopia&#x00026;journal=front+hum+neurosci&#x00026;volume=16&#x00026;pages=949395\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref28\" id=\"ref28\">\u003c/a>28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: \u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26004760/\">https://pubmed.ncbi.nlm.nih.gov/26004760/\u003c/a>\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?publication_year=2025&#x00026;\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref29\" id=\"ref29\">\u003c/a>29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. \u003ci>strabismus\u003c/i>. (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40226898\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1080/09273972.2025.2478078\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+chedid&#x00026;author=m+fronius&#x00026;author=y+wenner&#x00026;author=l+cirina&#x00026;author=t+kohnen&#x00026;author=c+kuhli-hattenbach&#x00026;publication_year=2025&#x00026;title=optical+coherence+tomography+(oct)+parameters+in+amblyopia&#x00026;journal=strabismus&#x00026;volume=1&#x2013;11&#x00026;pages=1-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref30\" id=\"ref30\">\u003c/a>30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. \u003ci>j vis\u003c/i>. (2023) 23:14. doi: 10.1167/jov.23.1.14 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/36662501\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1167/jov.23.1.14\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=dm+levi&#x00026;publication_year=2023&#x00026;title=applications+and+implications+for+extended+reality+to+improve+binocular+vision+and+stereopsis&#x00026;journal=j+vis&#x00026;volume=23&#x00026;pages=14\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref31\" id=\"ref31\">\u003c/a>31. lunghi, c, and sale, a. a cycling lane for brain rewiring. \u003ci>curr biol\u003c/i>. (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26654367\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2015.10.026\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=a+sale&#x00026;publication_year=2015&#x00026;title=a+cycling+lane+for+brain+rewiring&#x00026;journal=curr+biol&#x00026;volume=25&#x00026;pages=r1122-3\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref32\" id=\"ref32\">\u003c/a>32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. \u003ci>annal. clin. transl. neurol.\u003c/i> (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30847360\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1002/acn3.698\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=at+sframeli&#x00026;author=a+lepri&#x00026;author=m+lepri&#x00026;author=d+lisi&#x00026;author=a+sale&#x00026;publication_year=2019&#x00026;title=a+new+counterintuitive+training+for+adult+amblyopia&#x00026;journal=annal.+clin.+transl.+neurol.&#x00026;volume=6&#x00026;pages=274-84\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003c/div> \u003cdiv class=\"thinlinem20\">\u003c/div> \u003cdiv class=\"abstractsummary\">\n\u003cp>\u003cspan>keywords:\u003c/span> amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity\u003c/p>\n\u003cp>\u003cspan>citation:\u003c/span> shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. \u003ci>front. neurol\u003c/i>. 16:1639913. doi: 10.3389/fneur.2025.1639913\u003c/p>\n\u003cp class=\"timestamps\">\u003cspan>received:\u003c/span> 03 june 2025; \u003cspan>accepted:\u003c/span> 31 july 2025;\u003cbr> \u003cspan>published:\u003c/span> 21 august 2025.\u003c/p> \u003cdiv>\n\u003cp>edited by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/2271562/overview\">gordon plant\u003c/a>, university college london, united kingdom\u003c/div> \u003cdiv>\n\u003cp>reviewed by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/1863925/overview\">sara samadzadeh\u003c/a>, charit&#x00e9; university medicine berlin, germany\u003cbr> \u003ca href=\"https://loop.frontiersin.org/people/870962/overview\">alistair r. fielder\u003c/a>, city university of london, united kingdom\u003c/div>\n\u003cp>\u003cspan>copyright\u003c/span> &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">creative commons attribution license (cc by)\u003c/a>. the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms.\u003c/p>\n\u003cp>\u003cspan>&#x0002a;correspondence:\u003c/span> i. betina ip, \u003ca id=\"encmail\">ymv0aw5hlmlwqg5ky24ub3guywmudws=\u003c/a>\u003c/p>\n\u003cp>\u003cspan>\u003csup>&#x2020;\u003c/sup>\u003c/span>these authors share senior authorship\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div>","\u003cul class=\"flyoutjournal\"> \u003cli>\u003ca href=\"#h1\">abstract\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h2\">introduction\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h3\">methods\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h4\">results\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h5\">discussion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h6\">conclusion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h7\">data availability statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h8\">author contributions\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h9\">funding\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h10\">conflict of interest\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h11\">generative ai statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h12\">publisher&#x2019;s note\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h13\">author disclaimer\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h14\">references\u003c/a>\u003c/li> \u003c/ul>",[719,725,731],{"name":720,"fileserverpackageentryid":19,"fileserverid":721,"fileserverversionnumber":439,"type":722},"epub.epub","1639913/epub",{"code":723,"name":724},"epub","epub",{"name":726,"fileserverpackageentryid":19,"fileserverid":727,"fileserverversionnumber":439,"type":728},"publishers-proof.pdf","1639913/publishers-proof",{"code":729,"name":730},"pdf","pdf",{"name":732,"fileserverpackageentryid":733,"fileserverid":734,"fileserverversionnumber":439,"type":735},"fneur-16-1639913.xml","fneur-16-1639913/fneur-16-1639913.xml","1639913/xml",{"code":736,"name":737},"nlm_xml","xml","v3",{"title":740,"link":741,"meta":745,"script":869},"frontiers | selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials",[742],{"rel":743,"href":744},"canonical","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/full",[746,749,752,754,757,761,764,768,771,774,777,779,781,783,785,787,790,793,795,798,800,802,805,808,811,814,817,821,825,828,831,834,837,840,843,846,849,852,855,858,861,864,866],{"hid":747,"property":747,"name":747,"content":748},"description","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in ea...",{"hid":750,"property":750,"name":751,"content":740},"og:title","title",{"hid":753,"property":753,"name":747,"content":748},"og:description",{"hid":755,"name":755,"content":756},"keywords","strabismus,neuroplasticity,amblyopia,fluoxetine,ssris,anisometropia,citalopram",{"hid":758,"property":758,"name":759,"content":760},"og:site_name","site_name","frontiers",{"hid":762,"property":762,"name":432,"content":763},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg",{"hid":765,"property":765,"name":766,"content":767},"og:type","type","article",{"hid":769,"property":769,"name":770,"content":744},"og:url","url",{"hid":772,"name":772,"content":773},"twitter:card","summary_large_image",{"hid":775,"name":775,"content":776},"citation_volume","16",{"hid":778,"name":778,"content":116},"citation_journal_title",{"hid":780,"name":780,"content":760},"citation_publisher",{"hid":782,"name":782,"content":700},"citation_journal_abbrev",{"hid":784,"name":784,"content":701},"citation_issn",{"hid":786,"name":786,"content":583},"citation_doi",{"hid":788,"name":788,"content":789},"citation_firstpage","1639913",{"hid":791,"name":791,"content":792},"citation_language","english",{"hid":794,"name":794,"content":584},"citation_title",{"hid":796,"name":796,"content":797},"citation_keywords","strabismus; neuroplasticity; amblyopia; fluoxetine; ssris; anisometropia; citalopram",{"hid":799,"name":799,"content":589},"citation_abstract",{"hid":801,"name":801,"content":598},"citation_article_type",{"hid":803,"name":803,"content":804},"citation_pdf_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/pdf",{"hid":806,"name":806,"content":807},"citation_xml_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/xml",{"hid":809,"name":809,"content":810},"citation_fulltext_world_readable","yes",{"hid":812,"name":812,"content":813},"citation_online_date","2025/07/31",{"hid":815,"name":815,"content":816},"citation_publication_date","2025/08/21",{"hid":818,"name":819,"content":820},"citation_author_0","citation_author","shamsher, ehtesham ",{"hid":822,"name":823,"content":824},"citation_author_institution_0","citation_author_institution","oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, united kingdom",{"hid":826,"name":819,"content":827},"citation_author_1","saccaro, luisa ",{"hid":829,"name":823,"content":830},"citation_author_institution_1","faculty of medicine, universidade de mogi das cruzes, brazil",{"hid":832,"name":819,"content":833},"citation_author_2","pungirum, victor barreiros ",{"hid":835,"name":823,"content":836},"citation_author_institution_2","faculty of medical sciences, university of buenos aires, argentina",{"hid":838,"name":819,"content":839},"citation_author_3","tran, nghi bao ",{"hid":841,"name":823,"content":842},"citation_author_institution_3","faculty of medicine, university of debrecen, hungary",{"hid":844,"name":819,"content":845},"citation_author_4","alghaith, omar a. h. a. ",{"hid":847,"name":823,"content":848},"citation_author_institution_4","institute of ophthalmology, university college london, united kingdom",{"hid":850,"name":819,"content":851},"citation_author_5","khabazianzadeh, fatemeh ",{"hid":853,"name":823,"content":854},"citation_author_institution_5","eye research center, khatam-al-anbia hospital, mashad university of medical sciences, iran",{"hid":856,"name":819,"content":857},"citation_author_6","bridge, holly ",{"hid":859,"name":823,"content":860},"citation_author_institution_6","nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, united kingdom",{"hid":862,"name":819,"content":863},"citation_author_7","ip, i. betina ",{"hid":865,"name":823,"content":860},"citation_author_institution_7",{"hid":867,"name":867,"content":868},"dc.identifier","doi:10.3389/fneur.2025.1639913",[870,873,875,877,879],{"src":871,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":874,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/mathjax.js?config=tex-mml-am_chtml",{"src":876,"body":13,"type":872,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":878,"body":13,"type":872,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1639913?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":880,"body":13,"type":872,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articlehubslug":19,"articlehubpage":882,"articlehubarticleslist":883,"canjournalhasarticlehub":379,"articledoilist":884},{},[],[],{"title":19,"image":-1,"breadcrumbs":886,"linkscollection":887,"metricscollection":889},[],{"total":436,"items":888},[],{"total":436,"items":890},[]] window.__nuxt__={};window.__nuxt__.config={public:{isdevmode:false,appname:"article-pages-2024",baseurl:"https://www.frontiersin.org",domain:"frontiersin.org",loopurl:"https://loop.frontiersin.org",ssmaindomain:"frontiersin.org",contentfulurl:"https://graphql.contentful.com/content/v1/spaces",spaceid:1,spacename:"frontiers",livespaceid:1,tenantlogourl:"",frontiersgraphurl:"https://apollo-federation-gateway.frontiersin.org",registrationapiurl:"https://onboarding-ui.frontiersin.org",emaildigestapiurl:"https://api-email-digest.frontiersin.org",journalfilesapiurl:"https://files-journal-api.frontiersin.org",searchapiurl:"https://search-api.frontiersin.org",productionforumapiurl:"https://production-forum-api-v2.frontiersin.org",gtmserverurl:"https://tag-manager.frontiersin.org",gtmid:"gtm-m322fv2",gtmauth:"owvbwxfajr21yqv1fe1caq",gtmpreview:"env-1",figsharepluginurl:"https://widgets.figshare.com/static/figshare.js",figshareapiurl:"https://api.figshare.com/v2/collections/search",figsharetimeout:3000,crossmarkpublisheddate:"2015/08/24",googlerecaptchasitekey:"6ldg3i0uaaaaaoc4quh35ubhgjotehp_stxhgr_v",googlerecaptchakeyname:"frontiersrecaptchav2",faviconsize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantfavicon-frontiers.png",faviconsize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantfavicon-frontiers.png",faviconsize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantfavicon-frontiers.png",faviconsize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantfavicon-frontiers.png",faviconsize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantfavicon-frontiers.png",socialmediaimg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/guidelines-frontiers_logo_1200x628_1-91to1.png",linkedarticlecopytext:"'{\"articletypecopytext\":[{\"articletypeid\":0,\"originalarticlecopytext\":\"part of this article's content has been mentioned in:\",\"linkedarticlecopytext\":\"this article mentions parts of:\"},{\"articletypeid\":122,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an erratum on:\"},{\"articletypeid\":129,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an addendum to:\"},{\"articletypeid\":128,\"originalarticlecopytext\":\"a correction has been applied to this article in:\",\"linkedarticlecopytext\":\"this article is a correction to:\"},{\"articletypeid\":134,\"originalarticlecopytext\":\"a retraction of this article was approved in:\",\"linkedarticlecopytext\":\"this article is a retraction of:\"},{\"articletypeid\":29,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"},{\"articletypeid\":30,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"}],\"articleidcopytext\":[]}'\n",acceptedarticleexcludedjournalids:"'[2766,979]'\n",articletypeconfigurablelabel:"\u003c\u003carticle-type:uppercase>> article",settingsfeaturesswitchers:"'{\"displaytitlepilllabels\":true,\"displayrelatedarticlesbox\":true,\"showeditors\":true,\"showreviewers\":true,\"showloopimpactlink\":true,\"enablefigshare\":false,\"usexmlimages\":true}'\n",journalswitharticlehub:"'{\"strings\":[\"science\"]}'\n",terminologysettings:"'{\"terms\":[{\"sequencenumber\":1,\"key\":\"frontiers\",\"tenantterm\":\"frontiers\",\"frontiersdefaultterm\":\"frontiers\",\"category\":\"customer\"},{\"sequencenumber\":2,\"key\":\"submission_system\",\"tenantterm\":\"submission system\",\"frontiersdefaultterm\":\"submission system\",\"category\":\"product\"},{\"sequencenumber\":3,\"key\":\"public_pages\",\"tenantterm\":\"public pages\",\"frontiersdefaultterm\":\"public pages\",\"category\":\"product\"},{\"sequencenumber\":4,\"key\":\"my_frontiers\",\"tenantterm\":\"my frontiers\",\"frontiersdefaultterm\":\"my frontiers\",\"category\":\"product\"},{\"sequencenumber\":5,\"key\":\"digital_editorial_office\",\"tenantterm\":\"digital editorial office\",\"frontiersdefaultterm\":\"digital editorial office\",\"category\":\"product\"},{\"sequencenumber\":6,\"key\":\"deo\",\"tenantterm\":\"deo\",\"frontiersdefaultterm\":\"deo\",\"category\":\"product\"},{\"sequencenumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantterm\":\"digital editorial office for chiefs\",\"frontiersdefaultterm\":\"digital editorial office for chiefs\",\"category\":\"product\"},{\"sequencenumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantterm\":\"digital editorial office for eof\",\"frontiersdefaultterm\":\"digital editorial office for eof\",\"category\":\"product\"},{\"sequencenumber\":9,\"key\":\"editorial_office\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"product\"},{\"sequencenumber\":10,\"key\":\"eof\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"product\"},{\"sequencenumber\":11,\"key\":\"research_topic_management\",\"tenantterm\":\"research topic management\",\"frontiersdefaultterm\":\"research topic management\",\"category\":\"product\"},{\"sequencenumber\":12,\"key\":\"review_forum\",\"tenantterm\":\"review forum\",\"frontiersdefaultterm\":\"review forum\",\"category\":\"product\"},{\"sequencenumber\":13,\"key\":\"accounting_office\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"product\"},{\"sequencenumber\":14,\"key\":\"aof\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"product\"},{\"sequencenumber\":15,\"key\":\"publishing_office\",\"tenantterm\":\"publishing office\",\"frontiersdefaultterm\":\"publishing office\",\"category\":\"product\"},{\"sequencenumber\":16,\"key\":\"production_office\",\"tenantterm\":\"production office forum\",\"frontiersdefaultterm\":\"production office forum\",\"category\":\"product\"},{\"sequencenumber\":17,\"key\":\"pof\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"product\"},{\"sequencenumber\":18,\"key\":\"book_office_forum\",\"tenantterm\":\"book office forum\",\"frontiersdefaultterm\":\"book office forum\",\"category\":\"product\"},{\"sequencenumber\":19,\"key\":\"bof\",\"tenantterm\":\"bof\",\"frontiersdefaultterm\":\"bof\",\"category\":\"product\"},{\"sequencenumber\":20,\"key\":\"aira\",\"tenantterm\":\"aira\",\"frontiersdefaultterm\":\"aira\",\"category\":\"product\"},{\"sequencenumber\":21,\"key\":\"editorial_board_management\",\"tenantterm\":\"editorial board management\",\"frontiersdefaultterm\":\"editorial board management\",\"category\":\"product\"},{\"sequencenumber\":22,\"key\":\"ebm\",\"tenantterm\":\"ebm\",\"frontiersdefaultterm\":\"ebm\",\"category\":\"product\"},{\"sequencenumber\":23,\"key\":\"domain\",\"tenantterm\":\"domain\",\"frontiersdefaultterm\":\"domain\",\"category\":\"taxonomy\"},{\"sequencenumber\":24,\"key\":\"journal\",\"tenantterm\":\"journal\",\"frontiersdefaultterm\":\"journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":25,\"key\":\"section\",\"tenantterm\":\"section\",\"frontiersdefaultterm\":\"section\",\"category\":\"taxonomy\"},{\"sequencenumber\":26,\"key\":\"domains\",\"tenantterm\":\"domains\",\"frontiersdefaultterm\":\"domains\",\"category\":\"taxonomy\"},{\"sequencenumber\":27,\"key\":\"specialty_section\",\"tenantterm\":\"specialty section\",\"frontiersdefaultterm\":\"specialty section\",\"category\":\"taxonomy\"},{\"sequencenumber\":28,\"key\":\"specialty_journal\",\"tenantterm\":\"specialty journal\",\"frontiersdefaultterm\":\"specialty journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":29,\"key\":\"journals\",\"tenantterm\":\"journals\",\"frontiersdefaultterm\":\"journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":30,\"key\":\"sections\",\"tenantterm\":\"sections\",\"frontiersdefaultterm\":\"sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":31,\"key\":\"specialty_sections\",\"tenantterm\":\"specialty sections\",\"frontiersdefaultterm\":\"specialty sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":32,\"key\":\"specialty_journals\",\"tenantterm\":\"specialty journals\",\"frontiersdefaultterm\":\"specialty journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":33,\"key\":\"manuscript\",\"tenantterm\":\"manuscript\",\"frontiersdefaultterm\":\"manuscript\",\"category\":\"core\"},{\"sequencenumber\":34,\"key\":\"manuscripts\",\"tenantterm\":\"manuscripts\",\"frontiersdefaultterm\":\"manuscripts\",\"category\":\"core\"},{\"sequencenumber\":35,\"key\":\"article\",\"tenantterm\":\"article\",\"frontiersdefaultterm\":\"article\",\"category\":\"core\"},{\"sequencenumber\":36,\"key\":\"articles\",\"tenantterm\":\"articles\",\"frontiersdefaultterm\":\"articles\",\"category\":\"core\"},{\"sequencenumber\":37,\"key\":\"article_type\",\"tenantterm\":\"article type\",\"frontiersdefaultterm\":\"article type\",\"category\":\"core\"},{\"sequencenumber\":38,\"key\":\"article_types\",\"tenantterm\":\"article types\",\"frontiersdefaultterm\":\"article types\",\"category\":\"core\"},{\"sequencenumber\":39,\"key\":\"author\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":40,\"key\":\"authors\",\"tenantterm\":\"authors\",\"frontiersdefaultterm\":\"authors\",\"category\":\"label (role)\"},{\"sequencenumber\":41,\"key\":\"authoring\",\"tenantterm\":\"authoring\",\"frontiersdefaultterm\":\"authoring\",\"category\":\"core\"},{\"sequencenumber\":42,\"key\":\"authored\",\"tenantterm\":\"authored\",\"frontiersdefaultterm\":\"authored\",\"category\":\"core\"},{\"sequencenumber\":43,\"key\":\"accept\",\"tenantterm\":\"accept\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":44,\"key\":\"accepted\",\"tenantterm\":\"accepted\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"description\":\"an editorial role on a field journal that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantterm\":\"assistant specialty chief editors\",\"frontiersdefaultterm\":\"assistant specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":48,\"key\":\"associate_editor\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":49,\"key\":\"specialty_chief_editor\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":50,\"key\":\"specialty_chief_editors\",\"tenantterm\":\"specialty chief editors\",\"frontiersdefaultterm\":\"specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":51,\"key\":\"chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":52,\"key\":\"chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":53,\"key\":\"call_for_participation\",\"tenantterm\":\"call for participation\",\"frontiersdefaultterm\":\"call for participation\",\"category\":\"process\"},{\"sequencenumber\":54,\"key\":\"citation\",\"tenantterm\":\"citation\",\"frontiersdefaultterm\":\"citation\",\"category\":\"misc.\"},{\"sequencenumber\":55,\"key\":\"citations\",\"tenantterm\":\"citations\",\"frontiersdefaultterm\":\"citations\",\"category\":\"misc.\"},{\"sequencenumber\":56,\"key\":\"contributor\",\"tenantterm\":\"contributor\",\"frontiersdefaultterm\":\"contributor\",\"category\":\"label (role)\"},{\"sequencenumber\":57,\"key\":\"contributors\",\"tenantterm\":\"contributors\",\"frontiersdefaultterm\":\"contributors\",\"category\":\"label (role)\"},{\"sequencenumber\":58,\"key\":\"corresponding_author\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":59,\"key\":\"corresponding_authors\",\"tenantterm\":\"corresponding authors\",\"frontiersdefaultterm\":\"corresponding authors\",\"category\":\"label (role)\"},{\"sequencenumber\":60,\"key\":\"decline\",\"tenantterm\":\"decline\",\"frontiersdefaultterm\":\"decline\",\"category\":\"process\"},{\"sequencenumber\":61,\"key\":\"declined\",\"tenantterm\":\"declined\",\"frontiersdefaultterm\":\"declined\",\"category\":\"process\"},{\"sequencenumber\":62,\"key\":\"reject\",\"tenantterm\":\"reject\",\"frontiersdefaultterm\":\"reject\",\"category\":\"process\"},{\"sequencenumber\":63,\"key\":\"rejected\",\"tenantterm\":\"rejected\",\"frontiersdefaultterm\":\"rejected\",\"category\":\"process\"},{\"sequencenumber\":64,\"key\":\"publish\",\"tenantterm\":\"publish\",\"frontiersdefaultterm\":\"publish\",\"category\":\"core\"},{\"sequencenumber\":65,\"key\":\"published\",\"tenantterm\":\"published\",\"frontiersdefaultterm\":\"published\",\"category\":\"core\"},{\"sequencenumber\":66,\"key\":\"publication\",\"tenantterm\":\"publication\",\"frontiersdefaultterm\":\"publication\",\"category\":\"core\"},{\"sequencenumber\":67,\"key\":\"peer_review\",\"tenantterm\":\"peer review\",\"frontiersdefaultterm\":\"peer review\",\"category\":\"peer review process\"},{\"sequencenumber\":68,\"key\":\"peer_reviewed\",\"tenantterm\":\"peer reviewed\",\"frontiersdefaultterm\":\"peer reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":69,\"key\":\"initial_validation\",\"tenantterm\":\"initial validation\",\"frontiersdefaultterm\":\"initial validation\",\"category\":\"peer review process\"},{\"sequencenumber\":70,\"key\":\"editorial_assignment\",\"tenantterm\":\"editorial assignment\",\"frontiersdefaultterm\":\"editorial assignment\",\"category\":\"peer review process\"},{\"sequencenumber\":71,\"key\":\"independent_review\",\"tenantterm\":\"independent review\",\"frontiersdefaultterm\":\"independent review\",\"category\":\"peer review process\"},{\"sequencenumber\":72,\"key\":\"interactive_review\",\"tenantterm\":\"interactive review\",\"frontiersdefaultterm\":\"interactive review\",\"category\":\"peer review process\"},{\"sequencenumber\":73,\"key\":\"review\",\"tenantterm\":\"review\",\"frontiersdefaultterm\":\"review\",\"category\":\"peer review process\"},{\"sequencenumber\":74,\"key\":\"reviewing\",\"tenantterm\":\"reviewing\",\"frontiersdefaultterm\":\"reviewing\",\"category\":\"peer review process\"},{\"sequencenumber\":75,\"key\":\"reviewer\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":76,\"key\":\"reviewers\",\"tenantterm\":\"reviewers\",\"frontiersdefaultterm\":\"reviewers\",\"category\":\"label (role)\"},{\"sequencenumber\":77,\"key\":\"review_finalized\",\"tenantterm\":\"review finalized\",\"frontiersdefaultterm\":\"review finalized\",\"category\":\"peer review process\"},{\"sequencenumber\":78,\"key\":\"final_decision\",\"tenantterm\":\"final decision\",\"frontiersdefaultterm\":\"final decision\",\"category\":\"peer review process\"},{\"sequencenumber\":79,\"key\":\"final_validation\",\"tenantterm\":\"final validation\",\"frontiersdefaultterm\":\"final validation\",\"category\":\"peer review process\"},{\"sequencenumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantterm\":\"recommend to accept manuscript\",\"frontiersdefaultterm\":\"accept manuscript\",\"category\":\"process\"},{\"sequencenumber\":81,\"key\":\"fee\",\"tenantterm\":\"fee\",\"frontiersdefaultterm\":\"fee\",\"category\":\"accounting\"},{\"sequencenumber\":82,\"key\":\"fees\",\"tenantterm\":\"fees\",\"frontiersdefaultterm\":\"fees\",\"category\":\"accounting\"},{\"sequencenumber\":83,\"key\":\"guest_associate_editor\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":84,\"key\":\"guest_associate_editors\",\"tenantterm\":\"guest associate editors\",\"frontiersdefaultterm\":\"guest associate editors\",\"category\":\"label (role)\"},{\"sequencenumber\":85,\"key\":\"in_review\",\"tenantterm\":\"in review\",\"frontiersdefaultterm\":\"in review\",\"category\":\"peer review process\"},{\"sequencenumber\":86,\"key\":\"institutional_member\",\"tenantterm\":\"institutional partner\",\"frontiersdefaultterm\":\"institutional partner\",\"category\":\"accounting\"},{\"sequencenumber\":87,\"key\":\"institutional_membership\",\"tenantterm\":\"institutional partnership\",\"frontiersdefaultterm\":\"institutional partnership\",\"category\":\"accounting\"},{\"sequencenumber\":88,\"key\":\"article_processing_charge\",\"tenantterm\":\"article processing charge\",\"frontiersdefaultterm\":\"article processing charge\",\"category\":\"accounting\"},{\"sequencenumber\":89,\"key\":\"article_processing_charges\",\"tenantterm\":\"article processing charges\",\"frontiersdefaultterm\":\"article processing charges\",\"category\":\"accounting\"},{\"sequencenumber\":90,\"key\":\"apcs\",\"tenantterm\":\"apcs\",\"frontiersdefaultterm\":\"apcs\",\"category\":\"accounting\"},{\"sequencenumber\":91,\"key\":\"apc\",\"tenantterm\":\"apc\",\"frontiersdefaultterm\":\"apc\",\"category\":\"accounting\"},{\"sequencenumber\":92,\"key\":\"received\",\"tenantterm\":\"received\",\"frontiersdefaultterm\":\"received\",\"description\":\"date manuscript was received on.\",\"category\":\"core\"},{\"sequencenumber\":93,\"key\":\"transferred\",\"tenantterm\":\"transferred\",\"frontiersdefaultterm\":\"transferred\",\"category\":\"core\"},{\"sequencenumber\":94,\"key\":\"transfer\",\"tenantterm\":\"transfer\",\"frontiersdefaultterm\":\"transfer\",\"category\":\"core\"},{\"sequencenumber\":95,\"key\":\"research_topic\",\"tenantterm\":\"research topic\",\"frontiersdefaultterm\":\"research topic\",\"category\":\"core\"},{\"sequencenumber\":96,\"key\":\"research_topics\",\"tenantterm\":\"research topics\",\"frontiersdefaultterm\":\"research topics\",\"category\":\"core\"},{\"sequencenumber\":97,\"key\":\"topic_editor\",\"tenantterm\":\"topic editor\",\"frontiersdefaultterm\":\"topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":98,\"key\":\"review_editor\",\"tenantterm\":\"community reviewer\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":99,\"key\":\"title\",\"tenantterm\":\"title\",\"frontiersdefaultterm\":\"title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":100,\"key\":\"running_title\",\"tenantterm\":\"running title\",\"frontiersdefaultterm\":\"running title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":101,\"key\":\"submit\",\"tenantterm\":\"submit\",\"frontiersdefaultterm\":\"submit\",\"category\":\"process\"},{\"sequencenumber\":102,\"key\":\"submitted\",\"tenantterm\":\"submitted\",\"frontiersdefaultterm\":\"submitted\",\"category\":\"process\"},{\"sequencenumber\":103,\"key\":\"submitting\",\"tenantterm\":\"submitting\",\"frontiersdefaultterm\":\"submitting\",\"category\":\"process\"},{\"sequencenumber\":104,\"key\":\"t_e\",\"tenantterm\":\"te\",\"frontiersdefaultterm\":\"te\",\"category\":\"label (role)\"},{\"sequencenumber\":105,\"key\":\"topic\",\"tenantterm\":\"topic\",\"frontiersdefaultterm\":\"topic\",\"category\":\"process\"},{\"sequencenumber\":106,\"key\":\"topic_summary\",\"tenantterm\":\"topic summary\",\"frontiersdefaultterm\":\"topic summary\",\"category\":\"process\"},{\"sequencenumber\":107,\"key\":\"figure\",\"tenantterm\":\"figure\",\"frontiersdefaultterm\":\"figure\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":108,\"key\":\"figures\",\"tenantterm\":\"figures\",\"frontiersdefaultterm\":\"figures\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":109,\"key\":\"editorial_file\",\"tenantterm\":\"editorial file\",\"frontiersdefaultterm\":\"editorial file\",\"category\":\"core\"},{\"sequencenumber\":110,\"key\":\"editorial_files\",\"tenantterm\":\"editorial files\",\"frontiersdefaultterm\":\"editorial files\",\"category\":\"core\"},{\"sequencenumber\":111,\"key\":\"e_book\",\"tenantterm\":\"e-book\",\"frontiersdefaultterm\":\"e-book\",\"category\":\"core\"},{\"sequencenumber\":112,\"key\":\"organization\",\"tenantterm\":\"organization\",\"frontiersdefaultterm\":\"organization\",\"category\":\"core\"},{\"sequencenumber\":113,\"key\":\"institution\",\"tenantterm\":\"institution\",\"frontiersdefaultterm\":\"institution\",\"category\":\"core\"},{\"sequencenumber\":114,\"key\":\"reference\",\"tenantterm\":\"reference\",\"frontiersdefaultterm\":\"reference\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":115,\"key\":\"references\",\"tenantterm\":\"references\",\"frontiersdefaultterm\":\"references\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":116,\"key\":\"sce\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"description\":\"abbreviation for specialty chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":117,\"key\":\"submission\",\"tenantterm\":\"submission\",\"frontiersdefaultterm\":\"submission\",\"category\":\"process\"},{\"sequencenumber\":118,\"key\":\"submissions\",\"tenantterm\":\"submissions\",\"frontiersdefaultterm\":\"submissions\",\"category\":\"process\"},{\"sequencenumber\":119,\"key\":\"editing\",\"tenantterm\":\"editing\",\"frontiersdefaultterm\":\"editing\",\"category\":\"process\"},{\"sequencenumber\":120,\"key\":\"in_preparation\",\"tenantterm\":\"in preparation\",\"frontiersdefaultterm\":\"in preparation\",\"category\":\"process\"},{\"sequencenumber\":121,\"key\":\"country_region\",\"tenantterm\":\"country/region\",\"frontiersdefaultterm\":\"country/region\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":122,\"key\":\"countries_regions\",\"tenantterm\":\"countries/regions\",\"frontiersdefaultterm\":\"countries/regions\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":123,\"key\":\"specialty\",\"tenantterm\":\"specialty\",\"frontiersdefaultterm\":\"specialty\",\"category\":\"core\"},{\"sequencenumber\":124,\"key\":\"specialties\",\"tenantterm\":\"specialties\",\"frontiersdefaultterm\":\"specialties\",\"category\":\"core\"},{\"sequencenumber\":125,\"key\":\"associate_editors\",\"tenantterm\":\"associate editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":126,\"key\":\"reviewed\",\"tenantterm\":\"reviewed\",\"frontiersdefaultterm\":\"reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":127,\"key\":\"institutional_members\",\"tenantterm\":\"institutional partners\",\"frontiersdefaultterm\":\"institutional partners\",\"category\":\"accounting\"},{\"sequencenumber\":128,\"key\":\"institutional_memberships\",\"tenantterm\":\"institutional partnerships\",\"frontiersdefaultterm\":\"institutional partnerships\",\"category\":\"accounting\"},{\"sequencenumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantterm\":\"assistant field chief editors\",\"frontiersdefaultterm\":\"assistant field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":130,\"key\":\"publications\",\"tenantterm\":\"publications\",\"frontiersdefaultterm\":\"publications\",\"category\":\"process\"},{\"sequencenumber\":131,\"key\":\"ae_accepted\",\"tenantterm\":\"recommended acceptance\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":132,\"key\":\"field_journal\",\"tenantterm\":\"field journal\",\"frontiersdefaultterm\":\"field journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":133,\"key\":\"field_journals\",\"tenantterm\":\"field journals\",\"frontiersdefaultterm\":\"field journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":134,\"key\":\"program_manager\",\"tenantterm\":\"program manager\",\"frontiersdefaultterm\":\"program manager\",\"category\":\"label (role)\"},{\"sequencenumber\":135,\"key\":\"journal_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":136,\"key\":\"journal_specialist\",\"tenantterm\":\"journal specialist\",\"frontiersdefaultterm\":\"journal specialist\",\"category\":\"label (role)\"},{\"sequencenumber\":137,\"key\":\"program_managers\",\"tenantterm\":\"program managers\",\"frontiersdefaultterm\":\"program managers\",\"category\":\"label (role)\"},{\"sequencenumber\":138,\"key\":\"journal_managers\",\"tenantterm\":\"journal managers\",\"frontiersdefaultterm\":\"journal managers\",\"category\":\"label (role)\"},{\"sequencenumber\":139,\"key\":\"journal_specialists\",\"tenantterm\":\"journal specialists\",\"frontiersdefaultterm\":\"journal specialists\",\"category\":\"label (role)\"},{\"sequencenumber\":140,\"key\":\"cover_letter\",\"tenantterm\":\"manuscript contribution to the field\",\"frontiersdefaultterm\":\"manuscript contribution to the field\",\"category\":\"process\"},{\"sequencenumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantterm\":\"recommended to accept manuscript\",\"frontiersdefaultterm\":\"accepted manuscript\",\"category\":\"process\"},{\"sequencenumber\":142,\"key\":\"recommend_for_rejection\",\"tenantterm\":\"recommend for rejection\",\"frontiersdefaultterm\":\"recommend for rejection\",\"category\":\"process\"},{\"sequencenumber\":143,\"key\":\"recommended_for_rejection\",\"tenantterm\":\"recommended for rejection\",\"frontiersdefaultterm\":\"recommended for rejection\",\"category\":\"process\"},{\"sequencenumber\":144,\"key\":\"ae\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"description\":\"associate editor - board member\",\"category\":\"label (role)\"},{\"sequencenumber\":145,\"key\":\"re\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"description\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":146,\"key\":\"rev\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"description\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":147,\"key\":\"aut\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"description\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":148,\"key\":\"coraut\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"description\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":149,\"key\":\"saut\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"description\":\"submitting author\",\"category\":\"label (role)\"},{\"sequencenumber\":150,\"key\":\"coaut\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"description\":\"co-author\",\"category\":\"label (role)\"},{\"sequencenumber\":151,\"key\":\"tsof\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"description\":\"typesetter\",\"category\":\"label (role)\"},{\"sequencenumber\":152,\"key\":\"typesetting_office\",\"tenantterm\":\"typesetting office\",\"frontiersdefaultterm\":\"typesetting office\",\"category\":\"product\"},{\"sequencenumber\":153,\"key\":\"config\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"description\":\"configuration office role\",\"category\":\"label (role)\"},{\"sequencenumber\":154,\"key\":\"jm\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"description\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":155,\"key\":\"rte\",\"tenantterm\":\"rte\",\"frontiersdefaultterm\":\"rte\",\"description\":\"research topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":156,\"key\":\"organizations\",\"tenantterm\":\"organizations\",\"frontiersdefaultterm\":\"organizations\",\"category\":\"core\"},{\"sequencenumber\":157,\"key\":\"publishing\",\"tenantterm\":\"publishing\",\"frontiersdefaultterm\":\"publishing\",\"category\":\"core\"},{\"sequencenumber\":158,\"key\":\"acceptance\",\"tenantterm\":\"acceptance\",\"frontiersdefaultterm\":\"acceptance\",\"category\":\"process\"},{\"sequencenumber\":159,\"key\":\"preferred_associate_editor\",\"tenantterm\":\"preferred associate editor\",\"frontiersdefaultterm\":\"preferred associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":160,\"key\":\"topic_editors\",\"tenantterm\":\"topic editors\",\"frontiersdefaultterm\":\"topic editors\",\"category\":\"label (role)\"},{\"sequencenumber\":161,\"key\":\"institutions\",\"tenantterm\":\"institutions\",\"frontiersdefaultterm\":\"institutions\",\"category\":\"core\"},{\"sequencenumber\":162,\"key\":\"author(s)\",\"tenantterm\":\"author(s)\",\"frontiersdefaultterm\":\"author(s)\",\"category\":\"label (role)\"},{\"sequencenumber\":163,\"key\":\"figure(s)\",\"tenantterm\":\"figure(s)\",\"frontiersdefaultterm\":\"figure(s)\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":164,\"key\":\"co-authors\",\"tenantterm\":\"co-authors\",\"frontiersdefaultterm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"label (role)\"},{\"sequencenumber\":165,\"key\":\"editorial_board_members\",\"tenantterm\":\"editorial board members\",\"frontiersdefaultterm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"label (role)\"},{\"sequencenumber\":166,\"key\":\"editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"product\"},{\"sequencenumber\":167,\"key\":\"co-authorship\",\"tenantterm\":\"co-authorship\",\"frontiersdefaultterm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"misc.\"},{\"sequencenumber\":168,\"key\":\"role_id_1\",\"tenantterm\":\"registration office\",\"frontiersdefaultterm\":\"registration office\",\"category\":\"user role\"},{\"sequencenumber\":169,\"key\":\"role_id_2\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"user role\"},{\"sequencenumber\":170,\"key\":\"role_id_7\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":171,\"key\":\"role_id_8\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":172,\"key\":\"role_id_9\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":173,\"key\":\"role_id_10\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":174,\"key\":\"role_id_11\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"category\":\"user role\"},{\"sequencenumber\":175,\"key\":\"role_id_12\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"user role\"},{\"sequencenumber\":176,\"key\":\"role_id_13\",\"tenantterm\":\"review editor\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"user role\"},{\"sequencenumber\":177,\"key\":\"role_id_14\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"user role\"},{\"sequencenumber\":178,\"key\":\"role_id_15\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"user role\"},{\"sequencenumber\":179,\"key\":\"role_id_16\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"user role\"},{\"sequencenumber\":180,\"key\":\"role_id_17\",\"tenantterm\":\"submitting author\",\"frontiersdefaultterm\":\"submitting author\",\"category\":\"user role\"},{\"sequencenumber\":181,\"key\":\"role_id_18\",\"tenantterm\":\"co-author\",\"frontiersdefaultterm\":\"co-author\",\"category\":\"user role\"},{\"sequencenumber\":182,\"key\":\"role_id_20\",\"tenantterm\":\"production office\",\"frontiersdefaultterm\":\"production office\",\"category\":\"user role\"},{\"sequencenumber\":183,\"key\":\"role_id_22\",\"tenantterm\":\"typesetting office (typesetter)\",\"frontiersdefaultterm\":\"typesetting office (typesetter)\",\"category\":\"user role\"},{\"sequencenumber\":184,\"key\":\"role_id_24\",\"tenantterm\":\"registered user\",\"frontiersdefaultterm\":\"registered user\",\"category\":\"user role\"},{\"sequencenumber\":185,\"key\":\"role_id_35\",\"tenantterm\":\"job office\",\"frontiersdefaultterm\":\"job office\",\"category\":\"user role\"},{\"sequencenumber\":186,\"key\":\"role_id_41\",\"tenantterm\":\"special event administrator\",\"frontiersdefaultterm\":\"special event administrator\",\"category\":\"user role\"},{\"sequencenumber\":187,\"key\":\"role_id_42\",\"tenantterm\":\"special event reviewer\",\"frontiersdefaultterm\":\"special event reviewer\",\"category\":\"user role\"},{\"sequencenumber\":188,\"key\":\"role_id_43\",\"tenantterm\":\"submit abstract\",\"frontiersdefaultterm\":\"submit abstract\",\"category\":\"user role\"},{\"sequencenumber\":189,\"key\":\"role_id_52\",\"tenantterm\":\"events office\",\"frontiersdefaultterm\":\"events office\",\"category\":\"user role\"},{\"sequencenumber\":190,\"key\":\"role_id_53\",\"tenantterm\":\"event administrator\",\"frontiersdefaultterm\":\"event administrator\",\"category\":\"user role\"},{\"sequencenumber\":191,\"key\":\"role_id_89\",\"tenantterm\":\"content management office\",\"frontiersdefaultterm\":\"content management office\",\"category\":\"user role\"},{\"sequencenumber\":192,\"key\":\"role_id_98\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"user role\"},{\"sequencenumber\":193,\"key\":\"role_id_99\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":194,\"key\":\"role_id_103\",\"tenantterm\":\"configuration office\",\"frontiersdefaultterm\":\"configuration office\",\"category\":\"user role\"},{\"sequencenumber\":195,\"key\":\"role_id_104\",\"tenantterm\":\"beta user\",\"frontiersdefaultterm\":\"beta user\",\"category\":\"user role\"},{\"sequencenumber\":196,\"key\":\"role_id_106\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":197,\"key\":\"role_id_107\",\"tenantterm\":\"rt management beta user\",\"frontiersdefaultterm\":\"rt management beta user\",\"category\":\"user role\"},{\"sequencenumber\":198,\"key\":\"role_id_108\",\"tenantterm\":\"deo beta user\",\"frontiersdefaultterm\":\"deo beta user\",\"category\":\"user role\"},{\"sequencenumber\":199,\"key\":\"role_id_109\",\"tenantterm\":\"search beta user\",\"frontiersdefaultterm\":\"search beta user\",\"category\":\"user role\"},{\"sequencenumber\":200,\"key\":\"role_id_110\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"user role\"},{\"sequencenumber\":201,\"key\":\"role_id_111\",\"tenantterm\":\"myfrontiers beta user\",\"frontiersdefaultterm\":\"myfrontiers beta user\",\"category\":\"user role\"},{\"sequencenumber\":202,\"key\":\"role_id_21\",\"tenantterm\":\"copy editor\",\"frontiersdefaultterm\":\"copy editor\",\"category\":\"user role\"},{\"sequencenumber\":203,\"key\":\"role_id_1_abr\",\"tenantterm\":\"rof\",\"frontiersdefaultterm\":\"rof\",\"category\":\"user role\"},{\"sequencenumber\":204,\"key\":\"role_id_2_abr\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"user role\"},{\"sequencenumber\":205,\"key\":\"role_id_7_abr\",\"tenantterm\":\"fce\",\"frontiersdefaultterm\":\"fce\",\"category\":\"user role\"},{\"sequencenumber\":206,\"key\":\"role_id_8_abr\",\"tenantterm\":\"afce\",\"frontiersdefaultterm\":\"afce\",\"category\":\"user role\"},{\"sequencenumber\":207,\"key\":\"role_id_9_abr\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"category\":\"user role\"},{\"sequencenumber\":208,\"key\":\"role_id_10_abr\",\"tenantterm\":\"asce\",\"frontiersdefaultterm\":\"asce\",\"category\":\"user role\"},{\"sequencenumber\":209,\"key\":\"role_id_11_abr\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"category\":\"user role\"},{\"sequencenumber\":210,\"key\":\"role_id_12_abr\",\"tenantterm\":\"gae\",\"frontiersdefaultterm\":\"gae\",\"category\":\"user role\"},{\"sequencenumber\":211,\"key\":\"role_id_13_abr\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"category\":\"user role\"},{\"sequencenumber\":212,\"key\":\"role_id_14_abr\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"category\":\"user role\"},{\"sequencenumber\":213,\"key\":\"role_id_15_abr\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"category\":\"user role\"},{\"sequencenumber\":214,\"key\":\"role_id_16_abr\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"category\":\"user role\"},{\"sequencenumber\":215,\"key\":\"role_id_17_abr\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"category\":\"user role\"},{\"sequencenumber\":216,\"key\":\"role_id_18_abr\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"category\":\"user role\"},{\"sequencenumber\":217,\"key\":\"role_id_20_abr\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"user role\"},{\"sequencenumber\":218,\"key\":\"role_id_22_abr\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"category\":\"user role\"},{\"sequencenumber\":219,\"key\":\"role_id_24_abr\",\"tenantterm\":\"ru\",\"frontiersdefaultterm\":\"ru\",\"category\":\"user role\"},{\"sequencenumber\":220,\"key\":\"role_id_35_abr\",\"tenantterm\":\"jof\",\"frontiersdefaultterm\":\"jof\",\"category\":\"user role\"},{\"sequencenumber\":221,\"key\":\"role_id_41_abr\",\"tenantterm\":\"se-adm\",\"frontiersdefaultterm\":\"se-adm\",\"category\":\"user role\"},{\"sequencenumber\":222,\"key\":\"role_id_42_abr\",\"tenantterm\":\"se-rev\",\"frontiersdefaultterm\":\"se-rev\",\"category\":\"user role\"},{\"sequencenumber\":223,\"key\":\"role_id_43_abr\",\"tenantterm\":\"se-aut\",\"frontiersdefaultterm\":\"se-aut\",\"category\":\"user role\"},{\"sequencenumber\":224,\"key\":\"role_id_52_abr\",\"tenantterm\":\"evof\",\"frontiersdefaultterm\":\"evof\",\"category\":\"user role\"},{\"sequencenumber\":225,\"key\":\"role_id_53_abr\",\"tenantterm\":\"ev-adm\",\"frontiersdefaultterm\":\"ev-adm\",\"category\":\"user role\"},{\"sequencenumber\":226,\"key\":\"role_id_89_abr\",\"tenantterm\":\"comof\",\"frontiersdefaultterm\":\"comof\",\"category\":\"user role\"},{\"sequencenumber\":227,\"key\":\"role_id_98_abr\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"user role\"},{\"sequencenumber\":228,\"key\":\"role_id_99_abr\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":229,\"key\":\"role_id_103_abr\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"category\":\"user role\"},{\"sequencenumber\":230,\"key\":\"role_id_104_abr\",\"tenantterm\":\"beta\",\"frontiersdefaultterm\":\"beta\",\"category\":\"user role\"},{\"sequencenumber\":231,\"key\":\"role_id_106_abr\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":232,\"key\":\"role_id_107_abr\",\"tenantterm\":\"rtbeta\",\"frontiersdefaultterm\":\"rtbeta\",\"category\":\"user role\"},{\"sequencenumber\":233,\"key\":\"role_id_108_abr\",\"tenantterm\":\"deobeta\",\"frontiersdefaultterm\":\"deobeta\",\"category\":\"user role\"},{\"sequencenumber\":234,\"key\":\"role_id_109_abr\",\"tenantterm\":\"searchbeta\",\"frontiersdefaultterm\":\"searchbeta\",\"category\":\"user role\"},{\"sequencenumber\":235,\"key\":\"role_id_110_abr\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"category\":\"user role\"},{\"sequencenumber\":236,\"key\":\"role_id_111_abr\",\"tenantterm\":\"mfbeta\",\"frontiersdefaultterm\":\"mfbeta\",\"category\":\"user role\"},{\"sequencenumber\":237,\"key\":\"role_id_21_abr\",\"tenantterm\":\"coped\",\"frontiersdefaultterm\":\"coped\",\"category\":\"user role\"},{\"sequencenumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"this is the label for the review editorial board\",\"category\":\"label\"},{\"sequencenumber\":239,\"key\":\"field_chief_editor\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":240,\"key\":\"field_chief_editors\",\"tenantterm\":\"field chief editors\",\"frontiersdefaultterm\":\"field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":241,\"key\":\"editor\",\"tenantterm\":\"editor\",\"frontiersdefaultterm\":\"editor\",\"category\":\"label (role)\"},{\"sequencenumber\":242,\"key\":\"editors\",\"tenantterm\":\"editors\",\"frontiersdefaultterm\":\"editors\",\"category\":\"label (role)\"},{\"sequencenumber\":243,\"key\":\"board\",\"tenantterm\":\"board\",\"frontiersdefaultterm\":\"board\",\"category\":\"label\"},{\"sequencenumber\":244,\"key\":\"boards\",\"tenantterm\":\"boards\",\"frontiersdefaultterm\":\"boards\",\"category\":\"label\"},{\"sequencenumber\":245,\"key\":\"article_collection\",\"tenantterm\":\"article collection\",\"frontiersdefaultterm\":\"article collection\",\"category\":\"label\"},{\"sequencenumber\":246,\"key\":\"article_collections\",\"tenantterm\":\"article collections\",\"frontiersdefaultterm\":\"article collections\",\"category\":\"label\"},{\"sequencenumber\":247,\"key\":\"handling_editor\",\"tenantterm\":\"handling editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":248,\"key\":\"handling_editors\",\"tenantterm\":\"handling editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":249,\"key\":\"ae_accept\",\"tenantterm\":\"recommend acceptance\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":250,\"key\":\"rtm\",\"tenantterm\":\"rtm\",\"frontiersdefaultterm\":\"rtm\",\"category\":\"product\"},{\"sequencenumber\":251,\"key\":\"frontiers_media_sa\",\"tenantterm\":\"frontiers media s.a\",\"frontiersdefaultterm\":\"frontiers media s.a\",\"category\":\"customer\"},{\"sequencenumber\":252,\"key\":\"review_editors\",\"tenantterm\":\"community reviewers\",\"frontiersdefaultterm\":\"review editors\",\"category\":\"label (role)\"},{\"sequencenumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":255,\"key\":\"call_for_papers\",\"tenantterm\":\"call for papers\",\"frontiersdefaultterm\":\"call for papers\",\"category\":\"label\"},{\"sequencenumber\":256,\"key\":\"calls_for_papers\",\"tenantterm\":\"calls for papers\",\"frontiersdefaultterm\":\"calls for papers\",\"category\":\"label\"},{\"sequencenumber\":257,\"key\":\"supervising_editor\",\"tenantterm\":\"supervising editor\",\"frontiersdefaultterm\":\"supervising editor\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editor\"},{\"sequencenumber\":258,\"key\":\"supervising_editors\",\"tenantterm\":\"supervising editors\",\"frontiersdefaultterm\":\"supervising editors\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editors\"},{\"sequencenumber\":259,\"key\":\"reviewer_endorse\",\"tenantterm\":\"endorse\",\"frontiersdefaultterm\":\"endorse\",\"category\":\"label\"},{\"sequencenumber\":260,\"key\":\"reviewer_endorsed\",\"tenantterm\":\"endorsed\",\"frontiersdefaultterm\":\"endorsed\",\"category\":\"label\"},{\"sequencenumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantterm\":\"endorse publication\",\"frontiersdefaultterm\":\"endorse publication\",\"category\":\"label\"},{\"sequencenumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantterm\":\"endorsed publication\",\"frontiersdefaultterm\":\"endorsed publication\",\"category\":\"label\"},{\"sequencenumber\":263,\"key\":\"editor_role\",\"tenantterm\":\"editor role\",\"frontiersdefaultterm\":\"editor role\",\"category\":\"label\"},{\"sequencenumber\":264,\"key\":\"editor_roles\",\"tenantterm\":\"editor roles\",\"frontiersdefaultterm\":\"editor roles\",\"category\":\"label\"},{\"sequencenumber\":265,\"key\":\"editorial_role\",\"tenantterm\":\"editorial role\",\"frontiersdefaultterm\":\"editorial role\",\"category\":\"label\"},{\"sequencenumber\":266,\"key\":\"editorial_roles\",\"tenantterm\":\"editorial roles\",\"frontiersdefaultterm\":\"editorial roles\",\"category\":\"label\"},{\"sequencenumber\":267,\"key\":\"call_for_paper\",\"tenantterm\":\"call for paper\",\"frontiersdefaultterm\":\"call for paper\",\"category\":\"label\"},{\"sequencenumber\":268,\"key\":\"research_topic_abstract\",\"tenantterm\":\"manuscript summary\",\"frontiersdefaultterm\":\"manuscript summary\",\"category\":\"process\"},{\"sequencenumber\":269,\"key\":\"research_topic_abstracts\",\"tenantterm\":\"manuscript summaries\",\"frontiersdefaultterm\":\"manuscript summaries\",\"category\":\"process\"},{\"sequencenumber\":270,\"key\":\"submissions_team_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"content manager\",\"category\":\"process\"},{\"sequencenumber\":271,\"key\":\"submissions_team\",\"tenantterm\":\"journal team\",\"frontiersdefaultterm\":\"content team\",\"category\":\"process\"},{\"sequencenumber\":272,\"key\":\"topic_coordinator\",\"tenantterm\":\"topic coordinator\",\"frontiersdefaultterm\":\"topic coordinator\",\"category\":\"process\"},{\"sequencenumber\":273,\"key\":\"topic_coordinators\",\"tenantterm\":\"topic coordinators\",\"frontiersdefaultterm\":\"topic coordinators\",\"category\":\"process\"},{\"sequencenumber\":274,\"key\":\"frontiers_journal_team\",\"tenantterm\":\"frontiers journal team\",\"frontiersdefaultterm\":\"frontiers journal team\",\"category\":\"label (role)\"},{\"sequencenumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantterm\":\"rt:ic submission\",\"frontiersdefaultterm\":\"rt:ic submission\",\"category\":\"label (role)\"},{\"sequencenumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantterm\":\"rt:ic submission participant\",\"frontiersdefaultterm\":\"rt:ic submission participant\",\"category\":\"label (role)\"}]}'\n",impactgtmid:"gtm-njf2ml9b",impactgtmauth:"fyo-7nodm9w37qgfms03sa",impactgtmpreview:"env-1",impactgooglemapsapikey:"aizasyctehx2eu8pwfi86gw9fi00ftcykk6ifr8",qualtricsv4tov3:"'{\"enabled\":true,\"interceptid\":\"si_er0e2ze69oz8yn4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricsumux:"'{\"enabled\":false,\"interceptid\":\"si_89fphy3etxqbwtu\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricscontinuousbrand:"'{\"enabled\":true,\"interceptid\":\"si_9zut94ut81fcrh4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",defaultarticletemplate:"v3"},app:{baseurl:"/",buildid:"f2d5b6d8-d01c-4534-90b9-d659f10f17ca",buildassetsdir:"ap-2024/_nuxt",cdnurl:""}}## Results
four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps. conclusion: while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies. systematic review registration: crd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077 . introduction amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children ( 1 , 2 ). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye ( 3 &#x2013; 5 ). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye ( 5 ). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) ( 6 ). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function ( 6 ). the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children ( 7 ). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed ( 6 ). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old ( 8 ). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity ( 6 , 9 ). therefore, novel treatment paradigms are needed to treat amblyopia in adults. selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy ( 10 ). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex ( 11 ). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes ( 12 , 13 ), while others fail to demonstrate efficacy ( 9 , 14 ). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information. methods search strategy and eligibility criteria this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement ( 15 ). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus. we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations. data extraction data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus. endpoints the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation. quality assessment (risk of bias) the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) ( 16 ). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed ( 17 ). discrepancies were resolved through consensus following a discussion of the reasons for the differences. statistical analysis statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student t -test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i 2 statistics, with p &#x202f;&#x0003c;&#x202f;0.10 and i 2 &#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it. results the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies ( 9 , 12 &#x2013; 14 ) were included, encompassing 139 patients from four rcts ( figure 1 ). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in table 1 . three studies had fluoxetine and one citalopram as the intervention group. figure 1 figure 1 . prisma flow diagram of study screening and selection. table 1 table 1 . baseline characteristics of included studies. all four studies ( 9 , 12 &#x2013; 14 ) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004, i 2 =&#x202f;23%, figure 2 ). only three studies ( 12 &#x2013; 14 ) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, p &#x202f;=&#x202f;0.76, i 2 =&#x202f;0%, figure 3a ) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, p &#x202f;=&#x202f;0.48, i 2 =&#x202f;0%, figure 3b ) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size. figure 2 figure 2 . visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo. figure 3 figure 3 . visual evoked potential (vep) did not improve with ssri. (a) p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. (b) p100 latency improvement was not statistically significantly different between the ssri and placebo group. all studies were evaluated as having a low risk of bias ( table 2 ). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial ( figure 4 ). table 2 table 2 . risk of bias summary for randomized studies. figure 4 figure 4 . funnel plot for visual acuity improvement. there is no publication bias. discussion this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency. current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants ( 9 , 12 &#x2013; 14 ) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic. ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation ( 18 ). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia ( 19 ). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye ( 19 ). in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit ( 20 ). donepezil showed an improvement of the va in an open-label pilot study ( 21 ). across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods ( 11 ). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment ( 12 , 13 ) whereas others did not ( 9 , 14 ). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans ( 22 ). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans ( 22 ). similarly, measuring of visual acuity in rodents and humans cannot be standardized ( 22 ). mitchell et al. ( 22 ) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans ( 22 ). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies ( 12 , 13 ) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes ( 23 ). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) ( 24 ) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials ( 25 &#x2013; 27 ). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba ( 28 ), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes. given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy ( 29 ), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven. heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings. to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature. other modalities of treatment are also currently under research. extended-reality (xr) devices ( 30 ), physical activity (cycling) ( 31 ) and more recently the occlusion of the amblyopic eye combined with physical activity ( 32 ) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects. in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial ( 16 ) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks. conclusion this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes. data availability statement the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author. author contributions es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology. funding the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\r1\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z). conflict of interest the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the handling editor gp declared a shared parent affiliation with the author oa at the time of review. the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision. generative ai statement the authors declare that no gen ai was used in the creation of this manuscript. publisher&#x2019;s note all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. author disclaimer the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care. references 1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. front pediatr . (2022) 10:819998. doi: 10.3389/fped.2022.819998 pubmed abstract | crossref full text | google scholar 2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. rom j ophthalmol . (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 pubmed abstract | crossref full text | google scholar 3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. cereb cortex . (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 pubmed abstract | crossref full text | google scholar 4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. j neurosci . (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 pubmed abstract | crossref full text | google scholar 5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. eye . (1996) 10:250&#x2013;8. google scholar 6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. bmc ophthalmol . (2020) 20:203. doi: 10.1186/s12886-020-01442-9 pubmed abstract | crossref full text | google scholar 7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. optom vis sci . (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 pubmed abstract | crossref full text | google scholar 8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. curr biol . (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 pubmed abstract | crossref full text | google scholar 9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. sci rep . (2018) 8:12830. doi: 10.1038/s41598-018-31169-z pubmed abstract | crossref full text | google scholar 10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. j neurosci . (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 pubmed abstract | crossref full text | google scholar 11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. science . (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516 crossref full text | google scholar 12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. eye . (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z pubmed abstract | crossref full text | google scholar 13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. j aapos . (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 pubmed abstract | crossref full text | google scholar 14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. neural plast . (2019) 2019:5857243. doi: 10.1155/2019/5857243 crossref full text | google scholar 15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. bmj . (2009) 339:b2535. doi: 10.1136/bmj.b2535 pubmed abstract | crossref full text | google scholar 16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. bmj . (2019) 366:l4898. doi: 10.1136/bmj.l4898 pubmed abstract | crossref full text | google scholar 17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. bmj . (2011) 343:d5928. doi: 10.1136/bmj.d5928 pubmed abstract | crossref full text | google scholar 18. feighner, jp. mechanism of action of antidepressant medications. j clin psychiatry . (1999) 60:4&#x2013;11. google scholar 19. morishita, h, and hensch, tk. critical period revisited: impact on vision. curr opin neurobiol . (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 pubmed abstract | crossref full text | google scholar 20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. ophthalmology . (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 pubmed abstract | crossref full text | google scholar 21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. sci rep . (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 pubmed abstract | crossref full text | google scholar 22. mitchell, d, and sengpiel, f. animal models of amblyopia. vis neurosci . (2018) 35:e017. doi: 10.1017/s0952523817000244 pubmed abstract | crossref full text | google scholar 23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). doc ophthalmol . (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y pubmed abstract | crossref full text | google scholar 24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. brain struct funct . (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 pubmed abstract | crossref full text | google scholar 25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. imaging neurosci. (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 pubmed abstract | crossref full text | google scholar 26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. perception . (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 pubmed abstract | crossref full text | google scholar 27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. front hum neurosci . (2022) 16:949395. doi: 10.3389/fnhum.2022.949395 crossref full text | google scholar 28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: https://pubmed.ncbi.nlm.nih.gov/26004760/ google scholar 29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. strabismus . (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 pubmed abstract | crossref full text | google scholar 30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. j vis . (2023) 23:14. doi: 10.1167/jov.23.1.14 pubmed abstract | crossref full text | google scholar 31. lunghi, c, and sale, a. a cycling lane for brain rewiring. curr biol . (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 pubmed abstract | crossref full text | google scholar 32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. annal. clin. transl. neurol. (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 pubmed abstract | crossref full text | google scholar keywords: amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity citation: shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. front. neurol . 16:1639913. doi: 10.3389/fneur.2025.1639913 received: 03 june 2025; accepted: 31 july 2025; published: 21 august 2025. edited by: gordon plant , university college london, united kingdom reviewed by: sara samadzadeh , charit&#x00e9; university medicine berlin, germany alistair r. fielder , city university of london, united kingdom copyright &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the creative commons attribution license (cc by) . the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. &#x0002a;correspondence: i. betina ip, ymv0aw5hlmlwqg5ky24ub3guywmudws= &#x2020; these authors share senior authorship disclaimer: all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. download article download pdf readcube epub xml share on export citation endnote reference manager simple text file bibtex 1,812 total views 250 downloads citation numbers are available from dimensions view article impact view altmetric score share on edited by g p gordon plant reviewed by a r alistair r fielder s s sara samadzadeh table of contents abstract introduction methods results discussion conclusion data availability statement author contributions funding conflict of interest generative ai statement publisher&#x2019;s note author disclaimer references export citation endnote reference manager simple text file bibtex check for updates frontiers&#39; impact articles published with frontiers have received 12 million total citations your research is the real superpower - learn how we maximise its impact through our leading community journals explore our impact metrics supplementary material download article download download pdf readcube epub xml guidelines author guidelines services for authors policies and publication ethics editor guidelines fee policy explore articles research topics journals how we publish outreach frontiers forum frontiers policy labs frontiers for young minds frontiers planet prize connect help center emails and alerts contact us submit career opportunities follow us © 2025 frontiers media s.a. all rights reserved privacy policy | terms and conditions [["shallowreactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverrendered":13,"path":14,"pinia":15},["shallowreactive",3],{},["reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","frontiers articles","https://article-pages-2024.frontiersin.org/",["set"],["shallowreactive",12],{},true,"/journals/neurology/articles/10.3389/fneur.2025.1639913/full",["reactive",16],{"main":17,"user":579,"article":580,"articlehub":881,"mainheader":885},{"ibar":18,"footer":296,"newslettercomponent":-1,"snackbaritem":378,"toggleshowsnackbar":379,"contentfuljournal":380,"graphjournal":480,"settingsfeaturesswitchers":484,"templatetogglebanner":485,"tenantconfig":544},{"tenantlogo":19,"journallogo":19,"aboutus":20,"submiturl":113,"showsubmitbutton":13,"journal":114,"sectionterm":227,"aboutjournal":228,"mainlinks":277,"journallinks":284,"helpcenterlink":293},"",[21,38,47,71,87],{"title":22,"links":23},"who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"arialabel":28},"mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"arialabel":28},"history","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"arialabel":28},"leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"arialabel":28},"awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"impact and progress",[41,44],{"text":42,"url":43,"target":27,"arialabel":28},"frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"arialabel":28},"our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"arialabel":28},"how we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"arialabel":28},"open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"arialabel":28},"peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"arialabel":28},"research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"arialabel":28},"research topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"arialabel":28},"fair² data management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"arialabel":28},"fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"services",[74,78,81,84],{"text":75,"url":76,"target":77,"arialabel":28},"societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"arialabel":28},"national consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"arialabel":28},"institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"arialabel":28},"collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"more from frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"arialabel":93},"frontiers forum","https://forum.frontiersin.org/","this link will take you to the frontiers forum website",{"text":95,"url":96,"target":27,"arialabel":28},"frontiers planet prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"arialabel":100},"press office","https://pressoffice.frontiersin.org/","this link will take you to the frontiers press office website",{"text":102,"url":103,"target":27,"arialabel":104},"sustainability","https://www.frontiersin.org/about/sustainability","link to information about frontiers' sustainability",{"text":106,"url":107,"target":77,"arialabel":108},"career opportunities","https://careers.frontiersin.org/","this link will take you to the frontiers careers website",{"text":110,"url":111,"target":27,"arialabel":112},"contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=54&specialtyid=0&entitytype=2&entityid=141",{"id":115,"name":116,"slug":117,"sections":118},141,"frontiers in neurology","neurology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223],{"id":120,"name":121,"slug":122},156,"applied neuroimaging","applied-neuroimaging",{"id":124,"name":125,"slug":126},3712,"artificial intelligence in neurology","artificial-intelligence-in-neurology",{"id":128,"name":129,"slug":130},3023,"autonomic disorders","autonomic-disorders",{"id":132,"name":133,"slug":134},3740,"cognitive and behavioral neurology","cognitive-and-behavioral-neurology",{"id":136,"name":137,"slug":138},1439,"dementia and neurodegenerative diseases","dementia-and-neurodegenerative-diseases",{"id":140,"name":141,"slug":142},2038,"diagnostic neuropathology","diagnostic-neuropathology",{"id":144,"name":145,"slug":146},143,"endovascular and interventional neurology","endovascular-and-interventional-neurology",{"id":148,"name":149,"slug":150},144,"epilepsy","epilepsy",{"id":152,"name":153,"slug":154},1784,"experimental therapeutics","experimental-therapeutics",{"id":156,"name":157,"slug":158},153,"headache and neurogenic pain","headache-and-neurogenic-pain",{"id":160,"name":161,"slug":162},145,"movement disorders","movement-disorders",{"id":164,"name":165,"slug":166},147,"multiple sclerosis and neuroimmunology","multiple-sclerosis-and-neuroimmunology",{"id":168,"name":169,"slug":170},150,"neuro-oncology and neurosurgical oncology","neuro-oncology-and-neurosurgical-oncology",{"id":172,"name":173,"slug":174},154,"neuro-ophthalmology","neuro-ophthalmology",{"id":176,"name":177,"slug":178},155,"neuro-otology","neuro-otology",{"id":180,"name":181,"slug":182},159,"neurocritical and neurohospitalist care","neurocritical-and-neurohospitalist-care",{"id":184,"name":185,"slug":186},1339,"neuroepidemiology","neuroepidemiology",{"id":188,"name":189,"slug":190},160,"neurogenetics","neurogenetics",{"id":192,"name":193,"slug":194},1334,"neuroinfectious diseases","neuroinfectious-diseases",{"id":196,"name":197,"slug":198},2345,"neurological biomarkers","neurological-biomarkers",{"id":200,"name":201,"slug":202},146,"neuromuscular disorders and peripheral neuropathies","neuromuscular-disorders-and-peripheral-neuropathies",{"id":204,"name":205,"slug":206},547,"neurorehabilitation","neurorehabilitation",{"id":208,"name":209,"slug":210},3418,"neurotechnology","neurotechnology",{"id":212,"name":213,"slug":214},163,"neurotrauma","neurotrauma",{"id":216,"name":217,"slug":218},161,"pediatric neurology","pediatric-neurology",{"id":220,"name":221,"slug":222},151,"sleep disorders","sleep-disorders",{"id":224,"name":225,"slug":226},142,"stroke","stroke","sections",[229,253],{"title":230,"links":231},"scope",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"arialabel":28},"field chief editors","https://www.frontiersin.org/journals/neurology/about#about-editors",{"text":236,"url":237,"target":27,"arialabel":28},"mission & scope","https://www.frontiersin.org/journals/neurology/about#about-scope",{"text":239,"url":240,"target":27,"arialabel":28},"facts","https://www.frontiersin.org/journals/neurology/about#about-facts",{"text":242,"url":243,"target":27,"arialabel":28},"journal sections","https://www.frontiersin.org/journals/neurology/about#about-submission",{"text":245,"url":246,"target":27,"arialabel":28},"open access statement","https://www.frontiersin.org/journals/neurology/about#about-open",{"text":248,"url":249,"target":27,"arialabel":28},"copyright statement","https://www.frontiersin.org/journals/neurology/about#copyright-statement",{"text":251,"url":252,"target":27,"arialabel":28},"quality","https://www.frontiersin.org/journals/neurology/about#about-quality",{"title":254,"links":255},"for authors",[256,259,262,265,268,271,274],{"text":257,"url":258,"target":27,"arialabel":28},"why submit?","https://www.frontiersin.org/journals/neurology/for-authors/why-submit",{"text":260,"url":261,"target":27,"arialabel":28},"article types","https://www.frontiersin.org/journals/neurology/for-authors/article-types",{"text":263,"url":264,"target":27,"arialabel":28},"author guidelines","https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines",{"text":266,"url":267,"target":27,"arialabel":28},"editor guidelines","https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines",{"text":269,"url":270,"target":27,"arialabel":28},"publishing fees","https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees",{"text":272,"url":273,"target":27,"arialabel":28},"submission checklist","https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist",{"text":275,"url":276,"target":27,"arialabel":28},"contact editorial office","https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office",[278,281],{"text":279,"url":280,"target":27,"arialabel":28},"all journals","https://www.frontiersin.org/journals",{"text":282,"url":283,"target":27,"arialabel":28},"all articles","https://www.frontiersin.org/articles",[285,288,290],{"text":286,"url":287,"target":27,"arialabel":28},"articles","articles",{"text":63,"url":289,"target":27,"arialabel":28},"research-topics",{"text":291,"url":292,"target":27,"arialabel":28},"editorial board","editors",{"text":294,"url":295,"target":77,"arialabel":294},"help center","https://helpcenter.frontiersin.org",{"blocks":297,"sociallinks":351,"copyright":375,"termsandconditionsurl":376,"privacypolicyurl":377},[298,312,322,336],{"title":299,"links":300},"guidelines",[301,303,306,309,311],{"text":263,"url":302,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":304,"url":305,"target":27,"arialabel":28},"services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":307,"url":308,"target":27,"arialabel":28},"policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":266,"url":310,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"arialabel":28},{"title":313,"links":314},"explore",[315,316,319,321],{"text":286,"url":283,"target":27,"arialabel":28},{"text":317,"url":318,"target":27,"arialabel":28},"research topics ","https://www.frontiersin.org/research-topics",{"text":320,"url":280,"target":27,"arialabel":28},"journals",{"text":51,"url":52,"target":27,"arialabel":28},{"title":323,"links":324},"outreach",[325,328,331,335],{"text":326,"url":92,"target":77,"arialabel":327},"frontiers forum ","frontiers forum website",{"text":329,"url":330,"target":77,"arialabel":28},"frontiers policy labs ","https://policylabs.frontiersin.org/",{"text":332,"url":333,"target":77,"arialabel":334},"frontiers for young minds","https://kids.frontiersin.org/","frontiers for young minds journal",{"text":95,"url":96,"target":27,"arialabel":28},{"title":337,"links":338},"connect",[339,340,344,347,350],{"text":294,"url":295,"target":77,"arialabel":294},{"text":341,"url":342,"target":77,"arialabel":343},"emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","subscribe to frontiers emails",{"text":345,"url":111,"target":27,"arialabel":346},"contact us ","subscribe to newsletter",{"text":348,"url":349,"target":27,"arialabel":28},"submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"arialabel":28},[352,360,365,370],{"link":353,"type":356,"color":357,"icon":358,"size":359,"hiddentext":13},{"text":354,"url":355,"target":77,"arialabel":354},"frontiers facebook","https://www.facebook.com/frontiersin","link","grey","facebook","medium",{"link":361,"type":356,"color":357,"icon":364,"size":359,"hiddentext":13},{"text":362,"url":363,"target":77,"arialabel":28},"frontiers twitter","https://twitter.com/frontiersin","twitter",{"link":366,"type":356,"color":357,"icon":369,"size":359,"hiddentext":13},{"text":367,"url":368,"target":77,"arialabel":28},"frontiers linkedin","https://www.linkedin.com/company/frontiers","linkedin",{"link":371,"type":356,"color":357,"icon":374,"size":359,"hiddentext":13},{"text":372,"url":373,"target":77,"arialabel":28},"frontiers instagram","https://www.instagram.com/frontiersin_","instagram","frontiers media s.a. all rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":381,"identifier":115,"name":116,"slug":117,"banner":382,"description":473,"mission":474,"palette":475,"impactfactor":476,"citescore":477,"citations":478,"showtagline":28,"twitter":479},"journal",[383],{"id":384,"src":385,"name":386,"tags":387,"type":432,"width":433,"height":434,"idhash":435,"archive":436,"brandid":437,"limited":436,"filesize":438,"ispublic":439,"original":440,"copyright":19,"extension":441,"thumbnails":443,"datecreated":451,"description":452,"orientation":453,"usercreated":454,"watermarked":436,"datemodified":451,"datepublished":455,"ecsarchivefiles":456,"propertyoptions":457,"property_channel":462,"property_sub-type":464,"property_asset_type":466,"activeoriginalfocuspoint":468,"property_office_department":471},"d315adb2-2967-48b6-be3b61009343d69e","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/webimage-810a1e19-163c-4fd0-bfd3d50a4721b642.png","fneur_main visual_cyan_website",[388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,117,430,431],"professional","device","medical","close up","technology","wires","brain waves","record","digital","selective focus","laboratory","brain","health","electrodes","computer","examination","electroencephalography","scan","study","oncology","examine","electroencephalogram","neurosurgery","science","doctor","diagnose","magnetic","patient","modern","electroencephalograph","equipment","office","healthcare","scanning","instrument","eeg","hospital","ct","technician","medicine","ultrasound","radiology","diagnostic","lab","image",5052,3368,"62463d527f6ddd4d",0,"22c10171-81b3-4da6-99342f272a32e8bb",5758943,1,"https://brand.frontiersin.org/m/62463d527f6ddd4d/original/fneur_main-visual_cyan_website.jpg",[442],"jpg",{"mini":444,"thul":445,"webimage":385,"guidelines":446,"websitejpg_xl":447,"websitewebp_l":448,"websitewebp_m":449,"websitewebp_xl":450},"https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/mini-a927c1b7-02f8-4d29-94320f509270457d.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/thul-fcd9f16d-d1a9-4535-a7e4c140224266b9.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/guidelines-fneur_main visual_cyan_website.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitejpg_xl-fneur_main visual_cyan_website.jpg","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_l-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_m-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_xl-fneur_main visual_cyan_website.webp","2022-06-27t10:00:23z","charming young woman undergoing electroencephalography; shutterstock id 695951221; purchase_order: main visual; job: ; client: ; other:","landscape","caroline sutter","2022-06-27t06:08:46z",[],[458,459,460,461],"414fb2d4-2283-43fd-be14e534eca67928","6c18119b-14bd-4951-b437696f4357bd33","7c692885-db25-4858-b1fb4ff47b241e9b","d88c0047-ec30-4506-a7df28a4d765e1cf",[463],"frontiersin_org",[465],"main_visual",[467],"photography",{"x":469,"y":470},2526,1684,[472],"publishing","the world's most cited clinical neurology journal, exploring the diagnosis, causes, treatment, and public health aspects of neurological illnesses to improve patient care.","\u003cp>frontiers in neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. it is indexed in pubmed central (pmc), scopus, and the doaj.\u003c/p>\n\n\u003cp>led by field chief editor prof. irene litvan (university of california, san diego, usa), frontiers in neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.\u003c/p>\n\n\u003cp>the journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:\u003c/p>\n\n\u003cul>\n \u003cli>artificial intelligence in neurology\u003c/li>\n \u003cli>applied neuroimaging\u003c/li>\n \u003cli>autonomic disorders\u003c/li>\n \u003cli>cognitive behavioural neurology\u003c/li>\n \u003cli>dementia and neurodegenerative diseases\u003c/li>\n \u003cli>diagnostic and forensic neuropathology\u003c/li>\n \u003cli>endovascular and interventional neurology\u003c/li>\n \u003cli>epilepsy\u003c/li>\n \u003cli>experimental therapeutics\u003c/li>\n \u003cli>headache and neurogenic pain\u003c/li>\n \u003cli>movement disorders\u003c/li>\n \u003cli>multiple sclerosis and neuroimmunology\u003c/li>\n \u003cli>neuro-oncology and neurosurgical oncology\u003c/li>\n \u003cli>neuro-ophthalmology\u003c/li>\n \u003cli>neuro-otology\u003c/li>\n \u003cli>neurocritical and neurohospitalist care\u003c/li>\n \u003cli>neuroepidemiology\u003c/li>\n \u003cli>neurogenetics\u003c/li>\n \u003cli>neuroinfectious diseases\u003c/li>\n \u003cli>neurological biomarkers\u003c/li>\n \u003cli>neuromuscular disorders and peripheral neuropathies\u003c/li>\n \u003cli>neurorehabilitation\u003c/li>\n \u003cli>neurotechnology\u003c/li>\n \u003cli>neurotrauma\u003c/li>\n \u003cli>pediatric neurology\u003c/li>\n \u003cli>sleep disorders\u003c/li>\n \u003cli>stroke\u003c/li>\n\u003c/ul>\n\n\u003cp>in particular, the journal welcomes submissions that support and advance the un’s \u003ca href=https://globalgoals.org/goals/>sustainable development goals\u003c/a> (sdgs), notably \u003ca href=https://globalgoals.org/goals/3-good-health-and-well-being/>sdg 3: good health and well-being\u003c/a>.\u003c/p>\n\n\u003cp>manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.\u003c/p>\n\n\u003cp>the journal no longer accepts papers concerning simple bibliometric studies. authors are still welcome to submit systematic reviews using publicly available data, but these must adhere to the \u003ca href=https://www.prisma-statement.org/>prisma guidelines\u003c/a> and have a conclusion related to neurological research. studies without this primary focus will be transferred to a more applicable journal.\u003c/p>\n\n\u003cp>frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as nhanes or mendelian randomization studies, must include appropriate validation. please refer to the \u003ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,standards%20for%20research%20methodology,-experiments\">frontiers standards for research methodology policy\u003c/a> for more information. manuscripts not adhering to these standards will not be considered.\u003cp>\n\n\u003cp>frontiers in neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.\u003c/p>","cyan","3.4","4.8","273537","@frontneurol",{"id":115,"name":116,"slug":117,"abbreviation":481,"isonline":13,"isopenforsubmissions":13,"citescore":482,"impactfactor":483},"fneur",5.2,2.8,{"displaytitlepilllabels":13,"displayrelatedarticlesbox":13,"showeditors":13,"showreviewers":13,"showloopimpactlink":13,"enablefigshare":379,"usexmlimages":13},{"ispublic":13,"allowcompanyusers":379,"whitelistemails":486,"enablealljournals":13,"whitelistjournals":508},[487,488,489,490,491,492,493,494,495,492,496,497,498,499,500,501,502,503,504,505,506,507],"y2fybg9zlmxvcmnhqgzyb250awvyc2lulm9yzw==","zgfuawvslmx1ekbmcm9udgllcnnpbi5vcmc=","bgf1cmeudgvuyubmcm9udgllcnnpbi5vcmc=","cmfmywvslnjpyw5jag9aznjvbnrpzxjzaw4ub3jn","amftzxmuc21hbgxib25lqgzyb250awvyc2lulm9yzw==","znjhbi5tb3jlbm9aznjvbnrpzxjzaw4ub3jn","c2ftdwvslmzlcm5hbmrlekbmcm9udgllcnnpbi5vcmc=","ymfyymfyys5jyxjjyw5naxvaznjvbnrpzxjzaw4ub3jn","axzhbi5zyw50yw1hcmlhqgzyb250awvyc2lulm9yzw==","ahvllnryyw5aznjvbnrpzxjzaw4ub3jn","z29uy2fsby52yxjnyxnaznjvbnrpzxjzaw4ub3jn","bhvjawuuc2vubkbmcm9udgllcnnpbi5vcmc=","bg9ybi5mcmfzzxjaznjvbnrpzxjzaw4ub3jn","zwxzys5jyxjyb25aznjvbnrpzxjzaw4ub3jn","bwfhcnrlbi52yw5kawpja0bmcm9udgllcnnpbi5vcmc=","ymluzgh1lmtyaxnobmfuqgzyb250awvyc2lulm9yzw==","bwf0dghldy5hdhr3yxrlcnnaznjvbnrpzxjzaw4ub3jn","z2l1bglhlnzhbhnly2noaubmcm9udgllcnnpbi5vcmc=","zmfiawfulmrlbgxhbw9ydgvaznjvbnrpzxjzaw4ub3jn","dmlqyxlhbi5wcebwaxrzb2x1dglvbnmuy29t","z3vpbgxhdw1llnnldxjhdebmcm9udgllcnnpbi5vcmc=",[509,510,511,512,513,514,439,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,115,530,531,532,533,534,535,536,537,538,539,540,541,542,543],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceid":439,"name":439,"availablejournalpages":545,"announcement":549},[287,292,289,546,547,548],"volumes","about","community-reviewers",{"__typename":550,"sys":551,"preheader":42,"title":553,"description":554,"image":555,"link":577},"announcement",{"id":552},"5ittnttqgazppgh6rx0alm","articles published with frontiers have received 12 million total citations","your research is the real superpower - learn how we maximise its impact through our leading community journals",[556],{"archive":436,"brandid":437,"copyright":28,"datecreated":557,"datemodified":558,"datepublished":559,"description":28,"extension":560,"filesize":562,"height":563,"id":564,"ispublic":436,"limited":436,"name":565,"orientation":453,"original":28,"thumbnails":566,"type":432,"watermarked":436,"width":573,"videopreviewurls":574,"tags":575,"textmetaproperties":576,"src":567},"2025-06-18t12:58:01z","2025-06-18t14:15:34z","2025-06-18t12:57:32z",[561],"png",1365026,920,"7c5269c4-3c83-4591-951a74d15b95daea","impact metrics banner for article pages",{"webimage":567,"thul":568,"mini":569,"websitewebp_l":570,"websitewebp_m":571,"guidelines":572},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_l/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_m/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/guidelines/impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":578,"url":43,"target":27,"arialabel":28},"explore our impact metrics",{"loggeduserinfo":-1},{"currentarticle":581,"ispreviewpage":379,"hassupplementaldata":379,"showcrossmarkwidget":13,"articletemplate":738,"currentarticlepagemetainfo":739,"xmlparsedarticlecontent":-1,"xmlparsingerror":-1},{"id":582,"doi":583,"title":584,"acceptancedate":585,"receptiondate":586,"publicationdate":587,"lastmodifieddate":588,"ispublished":13,"abstract":589,"researchtopic":590,"articletype":596,"stage":599,"keywords":601,"authors":609,"editors":675,"reviewers":683,"journal":699,"section":707,"impactmetrics":709,"volume":712,"articlevolume":713,"relatedarticles":714,"ispublishedv2":13,"contents":715,"files":718},1639913,"10.3389/fneur.2025.1639913","selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials","2025-07-31t18:15:51.000z","2025-06-03t00:38:20.000z","2025-08-21t00:00:00.000z","2025-10-21t02:26:11.259z","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.methodswe systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i2 statistics.resultsfour rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04–0.14, p = 0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.conclusionwhile ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.systematic review registrationcrd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077.",{"id":591,"title":592,"articlescount":593,"ismagazinepage":379,"slug":594,"isopenforsubmission":13,"views":595},61549,"advances in understanding visual disorders linked to cortical dysfunction",10,"advances-in-understanding-visual-disorders-linked-to-cortical-dysfunction",15702,{"id":597,"name":598},136,"systematic review",{"id":600,"name":19},18,[602,603,604,605,606,607,608],"strabismus","neuroplasticity","amblyopia","fluoxetine","ssris","anisometropia","citalopram",[610,619,627,636,645,652,660,668],{"id":611,"firstname":612,"middlename":19,"lastname":613,"givennames":614,"iscorresponding":379,"isprofilepublic":13,"userid":611,"email":-1,"affiliations":615},3083093,"ehtesham","shamsher","ehtesham ",[616],{"organizationname":617,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust","united kingdom",{"id":436,"firstname":620,"middlename":19,"lastname":621,"givennames":622,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":623},"luisa","saccaro","luisa ",[624],{"organizationname":625,"countryname":626,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, universidade de mogi das cruzes","brazil",{"id":628,"firstname":629,"middlename":19,"lastname":630,"givennames":631,"iscorresponding":379,"isprofilepublic":13,"userid":628,"email":-1,"affiliations":632},3089392,"victor barreiros","pungirum","victor barreiros ",[633],{"organizationname":634,"countryname":635,"cityname":19,"statename":19,"zipcode":19},"faculty of medical sciences, university of buenos aires","argentina",{"id":637,"firstname":638,"middlename":19,"lastname":639,"givennames":640,"iscorresponding":379,"isprofilepublic":13,"userid":637,"email":-1,"affiliations":641},3162299,"nghi bao","tran","nghi bao ",[642],{"organizationname":643,"countryname":644,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, university of debrecen","hungary",{"id":436,"firstname":646,"middlename":19,"lastname":647,"givennames":648,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":649},"omar a. h. a.","alghaith","omar a. h. a. ",[650],{"organizationname":651,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"institute of ophthalmology, university college london",{"id":436,"firstname":653,"middlename":19,"lastname":654,"givennames":655,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":656},"fatemeh","khabazianzadeh","fatemeh ",[657],{"organizationname":658,"countryname":659,"cityname":19,"statename":19,"zipcode":19},"eye research center, khatam-al-anbia hospital, mashad university of medical sciences","iran",{"id":661,"firstname":662,"middlename":19,"lastname":663,"givennames":664,"iscorresponding":379,"isprofilepublic":13,"userid":661,"email":-1,"affiliations":665},30975,"holly","bridge","holly ",[666],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging",{"id":669,"firstname":670,"middlename":19,"lastname":671,"givennames":672,"iscorresponding":379,"isprofilepublic":13,"userid":669,"email":-1,"affiliations":673},318592,"i. betina","ip","i. betina ",[674],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},[676],{"id":677,"firstname":678,"middlename":19,"lastname":679,"givennames":680,"iscorresponding":379,"isprofilepublic":13,"userid":677,"email":-1,"affiliations":681},2271562,"gordon","plant","gordon ",[682],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},[684,692],{"id":685,"firstname":686,"middlename":687,"lastname":688,"givennames":689,"iscorresponding":379,"isprofilepublic":13,"userid":685,"email":-1,"affiliations":690},870962,"alistair","r","fielder","alistair r",[691],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":693,"firstname":694,"middlename":19,"lastname":695,"givennames":696,"iscorresponding":379,"isprofilepublic":13,"userid":693,"email":-1,"affiliations":697},1863925,"sara","samadzadeh","sara ",[698],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":115,"slug":117,"name":116,"shortname":700,"electronicissn":701,"field":702,"specialtyid":28,"journalsectionpaths":705},"front. neurol.","1664-2295",{"id":703,"domainid":704},54,2,[706],{"section":707},{"id":172,"name":173,"slug":174,"specialtyid":708},758,{"views":710,"downloads":711,"citations":436},1812,250,16,"volume 16 - 2025",[],{"titlehtml":584,"fulltexthtml":716,"menuhtml":717},"\u003cdiv class=\"journalabstract\"> \u003ca id=\"h1\" name=\"h1\">\u003c/a>\n \u003cdiv class=\"authors\">\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3083093\" class=\"user-id-3083093\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3083093/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"ehtesham shamsher\">ehtesham shamsher\u003c/a>\u003csup>1\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"luisa saccaro\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">luisa saccaro\u003csup>2\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3089392\" class=\"user-id-3089392\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3089392/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"victor barreiros pungirum\">victor barreiros pungirum\u003c/a>\u003csup>3\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3162299\" class=\"user-id-3162299\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3162299/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"nghi bao tran\">nghi bao tran\u003c/a>\u003csup>4\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"omar a. h. a. alghaith\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">omar a. h. a. alghaith\u003csup>5\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"fatemeh khabazianzadeh\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">fatemeh khabazianzadeh\u003csup>6\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/30975\" class=\"user-id-30975\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/30975/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"holly bridge&#x;\">holly bridge\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/318592\" class=\"user-id-318592\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/318592/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"i. betina ip&#xa;&#x;\">i. betina ip\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x0002a;\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003c/div> \u003cul class=\"notes\"> \u003cli>\u003cspan>\u003csup>1\u003c/sup>\u003c/span>oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, oxford, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>2\u003c/sup>\u003c/span>faculty of medicine, universidade de mogi das cruzes, mogi das cruzes, brazil\u003c/li> \u003cli>\u003cspan>\u003csup>3\u003c/sup>\u003c/span>faculty of medical sciences, university of buenos aires, buenos aires, argentina\u003c/li> \u003cli>\u003cspan>\u003csup>4\u003c/sup>\u003c/span>faculty of medicine, university of debrecen, debrecen, hungary\u003c/li> \u003cli>\u003cspan>\u003csup>5\u003c/sup>\u003c/span>institute of ophthalmology, university college london, london, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>6\u003c/sup>\u003c/span>eye research center, khatam-al-anbia hospital, mashad university of medical sciences, mashhad, iran\u003c/li> \u003cli>\u003cspan>\u003csup>7\u003c/sup>\u003c/span>nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, oxford, united kingdom\u003c/li> \u003c/ul>\n\u003cp class=\"mb15\">\u003cb>introduction:\u003c/b> amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>methods:\u003c/b> we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i\u003csup>2\u003c/sup> statistics.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>results:\u003c/b> four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>conclusion:\u003c/b> while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.\u003c/p>\n\u003cp class=\"mb0\">\u003cb>systematic review registration:\u003c/b> crd42025633077, \u003ca href=\"https://www.crd.york.ac.uk/prospero/view/crd42025633077\">https://www.crd.york.ac.uk/prospero/view/crd42025633077\u003c/a>.\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div> \u003cdiv class=\"journalfulltext\"> \u003ca id=\"h2\" name=\"h2\">\u003c/a>\n\u003ch2>introduction\u003c/h2>\n\u003cp class=\"mb15\">amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children (\u003ca href=\"#ref1\">1\u003c/a>, \u003ca href=\"#ref2\">2\u003c/a>). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye (\u003ca href=\"#ref3\">3\u003c/a>&#x2013;\u003ca href=\"#ref5\">5\u003c/a>). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye (\u003ca href=\"#ref5\">5\u003c/a>). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) (\u003ca href=\"#ref6\">6\u003c/a>). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function (\u003ca href=\"#ref6\">6\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children (\u003ca href=\"#ref7\">7\u003c/a>). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed (\u003ca href=\"#ref6\">6\u003c/a>). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old (\u003ca href=\"#ref8\">8\u003c/a>). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity (\u003ca href=\"#ref6\">6\u003c/a>, \u003ca href=\"#ref9\">9\u003c/a>). therefore, novel treatment paradigms are needed to treat amblyopia in adults.\u003c/p>\n\u003cp class=\"mb0\">selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy (\u003ca href=\"#ref10\">10\u003c/a>). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex (\u003ca href=\"#ref11\">11\u003c/a>). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>), while others fail to demonstrate efficacy (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information.\u003c/p> \u003ca id=\"h3\" name=\"h3\">\u003c/a>\n\u003ch2>methods\u003c/h2>\n\u003ch3>search strategy and eligibility criteria\u003c/h3>\n\u003cp class=\"mb15\">this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement (\u003ca href=\"#ref15\">15\u003c/a>). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus.\u003c/p>\n\u003cp class=\"mb0\">we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations.\u003c/p>\n\u003ch3>data extraction\u003c/h3>\n\u003cp class=\"mb0\">data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus.\u003c/p>\n\u003ch3>endpoints\u003c/h3>\n\u003cp class=\"mb0\">the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation.\u003c/p>\n\u003ch3>quality assessment (risk of bias)\u003c/h3>\n\u003cp class=\"mb0\">the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) (\u003ca href=\"#ref16\">16\u003c/a>). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed (\u003ca href=\"#ref17\">17\u003c/a>). discrepancies were resolved through consensus following a discussion of the reasons for the differences.\u003c/p>\n\u003ch3>statistical analysis\u003c/h3>\n\u003cp class=\"mb0\">statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student \u003ci>t\u003c/i>-test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i\u003csup>2\u003c/sup> statistics, with \u003ci>p\u003c/i>&#x202f;&#x0003c;&#x202f;0.10 and i\u003csup>2\u003c/sup>&#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it.\u003c/p> \u003ca id=\"h4\" name=\"h4\">\u003c/a>\n\u003ch2>results\u003c/h2>\n\u003cp class=\"mb0\">the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) were included, encompassing 139 patients from four rcts (\u003ca href=\"#fig1\">figure 1\u003c/a>). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in \u003ca href=\"#tab1\">table 1\u003c/a>. three studies had fluoxetine and one citalopram as the intervention group.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" name=\"figure1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" alt=\"flowchart detailing a study selection process: identification phase shows pubmed with fifty-five results, embase with three hundred ninety-six results, cochrane with thirty results, totaling four hundred eighty-one. screening phase removes four hundred seventy-two as duplicates or non-criteria matches. eligibility phase reviews nine full-text studies; discards one conference abstract and four from the manuscript registry. four studies remain included.\" id=\"fig1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 1\u003c/b>. prisma flow diagram of study screening and selection.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">table 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" name=\"table1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" alt=\"www.frontiersin.org\" id=\"tab1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 1\u003c/b>. baseline characteristics of included studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004, i\u003csup>2\u003c/sup> =&#x202f;23%, \u003ca href=\"#fig2\">figure 2\u003c/a>). only three studies (\u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.76, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3a\u003c/a>) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.48, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3b\u003c/a>) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" name=\"figure2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" alt=\"forest plot showing the mean differences from four studies comparing the effects of ssri to placebo. each study is represented by a red square with horizontal lines indicating confidence intervals. the total effect is represented by a black diamond indicating a mean difference of 0.09 with a confidence interval of 0.04 to 0.14, favoring ssri. heterogeneity measures show tau-squared equals zero, chi-squared equals 3.90 with a p-value of 0.27, and i-squared equals 23%.\" id=\"fig2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 2\u003c/b>. visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 3\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" name=\"figure3\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" alt=\"forest plots a and b compare mean differences for several studies on ssri effectiveness. plot a shows a total mean difference of 0.34, favoring placebo, with no heterogeneity. plot b shows a total mean difference of 1.76, still favoring placebo, with no heterogeneity. each plot displays individual study results with confidence intervals and weight distributions.\" id=\"fig3\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 3\u003c/b>. visual evoked potential (vep) did not improve with ssri. \u003cb>(a)\u003c/b> p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. \u003cb>(b)\u003c/b> p100 latency improvement was not statistically significantly different between the ssri and placebo group.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all studies were evaluated as having a low risk of bias (\u003ca href=\"#tab2\">table 2\u003c/a>). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial (\u003ca href=\"#fig4\">figure 4\u003c/a>).\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">table 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" name=\"table2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" alt=\"www.frontiersin.org\" id=\"tab2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 2\u003c/b>. risk of bias summary for randomized studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 4\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" name=\"figure4\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" alt=\"funnel plot depicting standard error of mean difference (se[md]) on the y-axis versus mean difference (md) on the x-axis. points representing studies are scattered around a central vertical line, with dashed lines forming an inverted triangle indicating data distribution.\" id=\"fig4\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 4\u003c/b>. funnel plot for visual acuity improvement. there is no publication bias.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div> \u003ca id=\"h5\" name=\"h5\">\u003c/a>\n\u003ch2>discussion\u003c/h2>\n\u003cp class=\"mb15\">this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency.\u003c/p>\n\u003cp class=\"mb15\">current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic.\u003c/p>\n\u003cp class=\"mb15\">ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation (\u003ca href=\"#ref18\">18\u003c/a>). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia (\u003ca href=\"#ref19\">19\u003c/a>). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye (\u003ca href=\"#ref19\">19\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit (\u003ca href=\"#ref20\">20\u003c/a>). donepezil showed an improvement of the va in an open-label pilot study (\u003ca href=\"#ref21\">21\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods (\u003ca href=\"#ref11\">11\u003c/a>). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) whereas others did not (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans (\u003ca href=\"#ref22\">22\u003c/a>). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans (\u003ca href=\"#ref22\">22\u003c/a>). similarly, measuring of visual acuity in rodents and humans cannot be standardized (\u003ca href=\"#ref22\">22\u003c/a>). mitchell et al. (\u003ca href=\"#ref22\">22\u003c/a>) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans (\u003ca href=\"#ref22\">22\u003c/a>). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes (\u003ca href=\"#ref23\">23\u003c/a>). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) (\u003ca href=\"#ref24\">24\u003c/a>) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials (\u003ca href=\"#ref25\">25\u003c/a>&#x2013;\u003ca href=\"#ref27\">27\u003c/a>). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba (\u003ca href=\"#ref28\">28\u003c/a>), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes.\u003c/p>\n\u003cp class=\"mb15\">given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy (\u003ca href=\"#ref29\">29\u003c/a>), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven.\u003c/p>\n\u003cp class=\"mb15\">heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings.\u003c/p>\n\u003cp class=\"mb15\">to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature.\u003c/p>\n\u003cp class=\"mb15\">other modalities of treatment are also currently under research. extended-reality (xr) devices (\u003ca href=\"#ref30\">30\u003c/a>), physical activity (cycling) (\u003ca href=\"#ref31\">31\u003c/a>) and more recently the occlusion of the amblyopic eye combined with physical activity (\u003ca href=\"#ref32\">32\u003c/a>) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects.\u003c/p>\n\u003cp class=\"mb0\">in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial (\u003ca href=\"#ref16\">16\u003c/a>) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks.\u003c/p> \u003ca id=\"h6\" name=\"h6\">\u003c/a>\n\u003ch2>conclusion\u003c/h2>\n\u003cp class=\"mb0\">this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes.\u003c/p> \u003ca id=\"h7\" name=\"h7\">\u003c/a>\n\u003ch2>data availability statement\u003c/h2>\n\u003cp class=\"mb0\">the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.\u003c/p> \u003ca id=\"h8\" name=\"h8\">\u003c/a>\n\u003ch2>author contributions\u003c/h2>\n\u003cp class=\"mb0\">es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology.\u003c/p> \u003ca id=\"h9\" name=\"h9\">\u003c/a>\n\u003ch2>funding\u003c/h2>\n\u003cp class=\"mb0\">the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\\r1\\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z).\u003c/p> \u003ca id=\"h10\" name=\"h10\">\u003c/a>\n\u003ch2>conflict of interest\u003c/h2>\n\u003cp class=\"mb15\">the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003c/p>\n\u003cp class=\"mb15\">the handling editor gp declared a shared parent affiliation with the author oa at the time of review.\u003c/p>\n\u003cp class=\"mb0\">the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision.\u003c/p> \u003ca id=\"h11\" name=\"h11\">\u003c/a>\n\u003ch2>generative ai statement\u003c/h2>\n\u003cp class=\"mb0\">the authors declare that no gen ai was used in the creation of this manuscript.\u003c/p> \u003ca id=\"h12\" name=\"h12\">\u003c/a>\n\u003ch2>publisher&#x2019;s note\u003c/h2>\n\u003cp class=\"mb0\">all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003c/p> \u003ca id=\"h13\" name=\"h13\">\u003c/a>\n\u003ch2>author disclaimer\u003c/h2>\n\u003cp class=\"mb0\">the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care.\u003c/p> \u003ca id=\"h14\" name=\"h14\">\u003c/a>\n\u003ch2>references\u003c/h2>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref1\" id=\"ref1\">\u003c/a>1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. \u003ci>front pediatr\u003c/i>. (2022) 10:819998. doi: 10.3389/fped.2022.819998 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/35601430\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.3389/fped.2022.819998\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=b+hu&#x00026;author=z+liu&#x00026;author=j+zhao&#x00026;author=l+zeng&#x00026;author=g+hao&#x00026;author=d+shui&#x00026;publication_year=2022&#x00026;title=the+global+prevalence+of+amblyopia+in+children:+a+systematic+review+and+meta-analysis&#x00026;journal=front+pediatr&#x00026;volume=10&#x00026;pages=819998\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref2\" id=\"ref2\">\u003c/a>2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. \u003ci>rom j ophthalmol\u003c/i>. (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33367172\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.22336/rjo.2020.56\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mostafaie&#x00026;author=m+ghojazadeh&#x00026;author=h+hosseinifard&#x00026;author=h+manaflouyan&#x00026;author=f+farhadi&#x00026;author=n+taheri&#x00026;publication_year=2020&#x00026;title=a+systematic+review+of+amblyopia+prevalence+among+the+children+of+the+world&#x00026;journal=rom+j+ophthalmol&#x00026;volume=64&#x00026;pages=342-55\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref3\" id=\"ref3\">\u003c/a>3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. \u003ci>cereb cortex\u003c/i>. (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/16400161\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1093/cercor/bhj110\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=ku+jirmann&#x00026;author=v+vorobyov&#x00026;author=ut+eysel&#x00026;publication_year=2006&#x00026;title=strabismic+suppression+is+mediated+by+inhibitory+interactions+in+the+primary+visual+cortex&#x00026;journal=cereb+cortex&#x00026;volume=16&#x00026;pages=1750-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref4\" id=\"ref4\">\u003c/a>4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. \u003ci>j neurosci\u003c/i>. (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/7965083\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.14-11-06855.1994\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;author=pc+kind&#x00026;author=r+harrad&#x00026;publication_year=1994&#x00026;title=interocular+suppression+in+the+visual+cortex+of+strabismic+cats&#x00026;journal=j+neurosci&#x00026;volume=14&#x00026;pages=6855-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref5\" id=\"ref5\">\u003c/a>5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. \u003ci>eye\u003c/i>. (1996) 10:250&#x2013;8.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;publication_year=1996&#x00026;title=the+neural+basis+of+suppression+and+amblyopia+in+strabismus&#x00026;journal=eye&#x00026;volume=10&#x00026;pages=250-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref6\" id=\"ref6\">\u003c/a>6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. \u003ci>bmc ophthalmol\u003c/i>. (2020) 20:203. doi: 10.1186/s12886-020-01442-9 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/32450849\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1186/s12886-020-01442-9\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=y+li&#x00026;author=h+sun&#x00026;author=x+zhu&#x00026;author=y+su&#x00026;author=t+yu&#x00026;author=x+wu&#x00026;publication_year=2020&#x00026;title=efficacy+of+interventions+for+amblyopia:+a+systematic+review+and+network+meta-analysis&#x00026;journal=bmc+ophthalmol&#x00026;volume=20&#x00026;pages=203\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref7\" id=\"ref7\">\u003c/a>7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. \u003ci>optom vis sci\u003c/i>. (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19417699\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1097/opx.0b013e3181a7b3e5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mj+moseley&#x00026;author=ar+fielder&#x00026;author=ce+stewart&#x00026;publication_year=2009&#x00026;title=the+optical+treatment+of+amblyopia&#x00026;journal=optom+vis+sci&#x00026;volume=86&#x00026;pages=629-33\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref8\" id=\"ref8\">\u003c/a>8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. \u003ci>curr biol\u003c/i>. (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25247373\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2014.05.063\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;publication_year=2014&#x00026;title=plasticity+of+the+visual+cortex+and+treatment+of+amblyopia&#x00026;journal=curr+biol&#x00026;volume=24&#x00026;pages=r936-40\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref9\" id=\"ref9\">\u003c/a>9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. \u003ci>sci rep\u003c/i>. (2018) 8:12830. doi: 10.1038/s41598-018-31169-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30150750\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-018-31169-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=hj+huttunen&#x00026;author=jm+palva&#x00026;author=l+lindberg&#x00026;author=s+palva&#x00026;author=v+saarela&#x00026;author=e+karvonen&#x00026;publication_year=2018&#x00026;title=fluoxetine+does+not+enhance+the+effect+of+perceptual+learning+on+visual+function+in+adults+with+amblyopia&#x00026;journal=sci+rep&#x00026;volume=8&#x00026;pages=12830\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref10\" id=\"ref10\">\u003c/a>10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. \u003ci>j neurosci\u003c/i>. (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/21068299\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.4812-10.2010\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+bavelier&#x00026;author=dm+levi&#x00026;author=rw+li&#x00026;author=y+dan&#x00026;author=tk+hensch&#x00026;publication_year=2010&#x00026;title=removing+brakes+on+adult+brain+plasticity:+from+molecular+to+behavioral+interventions&#x00026;journal=j+neurosci&#x00026;volume=30&#x00026;pages=14964-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref11\" id=\"ref11\">\u003c/a>11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. \u003ci>science\u003c/i>. (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1126/science.1150516\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=m+vetencourt&#x00026;author=v+jf&#x00026;author=a+sale&#x00026;author=a+viegi&#x00026;author=l+baroncelli&#x00026;author=r+de+pasquale&#x00026;publication_year=2008&#x00026;title=the+antidepressant+fluoxetine+restores+plasticity+in+the+adult+visual+cortex&#x00026;journal=science&#x00026;volume=320&#x00026;pages=385-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref12\" id=\"ref12\">\u003c/a>12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. \u003ci>eye\u003c/i>. (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30783259\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41433-019-0360-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mh+sharif&#x00026;author=mr+talebnejad&#x00026;author=k+rastegar&#x00026;author=mr+khalili&#x00026;author=mh+nowroozzadeh&#x00026;publication_year=2019&#x00026;title=oral+fluoxetine+in+the+management+of+amblyopic+patients+aged+between+10+and+40+years+old:+a+randomized+clinical+trial&#x00026;journal=eye&#x00026;volume=33&#x00026;pages=1060-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref13\" id=\"ref13\">\u003c/a>13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. \u003ci>j aapos\u003c/i>. (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/39304030\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.jaapos.2024.104009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mirmohammadsadeghi&#x00026;author=a+mousavi&#x00026;author=mr+akbari&#x00026;author=h+khojasteh&#x00026;author=b+masoomian&#x00026;author=m+sadeghi&#x00026;publication_year=2024&#x00026;title=fluoxetine+as+a+possible+treatment+for+adult+amblyopia:+results+of+a+double-blind+randomized+placebo-controlled+trial&#x00026;journal=j+aapos&#x00026;volume=28&#x00026;pages=104009\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref14\" id=\"ref14\">\u003c/a>14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. \u003ci>neural plast\u003c/i>. (2019) 2019:5857243. doi: 10.1155/2019/5857243\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1155/2019/5857243\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ak+lagas&#x00026;author=jm+black&#x00026;author=br+russell&#x00026;author=rr+kydd&#x00026;author=b+thompson&#x00026;publication_year=2019&#x00026;title=the+effect+of+combined+patching+and+citalopram+on+visual+acuity+in+adults+with+amblyopia:+a+randomized+crossover+placebo-controlled+trial&#x00026;journal=neural+plast&#x00026;volume=2019&#x00026;pages=5857243\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref15\" id=\"ref15\">\u003c/a>15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. \u003ci>bmj\u003c/i>. (2009) 339:b2535. doi: 10.1136/bmj.b2535 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19622551\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.b2535\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+moher&#x00026;author=a+liberati&#x00026;author=j+tetzlaff&#x00026;author=dg+altman&#x00026;publication_year=2009&#x00026;title=preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+the+prisma+statement&#x00026;journal=bmj&#x00026;volume=339&#x00026;pages=b2535\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref16\" id=\"ref16\">\u003c/a>16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2019) 366:l4898. doi: 10.1136/bmj.l4898 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/31462531\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.l4898\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jac+sterne&#x00026;author=j+savovi&#x0107;&#x00026;author=mj+page&#x00026;author=rg+elbers&#x00026;author=ns+blencowe&#x00026;author=i+boutron&#x00026;publication_year=2019&#x00026;title=rob+2:+a+revised+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=366&#x00026;pages=l4898\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref17\" id=\"ref17\">\u003c/a>17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2011) 343:d5928. doi: 10.1136/bmj.d5928 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/22008217\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.d5928\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jpt+higgins&#x00026;author=dg+altman&#x00026;author=pc+g&#x000f8;tzsche&#x00026;author=p+j&#x000fc;ni&#x00026;author=d+moher&#x00026;author=ad+oxman&#x00026;publication_year=2011&#x00026;title=the+cochrane+collaboration&#x2019;s+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=343&#x00026;pages=d5928\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref18\" id=\"ref18\">\u003c/a>18. feighner, jp. mechanism of action of antidepressant medications. \u003ci>j clin psychiatry\u003c/i>. (1999) 60:4&#x2013;11.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=jp+feighner&#x00026;publication_year=1999&#x00026;title=mechanism+of+action+of+antidepressant+medications&#x00026;journal=j+clin+psychiatry&#x00026;volume=60&#x00026;pages=4-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref19\" id=\"ref19\">\u003c/a>19. morishita, h, and hensch, tk. critical period revisited: impact on vision. \u003ci>curr opin neurobiol\u003c/i>. (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/18534841\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.conb.2008.05.009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+morishita&#x00026;author=tk+hensch&#x00026;publication_year=2008&#x00026;title=critical+period+revisited:+impact+on+vision&#x00026;journal=curr+opin+neurobiol&#x00026;volume=18&#x00026;pages=101-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref20\" id=\"ref20\">\u003c/a>20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. \u003ci>ophthalmology\u003c/i>. (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25676904\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.ophtha.2015.01.002\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mx+repka&#x00026;author=rt+kraker&#x00026;author=tw+dean&#x00026;author=rw+beck&#x00026;author=rm+siatkowski&#x00026;publication_year=2015&#x00026;title=a+randomized+trial+of+levodopa+as+treatment+for+residual+amblyopia+in+older+children&#x00026;journal=ophthalmology&#x00026;volume=122&#x00026;pages=874-81\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref21\" id=\"ref21\">\u003c/a>21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. \u003ci>sci rep\u003c/i>. (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37349338\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-023-34891-5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+wu&#x00026;author=ed+gaier&#x00026;author=br+nihalani&#x00026;author=s+whitecross&#x00026;author=tk+hensch&#x00026;author=dg+hunter&#x00026;publication_year=2023&#x00026;title=durable+recovery+from+amblyopia+with+donepezil&#x00026;journal=sci+rep&#x00026;volume=13&#x00026;pages=10161\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref22\" id=\"ref22\">\u003c/a>22. mitchell, d, and sengpiel, f. animal models of amblyopia. \u003ci>vis neurosci\u003c/i>. (2018) 35:e017. doi: 10.1017/s0952523817000244 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/29905121\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1017/s0952523817000244\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+mitchell&#x00026;author=f+sengpiel&#x00026;publication_year=2018&#x00026;title=animal+models+of+amblyopia&#x00026;journal=vis+neurosci&#x00026;volume=35&#x00026;pages=e017\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref23\" id=\"ref23\">\u003c/a>23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). \u003ci>doc ophthalmol\u003c/i>. (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/27443562\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s10633-016-9553-y\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jv+odom&#x00026;author=m+bach&#x00026;author=m+brigell&#x00026;author=ge+holder&#x00026;author=dl+mcculloch&#x00026;author=a+mizota&#x00026;publication_year=2016&#x00026;title=iscev+standard+for+clinical+visual+evoked+potentials:+(2016+update)&#x00026;journal=doc+ophthalmol&#x00026;volume=133&#x00026;pages=1-9\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref24\" id=\"ref24\">\u003c/a>24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. \u003ci>brain struct funct\u003c/i>. (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33900453\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s00429-021-02273-0\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=h+bridge&#x00026;publication_year=2022&#x00026;title=investigating+the+neurochemistry+of+the+human+visual+system+using+magnetic+resonance+spectroscopy&#x00026;journal=brain+struct+funct&#x00026;volume=227&#x00026;pages=1491-505\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref25\" id=\"ref25\">\u003c/a>25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. \u003ci>imaging neurosci.\u003c/i> (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40110226\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1162/imag_a_00256\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=wt+clarke&#x00026;author=a+wyllie&#x00026;author=k+tracey&#x00026;author=j+matuszewski&#x00026;author=s+jbabdi&#x00026;publication_year=2024&#x00026;title=the+relationship+between+visual+acuity+loss+and+gabaergic+inhibition+in+amblyopia&#x00026;journal=imaging+neurosci.&#x00026;volume=2&#x00026;pages=1-18\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref26\" id=\"ref26\">\u003c/a>26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. \u003ci>perception\u003c/i>. (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37272064\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1177/03010066231178664\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+bridge&#x00026;author=ib+ip&#x00026;author=aj+parker&#x00026;publication_year=2023&#x00026;title=investigating+the+human+binocular+visual+system+using+multi-modal+magnetic+resonance+imaging&#x00026;journal=perception&#x00026;volume=52&#x00026;pages=441-58\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref27\" id=\"ref27\">\u003c/a>27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. \u003ci>front hum neurosci\u003c/i>. (2022) 16:949395. doi: 10.3389/fnhum.2022.949395\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.3389/fnhum.2022.949395\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mukerji&#x00026;author=kn+byrne&#x00026;author=e+yang&#x00026;author=dm+levi&#x00026;author=ma+silver&#x00026;publication_year=2022&#x00026;title=visual+cortical+&#x03b3;&#x02212;aminobutyric+acid+and+perceptual+suppression+in+amblyopia&#x00026;journal=front+hum+neurosci&#x00026;volume=16&#x00026;pages=949395\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref28\" id=\"ref28\">\u003c/a>28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: \u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26004760/\">https://pubmed.ncbi.nlm.nih.gov/26004760/\u003c/a>\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?publication_year=2025&#x00026;\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref29\" id=\"ref29\">\u003c/a>29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. \u003ci>strabismus\u003c/i>. (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40226898\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1080/09273972.2025.2478078\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+chedid&#x00026;author=m+fronius&#x00026;author=y+wenner&#x00026;author=l+cirina&#x00026;author=t+kohnen&#x00026;author=c+kuhli-hattenbach&#x00026;publication_year=2025&#x00026;title=optical+coherence+tomography+(oct)+parameters+in+amblyopia&#x00026;journal=strabismus&#x00026;volume=1&#x2013;11&#x00026;pages=1-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref30\" id=\"ref30\">\u003c/a>30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. \u003ci>j vis\u003c/i>. (2023) 23:14. doi: 10.1167/jov.23.1.14 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/36662501\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1167/jov.23.1.14\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=dm+levi&#x00026;publication_year=2023&#x00026;title=applications+and+implications+for+extended+reality+to+improve+binocular+vision+and+stereopsis&#x00026;journal=j+vis&#x00026;volume=23&#x00026;pages=14\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref31\" id=\"ref31\">\u003c/a>31. lunghi, c, and sale, a. a cycling lane for brain rewiring. \u003ci>curr biol\u003c/i>. (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26654367\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2015.10.026\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=a+sale&#x00026;publication_year=2015&#x00026;title=a+cycling+lane+for+brain+rewiring&#x00026;journal=curr+biol&#x00026;volume=25&#x00026;pages=r1122-3\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref32\" id=\"ref32\">\u003c/a>32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. \u003ci>annal. clin. transl. neurol.\u003c/i> (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30847360\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1002/acn3.698\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=at+sframeli&#x00026;author=a+lepri&#x00026;author=m+lepri&#x00026;author=d+lisi&#x00026;author=a+sale&#x00026;publication_year=2019&#x00026;title=a+new+counterintuitive+training+for+adult+amblyopia&#x00026;journal=annal.+clin.+transl.+neurol.&#x00026;volume=6&#x00026;pages=274-84\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003c/div> \u003cdiv class=\"thinlinem20\">\u003c/div> \u003cdiv class=\"abstractsummary\">\n\u003cp>\u003cspan>keywords:\u003c/span> amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity\u003c/p>\n\u003cp>\u003cspan>citation:\u003c/span> shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. \u003ci>front. neurol\u003c/i>. 16:1639913. doi: 10.3389/fneur.2025.1639913\u003c/p>\n\u003cp class=\"timestamps\">\u003cspan>received:\u003c/span> 03 june 2025; \u003cspan>accepted:\u003c/span> 31 july 2025;\u003cbr> \u003cspan>published:\u003c/span> 21 august 2025.\u003c/p> \u003cdiv>\n\u003cp>edited by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/2271562/overview\">gordon plant\u003c/a>, university college london, united kingdom\u003c/div> \u003cdiv>\n\u003cp>reviewed by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/1863925/overview\">sara samadzadeh\u003c/a>, charit&#x00e9; university medicine berlin, germany\u003cbr> \u003ca href=\"https://loop.frontiersin.org/people/870962/overview\">alistair r. fielder\u003c/a>, city university of london, united kingdom\u003c/div>\n\u003cp>\u003cspan>copyright\u003c/span> &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">creative commons attribution license (cc by)\u003c/a>. the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms.\u003c/p>\n\u003cp>\u003cspan>&#x0002a;correspondence:\u003c/span> i. betina ip, \u003ca id=\"encmail\">ymv0aw5hlmlwqg5ky24ub3guywmudws=\u003c/a>\u003c/p>\n\u003cp>\u003cspan>\u003csup>&#x2020;\u003c/sup>\u003c/span>these authors share senior authorship\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div>","\u003cul class=\"flyoutjournal\"> \u003cli>\u003ca href=\"#h1\">abstract\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h2\">introduction\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h3\">methods\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h4\">results\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h5\">discussion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h6\">conclusion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h7\">data availability statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h8\">author contributions\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h9\">funding\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h10\">conflict of interest\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h11\">generative ai statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h12\">publisher&#x2019;s note\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h13\">author disclaimer\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h14\">references\u003c/a>\u003c/li> \u003c/ul>",[719,725,731],{"name":720,"fileserverpackageentryid":19,"fileserverid":721,"fileserverversionnumber":439,"type":722},"epub.epub","1639913/epub",{"code":723,"name":724},"epub","epub",{"name":726,"fileserverpackageentryid":19,"fileserverid":727,"fileserverversionnumber":439,"type":728},"publishers-proof.pdf","1639913/publishers-proof",{"code":729,"name":730},"pdf","pdf",{"name":732,"fileserverpackageentryid":733,"fileserverid":734,"fileserverversionnumber":439,"type":735},"fneur-16-1639913.xml","fneur-16-1639913/fneur-16-1639913.xml","1639913/xml",{"code":736,"name":737},"nlm_xml","xml","v3",{"title":740,"link":741,"meta":745,"script":869},"frontiers | selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials",[742],{"rel":743,"href":744},"canonical","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/full",[746,749,752,754,757,761,764,768,771,774,777,779,781,783,785,787,790,793,795,798,800,802,805,808,811,814,817,821,825,828,831,834,837,840,843,846,849,852,855,858,861,864,866],{"hid":747,"property":747,"name":747,"content":748},"description","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in ea...",{"hid":750,"property":750,"name":751,"content":740},"og:title","title",{"hid":753,"property":753,"name":747,"content":748},"og:description",{"hid":755,"name":755,"content":756},"keywords","strabismus,neuroplasticity,amblyopia,fluoxetine,ssris,anisometropia,citalopram",{"hid":758,"property":758,"name":759,"content":760},"og:site_name","site_name","frontiers",{"hid":762,"property":762,"name":432,"content":763},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg",{"hid":765,"property":765,"name":766,"content":767},"og:type","type","article",{"hid":769,"property":769,"name":770,"content":744},"og:url","url",{"hid":772,"name":772,"content":773},"twitter:card","summary_large_image",{"hid":775,"name":775,"content":776},"citation_volume","16",{"hid":778,"name":778,"content":116},"citation_journal_title",{"hid":780,"name":780,"content":760},"citation_publisher",{"hid":782,"name":782,"content":700},"citation_journal_abbrev",{"hid":784,"name":784,"content":701},"citation_issn",{"hid":786,"name":786,"content":583},"citation_doi",{"hid":788,"name":788,"content":789},"citation_firstpage","1639913",{"hid":791,"name":791,"content":792},"citation_language","english",{"hid":794,"name":794,"content":584},"citation_title",{"hid":796,"name":796,"content":797},"citation_keywords","strabismus; neuroplasticity; amblyopia; fluoxetine; ssris; anisometropia; citalopram",{"hid":799,"name":799,"content":589},"citation_abstract",{"hid":801,"name":801,"content":598},"citation_article_type",{"hid":803,"name":803,"content":804},"citation_pdf_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/pdf",{"hid":806,"name":806,"content":807},"citation_xml_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/xml",{"hid":809,"name":809,"content":810},"citation_fulltext_world_readable","yes",{"hid":812,"name":812,"content":813},"citation_online_date","2025/07/31",{"hid":815,"name":815,"content":816},"citation_publication_date","2025/08/21",{"hid":818,"name":819,"content":820},"citation_author_0","citation_author","shamsher, ehtesham ",{"hid":822,"name":823,"content":824},"citation_author_institution_0","citation_author_institution","oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, united kingdom",{"hid":826,"name":819,"content":827},"citation_author_1","saccaro, luisa ",{"hid":829,"name":823,"content":830},"citation_author_institution_1","faculty of medicine, universidade de mogi das cruzes, brazil",{"hid":832,"name":819,"content":833},"citation_author_2","pungirum, victor barreiros ",{"hid":835,"name":823,"content":836},"citation_author_institution_2","faculty of medical sciences, university of buenos aires, argentina",{"hid":838,"name":819,"content":839},"citation_author_3","tran, nghi bao ",{"hid":841,"name":823,"content":842},"citation_author_institution_3","faculty of medicine, university of debrecen, hungary",{"hid":844,"name":819,"content":845},"citation_author_4","alghaith, omar a. h. a. ",{"hid":847,"name":823,"content":848},"citation_author_institution_4","institute of ophthalmology, university college london, united kingdom",{"hid":850,"name":819,"content":851},"citation_author_5","khabazianzadeh, fatemeh ",{"hid":853,"name":823,"content":854},"citation_author_institution_5","eye research center, khatam-al-anbia hospital, mashad university of medical sciences, iran",{"hid":856,"name":819,"content":857},"citation_author_6","bridge, holly ",{"hid":859,"name":823,"content":860},"citation_author_institution_6","nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, united kingdom",{"hid":862,"name":819,"content":863},"citation_author_7","ip, i. betina ",{"hid":865,"name":823,"content":860},"citation_author_institution_7",{"hid":867,"name":867,"content":868},"dc.identifier","doi:10.3389/fneur.2025.1639913",[870,873,875,877,879],{"src":871,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":874,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/mathjax.js?config=tex-mml-am_chtml",{"src":876,"body":13,"type":872,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":878,"body":13,"type":872,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1639913?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":880,"body":13,"type":872,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articlehubslug":19,"articlehubpage":882,"articlehubarticleslist":883,"canjournalhasarticlehub":379,"articledoilist":884},{},[],[],{"title":19,"image":-1,"breadcrumbs":886,"linkscollection":887,"metricscollection":889},[],{"total":436,"items":888},[],{"total":436,"items":890},[]] window.__nuxt__={};window.__nuxt__.config={public:{isdevmode:false,appname:"article-pages-2024",baseurl:"https://www.frontiersin.org",domain:"frontiersin.org",loopurl:"https://loop.frontiersin.org",ssmaindomain:"frontiersin.org",contentfulurl:"https://graphql.contentful.com/content/v1/spaces",spaceid:1,spacename:"frontiers",livespaceid:1,tenantlogourl:"",frontiersgraphurl:"https://apollo-federation-gateway.frontiersin.org",registrationapiurl:"https://onboarding-ui.frontiersin.org",emaildigestapiurl:"https://api-email-digest.frontiersin.org",journalfilesapiurl:"https://files-journal-api.frontiersin.org",searchapiurl:"https://search-api.frontiersin.org",productionforumapiurl:"https://production-forum-api-v2.frontiersin.org",gtmserverurl:"https://tag-manager.frontiersin.org",gtmid:"gtm-m322fv2",gtmauth:"owvbwxfajr21yqv1fe1caq",gtmpreview:"env-1",figsharepluginurl:"https://widgets.figshare.com/static/figshare.js",figshareapiurl:"https://api.figshare.com/v2/collections/search",figsharetimeout:3000,crossmarkpublisheddate:"2015/08/24",googlerecaptchasitekey:"6ldg3i0uaaaaaoc4quh35ubhgjotehp_stxhgr_v",googlerecaptchakeyname:"frontiersrecaptchav2",faviconsize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantfavicon-frontiers.png",faviconsize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantfavicon-frontiers.png",faviconsize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantfavicon-frontiers.png",faviconsize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantfavicon-frontiers.png",faviconsize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantfavicon-frontiers.png",socialmediaimg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/guidelines-frontiers_logo_1200x628_1-91to1.png",linkedarticlecopytext:"'{\"articletypecopytext\":[{\"articletypeid\":0,\"originalarticlecopytext\":\"part of this article's content has been mentioned in:\",\"linkedarticlecopytext\":\"this article mentions parts of:\"},{\"articletypeid\":122,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an erratum on:\"},{\"articletypeid\":129,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an addendum to:\"},{\"articletypeid\":128,\"originalarticlecopytext\":\"a correction has been applied to this article in:\",\"linkedarticlecopytext\":\"this article is a correction to:\"},{\"articletypeid\":134,\"originalarticlecopytext\":\"a retraction of this article was approved in:\",\"linkedarticlecopytext\":\"this article is a retraction of:\"},{\"articletypeid\":29,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"},{\"articletypeid\":30,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"}],\"articleidcopytext\":[]}'\n",acceptedarticleexcludedjournalids:"'[2766,979]'\n",articletypeconfigurablelabel:"\u003c\u003carticle-type:uppercase>> article",settingsfeaturesswitchers:"'{\"displaytitlepilllabels\":true,\"displayrelatedarticlesbox\":true,\"showeditors\":true,\"showreviewers\":true,\"showloopimpactlink\":true,\"enablefigshare\":false,\"usexmlimages\":true}'\n",journalswitharticlehub:"'{\"strings\":[\"science\"]}'\n",terminologysettings:"'{\"terms\":[{\"sequencenumber\":1,\"key\":\"frontiers\",\"tenantterm\":\"frontiers\",\"frontiersdefaultterm\":\"frontiers\",\"category\":\"customer\"},{\"sequencenumber\":2,\"key\":\"submission_system\",\"tenantterm\":\"submission system\",\"frontiersdefaultterm\":\"submission system\",\"category\":\"product\"},{\"sequencenumber\":3,\"key\":\"public_pages\",\"tenantterm\":\"public pages\",\"frontiersdefaultterm\":\"public pages\",\"category\":\"product\"},{\"sequencenumber\":4,\"key\":\"my_frontiers\",\"tenantterm\":\"my frontiers\",\"frontiersdefaultterm\":\"my frontiers\",\"category\":\"product\"},{\"sequencenumber\":5,\"key\":\"digital_editorial_office\",\"tenantterm\":\"digital editorial office\",\"frontiersdefaultterm\":\"digital editorial office\",\"category\":\"product\"},{\"sequencenumber\":6,\"key\":\"deo\",\"tenantterm\":\"deo\",\"frontiersdefaultterm\":\"deo\",\"category\":\"product\"},{\"sequencenumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantterm\":\"digital editorial office for chiefs\",\"frontiersdefaultterm\":\"digital editorial office for chiefs\",\"category\":\"product\"},{\"sequencenumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantterm\":\"digital editorial office for eof\",\"frontiersdefaultterm\":\"digital editorial office for eof\",\"category\":\"product\"},{\"sequencenumber\":9,\"key\":\"editorial_office\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"product\"},{\"sequencenumber\":10,\"key\":\"eof\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"product\"},{\"sequencenumber\":11,\"key\":\"research_topic_management\",\"tenantterm\":\"research topic management\",\"frontiersdefaultterm\":\"research topic management\",\"category\":\"product\"},{\"sequencenumber\":12,\"key\":\"review_forum\",\"tenantterm\":\"review forum\",\"frontiersdefaultterm\":\"review forum\",\"category\":\"product\"},{\"sequencenumber\":13,\"key\":\"accounting_office\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"product\"},{\"sequencenumber\":14,\"key\":\"aof\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"product\"},{\"sequencenumber\":15,\"key\":\"publishing_office\",\"tenantterm\":\"publishing office\",\"frontiersdefaultterm\":\"publishing office\",\"category\":\"product\"},{\"sequencenumber\":16,\"key\":\"production_office\",\"tenantterm\":\"production office forum\",\"frontiersdefaultterm\":\"production office forum\",\"category\":\"product\"},{\"sequencenumber\":17,\"key\":\"pof\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"product\"},{\"sequencenumber\":18,\"key\":\"book_office_forum\",\"tenantterm\":\"book office forum\",\"frontiersdefaultterm\":\"book office forum\",\"category\":\"product\"},{\"sequencenumber\":19,\"key\":\"bof\",\"tenantterm\":\"bof\",\"frontiersdefaultterm\":\"bof\",\"category\":\"product\"},{\"sequencenumber\":20,\"key\":\"aira\",\"tenantterm\":\"aira\",\"frontiersdefaultterm\":\"aira\",\"category\":\"product\"},{\"sequencenumber\":21,\"key\":\"editorial_board_management\",\"tenantterm\":\"editorial board management\",\"frontiersdefaultterm\":\"editorial board management\",\"category\":\"product\"},{\"sequencenumber\":22,\"key\":\"ebm\",\"tenantterm\":\"ebm\",\"frontiersdefaultterm\":\"ebm\",\"category\":\"product\"},{\"sequencenumber\":23,\"key\":\"domain\",\"tenantterm\":\"domain\",\"frontiersdefaultterm\":\"domain\",\"category\":\"taxonomy\"},{\"sequencenumber\":24,\"key\":\"journal\",\"tenantterm\":\"journal\",\"frontiersdefaultterm\":\"journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":25,\"key\":\"section\",\"tenantterm\":\"section\",\"frontiersdefaultterm\":\"section\",\"category\":\"taxonomy\"},{\"sequencenumber\":26,\"key\":\"domains\",\"tenantterm\":\"domains\",\"frontiersdefaultterm\":\"domains\",\"category\":\"taxonomy\"},{\"sequencenumber\":27,\"key\":\"specialty_section\",\"tenantterm\":\"specialty section\",\"frontiersdefaultterm\":\"specialty section\",\"category\":\"taxonomy\"},{\"sequencenumber\":28,\"key\":\"specialty_journal\",\"tenantterm\":\"specialty journal\",\"frontiersdefaultterm\":\"specialty journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":29,\"key\":\"journals\",\"tenantterm\":\"journals\",\"frontiersdefaultterm\":\"journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":30,\"key\":\"sections\",\"tenantterm\":\"sections\",\"frontiersdefaultterm\":\"sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":31,\"key\":\"specialty_sections\",\"tenantterm\":\"specialty sections\",\"frontiersdefaultterm\":\"specialty sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":32,\"key\":\"specialty_journals\",\"tenantterm\":\"specialty journals\",\"frontiersdefaultterm\":\"specialty journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":33,\"key\":\"manuscript\",\"tenantterm\":\"manuscript\",\"frontiersdefaultterm\":\"manuscript\",\"category\":\"core\"},{\"sequencenumber\":34,\"key\":\"manuscripts\",\"tenantterm\":\"manuscripts\",\"frontiersdefaultterm\":\"manuscripts\",\"category\":\"core\"},{\"sequencenumber\":35,\"key\":\"article\",\"tenantterm\":\"article\",\"frontiersdefaultterm\":\"article\",\"category\":\"core\"},{\"sequencenumber\":36,\"key\":\"articles\",\"tenantterm\":\"articles\",\"frontiersdefaultterm\":\"articles\",\"category\":\"core\"},{\"sequencenumber\":37,\"key\":\"article_type\",\"tenantterm\":\"article type\",\"frontiersdefaultterm\":\"article type\",\"category\":\"core\"},{\"sequencenumber\":38,\"key\":\"article_types\",\"tenantterm\":\"article types\",\"frontiersdefaultterm\":\"article types\",\"category\":\"core\"},{\"sequencenumber\":39,\"key\":\"author\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":40,\"key\":\"authors\",\"tenantterm\":\"authors\",\"frontiersdefaultterm\":\"authors\",\"category\":\"label (role)\"},{\"sequencenumber\":41,\"key\":\"authoring\",\"tenantterm\":\"authoring\",\"frontiersdefaultterm\":\"authoring\",\"category\":\"core\"},{\"sequencenumber\":42,\"key\":\"authored\",\"tenantterm\":\"authored\",\"frontiersdefaultterm\":\"authored\",\"category\":\"core\"},{\"sequencenumber\":43,\"key\":\"accept\",\"tenantterm\":\"accept\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":44,\"key\":\"accepted\",\"tenantterm\":\"accepted\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"description\":\"an editorial role on a field journal that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantterm\":\"assistant specialty chief editors\",\"frontiersdefaultterm\":\"assistant specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":48,\"key\":\"associate_editor\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":49,\"key\":\"specialty_chief_editor\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":50,\"key\":\"specialty_chief_editors\",\"tenantterm\":\"specialty chief editors\",\"frontiersdefaultterm\":\"specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":51,\"key\":\"chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":52,\"key\":\"chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":53,\"key\":\"call_for_participation\",\"tenantterm\":\"call for participation\",\"frontiersdefaultterm\":\"call for participation\",\"category\":\"process\"},{\"sequencenumber\":54,\"key\":\"citation\",\"tenantterm\":\"citation\",\"frontiersdefaultterm\":\"citation\",\"category\":\"misc.\"},{\"sequencenumber\":55,\"key\":\"citations\",\"tenantterm\":\"citations\",\"frontiersdefaultterm\":\"citations\",\"category\":\"misc.\"},{\"sequencenumber\":56,\"key\":\"contributor\",\"tenantterm\":\"contributor\",\"frontiersdefaultterm\":\"contributor\",\"category\":\"label (role)\"},{\"sequencenumber\":57,\"key\":\"contributors\",\"tenantterm\":\"contributors\",\"frontiersdefaultterm\":\"contributors\",\"category\":\"label (role)\"},{\"sequencenumber\":58,\"key\":\"corresponding_author\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":59,\"key\":\"corresponding_authors\",\"tenantterm\":\"corresponding authors\",\"frontiersdefaultterm\":\"corresponding authors\",\"category\":\"label (role)\"},{\"sequencenumber\":60,\"key\":\"decline\",\"tenantterm\":\"decline\",\"frontiersdefaultterm\":\"decline\",\"category\":\"process\"},{\"sequencenumber\":61,\"key\":\"declined\",\"tenantterm\":\"declined\",\"frontiersdefaultterm\":\"declined\",\"category\":\"process\"},{\"sequencenumber\":62,\"key\":\"reject\",\"tenantterm\":\"reject\",\"frontiersdefaultterm\":\"reject\",\"category\":\"process\"},{\"sequencenumber\":63,\"key\":\"rejected\",\"tenantterm\":\"rejected\",\"frontiersdefaultterm\":\"rejected\",\"category\":\"process\"},{\"sequencenumber\":64,\"key\":\"publish\",\"tenantterm\":\"publish\",\"frontiersdefaultterm\":\"publish\",\"category\":\"core\"},{\"sequencenumber\":65,\"key\":\"published\",\"tenantterm\":\"published\",\"frontiersdefaultterm\":\"published\",\"category\":\"core\"},{\"sequencenumber\":66,\"key\":\"publication\",\"tenantterm\":\"publication\",\"frontiersdefaultterm\":\"publication\",\"category\":\"core\"},{\"sequencenumber\":67,\"key\":\"peer_review\",\"tenantterm\":\"peer review\",\"frontiersdefaultterm\":\"peer review\",\"category\":\"peer review process\"},{\"sequencenumber\":68,\"key\":\"peer_reviewed\",\"tenantterm\":\"peer reviewed\",\"frontiersdefaultterm\":\"peer reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":69,\"key\":\"initial_validation\",\"tenantterm\":\"initial validation\",\"frontiersdefaultterm\":\"initial validation\",\"category\":\"peer review process\"},{\"sequencenumber\":70,\"key\":\"editorial_assignment\",\"tenantterm\":\"editorial assignment\",\"frontiersdefaultterm\":\"editorial assignment\",\"category\":\"peer review process\"},{\"sequencenumber\":71,\"key\":\"independent_review\",\"tenantterm\":\"independent review\",\"frontiersdefaultterm\":\"independent review\",\"category\":\"peer review process\"},{\"sequencenumber\":72,\"key\":\"interactive_review\",\"tenantterm\":\"interactive review\",\"frontiersdefaultterm\":\"interactive review\",\"category\":\"peer review process\"},{\"sequencenumber\":73,\"key\":\"review\",\"tenantterm\":\"review\",\"frontiersdefaultterm\":\"review\",\"category\":\"peer review process\"},{\"sequencenumber\":74,\"key\":\"reviewing\",\"tenantterm\":\"reviewing\",\"frontiersdefaultterm\":\"reviewing\",\"category\":\"peer review process\"},{\"sequencenumber\":75,\"key\":\"reviewer\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":76,\"key\":\"reviewers\",\"tenantterm\":\"reviewers\",\"frontiersdefaultterm\":\"reviewers\",\"category\":\"label (role)\"},{\"sequencenumber\":77,\"key\":\"review_finalized\",\"tenantterm\":\"review finalized\",\"frontiersdefaultterm\":\"review finalized\",\"category\":\"peer review process\"},{\"sequencenumber\":78,\"key\":\"final_decision\",\"tenantterm\":\"final decision\",\"frontiersdefaultterm\":\"final decision\",\"category\":\"peer review process\"},{\"sequencenumber\":79,\"key\":\"final_validation\",\"tenantterm\":\"final validation\",\"frontiersdefaultterm\":\"final validation\",\"category\":\"peer review process\"},{\"sequencenumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantterm\":\"recommend to accept manuscript\",\"frontiersdefaultterm\":\"accept manuscript\",\"category\":\"process\"},{\"sequencenumber\":81,\"key\":\"fee\",\"tenantterm\":\"fee\",\"frontiersdefaultterm\":\"fee\",\"category\":\"accounting\"},{\"sequencenumber\":82,\"key\":\"fees\",\"tenantterm\":\"fees\",\"frontiersdefaultterm\":\"fees\",\"category\":\"accounting\"},{\"sequencenumber\":83,\"key\":\"guest_associate_editor\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":84,\"key\":\"guest_associate_editors\",\"tenantterm\":\"guest associate editors\",\"frontiersdefaultterm\":\"guest associate editors\",\"category\":\"label (role)\"},{\"sequencenumber\":85,\"key\":\"in_review\",\"tenantterm\":\"in review\",\"frontiersdefaultterm\":\"in review\",\"category\":\"peer review process\"},{\"sequencenumber\":86,\"key\":\"institutional_member\",\"tenantterm\":\"institutional partner\",\"frontiersdefaultterm\":\"institutional partner\",\"category\":\"accounting\"},{\"sequencenumber\":87,\"key\":\"institutional_membership\",\"tenantterm\":\"institutional partnership\",\"frontiersdefaultterm\":\"institutional partnership\",\"category\":\"accounting\"},{\"sequencenumber\":88,\"key\":\"article_processing_charge\",\"tenantterm\":\"article processing charge\",\"frontiersdefaultterm\":\"article processing charge\",\"category\":\"accounting\"},{\"sequencenumber\":89,\"key\":\"article_processing_charges\",\"tenantterm\":\"article processing charges\",\"frontiersdefaultterm\":\"article processing charges\",\"category\":\"accounting\"},{\"sequencenumber\":90,\"key\":\"apcs\",\"tenantterm\":\"apcs\",\"frontiersdefaultterm\":\"apcs\",\"category\":\"accounting\"},{\"sequencenumber\":91,\"key\":\"apc\",\"tenantterm\":\"apc\",\"frontiersdefaultterm\":\"apc\",\"category\":\"accounting\"},{\"sequencenumber\":92,\"key\":\"received\",\"tenantterm\":\"received\",\"frontiersdefaultterm\":\"received\",\"description\":\"date manuscript was received on.\",\"category\":\"core\"},{\"sequencenumber\":93,\"key\":\"transferred\",\"tenantterm\":\"transferred\",\"frontiersdefaultterm\":\"transferred\",\"category\":\"core\"},{\"sequencenumber\":94,\"key\":\"transfer\",\"tenantterm\":\"transfer\",\"frontiersdefaultterm\":\"transfer\",\"category\":\"core\"},{\"sequencenumber\":95,\"key\":\"research_topic\",\"tenantterm\":\"research topic\",\"frontiersdefaultterm\":\"research topic\",\"category\":\"core\"},{\"sequencenumber\":96,\"key\":\"research_topics\",\"tenantterm\":\"research topics\",\"frontiersdefaultterm\":\"research topics\",\"category\":\"core\"},{\"sequencenumber\":97,\"key\":\"topic_editor\",\"tenantterm\":\"topic editor\",\"frontiersdefaultterm\":\"topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":98,\"key\":\"review_editor\",\"tenantterm\":\"community reviewer\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":99,\"key\":\"title\",\"tenantterm\":\"title\",\"frontiersdefaultterm\":\"title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":100,\"key\":\"running_title\",\"tenantterm\":\"running title\",\"frontiersdefaultterm\":\"running title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":101,\"key\":\"submit\",\"tenantterm\":\"submit\",\"frontiersdefaultterm\":\"submit\",\"category\":\"process\"},{\"sequencenumber\":102,\"key\":\"submitted\",\"tenantterm\":\"submitted\",\"frontiersdefaultterm\":\"submitted\",\"category\":\"process\"},{\"sequencenumber\":103,\"key\":\"submitting\",\"tenantterm\":\"submitting\",\"frontiersdefaultterm\":\"submitting\",\"category\":\"process\"},{\"sequencenumber\":104,\"key\":\"t_e\",\"tenantterm\":\"te\",\"frontiersdefaultterm\":\"te\",\"category\":\"label (role)\"},{\"sequencenumber\":105,\"key\":\"topic\",\"tenantterm\":\"topic\",\"frontiersdefaultterm\":\"topic\",\"category\":\"process\"},{\"sequencenumber\":106,\"key\":\"topic_summary\",\"tenantterm\":\"topic summary\",\"frontiersdefaultterm\":\"topic summary\",\"category\":\"process\"},{\"sequencenumber\":107,\"key\":\"figure\",\"tenantterm\":\"figure\",\"frontiersdefaultterm\":\"figure\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":108,\"key\":\"figures\",\"tenantterm\":\"figures\",\"frontiersdefaultterm\":\"figures\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":109,\"key\":\"editorial_file\",\"tenantterm\":\"editorial file\",\"frontiersdefaultterm\":\"editorial file\",\"category\":\"core\"},{\"sequencenumber\":110,\"key\":\"editorial_files\",\"tenantterm\":\"editorial files\",\"frontiersdefaultterm\":\"editorial files\",\"category\":\"core\"},{\"sequencenumber\":111,\"key\":\"e_book\",\"tenantterm\":\"e-book\",\"frontiersdefaultterm\":\"e-book\",\"category\":\"core\"},{\"sequencenumber\":112,\"key\":\"organization\",\"tenantterm\":\"organization\",\"frontiersdefaultterm\":\"organization\",\"category\":\"core\"},{\"sequencenumber\":113,\"key\":\"institution\",\"tenantterm\":\"institution\",\"frontiersdefaultterm\":\"institution\",\"category\":\"core\"},{\"sequencenumber\":114,\"key\":\"reference\",\"tenantterm\":\"reference\",\"frontiersdefaultterm\":\"reference\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":115,\"key\":\"references\",\"tenantterm\":\"references\",\"frontiersdefaultterm\":\"references\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":116,\"key\":\"sce\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"description\":\"abbreviation for specialty chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":117,\"key\":\"submission\",\"tenantterm\":\"submission\",\"frontiersdefaultterm\":\"submission\",\"category\":\"process\"},{\"sequencenumber\":118,\"key\":\"submissions\",\"tenantterm\":\"submissions\",\"frontiersdefaultterm\":\"submissions\",\"category\":\"process\"},{\"sequencenumber\":119,\"key\":\"editing\",\"tenantterm\":\"editing\",\"frontiersdefaultterm\":\"editing\",\"category\":\"process\"},{\"sequencenumber\":120,\"key\":\"in_preparation\",\"tenantterm\":\"in preparation\",\"frontiersdefaultterm\":\"in preparation\",\"category\":\"process\"},{\"sequencenumber\":121,\"key\":\"country_region\",\"tenantterm\":\"country/region\",\"frontiersdefaultterm\":\"country/region\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":122,\"key\":\"countries_regions\",\"tenantterm\":\"countries/regions\",\"frontiersdefaultterm\":\"countries/regions\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":123,\"key\":\"specialty\",\"tenantterm\":\"specialty\",\"frontiersdefaultterm\":\"specialty\",\"category\":\"core\"},{\"sequencenumber\":124,\"key\":\"specialties\",\"tenantterm\":\"specialties\",\"frontiersdefaultterm\":\"specialties\",\"category\":\"core\"},{\"sequencenumber\":125,\"key\":\"associate_editors\",\"tenantterm\":\"associate editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":126,\"key\":\"reviewed\",\"tenantterm\":\"reviewed\",\"frontiersdefaultterm\":\"reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":127,\"key\":\"institutional_members\",\"tenantterm\":\"institutional partners\",\"frontiersdefaultterm\":\"institutional partners\",\"category\":\"accounting\"},{\"sequencenumber\":128,\"key\":\"institutional_memberships\",\"tenantterm\":\"institutional partnerships\",\"frontiersdefaultterm\":\"institutional partnerships\",\"category\":\"accounting\"},{\"sequencenumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantterm\":\"assistant field chief editors\",\"frontiersdefaultterm\":\"assistant field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":130,\"key\":\"publications\",\"tenantterm\":\"publications\",\"frontiersdefaultterm\":\"publications\",\"category\":\"process\"},{\"sequencenumber\":131,\"key\":\"ae_accepted\",\"tenantterm\":\"recommended acceptance\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":132,\"key\":\"field_journal\",\"tenantterm\":\"field journal\",\"frontiersdefaultterm\":\"field journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":133,\"key\":\"field_journals\",\"tenantterm\":\"field journals\",\"frontiersdefaultterm\":\"field journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":134,\"key\":\"program_manager\",\"tenantterm\":\"program manager\",\"frontiersdefaultterm\":\"program manager\",\"category\":\"label (role)\"},{\"sequencenumber\":135,\"key\":\"journal_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":136,\"key\":\"journal_specialist\",\"tenantterm\":\"journal specialist\",\"frontiersdefaultterm\":\"journal specialist\",\"category\":\"label (role)\"},{\"sequencenumber\":137,\"key\":\"program_managers\",\"tenantterm\":\"program managers\",\"frontiersdefaultterm\":\"program managers\",\"category\":\"label (role)\"},{\"sequencenumber\":138,\"key\":\"journal_managers\",\"tenantterm\":\"journal managers\",\"frontiersdefaultterm\":\"journal managers\",\"category\":\"label (role)\"},{\"sequencenumber\":139,\"key\":\"journal_specialists\",\"tenantterm\":\"journal specialists\",\"frontiersdefaultterm\":\"journal specialists\",\"category\":\"label (role)\"},{\"sequencenumber\":140,\"key\":\"cover_letter\",\"tenantterm\":\"manuscript contribution to the field\",\"frontiersdefaultterm\":\"manuscript contribution to the field\",\"category\":\"process\"},{\"sequencenumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantterm\":\"recommended to accept manuscript\",\"frontiersdefaultterm\":\"accepted manuscript\",\"category\":\"process\"},{\"sequencenumber\":142,\"key\":\"recommend_for_rejection\",\"tenantterm\":\"recommend for rejection\",\"frontiersdefaultterm\":\"recommend for rejection\",\"category\":\"process\"},{\"sequencenumber\":143,\"key\":\"recommended_for_rejection\",\"tenantterm\":\"recommended for rejection\",\"frontiersdefaultterm\":\"recommended for rejection\",\"category\":\"process\"},{\"sequencenumber\":144,\"key\":\"ae\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"description\":\"associate editor - board member\",\"category\":\"label (role)\"},{\"sequencenumber\":145,\"key\":\"re\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"description\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":146,\"key\":\"rev\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"description\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":147,\"key\":\"aut\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"description\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":148,\"key\":\"coraut\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"description\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":149,\"key\":\"saut\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"description\":\"submitting author\",\"category\":\"label (role)\"},{\"sequencenumber\":150,\"key\":\"coaut\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"description\":\"co-author\",\"category\":\"label (role)\"},{\"sequencenumber\":151,\"key\":\"tsof\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"description\":\"typesetter\",\"category\":\"label (role)\"},{\"sequencenumber\":152,\"key\":\"typesetting_office\",\"tenantterm\":\"typesetting office\",\"frontiersdefaultterm\":\"typesetting office\",\"category\":\"product\"},{\"sequencenumber\":153,\"key\":\"config\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"description\":\"configuration office role\",\"category\":\"label (role)\"},{\"sequencenumber\":154,\"key\":\"jm\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"description\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":155,\"key\":\"rte\",\"tenantterm\":\"rte\",\"frontiersdefaultterm\":\"rte\",\"description\":\"research topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":156,\"key\":\"organizations\",\"tenantterm\":\"organizations\",\"frontiersdefaultterm\":\"organizations\",\"category\":\"core\"},{\"sequencenumber\":157,\"key\":\"publishing\",\"tenantterm\":\"publishing\",\"frontiersdefaultterm\":\"publishing\",\"category\":\"core\"},{\"sequencenumber\":158,\"key\":\"acceptance\",\"tenantterm\":\"acceptance\",\"frontiersdefaultterm\":\"acceptance\",\"category\":\"process\"},{\"sequencenumber\":159,\"key\":\"preferred_associate_editor\",\"tenantterm\":\"preferred associate editor\",\"frontiersdefaultterm\":\"preferred associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":160,\"key\":\"topic_editors\",\"tenantterm\":\"topic editors\",\"frontiersdefaultterm\":\"topic editors\",\"category\":\"label (role)\"},{\"sequencenumber\":161,\"key\":\"institutions\",\"tenantterm\":\"institutions\",\"frontiersdefaultterm\":\"institutions\",\"category\":\"core\"},{\"sequencenumber\":162,\"key\":\"author(s)\",\"tenantterm\":\"author(s)\",\"frontiersdefaultterm\":\"author(s)\",\"category\":\"label (role)\"},{\"sequencenumber\":163,\"key\":\"figure(s)\",\"tenantterm\":\"figure(s)\",\"frontiersdefaultterm\":\"figure(s)\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":164,\"key\":\"co-authors\",\"tenantterm\":\"co-authors\",\"frontiersdefaultterm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"label (role)\"},{\"sequencenumber\":165,\"key\":\"editorial_board_members\",\"tenantterm\":\"editorial board members\",\"frontiersdefaultterm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"label (role)\"},{\"sequencenumber\":166,\"key\":\"editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"product\"},{\"sequencenumber\":167,\"key\":\"co-authorship\",\"tenantterm\":\"co-authorship\",\"frontiersdefaultterm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"misc.\"},{\"sequencenumber\":168,\"key\":\"role_id_1\",\"tenantterm\":\"registration office\",\"frontiersdefaultterm\":\"registration office\",\"category\":\"user role\"},{\"sequencenumber\":169,\"key\":\"role_id_2\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"user role\"},{\"sequencenumber\":170,\"key\":\"role_id_7\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":171,\"key\":\"role_id_8\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":172,\"key\":\"role_id_9\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":173,\"key\":\"role_id_10\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":174,\"key\":\"role_id_11\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"category\":\"user role\"},{\"sequencenumber\":175,\"key\":\"role_id_12\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"user role\"},{\"sequencenumber\":176,\"key\":\"role_id_13\",\"tenantterm\":\"review editor\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"user role\"},{\"sequencenumber\":177,\"key\":\"role_id_14\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"user role\"},{\"sequencenumber\":178,\"key\":\"role_id_15\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"user role\"},{\"sequencenumber\":179,\"key\":\"role_id_16\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"user role\"},{\"sequencenumber\":180,\"key\":\"role_id_17\",\"tenantterm\":\"submitting author\",\"frontiersdefaultterm\":\"submitting author\",\"category\":\"user role\"},{\"sequencenumber\":181,\"key\":\"role_id_18\",\"tenantterm\":\"co-author\",\"frontiersdefaultterm\":\"co-author\",\"category\":\"user role\"},{\"sequencenumber\":182,\"key\":\"role_id_20\",\"tenantterm\":\"production office\",\"frontiersdefaultterm\":\"production office\",\"category\":\"user role\"},{\"sequencenumber\":183,\"key\":\"role_id_22\",\"tenantterm\":\"typesetting office (typesetter)\",\"frontiersdefaultterm\":\"typesetting office (typesetter)\",\"category\":\"user role\"},{\"sequencenumber\":184,\"key\":\"role_id_24\",\"tenantterm\":\"registered user\",\"frontiersdefaultterm\":\"registered user\",\"category\":\"user role\"},{\"sequencenumber\":185,\"key\":\"role_id_35\",\"tenantterm\":\"job office\",\"frontiersdefaultterm\":\"job office\",\"category\":\"user role\"},{\"sequencenumber\":186,\"key\":\"role_id_41\",\"tenantterm\":\"special event administrator\",\"frontiersdefaultterm\":\"special event administrator\",\"category\":\"user role\"},{\"sequencenumber\":187,\"key\":\"role_id_42\",\"tenantterm\":\"special event reviewer\",\"frontiersdefaultterm\":\"special event reviewer\",\"category\":\"user role\"},{\"sequencenumber\":188,\"key\":\"role_id_43\",\"tenantterm\":\"submit abstract\",\"frontiersdefaultterm\":\"submit abstract\",\"category\":\"user role\"},{\"sequencenumber\":189,\"key\":\"role_id_52\",\"tenantterm\":\"events office\",\"frontiersdefaultterm\":\"events office\",\"category\":\"user role\"},{\"sequencenumber\":190,\"key\":\"role_id_53\",\"tenantterm\":\"event administrator\",\"frontiersdefaultterm\":\"event administrator\",\"category\":\"user role\"},{\"sequencenumber\":191,\"key\":\"role_id_89\",\"tenantterm\":\"content management office\",\"frontiersdefaultterm\":\"content management office\",\"category\":\"user role\"},{\"sequencenumber\":192,\"key\":\"role_id_98\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"user role\"},{\"sequencenumber\":193,\"key\":\"role_id_99\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":194,\"key\":\"role_id_103\",\"tenantterm\":\"configuration office\",\"frontiersdefaultterm\":\"configuration office\",\"category\":\"user role\"},{\"sequencenumber\":195,\"key\":\"role_id_104\",\"tenantterm\":\"beta user\",\"frontiersdefaultterm\":\"beta user\",\"category\":\"user role\"},{\"sequencenumber\":196,\"key\":\"role_id_106\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":197,\"key\":\"role_id_107\",\"tenantterm\":\"rt management beta user\",\"frontiersdefaultterm\":\"rt management beta user\",\"category\":\"user role\"},{\"sequencenumber\":198,\"key\":\"role_id_108\",\"tenantterm\":\"deo beta user\",\"frontiersdefaultterm\":\"deo beta user\",\"category\":\"user role\"},{\"sequencenumber\":199,\"key\":\"role_id_109\",\"tenantterm\":\"search beta user\",\"frontiersdefaultterm\":\"search beta user\",\"category\":\"user role\"},{\"sequencenumber\":200,\"key\":\"role_id_110\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"user role\"},{\"sequencenumber\":201,\"key\":\"role_id_111\",\"tenantterm\":\"myfrontiers beta user\",\"frontiersdefaultterm\":\"myfrontiers beta user\",\"category\":\"user role\"},{\"sequencenumber\":202,\"key\":\"role_id_21\",\"tenantterm\":\"copy editor\",\"frontiersdefaultterm\":\"copy editor\",\"category\":\"user role\"},{\"sequencenumber\":203,\"key\":\"role_id_1_abr\",\"tenantterm\":\"rof\",\"frontiersdefaultterm\":\"rof\",\"category\":\"user role\"},{\"sequencenumber\":204,\"key\":\"role_id_2_abr\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"user role\"},{\"sequencenumber\":205,\"key\":\"role_id_7_abr\",\"tenantterm\":\"fce\",\"frontiersdefaultterm\":\"fce\",\"category\":\"user role\"},{\"sequencenumber\":206,\"key\":\"role_id_8_abr\",\"tenantterm\":\"afce\",\"frontiersdefaultterm\":\"afce\",\"category\":\"user role\"},{\"sequencenumber\":207,\"key\":\"role_id_9_abr\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"category\":\"user role\"},{\"sequencenumber\":208,\"key\":\"role_id_10_abr\",\"tenantterm\":\"asce\",\"frontiersdefaultterm\":\"asce\",\"category\":\"user role\"},{\"sequencenumber\":209,\"key\":\"role_id_11_abr\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"category\":\"user role\"},{\"sequencenumber\":210,\"key\":\"role_id_12_abr\",\"tenantterm\":\"gae\",\"frontiersdefaultterm\":\"gae\",\"category\":\"user role\"},{\"sequencenumber\":211,\"key\":\"role_id_13_abr\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"category\":\"user role\"},{\"sequencenumber\":212,\"key\":\"role_id_14_abr\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"category\":\"user role\"},{\"sequencenumber\":213,\"key\":\"role_id_15_abr\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"category\":\"user role\"},{\"sequencenumber\":214,\"key\":\"role_id_16_abr\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"category\":\"user role\"},{\"sequencenumber\":215,\"key\":\"role_id_17_abr\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"category\":\"user role\"},{\"sequencenumber\":216,\"key\":\"role_id_18_abr\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"category\":\"user role\"},{\"sequencenumber\":217,\"key\":\"role_id_20_abr\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"user role\"},{\"sequencenumber\":218,\"key\":\"role_id_22_abr\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"category\":\"user role\"},{\"sequencenumber\":219,\"key\":\"role_id_24_abr\",\"tenantterm\":\"ru\",\"frontiersdefaultterm\":\"ru\",\"category\":\"user role\"},{\"sequencenumber\":220,\"key\":\"role_id_35_abr\",\"tenantterm\":\"jof\",\"frontiersdefaultterm\":\"jof\",\"category\":\"user role\"},{\"sequencenumber\":221,\"key\":\"role_id_41_abr\",\"tenantterm\":\"se-adm\",\"frontiersdefaultterm\":\"se-adm\",\"category\":\"user role\"},{\"sequencenumber\":222,\"key\":\"role_id_42_abr\",\"tenantterm\":\"se-rev\",\"frontiersdefaultterm\":\"se-rev\",\"category\":\"user role\"},{\"sequencenumber\":223,\"key\":\"role_id_43_abr\",\"tenantterm\":\"se-aut\",\"frontiersdefaultterm\":\"se-aut\",\"category\":\"user role\"},{\"sequencenumber\":224,\"key\":\"role_id_52_abr\",\"tenantterm\":\"evof\",\"frontiersdefaultterm\":\"evof\",\"category\":\"user role\"},{\"sequencenumber\":225,\"key\":\"role_id_53_abr\",\"tenantterm\":\"ev-adm\",\"frontiersdefaultterm\":\"ev-adm\",\"category\":\"user role\"},{\"sequencenumber\":226,\"key\":\"role_id_89_abr\",\"tenantterm\":\"comof\",\"frontiersdefaultterm\":\"comof\",\"category\":\"user role\"},{\"sequencenumber\":227,\"key\":\"role_id_98_abr\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"user role\"},{\"sequencenumber\":228,\"key\":\"role_id_99_abr\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":229,\"key\":\"role_id_103_abr\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"category\":\"user role\"},{\"sequencenumber\":230,\"key\":\"role_id_104_abr\",\"tenantterm\":\"beta\",\"frontiersdefaultterm\":\"beta\",\"category\":\"user role\"},{\"sequencenumber\":231,\"key\":\"role_id_106_abr\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":232,\"key\":\"role_id_107_abr\",\"tenantterm\":\"rtbeta\",\"frontiersdefaultterm\":\"rtbeta\",\"category\":\"user role\"},{\"sequencenumber\":233,\"key\":\"role_id_108_abr\",\"tenantterm\":\"deobeta\",\"frontiersdefaultterm\":\"deobeta\",\"category\":\"user role\"},{\"sequencenumber\":234,\"key\":\"role_id_109_abr\",\"tenantterm\":\"searchbeta\",\"frontiersdefaultterm\":\"searchbeta\",\"category\":\"user role\"},{\"sequencenumber\":235,\"key\":\"role_id_110_abr\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"category\":\"user role\"},{\"sequencenumber\":236,\"key\":\"role_id_111_abr\",\"tenantterm\":\"mfbeta\",\"frontiersdefaultterm\":\"mfbeta\",\"category\":\"user role\"},{\"sequencenumber\":237,\"key\":\"role_id_21_abr\",\"tenantterm\":\"coped\",\"frontiersdefaultterm\":\"coped\",\"category\":\"user role\"},{\"sequencenumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"this is the label for the review editorial board\",\"category\":\"label\"},{\"sequencenumber\":239,\"key\":\"field_chief_editor\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":240,\"key\":\"field_chief_editors\",\"tenantterm\":\"field chief editors\",\"frontiersdefaultterm\":\"field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":241,\"key\":\"editor\",\"tenantterm\":\"editor\",\"frontiersdefaultterm\":\"editor\",\"category\":\"label (role)\"},{\"sequencenumber\":242,\"key\":\"editors\",\"tenantterm\":\"editors\",\"frontiersdefaultterm\":\"editors\",\"category\":\"label (role)\"},{\"sequencenumber\":243,\"key\":\"board\",\"tenantterm\":\"board\",\"frontiersdefaultterm\":\"board\",\"category\":\"label\"},{\"sequencenumber\":244,\"key\":\"boards\",\"tenantterm\":\"boards\",\"frontiersdefaultterm\":\"boards\",\"category\":\"label\"},{\"sequencenumber\":245,\"key\":\"article_collection\",\"tenantterm\":\"article collection\",\"frontiersdefaultterm\":\"article collection\",\"category\":\"label\"},{\"sequencenumber\":246,\"key\":\"article_collections\",\"tenantterm\":\"article collections\",\"frontiersdefaultterm\":\"article collections\",\"category\":\"label\"},{\"sequencenumber\":247,\"key\":\"handling_editor\",\"tenantterm\":\"handling editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":248,\"key\":\"handling_editors\",\"tenantterm\":\"handling editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":249,\"key\":\"ae_accept\",\"tenantterm\":\"recommend acceptance\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":250,\"key\":\"rtm\",\"tenantterm\":\"rtm\",\"frontiersdefaultterm\":\"rtm\",\"category\":\"product\"},{\"sequencenumber\":251,\"key\":\"frontiers_media_sa\",\"tenantterm\":\"frontiers media s.a\",\"frontiersdefaultterm\":\"frontiers media s.a\",\"category\":\"customer\"},{\"sequencenumber\":252,\"key\":\"review_editors\",\"tenantterm\":\"community reviewers\",\"frontiersdefaultterm\":\"review editors\",\"category\":\"label (role)\"},{\"sequencenumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":255,\"key\":\"call_for_papers\",\"tenantterm\":\"call for papers\",\"frontiersdefaultterm\":\"call for papers\",\"category\":\"label\"},{\"sequencenumber\":256,\"key\":\"calls_for_papers\",\"tenantterm\":\"calls for papers\",\"frontiersdefaultterm\":\"calls for papers\",\"category\":\"label\"},{\"sequencenumber\":257,\"key\":\"supervising_editor\",\"tenantterm\":\"supervising editor\",\"frontiersdefaultterm\":\"supervising editor\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editor\"},{\"sequencenumber\":258,\"key\":\"supervising_editors\",\"tenantterm\":\"supervising editors\",\"frontiersdefaultterm\":\"supervising editors\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editors\"},{\"sequencenumber\":259,\"key\":\"reviewer_endorse\",\"tenantterm\":\"endorse\",\"frontiersdefaultterm\":\"endorse\",\"category\":\"label\"},{\"sequencenumber\":260,\"key\":\"reviewer_endorsed\",\"tenantterm\":\"endorsed\",\"frontiersdefaultterm\":\"endorsed\",\"category\":\"label\"},{\"sequencenumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantterm\":\"endorse publication\",\"frontiersdefaultterm\":\"endorse publication\",\"category\":\"label\"},{\"sequencenumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantterm\":\"endorsed publication\",\"frontiersdefaultterm\":\"endorsed publication\",\"category\":\"label\"},{\"sequencenumber\":263,\"key\":\"editor_role\",\"tenantterm\":\"editor role\",\"frontiersdefaultterm\":\"editor role\",\"category\":\"label\"},{\"sequencenumber\":264,\"key\":\"editor_roles\",\"tenantterm\":\"editor roles\",\"frontiersdefaultterm\":\"editor roles\",\"category\":\"label\"},{\"sequencenumber\":265,\"key\":\"editorial_role\",\"tenantterm\":\"editorial role\",\"frontiersdefaultterm\":\"editorial role\",\"category\":\"label\"},{\"sequencenumber\":266,\"key\":\"editorial_roles\",\"tenantterm\":\"editorial roles\",\"frontiersdefaultterm\":\"editorial roles\",\"category\":\"label\"},{\"sequencenumber\":267,\"key\":\"call_for_paper\",\"tenantterm\":\"call for paper\",\"frontiersdefaultterm\":\"call for paper\",\"category\":\"label\"},{\"sequencenumber\":268,\"key\":\"research_topic_abstract\",\"tenantterm\":\"manuscript summary\",\"frontiersdefaultterm\":\"manuscript summary\",\"category\":\"process\"},{\"sequencenumber\":269,\"key\":\"research_topic_abstracts\",\"tenantterm\":\"manuscript summaries\",\"frontiersdefaultterm\":\"manuscript summaries\",\"category\":\"process\"},{\"sequencenumber\":270,\"key\":\"submissions_team_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"content manager\",\"category\":\"process\"},{\"sequencenumber\":271,\"key\":\"submissions_team\",\"tenantterm\":\"journal team\",\"frontiersdefaultterm\":\"content team\",\"category\":\"process\"},{\"sequencenumber\":272,\"key\":\"topic_coordinator\",\"tenantterm\":\"topic coordinator\",\"frontiersdefaultterm\":\"topic coordinator\",\"category\":\"process\"},{\"sequencenumber\":273,\"key\":\"topic_coordinators\",\"tenantterm\":\"topic coordinators\",\"frontiersdefaultterm\":\"topic coordinators\",\"category\":\"process\"},{\"sequencenumber\":274,\"key\":\"frontiers_journal_team\",\"tenantterm\":\"frontiers journal team\",\"frontiersdefaultterm\":\"frontiers journal team\",\"category\":\"label (role)\"},{\"sequencenumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantterm\":\"rt:ic submission\",\"frontiersdefaultterm\":\"rt:ic submission\",\"category\":\"label (role)\"},{\"sequencenumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantterm\":\"rt:ic submission participant\",\"frontiersdefaultterm\":\"rt:ic submission participant\",\"category\":\"label (role)\"}]}'\n",impactgtmid:"gtm-njf2ml9b",impactgtmauth:"fyo-7nodm9w37qgfms03sa",impactgtmpreview:"env-1",impactgooglemapsapikey:"aizasyctehx2eu8pwfi86gw9fi00ftcykk6ifr8",qualtricsv4tov3:"'{\"enabled\":true,\"interceptid\":\"si_er0e2ze69oz8yn4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricsumux:"'{\"enabled\":false,\"interceptid\":\"si_89fphy3etxqbwtu\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricscontinuousbrand:"'{\"enabled\":true,\"interceptid\":\"si_9zut94ut81fcrh4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",defaultarticletemplate:"v3"},app:{baseurl:"/",buildid:"f2d5b6d8-d01c-4534-90b9-d659f10f17ca",buildassetsdir:"ap-2024/_nuxt",cdnurl:""}}## Discussion
of the reasons for the differences. statistical analysis statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student t -test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i 2 statistics, with p &#x202f;&#x0003c;&#x202f;0.10 and i 2 &#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it. results the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies ( 9 , 12 &#x2013; 14 ) were included, encompassing 139 patients from four rcts ( figure 1 ). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in table 1 . three studies had fluoxetine and one citalopram as the intervention group. figure 1 figure 1 . prisma flow diagram of study screening and selection. table 1 table 1 . baseline characteristics of included studies. all four studies ( 9 , 12 &#x2013; 14 ) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, p &#x202f;=&#x202f;0.0004, i 2 =&#x202f;23%, figure 2 ). only three studies ( 12 &#x2013; 14 ) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, p &#x202f;=&#x202f;0.76, i 2 =&#x202f;0%, figure 3a ) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, p &#x202f;=&#x202f;0.48, i 2 =&#x202f;0%, figure 3b ) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size. figure 2 figure 2 . visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo. figure 3 figure 3 . visual evoked potential (vep) did not improve with ssri. (a) p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. (b) p100 latency improvement was not statistically significantly different between the ssri and placebo group. all studies were evaluated as having a low risk of bias ( table 2 ). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial ( figure 4 ). table 2 table 2 . risk of bias summary for randomized studies. figure 4 figure 4 . funnel plot for visual acuity improvement. there is no publication bias. discussion this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency. current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants ( 9 , 12 &#x2013; 14 ) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic. ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation ( 18 ). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia ( 19 ). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye ( 19 ). in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit ( 20 ). donepezil showed an improvement of the va in an open-label pilot study ( 21 ). across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods ( 11 ). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment ( 12 , 13 ) whereas others did not ( 9 , 14 ). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans ( 22 ). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans ( 22 ). similarly, measuring of visual acuity in rodents and humans cannot be standardized ( 22 ). mitchell et al. ( 22 ) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans ( 22 ). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies ( 12 , 13 ) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes ( 23 ). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) ( 24 ) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials ( 25 &#x2013; 27 ). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba ( 28 ), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes. given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy ( 29 ), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven. heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings. to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature. other modalities of treatment are also currently under research. extended-reality (xr) devices ( 30 ), physical activity (cycling) ( 31 ) and more recently the occlusion of the amblyopic eye combined with physical activity ( 32 ) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects. in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial ( 16 ) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks. conclusion this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes. data availability statement the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author. author contributions es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology. funding the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\r1\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z). conflict of interest the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. the handling editor gp declared a shared parent affiliation with the author oa at the time of review. the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision. generative ai statement the authors declare that no gen ai was used in the creation of this manuscript. publisher&#x2019;s note all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. author disclaimer the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care. references 1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. front pediatr . (2022) 10:819998. doi: 10.3389/fped.2022.819998 pubmed abstract | crossref full text | google scholar 2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. rom j ophthalmol . (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 pubmed abstract | crossref full text | google scholar 3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. cereb cortex . (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 pubmed abstract | crossref full text | google scholar 4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. j neurosci . (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 pubmed abstract | crossref full text | google scholar 5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. eye . (1996) 10:250&#x2013;8. google scholar 6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. bmc ophthalmol . (2020) 20:203. doi: 10.1186/s12886-020-01442-9 pubmed abstract | crossref full text | google scholar 7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. optom vis sci . (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 pubmed abstract | crossref full text | google scholar 8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. curr biol . (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 pubmed abstract | crossref full text | google scholar 9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. sci rep . (2018) 8:12830. doi: 10.1038/s41598-018-31169-z pubmed abstract | crossref full text | google scholar 10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. j neurosci . (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 pubmed abstract | crossref full text | google scholar 11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. science . (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516 crossref full text | google scholar 12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. eye . (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z pubmed abstract | crossref full text | google scholar 13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. j aapos . (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 pubmed abstract | crossref full text | google scholar 14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. neural plast . (2019) 2019:5857243. doi: 10.1155/2019/5857243 crossref full text | google scholar 15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. bmj . (2009) 339:b2535. doi: 10.1136/bmj.b2535 pubmed abstract | crossref full text | google scholar 16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. bmj . (2019) 366:l4898. doi: 10.1136/bmj.l4898 pubmed abstract | crossref full text | google scholar 17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. bmj . (2011) 343:d5928. doi: 10.1136/bmj.d5928 pubmed abstract | crossref full text | google scholar 18. feighner, jp. mechanism of action of antidepressant medications. j clin psychiatry . (1999) 60:4&#x2013;11. google scholar 19. morishita, h, and hensch, tk. critical period revisited: impact on vision. curr opin neurobiol . (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 pubmed abstract | crossref full text | google scholar 20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. ophthalmology . (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 pubmed abstract | crossref full text | google scholar 21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. sci rep . (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 pubmed abstract | crossref full text | google scholar 22. mitchell, d, and sengpiel, f. animal models of amblyopia. vis neurosci . (2018) 35:e017. doi: 10.1017/s0952523817000244 pubmed abstract | crossref full text | google scholar 23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). doc ophthalmol . (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y pubmed abstract | crossref full text | google scholar 24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. brain struct funct . (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 pubmed abstract | crossref full text | google scholar 25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. imaging neurosci. (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 pubmed abstract | crossref full text | google scholar 26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. perception . (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 pubmed abstract | crossref full text | google scholar 27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. front hum neurosci . (2022) 16:949395. doi: 10.3389/fnhum.2022.949395 crossref full text | google scholar 28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: https://pubmed.ncbi.nlm.nih.gov/26004760/ google scholar 29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. strabismus . (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 pubmed abstract | crossref full text | google scholar 30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. j vis . (2023) 23:14. doi: 10.1167/jov.23.1.14 pubmed abstract | crossref full text | google scholar 31. lunghi, c, and sale, a. a cycling lane for brain rewiring. curr biol . (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 pubmed abstract | crossref full text | google scholar 32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. annal. clin. transl. neurol. (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 pubmed abstract | crossref full text | google scholar keywords: amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity citation: shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. front. neurol . 16:1639913. doi: 10.3389/fneur.2025.1639913 received: 03 june 2025; accepted: 31 july 2025; published: 21 august 2025. edited by: gordon plant , university college london, united kingdom reviewed by: sara samadzadeh , charit&#x00e9; university medicine berlin, germany alistair r. fielder , city university of london, united kingdom copyright &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the creative commons attribution license (cc by) . the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms. &#x0002a;correspondence: i. betina ip, ymv0aw5hlmlwqg5ky24ub3guywmudws= &#x2020; these authors share senior authorship disclaimer: all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher. download article download pdf readcube epub xml share on export citation endnote reference manager simple text file bibtex 1,812 total views 250 downloads citation numbers are available from dimensions view article impact view altmetric score share on edited by g p gordon plant reviewed by a r alistair r fielder s s sara samadzadeh table of contents abstract introduction methods results discussion conclusion data availability statement author contributions funding conflict of interest generative ai statement publisher&#x2019;s note author disclaimer references export citation endnote reference manager simple text file bibtex check for updates frontiers&#39; impact articles published with frontiers have received 12 million total citations your research is the real superpower - learn how we maximise its impact through our leading community journals explore our impact metrics supplementary material download article download download pdf readcube epub xml guidelines author guidelines services for authors policies and publication ethics editor guidelines fee policy explore articles research topics journals how we publish outreach frontiers forum frontiers policy labs frontiers for young minds frontiers planet prize connect help center emails and alerts contact us submit career opportunities follow us © 2025 frontiers media s.a. all rights reserved privacy policy | terms and conditions [["shallowreactive",1],{"data":2,"state":4,"once":10,"_errors":11,"serverrendered":13,"path":14,"pinia":15},["shallowreactive",3],{},["reactive",5],{"$ssite-config":6},{"env":7,"name":8,"url":9},"production","frontiers articles","https://article-pages-2024.frontiersin.org/",["set"],["shallowreactive",12],{},true,"/journals/neurology/articles/10.3389/fneur.2025.1639913/full",["reactive",16],{"main":17,"user":579,"article":580,"articlehub":881,"mainheader":885},{"ibar":18,"footer":296,"newslettercomponent":-1,"snackbaritem":378,"toggleshowsnackbar":379,"contentfuljournal":380,"graphjournal":480,"settingsfeaturesswitchers":484,"templatetogglebanner":485,"tenantconfig":544},{"tenantlogo":19,"journallogo":19,"aboutus":20,"submiturl":113,"showsubmitbutton":13,"journal":114,"sectionterm":227,"aboutjournal":228,"mainlinks":277,"journallinks":284,"helpcenterlink":293},"",[21,38,47,71,87],{"title":22,"links":23},"who we are",[24,29,32,35],{"text":25,"url":26,"target":27,"arialabel":28},"mission and values","https://www.frontiersin.org/about/mission","_self",null,{"text":30,"url":31,"target":27,"arialabel":28},"history","https://www.frontiersin.org/about/history",{"text":33,"url":34,"target":27,"arialabel":28},"leadership","https://www.frontiersin.org/about/leadership",{"text":36,"url":37,"target":27,"arialabel":28},"awards","https://www.frontiersin.org/about/awards",{"title":39,"links":40},"impact and progress",[41,44],{"text":42,"url":43,"target":27,"arialabel":28},"frontiers' impact","https://www.frontiersin.org/about/impact",{"text":45,"url":46,"target":27,"arialabel":28},"our annual reports","https://www.frontiersin.org/about/annual-reports",{"title":48,"links":49},"publishing model",[50,53,56,59,62,65,68],{"text":51,"url":52,"target":27,"arialabel":28},"how we publish","https://www.frontiersin.org/about/how-we-publish",{"text":54,"url":55,"target":27,"arialabel":28},"open access","https://www.frontiersin.org/about/open-access",{"text":57,"url":58,"target":27,"arialabel":28},"peer review","https://www.frontiersin.org/about/peer-review",{"text":60,"url":61,"target":27,"arialabel":28},"research integrity","https://www.frontiersin.org/about/research-integrity",{"text":63,"url":64,"target":27,"arialabel":28},"research topics","https://www.frontiersin.org/about/research-topics",{"text":66,"url":67,"target":27,"arialabel":28},"fair² data management","https://www.frontiersin.org/about/fair-data-management",{"text":69,"url":70,"target":27,"arialabel":28},"fee policy","https://www.frontiersin.org/about/fee-policy",{"title":72,"links":73},"services",[74,78,81,84],{"text":75,"url":76,"target":77,"arialabel":28},"societies","https://publishingpartnerships.frontiersin.org/","_blank",{"text":79,"url":80,"target":27,"arialabel":28},"national consortia","https://www.frontiersin.org/open-access-agreements/consortia",{"text":82,"url":83,"target":27,"arialabel":28},"institutional partnerships","https://www.frontiersin.org/about/open-access-agreements",{"text":85,"url":86,"target":27,"arialabel":28},"collaborators","https://www.frontiersin.org/about/collaborators",{"title":88,"links":89},"more from frontiers",[90,94,97,101,105,109],{"text":91,"url":92,"target":77,"arialabel":93},"frontiers forum","https://forum.frontiersin.org/","this link will take you to the frontiers forum website",{"text":95,"url":96,"target":27,"arialabel":28},"frontiers planet prize","https://www.frontiersin.org/about/frontiers-planet-prize",{"text":98,"url":99,"target":77,"arialabel":100},"press office","https://pressoffice.frontiersin.org/","this link will take you to the frontiers press office website",{"text":102,"url":103,"target":27,"arialabel":104},"sustainability","https://www.frontiersin.org/about/sustainability","link to information about frontiers' sustainability",{"text":106,"url":107,"target":77,"arialabel":108},"career opportunities","https://careers.frontiersin.org/","this link will take you to the frontiers careers website",{"text":110,"url":111,"target":27,"arialabel":112},"contact us","https://www.frontiersin.org/about/contact","this link will take you to the help pages to contact our support team","https://www.frontiersin.org/submission/submit?domainid=2&fieldid=54&specialtyid=0&entitytype=2&entityid=141",{"id":115,"name":116,"slug":117,"sections":118},141,"frontiers in neurology","neurology",[119,123,127,131,135,139,143,147,151,155,159,163,167,171,175,179,183,187,191,195,199,203,207,211,215,219,223],{"id":120,"name":121,"slug":122},156,"applied neuroimaging","applied-neuroimaging",{"id":124,"name":125,"slug":126},3712,"artificial intelligence in neurology","artificial-intelligence-in-neurology",{"id":128,"name":129,"slug":130},3023,"autonomic disorders","autonomic-disorders",{"id":132,"name":133,"slug":134},3740,"cognitive and behavioral neurology","cognitive-and-behavioral-neurology",{"id":136,"name":137,"slug":138},1439,"dementia and neurodegenerative diseases","dementia-and-neurodegenerative-diseases",{"id":140,"name":141,"slug":142},2038,"diagnostic neuropathology","diagnostic-neuropathology",{"id":144,"name":145,"slug":146},143,"endovascular and interventional neurology","endovascular-and-interventional-neurology",{"id":148,"name":149,"slug":150},144,"epilepsy","epilepsy",{"id":152,"name":153,"slug":154},1784,"experimental therapeutics","experimental-therapeutics",{"id":156,"name":157,"slug":158},153,"headache and neurogenic pain","headache-and-neurogenic-pain",{"id":160,"name":161,"slug":162},145,"movement disorders","movement-disorders",{"id":164,"name":165,"slug":166},147,"multiple sclerosis and neuroimmunology","multiple-sclerosis-and-neuroimmunology",{"id":168,"name":169,"slug":170},150,"neuro-oncology and neurosurgical oncology","neuro-oncology-and-neurosurgical-oncology",{"id":172,"name":173,"slug":174},154,"neuro-ophthalmology","neuro-ophthalmology",{"id":176,"name":177,"slug":178},155,"neuro-otology","neuro-otology",{"id":180,"name":181,"slug":182},159,"neurocritical and neurohospitalist care","neurocritical-and-neurohospitalist-care",{"id":184,"name":185,"slug":186},1339,"neuroepidemiology","neuroepidemiology",{"id":188,"name":189,"slug":190},160,"neurogenetics","neurogenetics",{"id":192,"name":193,"slug":194},1334,"neuroinfectious diseases","neuroinfectious-diseases",{"id":196,"name":197,"slug":198},2345,"neurological biomarkers","neurological-biomarkers",{"id":200,"name":201,"slug":202},146,"neuromuscular disorders and peripheral neuropathies","neuromuscular-disorders-and-peripheral-neuropathies",{"id":204,"name":205,"slug":206},547,"neurorehabilitation","neurorehabilitation",{"id":208,"name":209,"slug":210},3418,"neurotechnology","neurotechnology",{"id":212,"name":213,"slug":214},163,"neurotrauma","neurotrauma",{"id":216,"name":217,"slug":218},161,"pediatric neurology","pediatric-neurology",{"id":220,"name":221,"slug":222},151,"sleep disorders","sleep-disorders",{"id":224,"name":225,"slug":226},142,"stroke","stroke","sections",[229,253],{"title":230,"links":231},"scope",[232,235,238,241,244,247,250],{"text":233,"url":234,"target":27,"arialabel":28},"field chief editors","https://www.frontiersin.org/journals/neurology/about#about-editors",{"text":236,"url":237,"target":27,"arialabel":28},"mission & scope","https://www.frontiersin.org/journals/neurology/about#about-scope",{"text":239,"url":240,"target":27,"arialabel":28},"facts","https://www.frontiersin.org/journals/neurology/about#about-facts",{"text":242,"url":243,"target":27,"arialabel":28},"journal sections","https://www.frontiersin.org/journals/neurology/about#about-submission",{"text":245,"url":246,"target":27,"arialabel":28},"open access statement","https://www.frontiersin.org/journals/neurology/about#about-open",{"text":248,"url":249,"target":27,"arialabel":28},"copyright statement","https://www.frontiersin.org/journals/neurology/about#copyright-statement",{"text":251,"url":252,"target":27,"arialabel":28},"quality","https://www.frontiersin.org/journals/neurology/about#about-quality",{"title":254,"links":255},"for authors",[256,259,262,265,268,271,274],{"text":257,"url":258,"target":27,"arialabel":28},"why submit?","https://www.frontiersin.org/journals/neurology/for-authors/why-submit",{"text":260,"url":261,"target":27,"arialabel":28},"article types","https://www.frontiersin.org/journals/neurology/for-authors/article-types",{"text":263,"url":264,"target":27,"arialabel":28},"author guidelines","https://www.frontiersin.org/journals/neurology/for-authors/author-guidelines",{"text":266,"url":267,"target":27,"arialabel":28},"editor guidelines","https://www.frontiersin.org/journals/neurology/for-authors/editor-guidelines",{"text":269,"url":270,"target":27,"arialabel":28},"publishing fees","https://www.frontiersin.org/journals/neurology/for-authors/publishing-fees",{"text":272,"url":273,"target":27,"arialabel":28},"submission checklist","https://www.frontiersin.org/journals/neurology/for-authors/submission-checklist",{"text":275,"url":276,"target":27,"arialabel":28},"contact editorial office","https://www.frontiersin.org/journals/neurology/for-authors/contact-editorial-office",[278,281],{"text":279,"url":280,"target":27,"arialabel":28},"all journals","https://www.frontiersin.org/journals",{"text":282,"url":283,"target":27,"arialabel":28},"all articles","https://www.frontiersin.org/articles",[285,288,290],{"text":286,"url":287,"target":27,"arialabel":28},"articles","articles",{"text":63,"url":289,"target":27,"arialabel":28},"research-topics",{"text":291,"url":292,"target":27,"arialabel":28},"editorial board","editors",{"text":294,"url":295,"target":77,"arialabel":294},"help center","https://helpcenter.frontiersin.org",{"blocks":297,"sociallinks":351,"copyright":375,"termsandconditionsurl":376,"privacypolicyurl":377},[298,312,322,336],{"title":299,"links":300},"guidelines",[301,303,306,309,311],{"text":263,"url":302,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/author-guidelines",{"text":304,"url":305,"target":27,"arialabel":28},"services for authors","https://www.frontiersin.org/for-authors/author-services",{"text":307,"url":308,"target":27,"arialabel":28},"policies and publication ethics","https://www.frontiersin.org/guidelines/policies-and-publication-ethics",{"text":266,"url":310,"target":27,"arialabel":28},"https://www.frontiersin.org/guidelines/editor-guidelines",{"text":69,"url":70,"target":27,"arialabel":28},{"title":313,"links":314},"explore",[315,316,319,321],{"text":286,"url":283,"target":27,"arialabel":28},{"text":317,"url":318,"target":27,"arialabel":28},"research topics ","https://www.frontiersin.org/research-topics",{"text":320,"url":280,"target":27,"arialabel":28},"journals",{"text":51,"url":52,"target":27,"arialabel":28},{"title":323,"links":324},"outreach",[325,328,331,335],{"text":326,"url":92,"target":77,"arialabel":327},"frontiers forum ","frontiers forum website",{"text":329,"url":330,"target":77,"arialabel":28},"frontiers policy labs ","https://policylabs.frontiersin.org/",{"text":332,"url":333,"target":77,"arialabel":334},"frontiers for young minds","https://kids.frontiersin.org/","frontiers for young minds journal",{"text":95,"url":96,"target":27,"arialabel":28},{"title":337,"links":338},"connect",[339,340,344,347,350],{"text":294,"url":295,"target":77,"arialabel":294},{"text":341,"url":342,"target":77,"arialabel":343},"emails and alerts ","https://subscription-management.frontiersin.org/emails/preferences#block0","subscribe to frontiers emails",{"text":345,"url":111,"target":27,"arialabel":346},"contact us ","subscribe to newsletter",{"text":348,"url":349,"target":27,"arialabel":28},"submit","https://www.frontiersin.org/submission/submit",{"text":106,"url":107,"target":77,"arialabel":28},[352,360,365,370],{"link":353,"type":356,"color":357,"icon":358,"size":359,"hiddentext":13},{"text":354,"url":355,"target":77,"arialabel":354},"frontiers facebook","https://www.facebook.com/frontiersin","link","grey","facebook","medium",{"link":361,"type":356,"color":357,"icon":364,"size":359,"hiddentext":13},{"text":362,"url":363,"target":77,"arialabel":28},"frontiers twitter","https://twitter.com/frontiersin","twitter",{"link":366,"type":356,"color":357,"icon":369,"size":359,"hiddentext":13},{"text":367,"url":368,"target":77,"arialabel":28},"frontiers linkedin","https://www.linkedin.com/company/frontiers","linkedin",{"link":371,"type":356,"color":357,"icon":374,"size":359,"hiddentext":13},{"text":372,"url":373,"target":77,"arialabel":28},"frontiers instagram","https://www.instagram.com/frontiersin_","instagram","frontiers media s.a. all rights reserved","https://www.frontiersin.org/legal/terms-and-conditions","https://www.frontiersin.org/legal/privacy-policy",{},false,{"__typename":381,"identifier":115,"name":116,"slug":117,"banner":382,"description":473,"mission":474,"palette":475,"impactfactor":476,"citescore":477,"citations":478,"showtagline":28,"twitter":479},"journal",[383],{"id":384,"src":385,"name":386,"tags":387,"type":432,"width":433,"height":434,"idhash":435,"archive":436,"brandid":437,"limited":436,"filesize":438,"ispublic":439,"original":440,"copyright":19,"extension":441,"thumbnails":443,"datecreated":451,"description":452,"orientation":453,"usercreated":454,"watermarked":436,"datemodified":451,"datepublished":455,"ecsarchivefiles":456,"propertyoptions":457,"property_channel":462,"property_sub-type":464,"property_asset_type":466,"activeoriginalfocuspoint":468,"property_office_department":471},"d315adb2-2967-48b6-be3b61009343d69e","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/webimage-810a1e19-163c-4fd0-bfd3d50a4721b642.png","fneur_main visual_cyan_website",[388,389,390,391,392,393,394,395,396,397,398,399,400,401,402,403,404,405,406,407,408,409,410,411,412,413,414,415,416,417,418,419,420,421,422,423,424,425,426,427,428,429,117,430,431],"professional","device","medical","close up","technology","wires","brain waves","record","digital","selective focus","laboratory","brain","health","electrodes","computer","examination","electroencephalography","scan","study","oncology","examine","electroencephalogram","neurosurgery","science","doctor","diagnose","magnetic","patient","modern","electroencephalograph","equipment","office","healthcare","scanning","instrument","eeg","hospital","ct","technician","medicine","ultrasound","radiology","diagnostic","lab","image",5052,3368,"62463d527f6ddd4d",0,"22c10171-81b3-4da6-99342f272a32e8bb",5758943,1,"https://brand.frontiersin.org/m/62463d527f6ddd4d/original/fneur_main-visual_cyan_website.jpg",[442],"jpg",{"mini":444,"thul":445,"webimage":385,"guidelines":446,"websitejpg_xl":447,"websitewebp_l":448,"websitewebp_m":449,"websitewebp_xl":450},"https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/mini-a927c1b7-02f8-4d29-94320f509270457d.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/thul-fcd9f16d-d1a9-4535-a7e4c140224266b9.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/guidelines-fneur_main visual_cyan_website.png","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitejpg_xl-fneur_main visual_cyan_website.jpg","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_l-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_m-fneur_main visual_cyan_website.webp","https://d2csxpduxe849s.cloudfront.net/media/e32629c6-9347-4f84-81feaef7bfa342b3/d315adb2-2967-48b6-be3b61009343d69e/84855035-8c7e-4727-ab7cec390287243c/websitewebp_xl-fneur_main visual_cyan_website.webp","2022-06-27t10:00:23z","charming young woman undergoing electroencephalography; shutterstock id 695951221; purchase_order: main visual; job: ; client: ; other:","landscape","caroline sutter","2022-06-27t06:08:46z",[],[458,459,460,461],"414fb2d4-2283-43fd-be14e534eca67928","6c18119b-14bd-4951-b437696f4357bd33","7c692885-db25-4858-b1fb4ff47b241e9b","d88c0047-ec30-4506-a7df28a4d765e1cf",[463],"frontiersin_org",[465],"main_visual",[467],"photography",{"x":469,"y":470},2526,1684,[472],"publishing","the world's most cited clinical neurology journal, exploring the diagnosis, causes, treatment, and public health aspects of neurological illnesses to improve patient care.","\u003cp>frontiers in neurology is a multidisciplinary journal that addresses all areas of neurology to better understand, treat, and prevent neurological disorders. it is indexed in pubmed central (pmc), scopus, and the doaj.\u003c/p>\n\n\u003cp>led by field chief editor prof. irene litvan (university of california, san diego, usa), frontiers in neurology welcomes submissions that explore the diagnosis, nature, causes, treatment, and public health aspects of neurological disorders.\u003c/p>\n\n\u003cp>the journal covers a wide spectrum of basic, translational, and clinical research that help improve patient care, including but not limited to:\u003c/p>\n\n\u003cul>\n \u003cli>artificial intelligence in neurology\u003c/li>\n \u003cli>applied neuroimaging\u003c/li>\n \u003cli>autonomic disorders\u003c/li>\n \u003cli>cognitive behavioural neurology\u003c/li>\n \u003cli>dementia and neurodegenerative diseases\u003c/li>\n \u003cli>diagnostic and forensic neuropathology\u003c/li>\n \u003cli>endovascular and interventional neurology\u003c/li>\n \u003cli>epilepsy\u003c/li>\n \u003cli>experimental therapeutics\u003c/li>\n \u003cli>headache and neurogenic pain\u003c/li>\n \u003cli>movement disorders\u003c/li>\n \u003cli>multiple sclerosis and neuroimmunology\u003c/li>\n \u003cli>neuro-oncology and neurosurgical oncology\u003c/li>\n \u003cli>neuro-ophthalmology\u003c/li>\n \u003cli>neuro-otology\u003c/li>\n \u003cli>neurocritical and neurohospitalist care\u003c/li>\n \u003cli>neuroepidemiology\u003c/li>\n \u003cli>neurogenetics\u003c/li>\n \u003cli>neuroinfectious diseases\u003c/li>\n \u003cli>neurological biomarkers\u003c/li>\n \u003cli>neuromuscular disorders and peripheral neuropathies\u003c/li>\n \u003cli>neurorehabilitation\u003c/li>\n \u003cli>neurotechnology\u003c/li>\n \u003cli>neurotrauma\u003c/li>\n \u003cli>pediatric neurology\u003c/li>\n \u003cli>sleep disorders\u003c/li>\n \u003cli>stroke\u003c/li>\n\u003c/ul>\n\n\u003cp>in particular, the journal welcomes submissions that support and advance the un’s \u003ca href=https://globalgoals.org/goals/>sustainable development goals\u003c/a> (sdgs), notably \u003ca href=https://globalgoals.org/goals/3-good-health-and-well-being/>sdg 3: good health and well-being\u003c/a>.\u003c/p>\n\n\u003cp>manuscripts that focus solely on surgical techniques, clinical trials, or case reports are not suitable for publication in this journal. studies that do not provide significant insight into the neurological basis of disease or disorder, or those that do not contribute to the understanding of the fundamental mechanisms of neurology, diagnosis and treatment of neurological disorders are not appropriate for this journal.\u003c/p>\n\n\u003cp>the journal no longer accepts papers concerning simple bibliometric studies. authors are still welcome to submit systematic reviews using publicly available data, but these must adhere to the \u003ca href=https://www.prisma-statement.org/>prisma guidelines\u003c/a> and have a conclusion related to neurological research. studies without this primary focus will be transferred to a more applicable journal.\u003c/p>\n\n\u003cp>frontiers’ journals require that manuscripts primarily comprising computational studies of public data, such as nhanes or mendelian randomization studies, must include appropriate validation. please refer to the \u003ca href=\"https://www.frontiersin.org/guidelines/policies-and-publication-ethics#standards-for-research-methodology:~:text=complaints%20and%20allegations.-,standards%20for%20research%20methodology,-experiments\">frontiers standards for research methodology policy\u003c/a> for more information. manuscripts not adhering to these standards will not be considered.\u003cp>\n\n\u003cp>frontiers in neurology is committed to advancing developments in the field of neurology by communicating scientific knowledge to researchers, academics, clinicians and the public worldwide, to enable the scientific breakthroughs of the future.\u003c/p>","cyan","3.4","4.8","273537","@frontneurol",{"id":115,"name":116,"slug":117,"abbreviation":481,"isonline":13,"isopenforsubmissions":13,"citescore":482,"impactfactor":483},"fneur",5.2,2.8,{"displaytitlepilllabels":13,"displayrelatedarticlesbox":13,"showeditors":13,"showreviewers":13,"showloopimpactlink":13,"enablefigshare":379,"usexmlimages":13},{"ispublic":13,"allowcompanyusers":379,"whitelistemails":486,"enablealljournals":13,"whitelistjournals":508},[487,488,489,490,491,492,493,494,495,492,496,497,498,499,500,501,502,503,504,505,506,507],"y2fybg9zlmxvcmnhqgzyb250awvyc2lulm9yzw==","zgfuawvslmx1ekbmcm9udgllcnnpbi5vcmc=","bgf1cmeudgvuyubmcm9udgllcnnpbi5vcmc=","cmfmywvslnjpyw5jag9aznjvbnrpzxjzaw4ub3jn","amftzxmuc21hbgxib25lqgzyb250awvyc2lulm9yzw==","znjhbi5tb3jlbm9aznjvbnrpzxjzaw4ub3jn","c2ftdwvslmzlcm5hbmrlekbmcm9udgllcnnpbi5vcmc=","ymfyymfyys5jyxjjyw5naxvaznjvbnrpzxjzaw4ub3jn","axzhbi5zyw50yw1hcmlhqgzyb250awvyc2lulm9yzw==","ahvllnryyw5aznjvbnrpzxjzaw4ub3jn","z29uy2fsby52yxjnyxnaznjvbnrpzxjzaw4ub3jn","bhvjawuuc2vubkbmcm9udgllcnnpbi5vcmc=","bg9ybi5mcmfzzxjaznjvbnrpzxjzaw4ub3jn","zwxzys5jyxjyb25aznjvbnrpzxjzaw4ub3jn","bwfhcnrlbi52yw5kawpja0bmcm9udgllcnnpbi5vcmc=","ymluzgh1lmtyaxnobmfuqgzyb250awvyc2lulm9yzw==","bwf0dghldy5hdhr3yxrlcnnaznjvbnrpzxjzaw4ub3jn","z2l1bglhlnzhbhnly2noaubmcm9udgllcnnpbi5vcmc=","zmfiawfulmrlbgxhbw9ydgvaznjvbnrpzxjzaw4ub3jn","dmlqyxlhbi5wcebwaxrzb2x1dglvbnmuy29t","z3vpbgxhdw1llnnldxjhdebmcm9udgllcnnpbi5vcmc=",[509,510,511,512,513,514,439,515,516,517,518,519,520,521,522,523,524,525,526,527,528,529,115,530,531,532,533,534,535,536,537,538,539,540,541,542,543],2232,1729,2357,2456,2176,2333,1843,602,106,616,310,657,3123,1468,2137,628,1566,2726,2086,1490,451,1335,2655,1238,604,698,1547,176,1440,403,1239,755,2136,609,1534,{"spaceid":439,"name":439,"availablejournalpages":545,"announcement":549},[287,292,289,546,547,548],"volumes","about","community-reviewers",{"__typename":550,"sys":551,"preheader":42,"title":553,"description":554,"image":555,"link":577},"announcement",{"id":552},"5ittnttqgazppgh6rx0alm","articles published with frontiers have received 12 million total citations","your research is the real superpower - learn how we maximise its impact through our leading community journals",[556],{"archive":436,"brandid":437,"copyright":28,"datecreated":557,"datemodified":558,"datepublished":559,"description":28,"extension":560,"filesize":562,"height":563,"id":564,"ispublic":436,"limited":436,"name":565,"orientation":453,"original":28,"thumbnails":566,"type":432,"watermarked":436,"width":573,"videopreviewurls":574,"tags":575,"textmetaproperties":576,"src":567},"2025-06-18t12:58:01z","2025-06-18t14:15:34z","2025-06-18t12:57:32z",[561],"png",1365026,920,"7c5269c4-3c83-4591-951a74d15b95daea","impact metrics banner for article pages",{"webimage":567,"thul":568,"mini":569,"websitewebp_l":570,"websitewebp_m":571,"guidelines":572},"https://brand.frontiersin.org/m/59ee6275cb9a849c/webimage-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/thul-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/m/59ee6275cb9a849c/mini-impact-metrics-banner-for-article-pages.png","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_l/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/websitewebp_m/impact-metrics-banner-for-article-pages.webp","https://brand.frontiersin.org/asset/7c5269c4-3c83-4591-951a-74d15b95daea/guidelines/impact-metrics-banner-for-article-pages.png",1600,[],[],[],{"text":578,"url":43,"target":27,"arialabel":28},"explore our impact metrics",{"loggeduserinfo":-1},{"currentarticle":581,"ispreviewpage":379,"hassupplementaldata":379,"showcrossmarkwidget":13,"articletemplate":738,"currentarticlepagemetainfo":739,"xmlparsedarticlecontent":-1,"xmlparsingerror":-1},{"id":582,"doi":583,"title":584,"acceptancedate":585,"receptiondate":586,"publicationdate":587,"lastmodifieddate":588,"ispublished":13,"abstract":589,"researchtopic":590,"articletype":596,"stage":599,"keywords":601,"authors":609,"editors":675,"reviewers":683,"journal":699,"section":707,"impactmetrics":709,"volume":712,"articlevolume":713,"relatedarticles":714,"ispublishedv2":13,"contents":715,"files":718},1639913,"10.3389/fneur.2025.1639913","selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials","2025-07-31t18:15:51.000z","2025-06-03t00:38:20.000z","2025-08-21t00:00:00.000z","2025-10-21t02:26:11.259z","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.methodswe systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i2 statistics.resultsfour rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04–0.14, p = 0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.conclusionwhile ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.systematic review registrationcrd42025633077, https://www.crd.york.ac.uk/prospero/view/crd42025633077.",{"id":591,"title":592,"articlescount":593,"ismagazinepage":379,"slug":594,"isopenforsubmission":13,"views":595},61549,"advances in understanding visual disorders linked to cortical dysfunction",10,"advances-in-understanding-visual-disorders-linked-to-cortical-dysfunction",15702,{"id":597,"name":598},136,"systematic review",{"id":600,"name":19},18,[602,603,604,605,606,607,608],"strabismus","neuroplasticity","amblyopia","fluoxetine","ssris","anisometropia","citalopram",[610,619,627,636,645,652,660,668],{"id":611,"firstname":612,"middlename":19,"lastname":613,"givennames":614,"iscorresponding":379,"isprofilepublic":13,"userid":611,"email":-1,"affiliations":615},3083093,"ehtesham","shamsher","ehtesham ",[616],{"organizationname":617,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust","united kingdom",{"id":436,"firstname":620,"middlename":19,"lastname":621,"givennames":622,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":623},"luisa","saccaro","luisa ",[624],{"organizationname":625,"countryname":626,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, universidade de mogi das cruzes","brazil",{"id":628,"firstname":629,"middlename":19,"lastname":630,"givennames":631,"iscorresponding":379,"isprofilepublic":13,"userid":628,"email":-1,"affiliations":632},3089392,"victor barreiros","pungirum","victor barreiros ",[633],{"organizationname":634,"countryname":635,"cityname":19,"statename":19,"zipcode":19},"faculty of medical sciences, university of buenos aires","argentina",{"id":637,"firstname":638,"middlename":19,"lastname":639,"givennames":640,"iscorresponding":379,"isprofilepublic":13,"userid":637,"email":-1,"affiliations":641},3162299,"nghi bao","tran","nghi bao ",[642],{"organizationname":643,"countryname":644,"cityname":19,"statename":19,"zipcode":19},"faculty of medicine, university of debrecen","hungary",{"id":436,"firstname":646,"middlename":19,"lastname":647,"givennames":648,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":649},"omar a. h. a.","alghaith","omar a. h. a. ",[650],{"organizationname":651,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"institute of ophthalmology, university college london",{"id":436,"firstname":653,"middlename":19,"lastname":654,"givennames":655,"iscorresponding":379,"isprofilepublic":379,"userid":436,"email":-1,"affiliations":656},"fatemeh","khabazianzadeh","fatemeh ",[657],{"organizationname":658,"countryname":659,"cityname":19,"statename":19,"zipcode":19},"eye research center, khatam-al-anbia hospital, mashad university of medical sciences","iran",{"id":661,"firstname":662,"middlename":19,"lastname":663,"givennames":664,"iscorresponding":379,"isprofilepublic":13,"userid":661,"email":-1,"affiliations":665},30975,"holly","bridge","holly ",[666],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},"nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging",{"id":669,"firstname":670,"middlename":19,"lastname":671,"givennames":672,"iscorresponding":379,"isprofilepublic":13,"userid":669,"email":-1,"affiliations":673},318592,"i. betina","ip","i. betina ",[674],{"organizationname":667,"countryname":618,"cityname":19,"statename":19,"zipcode":19},[676],{"id":677,"firstname":678,"middlename":19,"lastname":679,"givennames":680,"iscorresponding":379,"isprofilepublic":13,"userid":677,"email":-1,"affiliations":681},2271562,"gordon","plant","gordon ",[682],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},[684,692],{"id":685,"firstname":686,"middlename":687,"lastname":688,"givennames":689,"iscorresponding":379,"isprofilepublic":13,"userid":685,"email":-1,"affiliations":690},870962,"alistair","r","fielder","alistair r",[691],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":693,"firstname":694,"middlename":19,"lastname":695,"givennames":696,"iscorresponding":379,"isprofilepublic":13,"userid":693,"email":-1,"affiliations":697},1863925,"sara","samadzadeh","sara ",[698],{"organizationname":19,"countryname":19,"cityname":19,"statename":19,"zipcode":19},{"id":115,"slug":117,"name":116,"shortname":700,"electronicissn":701,"field":702,"specialtyid":28,"journalsectionpaths":705},"front. neurol.","1664-2295",{"id":703,"domainid":704},54,2,[706],{"section":707},{"id":172,"name":173,"slug":174,"specialtyid":708},758,{"views":710,"downloads":711,"citations":436},1812,250,16,"volume 16 - 2025",[],{"titlehtml":584,"fulltexthtml":716,"menuhtml":717},"\u003cdiv class=\"journalabstract\"> \u003ca id=\"h1\" name=\"h1\">\u003c/a>\n \u003cdiv class=\"authors\">\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3083093\" class=\"user-id-3083093\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3083093/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"ehtesham shamsher\">ehtesham shamsher\u003c/a>\u003csup>1\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"luisa saccaro\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">luisa saccaro\u003csup>2\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3089392\" class=\"user-id-3089392\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3089392/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"victor barreiros pungirum\">victor barreiros pungirum\u003c/a>\u003csup>3\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/3162299\" class=\"user-id-3162299\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/3162299/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"nghi bao tran\">nghi bao tran\u003c/a>\u003csup>4\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"omar a. h. a. alghaith\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">omar a. h. a. alghaith\u003csup>5\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/cdn/images/profile/default_32.jpg\" alt=\"fatemeh khabazianzadeh\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\">fatemeh khabazianzadeh\u003csup>6\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/30975\" class=\"user-id-30975\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/30975/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"holly bridge&#x;\">holly bridge\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003cspan class=\"author-wrapper notranslate\">\u003ca href=\"https://loop.frontiersin.org/people/318592\" class=\"user-id-318592\">\u003cimg class=\"pr5\" src=\"https://loop.frontiersin.org/images/profile/318592/74\" onerror=\"this.onerror=null;this.src='https://loop.frontiersin.org/cdn/images/profile/default_32.jpg';\" alt=\"i. betina ip&#xa;&#x;\">i. betina ip\u003c/a>\u003csup>7\u003c/sup>\u003csup>&#x0002a;\u003c/sup>\u003csup>&#x2020;\u003c/sup>\u003c/span>\u003c/div> \u003cul class=\"notes\"> \u003cli>\u003cspan>\u003csup>1\u003c/sup>\u003c/span>oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, oxford, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>2\u003c/sup>\u003c/span>faculty of medicine, universidade de mogi das cruzes, mogi das cruzes, brazil\u003c/li> \u003cli>\u003cspan>\u003csup>3\u003c/sup>\u003c/span>faculty of medical sciences, university of buenos aires, buenos aires, argentina\u003c/li> \u003cli>\u003cspan>\u003csup>4\u003c/sup>\u003c/span>faculty of medicine, university of debrecen, debrecen, hungary\u003c/li> \u003cli>\u003cspan>\u003csup>5\u003c/sup>\u003c/span>institute of ophthalmology, university college london, london, united kingdom\u003c/li> \u003cli>\u003cspan>\u003csup>6\u003c/sup>\u003c/span>eye research center, khatam-al-anbia hospital, mashad university of medical sciences, mashhad, iran\u003c/li> \u003cli>\u003cspan>\u003csup>7\u003c/sup>\u003c/span>nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, oxford, united kingdom\u003c/li> \u003c/ul>\n\u003cp class=\"mb15\">\u003cb>introduction:\u003c/b> amblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in early childhood. after early childhood, efficacy of occlusion therapy is limited due to a reduction in neuronal plasticity, and no mainstay clinical treatment is available. selective serotonin reuptake inhibitors (ssris) have been hypothesized to enhance neuroplasticity in the adult brain, thereby facilitating improvements in amblyopia. we aimed to perform a systematic review and meta-analysis evaluating the effect of ssris on patients with amblyopia.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>methods:\u003c/b> we systematically searched pubmed, embase, and cochrane central for randomized controlled trials (rcts) and controlled observational studies comparing an ssri with placebo in patients with amblyopia. outcomes of interest were visual acuity (va) change and visual evoked potential (vep) change (p100 amplitude and latency). statistical analysis was performed using the web version of revman by calculating the mean difference between groups (md). heterogeneity was assessed with cochrane q test and i\u003csup>2\u003c/sup> statistics.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>results:\u003c/b> four rcts and 139 patients were included. 55% patients received ssris. three studies used fluoxetine and one study used citalopram as the intervention. while ssris use statistically improved va (md 0.09 logmar, 95% ci 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004), the extent of improvement was not clinically significant. ssris did not have any effect on veps.\u003c/p>\n\u003cp class=\"mb15\">\u003cb>conclusion:\u003c/b> while ssris significantly improved va in patients, the increase was not clinically significant as it represents less than one line of improvement on the snellen chart. given the minimal change in va, it may be necessary to combine ssris with other modalities of intervention to demonstrate a clinically significant effect. secondary endpoints that capture effects at the level of the retina and the brain would provide knowledge of physiological mechanisms that can improve future therapies.\u003c/p>\n\u003cp class=\"mb0\">\u003cb>systematic review registration:\u003c/b> crd42025633077, \u003ca href=\"https://www.crd.york.ac.uk/prospero/view/crd42025633077\">https://www.crd.york.ac.uk/prospero/view/crd42025633077\u003c/a>.\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div> \u003cdiv class=\"journalfulltext\"> \u003ca id=\"h2\" name=\"h2\">\u003c/a>\n\u003ch2>introduction\u003c/h2>\n\u003cp class=\"mb15\">amblyopia is a neurodevelopmental visual disorder characterized by reduced visual acuity in one eye with a prevalence reported to be between 1 and 5% in children (\u003ca href=\"#ref1\">1\u003c/a>, \u003ca href=\"#ref2\">2\u003c/a>). abnormal visual input during early childhood, a critical period of visual development, can lead to unequal quality of retinal stimulation between the two eyes. specifically, the neural connections from the affected eye do not develop normally, leading to a disruption in the balance of input from the two eyes in the visual cortex and suppression of input from the amblyopic eye (\u003ca href=\"#ref3\">3\u003c/a>&#x2013;\u003ca href=\"#ref5\">5\u003c/a>). prolonged and asymmetric suppression may lead to neural defects in the representation of the deviating eye, potentially causing amblyopia and favoring the dominant eye (\u003ca href=\"#ref5\">5\u003c/a>). common causes are anisometropia (difference in refraction power between both eyes of at least +1.00), strabismus (misalignment of the eyes causing eso-, exo-, hypo- or hypertropia), or deprivation (e.g., congenital cataracts, ptosis) (\u003ca href=\"#ref6\">6\u003c/a>). if untreated during childhood, amblyopia can result in permanent loss of normal monocular vision and impaired binocular function (\u003ca href=\"#ref6\">6\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">the standard therapeutic intervention for amblyopia commences with refractive adaption which allows the visual acuity deficits to be fully corrected in 25% children (\u003ca href=\"#ref7\">7\u003c/a>). if it is not corrected, occlusion of the dominant, non-amblyopic eye using a patch or pharmacological penalization, such as atropine drops, to stimulate the amblyopic eye can be performed (\u003ca href=\"#ref6\">6\u003c/a>). this approach leverages neural plasticity to increase the strength of visual input from the weaker eye. however, the effectiveness of this treatment is age-dependent and attempted early around age 5, with diminishing returns observed as the critical period for visual cortical plasticity closes around 8&#x202f;years old (\u003ca href=\"#ref8\">8\u003c/a>). in adults, the efficacy of occlusion therapy is thought to be markedly limited due to reduced synaptic remodeling capacity (\u003ca href=\"#ref6\">6\u003c/a>, \u003ca href=\"#ref9\">9\u003c/a>). therefore, novel treatment paradigms are needed to treat amblyopia in adults.\u003c/p>\n\u003cp class=\"mb0\">selective serotonin reuptake inhibitors (ssris) such as fluoxetine and citalopram have been hypothesized to enhance neuroplasticity in the adult brain, offering a potential pharmacological treatment for amblyopia in adults when used in combination with vision therapy (\u003ca href=\"#ref10\">10\u003c/a>). fluoxetine, in particular, has shown promise in preclinical studies, where it has been demonstrated to reactivate ocular dominance plasticity in animal models by increasing the brain-derived neurotrophic factor (bdnf) protein expression and decreasing gabaergic inhibition in the visual cortex (\u003ca href=\"#ref11\">11\u003c/a>). this suggests that ssris might open a therapeutic window for visual recovery beyond the critical period. however, the evidence from trials has been inconsistent, with some studies reporting significant improvements in visual outcomes (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>), while others fail to demonstrate efficacy (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). given the contradictory findings in the published literature and the absence of guidelines on the use of ssris in amblyopia, we performed a systematic review and meta-analysis to synthesize existing data and assess the overall efficacy of ssris in treating amblyopia to give both clinicians and basic scientists more accurate information.\u003c/p> \u003ca id=\"h3\" name=\"h3\">\u003c/a>\n\u003ch2>methods\u003c/h2>\n\u003ch3>search strategy and eligibility criteria\u003c/h3>\n\u003cp class=\"mb15\">this systematic review and meta-analysis was conducted and documented following the guidelines outlined in the cochrane collaboration handbook for systematic reviews of interventions and the preferred reporting items for systematic reviews and meta-analyses (prisma) statement (\u003ca href=\"#ref15\">15\u003c/a>). the research protocol was published using prospero (registration no. crd42025633077). two authors independently systematically searched pubmed, embase and cochrane from inception to january 7, 2025 for studies published in english using the following search query: (amblyopia or anisometropic or anisometropia or strabismic or strabismus or lazy) and (fluoxetine or citalopram or escitalopram or dapoxetine or fluvoxamine or paroxetine or sertraline or vorioxetine or ssri or ssris or serotonin). the same search query was used for each database. additionally, the references of the included studies were examined to identify any additional relevant studies. disagreements were resolved by consensus.\u003c/p>\n\u003cp class=\"mb0\">we included studies that met the following criteria: (1) randomized controlled trials (rcts), (2) comparing any ssri with placebo in patients with amblyopia, (3) reporting any outcome of interest. we excluded the following studies: (1) case reports, editorial letters, reviews, or (2) studies with missing data on the interventional group or control group or overlapping patient populations.\u003c/p>\n\u003ch3>data extraction\u003c/h3>\n\u003cp class=\"mb0\">data extraction was performed independently by two authors based on predefined search criteria. data were gathered from tables, text, and graphs. any disagreements were resolved through consensus.\u003c/p>\n\u003ch3>endpoints\u003c/h3>\n\u003cp class=\"mb0\">the primary endpoint was visual acuity (va) improvement after ssri treatment. va was measured using the logarithm of the minimum angle of resolution (logmar) chart. if the endpoint was not presented as a difference from baseline, it was calculated using the data available. the secondary endpoint was pattern-reversal visual evoked potential (vep) change (p100 amplitude and latency), an electrophysiological metric that evaluates cortical responses to visual stimulation.\u003c/p>\n\u003ch3>quality assessment (risk of bias)\u003c/h3>\n\u003cp class=\"mb0\">the risk of bias assessment was conducted by two independent authors using the cochrane collaboration&#x2019;s tool for evaluating the risk of bias in randomized trials (rob2) (\u003ca href=\"#ref16\">16\u003c/a>). each study was rated as having a high, low, or unclear risk of bias across five domains: selection bias, performance bias, detection bias, attrition bias, and reporting bias. to evaluate potential publication bias, funnel plots comparing study weights to point estimates were analyzed (\u003ca href=\"#ref17\">17\u003c/a>). discrepancies were resolved through consensus following a discussion of the reasons for the differences.\u003c/p>\n\u003ch3>statistical analysis\u003c/h3>\n\u003cp class=\"mb0\">statistical analysis was performed using review manager. continuous outcomes were pooled using mean differences (md). for crossover studies, a paired student \u003ci>t\u003c/i>-test was used followed by a generic inverse-variance method to pool them with non-crossover rcts. heterogeneity was assessed using the cochrane q test and i\u003csup>2\u003c/sup> statistics, with \u003ci>p\u003c/i>&#x202f;&#x0003c;&#x202f;0.10 and i\u003csup>2\u003c/sup>&#x202f;&#x0003e;&#x202f;25% considered indicative of significant heterogeneity. a random-effect model was applied. a leave-one-out sensitivity analysis was carried out by removing the crossover rct to ensure the results were not dependent on it.\u003c/p> \u003ca id=\"h4\" name=\"h4\">\u003c/a>\n\u003ch2>results\u003c/h2>\n\u003cp class=\"mb0\">the initial search identified 481 results. after excluding duplicates and studies that did not meet the eligibility criteria, nine studies were assessed in detail based on the inclusion criteria. four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) were included, encompassing 139 patients from four rcts (\u003ca href=\"#fig1\">figure 1\u003c/a>). among these, a total of 76 patients (55%) received ssris including five patients from a crossover study. all patients had their dominant eye occluded daily between 1 and 6&#x202f;h. the age range of included patients was between 11 and 57&#x202f;years old. study characteristics are reported in \u003ca href=\"#tab1\">table 1\u003c/a>. three studies had fluoxetine and one citalopram as the intervention group.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" name=\"figure1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg\" alt=\"flowchart detailing a study selection process: identification phase shows pubmed with fifty-five results, embase with three hundred ninety-six results, cochrane with thirty results, totaling four hundred eighty-one. screening phase removes four hundred seventy-two as duplicates or non-criteria matches. eligibility phase reviews nine full-text studies; discards one conference abstract and four from the manuscript registry. four studies remain included.\" id=\"fig1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 1\u003c/b>. prisma flow diagram of study screening and selection.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">table 1\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" name=\"table1\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t001.jpg\" alt=\"www.frontiersin.org\" id=\"tab1\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 1\u003c/b>. baseline characteristics of included studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all four studies (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the primary endpoint. patients in all studies had their dominant eye patched. patients treated with an ssri had an improvement in va compared to placebo (md 0.09 logmar, 95% confidence interval [ci] 0.04&#x2013;0.14, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.0004, i\u003csup>2\u003c/sup> =&#x202f;23%, \u003ca href=\"#fig2\">figure 2\u003c/a>). only three studies (\u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) included the secondary endpoint. ssris did not change vep compared to placebo. there were no differences in p100 amplitude (md 0.34&#x202f;&#x03bc;v, 95% ci &#x02212;1.84&#x2013;2.53, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.76, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3a\u003c/a>) or p100 latency (md 1.76&#x202f;ms, 95% ci &#x02212;3.08&#x2013;6.61, \u003ci>p\u003c/i>&#x202f;=&#x202f;0.48, i\u003csup>2\u003c/sup> =&#x202f;0%, \u003ca href=\"#fig3\">figure 3b\u003c/a>) between intervention and placebo groups. the sensitivity analysis for both outcomes did not change the effect size.\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">figure 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" name=\"figure2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g002.jpg\" alt=\"forest plot showing the mean differences from four studies comparing the effects of ssri to placebo. each study is represented by a red square with horizontal lines indicating confidence intervals. the total effect is represented by a black diamond indicating a mean difference of 0.09 with a confidence interval of 0.04 to 0.14, favoring ssri. heterogeneity measures show tau-squared equals zero, chi-squared equals 3.90 with a p-value of 0.27, and i-squared equals 23%.\" id=\"fig2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 2\u003c/b>. visual acuity (va) improved with selective serotonin receptor inhibitor (ssri). va improvement is statistically significant in the ssri group compared to placebo.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 3\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" name=\"figure3\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g003.jpg\" alt=\"forest plots a and b compare mean differences for several studies on ssri effectiveness. plot a shows a total mean difference of 0.34, favoring placebo, with no heterogeneity. plot b shows a total mean difference of 1.76, still favoring placebo, with no heterogeneity. each plot displays individual study results with confidence intervals and weight distributions.\" id=\"fig3\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 3\u003c/b>. visual evoked potential (vep) did not improve with ssri. \u003cb>(a)\u003c/b> p100 amplitude improvement was not statistically significantly different between the ssri and placebo group. \u003cb>(b)\u003c/b> p100 latency improvement was not statistically significantly different between the ssri and placebo group.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div>\n\u003cp class=\"mb0\">all studies were evaluated as having a low risk of bias (\u003ca href=\"#tab2\">table 2\u003c/a>). funnel plot analysis revealed no evidence of publication bias. the studies with comparable weights and md were symmetrically distributed, except for the crossover trial (\u003ca href=\"#fig4\">figure 4\u003c/a>).\u003c/p>\n\u003cdiv class=\"dottedline\">\u003c/div> \u003cdiv class=\"imageheaders\">table 2\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" name=\"table2\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-t002.jpg\" alt=\"www.frontiersin.org\" id=\"tab2\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>table 2\u003c/b>. risk of bias summary for randomized studies.\n\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline mb15\">\u003c/div>\n\u003cdiv class=\"imageheaders\">figure 4\u003c/div> \u003cdiv class=\"figuredesc\">\u003ca href=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" name=\"figure4\" target=\"_blank\">\n \u003cpicture>\n \u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=480&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 563px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=370&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1024px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=290&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"(max-width: 1441px)\">\u003csource type=\"image/webp\" srcset=\"https://images-provider.frontiersin.org/api/ipx/w=410&f=webp/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\">\u003csource type=\"image/jpg\" srcset=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" media=\"\"> \u003cimg src=\"https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g004.jpg\" alt=\"funnel plot depicting standard error of mean difference (se[md]) on the y-axis versus mean difference (md) on the x-axis. points representing studies are scattered around a central vertical line, with dashed lines forming an inverted triangle indicating data distribution.\" id=\"fig4\" loading=\"lazy\">\n \u003c/picture>\n\u003c/a>\n\u003cp>\u003cb>figure 4\u003c/b>. funnel plot for visual acuity improvement. there is no publication bias.\u003c/p>\u003c/div> \u003cdiv class=\"clear\">\u003c/div> \u003cdiv class=\"dottedline\">\u003c/div> \u003ca id=\"h5\" name=\"h5\">\u003c/a>\n\u003ch2>discussion\u003c/h2>\n\u003cp class=\"mb15\">this systematic review and meta-analysis of four studies with a total of 139 patients compared the use of an ssri (fluoxetine and citalopram) against placebo for amblyopia. while ssris slightly improved va, the improvement was not clinically significant. moreover, it did not change either vep amplitude or latency.\u003c/p>\n\u003cp class=\"mb15\">current evidence on the use of ssris for amblyopia is lacking as each clinical trial reports contradicting results with a low number of participants (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref12\">12\u003c/a>&#x2013;\u003ca href=\"#ref14\">14\u003c/a>) so, given the lack of treatment for amblyopia in adults, this meta-analysis pooled the available data on this topic.\u003c/p>\n\u003cp class=\"mb15\">ssris are used as a first-line pharmacotherapy for depression in both adult and pediatric patients. the therapeutic mechanism is inhibition of the serotonin transporter (sert) at the presynaptic terminal, thereby increasing the availability of serotonin in the synaptic gap and potentiating postsynaptic receptors stimulation (\u003ca href=\"#ref18\">18\u003c/a>). this mechanism not only addresses the monoamine hypothesis of depression but also promotes neuroplasticity and cortical activation, making ssris a potential adjuvant therapy for conditions such as amblyopia (\u003ca href=\"#ref19\">19\u003c/a>). they are well tolerated but risks such as qt interval prolongation and increased suicidality require careful monitoring. these properties highlight ssris as a promising option for improving visual outcomes when used in conjunction with occlusion of the dominant eye (\u003ca href=\"#ref19\">19\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">in addition to the serotonergic system, dopaminergic and cholinergic systems have been advocated to play a role in the treatment of amblyopia. levodopa was tested as an adjunct treatment with occlusion of the dominant eye in a randomized clinical trial including 7 to 12&#x202f;years old children with residual amblyopia but did not show any benefit (\u003ca href=\"#ref20\">20\u003c/a>). donepezil showed an improvement of the va in an open-label pilot study (\u003ca href=\"#ref21\">21\u003c/a>).\u003c/p>\n\u003cp class=\"mb15\">across the studies, there was a statistically significant improvement of va with ssri treatments compared to placebo. this finding is consistent with preclinical studies suggesting that ssris may enhance neuroplasticity in the visual cortex of rats and reactivate eye dominance after critical periods (\u003ca href=\"#ref11\">11\u003c/a>). in previous clinical trials, the results were contradictory as some studies showed benefit of ssri treatment (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) whereas others did not (\u003ca href=\"#ref9\">9\u003c/a>, \u003ca href=\"#ref14\">14\u003c/a>). although in this meta-analysis the va improvement was statistically significant with ssri treatments, it was not clinically significant as this represents an improvement of less than one line on the snellen va chart. although amblyopia has been studied on animal models for decades, animal models do not necessarily reflect the complexity of the human visual pathway. rodent models are mostly used for deprivation amblyopia and the magnitude of improvements is less than in humans (\u003ca href=\"#ref22\">22\u003c/a>). for example, monocular deprivation only leads to a reduction of a single octave in grating acuity while a significant decrease in visual acuity would be expected in humans (\u003ca href=\"#ref22\">22\u003c/a>). similarly, measuring of visual acuity in rodents and humans cannot be standardized (\u003ca href=\"#ref22\">22\u003c/a>). mitchell et al. (\u003ca href=\"#ref22\">22\u003c/a>) recommends using the &#x201c;two-species rule&#x201d; before starting any clinical trials to overcome the limitations of a single animal model and increase the likelihood that an intervention will translate to humans (\u003ca href=\"#ref22\">22\u003c/a>). veps were not significantly changed with ssris, suggesting that the va improvement was not translated into electrophysiological changes. this is consistent with previous clinical studies (\u003ca href=\"#ref12\">12\u003c/a>, \u003ca href=\"#ref13\">13\u003c/a>) and might suggest that the va improvement is not sufficient to impact neuronal plasticity or, more likely, veps are not sensitive enough to detect these small changes. as the pattern-reversal vep primarily assesses the integrity of the central visual pathway and represents a summed cortical signal, it may not capture small or spatially restricted changes (\u003ca href=\"#ref23\">23\u003c/a>). there is a need for better endpoints that capture neural processes underlying amblyopia. such endpoints should reflect physiological mechanisms, providing knowledge that can be used to improve therapies. other techniques may be more sensitive to small changes in neuronal plasticity related to amblyopia such as magnetic resonance spectroscopy (mrs) (\u003ca href=\"#ref24\">24\u003c/a>) which measures concentrations of neurochemicals including gaba and glutamate and could be used in future clinical trials (\u003ca href=\"#ref25\">25\u003c/a>&#x2013;\u003ca href=\"#ref27\">27\u003c/a>). mrs data can be collected in combination with established clinical endpoints such as best-corrected visual acuity in clinical trials to evaluate changes in the brain regions underlying amblyopic vision. promisingly, changes in eye dominance in normally sighted relate to mrs-measured gaba (\u003ca href=\"#ref28\">28\u003c/a>), indicating that the technique could also be sensitive to neuroplasticity due to therapy in amblyopes.\u003c/p>\n\u003cp class=\"mb15\">given the wide availability in the clinic and ease of data collection, optical coherence tomography (oct) would be optimally placed as an additional end point. however, while thinning in the macula has been reported in both fellow and amblyopic eyes after occlusion therapy (\u003ca href=\"#ref29\">29\u003c/a>), the magnitude of changes were not correlated to individual improvement. moreover, the longitudinal arm of this study was very small and the occlusion around 12&#x202f;months. patching performed over weeks, would unlikely result in structural changes in structural changes. the utility of oct for assessing neural changes following short term therapies has yet to be proven.\u003c/p>\n\u003cp class=\"mb15\">heterogeneity between studies included in this meta-analysis was minimal for both endpoints, indicating consistent effect sizes across clinical trials. the sensitivity analysis did not show a different effect size when removing the clinical trial with citalopram suggesting that fluoxetine and citalopram had the same effect. risk of bias assessment showed that all included studies had a low risk of bias and there was no publication bias, strengthening the reliability of our findings.\u003c/p>\n\u003cp class=\"mb15\">to our knowledge, this is the first meta-analysis showing an effect of ssris for the treatment of amblyopia in combination with occlusion of the dominant eye. since this study only includes rcts, it is a robust synthesis of all the available evidence in the literature.\u003c/p>\n\u003cp class=\"mb15\">other modalities of treatment are also currently under research. extended-reality (xr) devices (\u003ca href=\"#ref30\">30\u003c/a>), physical activity (cycling) (\u003ca href=\"#ref31\">31\u003c/a>) and more recently the occlusion of the amblyopic eye combined with physical activity (\u003ca href=\"#ref32\">32\u003c/a>) showed some improvement in the adult amblyopic eye. it may be that including ssri treatment alongside these interventions may increase any effects.\u003c/p>\n\u003cp class=\"mb0\">in terms of limitations, the number of patients included is low because there are only four published clinical trials, each of which has a small number of patients. secondly, one of the four studies included is a crossover trial (\u003ca href=\"#ref16\">16\u003c/a>) which leads to non-independence of effect size. this can also lead to a possible carryover effect, but it is reduced by having a washout period of 2&#x202f;weeks, allowing citalopram to be completely washed out. however, a sensitivity analysis did not show any significant difference when this crossover trial was excluded. thirdly, the patients included had anisometropic, strabismic or combined amblyopia, limiting the generalization of our results to other types of amblyopia. in addition, the age of patients included was between 11 and 57&#x202f;years old. given the variability in plasticity across this age range, a further sensitivity analysis was performed that showed no significant difference when the study that included patients under 18&#x202f;years old was removed. it would be helpful to determine the potential interaction between occlusion therapy and ssris, and how much of the effect can be attributed the ssri alone compared to combined treatment. unfortunately, no clinical trials have investigated the effect of ssris alone on amblyopia without patching. finally, no data were included on the safety profile of ssris in these clinical trials, making it difficult to assess the tradeoff between therapeutic effects and risks.\u003c/p> \u003ca id=\"h6\" name=\"h6\">\u003c/a>\n\u003ch2>conclusion\u003c/h2>\n\u003cp class=\"mb0\">this meta-analysis, which comprises 139 patients, shows that ssris slightly improve va in patients with amblyopia when combined with the occlusion of the dominant eye. however, while larger trials may increase the statistical power and inform of a more representative and generalisable effect, the current evidence shows that the limited improvement does not translate to clinically significant results. there is a need for endpoints to capture changes at the level of the retina and the brain that may relate to perceptual changes.\u003c/p> \u003ca id=\"h7\" name=\"h7\">\u003c/a>\n\u003ch2>data availability statement\u003c/h2>\n\u003cp class=\"mb0\">the original contributions presented in the study are included in the article, further inquiries can be directed to the corresponding author.\u003c/p> \u003ca id=\"h8\" name=\"h8\">\u003c/a>\n\u003ch2>author contributions\u003c/h2>\n\u003cp class=\"mb0\">es: writing &#x2013; review &#x00026; editing, investigation, conceptualization, writing &#x2013; original draft, visualization, data curation, formal analysis, methodology. ls: writing &#x2013; original draft, formal analysis, data curation. vp: methodology, formal analysis, writing &#x2013; review &#x00026; editing. nt: writing &#x2013; review &#x00026; editing, formal analysis. oa: data curation, writing &#x2013; review &#x00026; editing. fk: writing &#x2013; review &#x00026; editing. hb: supervision, writing &#x2013; review &#x00026; editing, methodology, validation, visualization. ii: writing &#x2013; review &#x00026; editing, supervision, validation, methodology.\u003c/p> \u003ca id=\"h9\" name=\"h9\">\u003c/a>\n\u003ch2>funding\u003c/h2>\n\u003cp class=\"mb0\">the author(s) declare that financial support was received for the research and/or publication of this article. this work was supported the royal society (dhf\\r1\\201141 to ibi), the mrc (mr/v034723/1 to hb and ibi) and the nihr oxford health biomedical research centre (nihr203316). the centre for integrative neuroimaging was supported by core funding from the wellcome trust (203139/z/16/z and 203139/a/16/z).\u003c/p> \u003ca id=\"h10\" name=\"h10\">\u003c/a>\n\u003ch2>conflict of interest\u003c/h2>\n\u003cp class=\"mb15\">the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.\u003c/p>\n\u003cp class=\"mb15\">the handling editor gp declared a shared parent affiliation with the author oa at the time of review.\u003c/p>\n\u003cp class=\"mb0\">the author(s) declared that they were an editorial board member of frontiers, at the time of submission. this had no impact on the peer review process and the final decision.\u003c/p> \u003ca id=\"h11\" name=\"h11\">\u003c/a>\n\u003ch2>generative ai statement\u003c/h2>\n\u003cp class=\"mb0\">the authors declare that no gen ai was used in the creation of this manuscript.\u003c/p> \u003ca id=\"h12\" name=\"h12\">\u003c/a>\n\u003ch2>publisher&#x2019;s note\u003c/h2>\n\u003cp class=\"mb0\">all claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.\u003c/p> \u003ca id=\"h13\" name=\"h13\">\u003c/a>\n\u003ch2>author disclaimer\u003c/h2>\n\u003cp class=\"mb0\">the views expressed are those of the author(s) and not necessarily those of the nihr or the department of health and social care.\u003c/p> \u003ca id=\"h14\" name=\"h14\">\u003c/a>\n\u003ch2>references\u003c/h2>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref1\" id=\"ref1\">\u003c/a>1. hu, b, liu, z, zhao, j, zeng, l, hao, g, shui, d, et al. the global prevalence of amblyopia in children: a systematic review and meta-analysis. \u003ci>front pediatr\u003c/i>. (2022) 10:819998. doi: 10.3389/fped.2022.819998 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/35601430\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.3389/fped.2022.819998\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=b+hu&#x00026;author=z+liu&#x00026;author=j+zhao&#x00026;author=l+zeng&#x00026;author=g+hao&#x00026;author=d+shui&#x00026;publication_year=2022&#x00026;title=the+global+prevalence+of+amblyopia+in+children:+a+systematic+review+and+meta-analysis&#x00026;journal=front+pediatr&#x00026;volume=10&#x00026;pages=819998\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref2\" id=\"ref2\">\u003c/a>2. mostafaie, a, ghojazadeh, m, hosseinifard, h, manaflouyan, h, farhadi, f, taheri, n, et al. a systematic review of amblyopia prevalence among the children of the world. \u003ci>rom j ophthalmol\u003c/i>. (2020) 64:342&#x2013;55. doi: 10.22336/rjo.2020.56 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33367172\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.22336/rjo.2020.56\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mostafaie&#x00026;author=m+ghojazadeh&#x00026;author=h+hosseinifard&#x00026;author=h+manaflouyan&#x00026;author=f+farhadi&#x00026;author=n+taheri&#x00026;publication_year=2020&#x00026;title=a+systematic+review+of+amblyopia+prevalence+among+the+children+of+the+world&#x00026;journal=rom+j+ophthalmol&#x00026;volume=64&#x00026;pages=342-55\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref3\" id=\"ref3\">\u003c/a>3. sengpiel, f, jirmann, ku, vorobyov, v, and eysel, ut. strabismic suppression is mediated by inhibitory interactions in the primary visual cortex. \u003ci>cereb cortex\u003c/i>. (2006) 16:1750&#x2013;8. doi: 10.1093/cercor/bhj110 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/16400161\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1093/cercor/bhj110\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=ku+jirmann&#x00026;author=v+vorobyov&#x00026;author=ut+eysel&#x00026;publication_year=2006&#x00026;title=strabismic+suppression+is+mediated+by+inhibitory+interactions+in+the+primary+visual+cortex&#x00026;journal=cereb+cortex&#x00026;volume=16&#x00026;pages=1750-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref4\" id=\"ref4\">\u003c/a>4. sengpiel, f, blakemore, c, kind, pc, and harrad, r. interocular suppression in the visual cortex of strabismic cats. \u003ci>j neurosci\u003c/i>. (1994) 14:6855&#x2013;71. doi: 10.1523/jneurosci.14-11-06855.1994 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/7965083\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.14-11-06855.1994\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;author=pc+kind&#x00026;author=r+harrad&#x00026;publication_year=1994&#x00026;title=interocular+suppression+in+the+visual+cortex+of+strabismic+cats&#x00026;journal=j+neurosci&#x00026;volume=14&#x00026;pages=6855-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref5\" id=\"ref5\">\u003c/a>5. sengpiel, f, and blakemore, c. the neural basis of suppression and amblyopia in strabismus. \u003ci>eye\u003c/i>. (1996) 10:250&#x2013;8.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;author=c+blakemore&#x00026;publication_year=1996&#x00026;title=the+neural+basis+of+suppression+and+amblyopia+in+strabismus&#x00026;journal=eye&#x00026;volume=10&#x00026;pages=250-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref6\" id=\"ref6\">\u003c/a>6. li, y, sun, h, zhu, x, su, y, yu, t, wu, x, et al. efficacy of interventions for amblyopia: a systematic review and network meta-analysis. \u003ci>bmc ophthalmol\u003c/i>. (2020) 20:203. doi: 10.1186/s12886-020-01442-9 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/32450849\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1186/s12886-020-01442-9\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=y+li&#x00026;author=h+sun&#x00026;author=x+zhu&#x00026;author=y+su&#x00026;author=t+yu&#x00026;author=x+wu&#x00026;publication_year=2020&#x00026;title=efficacy+of+interventions+for+amblyopia:+a+systematic+review+and+network+meta-analysis&#x00026;journal=bmc+ophthalmol&#x00026;volume=20&#x00026;pages=203\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref7\" id=\"ref7\">\u003c/a>7. moseley, mj, fielder, ar, and stewart, ce. the optical treatment of amblyopia. \u003ci>optom vis sci\u003c/i>. (2009) 86:629&#x2013;33. doi: 10.1097/opx.0b013e3181a7b3e5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19417699\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1097/opx.0b013e3181a7b3e5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mj+moseley&#x00026;author=ar+fielder&#x00026;author=ce+stewart&#x00026;publication_year=2009&#x00026;title=the+optical+treatment+of+amblyopia&#x00026;journal=optom+vis+sci&#x00026;volume=86&#x00026;pages=629-33\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref8\" id=\"ref8\">\u003c/a>8. sengpiel, f. plasticity of the visual cortex and treatment of amblyopia. \u003ci>curr biol\u003c/i>. (2014) 24:r936&#x2013;40. doi: 10.1016/j.cub.2014.05.063 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25247373\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2014.05.063\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=f+sengpiel&#x00026;publication_year=2014&#x00026;title=plasticity+of+the+visual+cortex+and+treatment+of+amblyopia&#x00026;journal=curr+biol&#x00026;volume=24&#x00026;pages=r936-40\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref9\" id=\"ref9\">\u003c/a>9. huttunen, hj, palva, jm, lindberg, l, palva, s, saarela, v, karvonen, e, et al. fluoxetine does not enhance the effect of perceptual learning on visual function in adults with amblyopia. \u003ci>sci rep\u003c/i>. (2018) 8:12830. doi: 10.1038/s41598-018-31169-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30150750\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-018-31169-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=hj+huttunen&#x00026;author=jm+palva&#x00026;author=l+lindberg&#x00026;author=s+palva&#x00026;author=v+saarela&#x00026;author=e+karvonen&#x00026;publication_year=2018&#x00026;title=fluoxetine+does+not+enhance+the+effect+of+perceptual+learning+on+visual+function+in+adults+with+amblyopia&#x00026;journal=sci+rep&#x00026;volume=8&#x00026;pages=12830\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref10\" id=\"ref10\">\u003c/a>10. bavelier, d, levi, dm, li, rw, dan, y, and hensch, tk. removing brakes on adult brain plasticity: from molecular to behavioral interventions. \u003ci>j neurosci\u003c/i>. (2010) 30:14964&#x2013;71. doi: 10.1523/jneurosci.4812-10.2010 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/21068299\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1523/jneurosci.4812-10.2010\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+bavelier&#x00026;author=dm+levi&#x00026;author=rw+li&#x00026;author=y+dan&#x00026;author=tk+hensch&#x00026;publication_year=2010&#x00026;title=removing+brakes+on+adult+brain+plasticity:+from+molecular+to+behavioral+interventions&#x00026;journal=j+neurosci&#x00026;volume=30&#x00026;pages=14964-71\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref11\" id=\"ref11\">\u003c/a>11. vetencourt, m, jf, v, sale, a, viegi, a, baroncelli, l, de pasquale, r, et al. the antidepressant fluoxetine restores plasticity in the adult visual cortex. \u003ci>science\u003c/i>. (2008) 320:385&#x2013;8. doi: 10.1126/science.1150516\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1126/science.1150516\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=m+vetencourt&#x00026;author=v+jf&#x00026;author=a+sale&#x00026;author=a+viegi&#x00026;author=l+baroncelli&#x00026;author=r+de+pasquale&#x00026;publication_year=2008&#x00026;title=the+antidepressant+fluoxetine+restores+plasticity+in+the+adult+visual+cortex&#x00026;journal=science&#x00026;volume=320&#x00026;pages=385-8\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref12\" id=\"ref12\">\u003c/a>12. sharif, mh, talebnejad, mr, rastegar, k, khalili, mr, and nowroozzadeh, mh. oral fluoxetine in the management of amblyopic patients aged between 10 and 40 years old: a randomized clinical trial. \u003ci>eye\u003c/i>. (2019) 33:1060&#x2013;7. doi: 10.1038/s41433-019-0360-z \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30783259\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41433-019-0360-z\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mh+sharif&#x00026;author=mr+talebnejad&#x00026;author=k+rastegar&#x00026;author=mr+khalili&#x00026;author=mh+nowroozzadeh&#x00026;publication_year=2019&#x00026;title=oral+fluoxetine+in+the+management+of+amblyopic+patients+aged+between+10+and+40+years+old:+a+randomized+clinical+trial&#x00026;journal=eye&#x00026;volume=33&#x00026;pages=1060-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref13\" id=\"ref13\">\u003c/a>13. mirmohammadsadeghi, a, mousavi, a, akbari, mr, khojasteh, h, masoomian, b, sadeghi, m, et al. fluoxetine as a possible treatment for adult amblyopia: results of a double-blind, randomized, placebo-controlled trial. \u003ci>j aapos\u003c/i>. (2024) 28:104009. doi: 10.1016/j.jaapos.2024.104009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/39304030\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.jaapos.2024.104009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mirmohammadsadeghi&#x00026;author=a+mousavi&#x00026;author=mr+akbari&#x00026;author=h+khojasteh&#x00026;author=b+masoomian&#x00026;author=m+sadeghi&#x00026;publication_year=2024&#x00026;title=fluoxetine+as+a+possible+treatment+for+adult+amblyopia:+results+of+a+double-blind+randomized+placebo-controlled+trial&#x00026;journal=j+aapos&#x00026;volume=28&#x00026;pages=104009\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref14\" id=\"ref14\">\u003c/a>14. lagas, ak, black, jm, russell, br, kydd, rr, and thompson, b. the effect of combined patching and citalopram on visual acuity in adults with amblyopia: a randomized, crossover, placebo-controlled trial. \u003ci>neural plast\u003c/i>. (2019) 2019:5857243. doi: 10.1155/2019/5857243\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.1155/2019/5857243\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ak+lagas&#x00026;author=jm+black&#x00026;author=br+russell&#x00026;author=rr+kydd&#x00026;author=b+thompson&#x00026;publication_year=2019&#x00026;title=the+effect+of+combined+patching+and+citalopram+on+visual+acuity+in+adults+with+amblyopia:+a+randomized+crossover+placebo-controlled+trial&#x00026;journal=neural+plast&#x00026;volume=2019&#x00026;pages=5857243\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref15\" id=\"ref15\">\u003c/a>15. moher, d, liberati, a, tetzlaff, j, and altman, dgprisma group. preferred reporting items for systematic reviews and meta-analyses: the prisma statement. \u003ci>bmj\u003c/i>. (2009) 339:b2535. doi: 10.1136/bmj.b2535 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/19622551\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.b2535\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+moher&#x00026;author=a+liberati&#x00026;author=j+tetzlaff&#x00026;author=dg+altman&#x00026;publication_year=2009&#x00026;title=preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+the+prisma+statement&#x00026;journal=bmj&#x00026;volume=339&#x00026;pages=b2535\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref16\" id=\"ref16\">\u003c/a>16. sterne, jac, savovi&#x0107;, j, page, mj, elbers, rg, blencowe, ns, boutron, i, et al. rob 2: a revised tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2019) 366:l4898. doi: 10.1136/bmj.l4898 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/31462531\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.l4898\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jac+sterne&#x00026;author=j+savovi&#x0107;&#x00026;author=mj+page&#x00026;author=rg+elbers&#x00026;author=ns+blencowe&#x00026;author=i+boutron&#x00026;publication_year=2019&#x00026;title=rob+2:+a+revised+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=366&#x00026;pages=l4898\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref17\" id=\"ref17\">\u003c/a>17. higgins, jpt, altman, dg, g&#x000f8;tzsche, pc, j&#x000fc;ni, p, moher, d, oxman, ad, et al. the cochrane collaboration&#x2019;s tool for assessing risk of bias in randomised trials. \u003ci>bmj\u003c/i>. (2011) 343:d5928. doi: 10.1136/bmj.d5928 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/22008217\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1136/bmj.d5928\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jpt+higgins&#x00026;author=dg+altman&#x00026;author=pc+g&#x000f8;tzsche&#x00026;author=p+j&#x000fc;ni&#x00026;author=d+moher&#x00026;author=ad+oxman&#x00026;publication_year=2011&#x00026;title=the+cochrane+collaboration&#x2019;s+tool+for+assessing+risk+of+bias+in+randomised+trials&#x00026;journal=bmj&#x00026;volume=343&#x00026;pages=d5928\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref18\" id=\"ref18\">\u003c/a>18. feighner, jp. mechanism of action of antidepressant medications. \u003ci>j clin psychiatry\u003c/i>. (1999) 60:4&#x2013;11.\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?author=jp+feighner&#x00026;publication_year=1999&#x00026;title=mechanism+of+action+of+antidepressant+medications&#x00026;journal=j+clin+psychiatry&#x00026;volume=60&#x00026;pages=4-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref19\" id=\"ref19\">\u003c/a>19. morishita, h, and hensch, tk. critical period revisited: impact on vision. \u003ci>curr opin neurobiol\u003c/i>. (2008) 18:101&#x2013;7. doi: 10.1016/j.conb.2008.05.009 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/18534841\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.conb.2008.05.009\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+morishita&#x00026;author=tk+hensch&#x00026;publication_year=2008&#x00026;title=critical+period+revisited:+impact+on+vision&#x00026;journal=curr+opin+neurobiol&#x00026;volume=18&#x00026;pages=101-7\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref20\" id=\"ref20\">\u003c/a>20. pediatric eye disease investigator grouprepka, mx, kraker, rt, dean, tw, beck, rw, siatkowski, rm, et al. a randomized trial of levodopa as treatment for residual amblyopia in older children. \u003ci>ophthalmology\u003c/i>. (2015) 122:874&#x2013;81. doi: 10.1016/j.ophtha.2015.01.002 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/25676904\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.ophtha.2015.01.002\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=mx+repka&#x00026;author=rt+kraker&#x00026;author=tw+dean&#x00026;author=rw+beck&#x00026;author=rm+siatkowski&#x00026;publication_year=2015&#x00026;title=a+randomized+trial+of+levodopa+as+treatment+for+residual+amblyopia+in+older+children&#x00026;journal=ophthalmology&#x00026;volume=122&#x00026;pages=874-81\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref21\" id=\"ref21\">\u003c/a>21. wu, c, gaier, ed, nihalani, br, whitecross, s, hensch, tk, and hunter, dg. durable recovery from amblyopia with donepezil. \u003ci>sci rep\u003c/i>. (2023) 13:10161. doi: 10.1038/s41598-023-34891-5 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37349338\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1038/s41598-023-34891-5\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+wu&#x00026;author=ed+gaier&#x00026;author=br+nihalani&#x00026;author=s+whitecross&#x00026;author=tk+hensch&#x00026;author=dg+hunter&#x00026;publication_year=2023&#x00026;title=durable+recovery+from+amblyopia+with+donepezil&#x00026;journal=sci+rep&#x00026;volume=13&#x00026;pages=10161\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref22\" id=\"ref22\">\u003c/a>22. mitchell, d, and sengpiel, f. animal models of amblyopia. \u003ci>vis neurosci\u003c/i>. (2018) 35:e017. doi: 10.1017/s0952523817000244 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/29905121\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1017/s0952523817000244\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=d+mitchell&#x00026;author=f+sengpiel&#x00026;publication_year=2018&#x00026;title=animal+models+of+amblyopia&#x00026;journal=vis+neurosci&#x00026;volume=35&#x00026;pages=e017\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref23\" id=\"ref23\">\u003c/a>23. odom, jv, bach, m, brigell, m, holder, ge, mcculloch, dl, mizota, a, et al. iscev standard for clinical visual evoked potentials: (2016 update). \u003ci>doc ophthalmol\u003c/i>. (2016) 133:1&#x2013;9. doi: 10.1007/s10633-016-9553-y \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/27443562\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s10633-016-9553-y\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=jv+odom&#x00026;author=m+bach&#x00026;author=m+brigell&#x00026;author=ge+holder&#x00026;author=dl+mcculloch&#x00026;author=a+mizota&#x00026;publication_year=2016&#x00026;title=iscev+standard+for+clinical+visual+evoked+potentials:+(2016+update)&#x00026;journal=doc+ophthalmol&#x00026;volume=133&#x00026;pages=1-9\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref24\" id=\"ref24\">\u003c/a>24. ip, ib, and bridge, h. investigating the neurochemistry of the human visual system using magnetic resonance spectroscopy. \u003ci>brain struct funct\u003c/i>. (2022) 227:1491&#x2013;505. doi: 10.1007/s00429-021-02273-0 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/33900453\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1007/s00429-021-02273-0\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=h+bridge&#x00026;publication_year=2022&#x00026;title=investigating+the+neurochemistry+of+the+human+visual+system+using+magnetic+resonance+spectroscopy&#x00026;journal=brain+struct+funct&#x00026;volume=227&#x00026;pages=1491-505\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref25\" id=\"ref25\">\u003c/a>25. ip, ib, clarke, wt, wyllie, a, tracey, k, matuszewski, j, jbabdi, s, et al. the relationship between visual acuity loss and gabaergic inhibition in amblyopia. \u003ci>imaging neurosci.\u003c/i> (2024) 2:1&#x2013;18. doi: 10.1162/imag_a_00256 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40110226\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1162/imag_a_00256\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=ib+ip&#x00026;author=wt+clarke&#x00026;author=a+wyllie&#x00026;author=k+tracey&#x00026;author=j+matuszewski&#x00026;author=s+jbabdi&#x00026;publication_year=2024&#x00026;title=the+relationship+between+visual+acuity+loss+and+gabaergic+inhibition+in+amblyopia&#x00026;journal=imaging+neurosci.&#x00026;volume=2&#x00026;pages=1-18\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref26\" id=\"ref26\">\u003c/a>26. bridge, h, ip, ib, and parker, aj. investigating the human binocular visual system using multi-modal magnetic resonance imaging. \u003ci>perception\u003c/i>. (2023) 52:441&#x2013;58. doi: 10.1177/03010066231178664 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/37272064\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1177/03010066231178664\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=h+bridge&#x00026;author=ib+ip&#x00026;author=aj+parker&#x00026;publication_year=2023&#x00026;title=investigating+the+human+binocular+visual+system+using+multi-modal+magnetic+resonance+imaging&#x00026;journal=perception&#x00026;volume=52&#x00026;pages=441-58\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref27\" id=\"ref27\">\u003c/a>27. mukerji, a, byrne, kn, yang, e, levi, dm, and silver, ma. visual cortical &#x03b3;&#x02212;aminobutyric acid and perceptual suppression in amblyopia. \u003ci>front hum neurosci\u003c/i>. (2022) 16:949395. doi: 10.3389/fnhum.2022.949395\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://doi.org/10.3389/fnhum.2022.949395\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+mukerji&#x00026;author=kn+byrne&#x00026;author=e+yang&#x00026;author=dm+levi&#x00026;author=ma+silver&#x00026;publication_year=2022&#x00026;title=visual+cortical+&#x03b3;&#x02212;aminobutyric+acid+and+perceptual+suppression+in+amblyopia&#x00026;journal=front+hum+neurosci&#x00026;volume=16&#x00026;pages=949395\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\" style=\"margin-bottom:0.5em;\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref28\" id=\"ref28\">\u003c/a>28. short-term monocular deprivation alters gaba in the adult human visual cortex - pubmed. (2025). available online at: \u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26004760/\">https://pubmed.ncbi.nlm.nih.gov/26004760/\u003c/a>\u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"http://scholar.google.com/scholar_lookup?publication_year=2025&#x00026;\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref29\" id=\"ref29\">\u003c/a>29. chedid, a, fronius, m, wenner, y, cirina, l, kohnen, t, and kuhli-hattenbach, c. optical coherence tomography (oct) parameters in amblyopia. \u003ci>strabismus\u003c/i>. (2025) 1&#x2013;11:1&#x2013;11. doi: 10.1080/09273972.2025.2478078 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/40226898\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1080/09273972.2025.2478078\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=a+chedid&#x00026;author=m+fronius&#x00026;author=y+wenner&#x00026;author=l+cirina&#x00026;author=t+kohnen&#x00026;author=c+kuhli-hattenbach&#x00026;publication_year=2025&#x00026;title=optical+coherence+tomography+(oct)+parameters+in+amblyopia&#x00026;journal=strabismus&#x00026;volume=1&#x2013;11&#x00026;pages=1-11\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref30\" id=\"ref30\">\u003c/a>30. levi, dm. applications and implications for extended reality to improve binocular vision and stereopsis. \u003ci>j vis\u003c/i>. (2023) 23:14. doi: 10.1167/jov.23.1.14 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/36662501\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1167/jov.23.1.14\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=dm+levi&#x00026;publication_year=2023&#x00026;title=applications+and+implications+for+extended+reality+to+improve+binocular+vision+and+stereopsis&#x00026;journal=j+vis&#x00026;volume=23&#x00026;pages=14\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref31\" id=\"ref31\">\u003c/a>31. lunghi, c, and sale, a. a cycling lane for brain rewiring. \u003ci>curr biol\u003c/i>. (2015) 25:r1122&#x2013;3. doi: 10.1016/j.cub.2015.10.026 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/26654367\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1016/j.cub.2015.10.026\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=a+sale&#x00026;publication_year=2015&#x00026;title=a+cycling+lane+for+brain+rewiring&#x00026;journal=curr+biol&#x00026;volume=25&#x00026;pages=r1122-3\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003cdiv class=\"references\">\n\u003cp class=\"referencescopy1\">\u003ca name=\"ref32\" id=\"ref32\">\u003c/a>32. lunghi, c, sframeli, at, lepri, a, lepri, m, lisi, d, sale, a, et al. a new counterintuitive training for adult amblyopia. \u003ci>annal. clin. transl. neurol.\u003c/i> (2019) 6:274&#x2013;84. doi: 10.1002/acn3.698 \u003c/p>\n\u003cp class=\"referencescopy2\">\u003ca href=\"https://pubmed.ncbi.nlm.nih.gov/30847360\" target=\"_blank\">pubmed abstract\u003c/a> | \u003ca href=\"https://doi.org/10.1002/acn3.698\" target=\"_blank\">crossref full text\u003c/a> | \u003ca href=\"http://scholar.google.com/scholar_lookup?author=c+lunghi&#x00026;author=at+sframeli&#x00026;author=a+lepri&#x00026;author=m+lepri&#x00026;author=d+lisi&#x00026;author=a+sale&#x00026;publication_year=2019&#x00026;title=a+new+counterintuitive+training+for+adult+amblyopia&#x00026;journal=annal.+clin.+transl.+neurol.&#x00026;volume=6&#x00026;pages=274-84\" target=\"_blank\">google scholar\u003c/a>\u003c/p>\u003c/div>\n\u003c/div> \u003cdiv class=\"thinlinem20\">\u003c/div> \u003cdiv class=\"abstractsummary\">\n\u003cp>\u003cspan>keywords:\u003c/span> amblyopia, strabismus, anisometropia, fluoxetine, citalopram, ssris, neuroplasticity\u003c/p>\n\u003cp>\u003cspan>citation:\u003c/span> shamsher e, saccaro l, pungirum vb, tran nb, alghaith oaha, khabazianzadeh f, bridge h and ip ib (2025) selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials. \u003ci>front. neurol\u003c/i>. 16:1639913. doi: 10.3389/fneur.2025.1639913\u003c/p>\n\u003cp class=\"timestamps\">\u003cspan>received:\u003c/span> 03 june 2025; \u003cspan>accepted:\u003c/span> 31 july 2025;\u003cbr> \u003cspan>published:\u003c/span> 21 august 2025.\u003c/p> \u003cdiv>\n\u003cp>edited by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/2271562/overview\">gordon plant\u003c/a>, university college london, united kingdom\u003c/div> \u003cdiv>\n\u003cp>reviewed by:\u003c/p> \u003ca href=\"https://loop.frontiersin.org/people/1863925/overview\">sara samadzadeh\u003c/a>, charit&#x00e9; university medicine berlin, germany\u003cbr> \u003ca href=\"https://loop.frontiersin.org/people/870962/overview\">alistair r. fielder\u003c/a>, city university of london, united kingdom\u003c/div>\n\u003cp>\u003cspan>copyright\u003c/span> &#x000a9; 2025 shamsher, saccaro, pungirum, tran, alghaith, khabazianzadeh, bridge and ip. this is an open-access article distributed under the terms of the \u003ca rel=\"license\" href=\"http://creativecommons.org/licenses/by/4.0/\" target=\"_blank\">creative commons attribution license (cc by)\u003c/a>. the use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. no use, distribution or reproduction is permitted which does not comply with these terms.\u003c/p>\n\u003cp>\u003cspan>&#x0002a;correspondence:\u003c/span> i. betina ip, \u003ca id=\"encmail\">ymv0aw5hlmlwqg5ky24ub3guywmudws=\u003c/a>\u003c/p>\n\u003cp>\u003cspan>\u003csup>&#x2020;\u003c/sup>\u003c/span>these authors share senior authorship\u003c/p> \u003cdiv class=\"clear\">\u003c/div> \u003c/div>","\u003cul class=\"flyoutjournal\"> \u003cli>\u003ca href=\"#h1\">abstract\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h2\">introduction\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h3\">methods\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h4\">results\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h5\">discussion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h6\">conclusion\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h7\">data availability statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h8\">author contributions\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h9\">funding\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h10\">conflict of interest\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h11\">generative ai statement\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h12\">publisher&#x2019;s note\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h13\">author disclaimer\u003c/a>\u003c/li> \u003cli>\u003ca href=\"#h14\">references\u003c/a>\u003c/li> \u003c/ul>",[719,725,731],{"name":720,"fileserverpackageentryid":19,"fileserverid":721,"fileserverversionnumber":439,"type":722},"epub.epub","1639913/epub",{"code":723,"name":724},"epub","epub",{"name":726,"fileserverpackageentryid":19,"fileserverid":727,"fileserverversionnumber":439,"type":728},"publishers-proof.pdf","1639913/publishers-proof",{"code":729,"name":730},"pdf","pdf",{"name":732,"fileserverpackageentryid":733,"fileserverid":734,"fileserverversionnumber":439,"type":735},"fneur-16-1639913.xml","fneur-16-1639913/fneur-16-1639913.xml","1639913/xml",{"code":736,"name":737},"nlm_xml","xml","v3",{"title":740,"link":741,"meta":745,"script":869},"frontiers | selective serotonin reuptake inhibitors for amblyopia treatment: a systematic review and meta-analysis of randomized controlled trials",[742],{"rel":743,"href":744},"canonical","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/full",[746,749,752,754,757,761,764,768,771,774,777,779,781,783,785,787,790,793,795,798,800,802,805,808,811,814,817,821,825,828,831,834,837,840,843,846,849,852,855,858,861,864,866],{"hid":747,"property":747,"name":747,"content":748},"description","introductionamblyopia is a neurodevelopmental visual disorder treated with occlusion or pharmacological penalization of the dominant, non-amblyopic eye in ea...",{"hid":750,"property":750,"name":751,"content":740},"og:title","title",{"hid":753,"property":753,"name":747,"content":748},"og:description",{"hid":755,"name":755,"content":756},"keywords","strabismus,neuroplasticity,amblyopia,fluoxetine,ssris,anisometropia,citalopram",{"hid":758,"property":758,"name":759,"content":760},"og:site_name","site_name","frontiers",{"hid":762,"property":762,"name":432,"content":763},"og:image","https://images-provider.frontiersin.org/api/ipx/w=1200&f=png/https://www.frontiersin.org/files/articles/1639913/fneur-16-1639913-html/image_m/fneur-16-1639913-g001.jpg",{"hid":765,"property":765,"name":766,"content":767},"og:type","type","article",{"hid":769,"property":769,"name":770,"content":744},"og:url","url",{"hid":772,"name":772,"content":773},"twitter:card","summary_large_image",{"hid":775,"name":775,"content":776},"citation_volume","16",{"hid":778,"name":778,"content":116},"citation_journal_title",{"hid":780,"name":780,"content":760},"citation_publisher",{"hid":782,"name":782,"content":700},"citation_journal_abbrev",{"hid":784,"name":784,"content":701},"citation_issn",{"hid":786,"name":786,"content":583},"citation_doi",{"hid":788,"name":788,"content":789},"citation_firstpage","1639913",{"hid":791,"name":791,"content":792},"citation_language","english",{"hid":794,"name":794,"content":584},"citation_title",{"hid":796,"name":796,"content":797},"citation_keywords","strabismus; neuroplasticity; amblyopia; fluoxetine; ssris; anisometropia; citalopram",{"hid":799,"name":799,"content":589},"citation_abstract",{"hid":801,"name":801,"content":598},"citation_article_type",{"hid":803,"name":803,"content":804},"citation_pdf_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/pdf",{"hid":806,"name":806,"content":807},"citation_xml_url","https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2025.1639913/xml",{"hid":809,"name":809,"content":810},"citation_fulltext_world_readable","yes",{"hid":812,"name":812,"content":813},"citation_online_date","2025/07/31",{"hid":815,"name":815,"content":816},"citation_publication_date","2025/08/21",{"hid":818,"name":819,"content":820},"citation_author_0","citation_author","shamsher, ehtesham ",{"hid":822,"name":823,"content":824},"citation_author_institution_0","citation_author_institution","oxford eye hospital, john radcliffe hospital, oxford university hospitals nhs foundation trust, united kingdom",{"hid":826,"name":819,"content":827},"citation_author_1","saccaro, luisa ",{"hid":829,"name":823,"content":830},"citation_author_institution_1","faculty of medicine, universidade de mogi das cruzes, brazil",{"hid":832,"name":819,"content":833},"citation_author_2","pungirum, victor barreiros ",{"hid":835,"name":823,"content":836},"citation_author_institution_2","faculty of medical sciences, university of buenos aires, argentina",{"hid":838,"name":819,"content":839},"citation_author_3","tran, nghi bao ",{"hid":841,"name":823,"content":842},"citation_author_institution_3","faculty of medicine, university of debrecen, hungary",{"hid":844,"name":819,"content":845},"citation_author_4","alghaith, omar a. h. a. ",{"hid":847,"name":823,"content":848},"citation_author_institution_4","institute of ophthalmology, university college london, united kingdom",{"hid":850,"name":819,"content":851},"citation_author_5","khabazianzadeh, fatemeh ",{"hid":853,"name":823,"content":854},"citation_author_institution_5","eye research center, khatam-al-anbia hospital, mashad university of medical sciences, iran",{"hid":856,"name":819,"content":857},"citation_author_6","bridge, holly ",{"hid":859,"name":823,"content":860},"citation_author_institution_6","nuffield department of clinical neurosciences, oxford university centre for integrative neuroimaging, united kingdom",{"hid":862,"name":819,"content":863},"citation_author_7","ip, i. betina ",{"hid":865,"name":823,"content":860},"citation_author_institution_7",{"hid":867,"name":867,"content":868},"dc.identifier","doi:10.3389/fneur.2025.1639913",[870,873,875,877,879],{"src":871,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6","text/javascript",{"src":874,"body":13,"type":872,"async":13},"https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/mathjax.js?config=tex-mml-am_chtml",{"src":876,"body":13,"type":872,"async":13},"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-f0bc9b243ff5677d05460c1eb71834ca998946d764eb3bc244ab4b18ba50d21e.js",{"src":878,"body":13,"type":872,"async":13},"https://api.altmetric.com/v1/doi/10.3389/fneur.2025.1639913?callback=_altmetric.embed_callback&domain=www.frontiersin.org&key=3c130976ca2b8f2e88f8377633751ba1&cache_until=14-15",{"src":880,"body":13,"type":872,"async":13},"https://crossmark-cdn.crossref.org/widget/v2.0/widget.js",{"articlehubslug":19,"articlehubpage":882,"articlehubarticleslist":883,"canjournalhasarticlehub":379,"articledoilist":884},{},[],[],{"title":19,"image":-1,"breadcrumbs":886,"linkscollection":887,"metricscollection":889},[],{"total":436,"items":888},[],{"total":436,"items":890},[]] window.__nuxt__={};window.__nuxt__.config={public:{isdevmode:false,appname:"article-pages-2024",baseurl:"https://www.frontiersin.org",domain:"frontiersin.org",loopurl:"https://loop.frontiersin.org",ssmaindomain:"frontiersin.org",contentfulurl:"https://graphql.contentful.com/content/v1/spaces",spaceid:1,spacename:"frontiers",livespaceid:1,tenantlogourl:"",frontiersgraphurl:"https://apollo-federation-gateway.frontiersin.org",registrationapiurl:"https://onboarding-ui.frontiersin.org",emaildigestapiurl:"https://api-email-digest.frontiersin.org",journalfilesapiurl:"https://files-journal-api.frontiersin.org",searchapiurl:"https://search-api.frontiersin.org",productionforumapiurl:"https://production-forum-api-v2.frontiersin.org",gtmserverurl:"https://tag-manager.frontiersin.org",gtmid:"gtm-m322fv2",gtmauth:"owvbwxfajr21yqv1fe1caq",gtmpreview:"env-1",figsharepluginurl:"https://widgets.figshare.com/static/figshare.js",figshareapiurl:"https://api.figshare.com/v2/collections/search",figsharetimeout:3000,crossmarkpublisheddate:"2015/08/24",googlerecaptchasitekey:"6ldg3i0uaaaaaoc4quh35ubhgjotehp_stxhgr_v",googlerecaptchakeyname:"frontiersrecaptchav2",faviconsize16:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_16-tenantfavicon-frontiers.png",faviconsize32:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_32-tenantfavicon-frontiers.png",faviconsize180:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_180-tenantfavicon-frontiers.png",faviconsize192:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_192-tenantfavicon-frontiers.png",faviconsize512:"https://static2.frontiersin.org/static-resources/tenants/frontiers/favicon_512-tenantfavicon-frontiers.png",socialmediaimg:"https://brand.frontiersin.org/m/1c8bcb536c789e11/guidelines-frontiers_logo_1200x628_1-91to1.png",linkedarticlecopytext:"'{\"articletypecopytext\":[{\"articletypeid\":0,\"originalarticlecopytext\":\"part of this article's content has been mentioned in:\",\"linkedarticlecopytext\":\"this article mentions parts of:\"},{\"articletypeid\":122,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an erratum on:\"},{\"articletypeid\":129,\"originalarticlecopytext\":\"parts of this article's content have been modified or rectified in:\",\"linkedarticlecopytext\":\"this article is an addendum to:\"},{\"articletypeid\":128,\"originalarticlecopytext\":\"a correction has been applied to this article in:\",\"linkedarticlecopytext\":\"this article is a correction to:\"},{\"articletypeid\":134,\"originalarticlecopytext\":\"a retraction of this article was approved in:\",\"linkedarticlecopytext\":\"this article is a retraction of:\"},{\"articletypeid\":29,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"},{\"articletypeid\":30,\"originalarticlecopytext\":\"a commentary has been posted on this article:\",\"linkedarticlecopytext\":\"this article is a commentary on:\"}],\"articleidcopytext\":[]}'\n",acceptedarticleexcludedjournalids:"'[2766,979]'\n",articletypeconfigurablelabel:"\u003c\u003carticle-type:uppercase>> article",settingsfeaturesswitchers:"'{\"displaytitlepilllabels\":true,\"displayrelatedarticlesbox\":true,\"showeditors\":true,\"showreviewers\":true,\"showloopimpactlink\":true,\"enablefigshare\":false,\"usexmlimages\":true}'\n",journalswitharticlehub:"'{\"strings\":[\"science\"]}'\n",terminologysettings:"'{\"terms\":[{\"sequencenumber\":1,\"key\":\"frontiers\",\"tenantterm\":\"frontiers\",\"frontiersdefaultterm\":\"frontiers\",\"category\":\"customer\"},{\"sequencenumber\":2,\"key\":\"submission_system\",\"tenantterm\":\"submission system\",\"frontiersdefaultterm\":\"submission system\",\"category\":\"product\"},{\"sequencenumber\":3,\"key\":\"public_pages\",\"tenantterm\":\"public pages\",\"frontiersdefaultterm\":\"public pages\",\"category\":\"product\"},{\"sequencenumber\":4,\"key\":\"my_frontiers\",\"tenantterm\":\"my frontiers\",\"frontiersdefaultterm\":\"my frontiers\",\"category\":\"product\"},{\"sequencenumber\":5,\"key\":\"digital_editorial_office\",\"tenantterm\":\"digital editorial office\",\"frontiersdefaultterm\":\"digital editorial office\",\"category\":\"product\"},{\"sequencenumber\":6,\"key\":\"deo\",\"tenantterm\":\"deo\",\"frontiersdefaultterm\":\"deo\",\"category\":\"product\"},{\"sequencenumber\":7,\"key\":\"digital_editorial_office_for_chiefs\",\"tenantterm\":\"digital editorial office for chiefs\",\"frontiersdefaultterm\":\"digital editorial office for chiefs\",\"category\":\"product\"},{\"sequencenumber\":8,\"key\":\"digital_editorial_office_for_eof\",\"tenantterm\":\"digital editorial office for eof\",\"frontiersdefaultterm\":\"digital editorial office for eof\",\"category\":\"product\"},{\"sequencenumber\":9,\"key\":\"editorial_office\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"product\"},{\"sequencenumber\":10,\"key\":\"eof\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"product\"},{\"sequencenumber\":11,\"key\":\"research_topic_management\",\"tenantterm\":\"research topic management\",\"frontiersdefaultterm\":\"research topic management\",\"category\":\"product\"},{\"sequencenumber\":12,\"key\":\"review_forum\",\"tenantterm\":\"review forum\",\"frontiersdefaultterm\":\"review forum\",\"category\":\"product\"},{\"sequencenumber\":13,\"key\":\"accounting_office\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"product\"},{\"sequencenumber\":14,\"key\":\"aof\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"product\"},{\"sequencenumber\":15,\"key\":\"publishing_office\",\"tenantterm\":\"publishing office\",\"frontiersdefaultterm\":\"publishing office\",\"category\":\"product\"},{\"sequencenumber\":16,\"key\":\"production_office\",\"tenantterm\":\"production office forum\",\"frontiersdefaultterm\":\"production office forum\",\"category\":\"product\"},{\"sequencenumber\":17,\"key\":\"pof\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"product\"},{\"sequencenumber\":18,\"key\":\"book_office_forum\",\"tenantterm\":\"book office forum\",\"frontiersdefaultterm\":\"book office forum\",\"category\":\"product\"},{\"sequencenumber\":19,\"key\":\"bof\",\"tenantterm\":\"bof\",\"frontiersdefaultterm\":\"bof\",\"category\":\"product\"},{\"sequencenumber\":20,\"key\":\"aira\",\"tenantterm\":\"aira\",\"frontiersdefaultterm\":\"aira\",\"category\":\"product\"},{\"sequencenumber\":21,\"key\":\"editorial_board_management\",\"tenantterm\":\"editorial board management\",\"frontiersdefaultterm\":\"editorial board management\",\"category\":\"product\"},{\"sequencenumber\":22,\"key\":\"ebm\",\"tenantterm\":\"ebm\",\"frontiersdefaultterm\":\"ebm\",\"category\":\"product\"},{\"sequencenumber\":23,\"key\":\"domain\",\"tenantterm\":\"domain\",\"frontiersdefaultterm\":\"domain\",\"category\":\"taxonomy\"},{\"sequencenumber\":24,\"key\":\"journal\",\"tenantterm\":\"journal\",\"frontiersdefaultterm\":\"journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":25,\"key\":\"section\",\"tenantterm\":\"section\",\"frontiersdefaultterm\":\"section\",\"category\":\"taxonomy\"},{\"sequencenumber\":26,\"key\":\"domains\",\"tenantterm\":\"domains\",\"frontiersdefaultterm\":\"domains\",\"category\":\"taxonomy\"},{\"sequencenumber\":27,\"key\":\"specialty_section\",\"tenantterm\":\"specialty section\",\"frontiersdefaultterm\":\"specialty section\",\"category\":\"taxonomy\"},{\"sequencenumber\":28,\"key\":\"specialty_journal\",\"tenantterm\":\"specialty journal\",\"frontiersdefaultterm\":\"specialty journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":29,\"key\":\"journals\",\"tenantterm\":\"journals\",\"frontiersdefaultterm\":\"journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":30,\"key\":\"sections\",\"tenantterm\":\"sections\",\"frontiersdefaultterm\":\"sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":31,\"key\":\"specialty_sections\",\"tenantterm\":\"specialty sections\",\"frontiersdefaultterm\":\"specialty sections\",\"category\":\"taxonomy\"},{\"sequencenumber\":32,\"key\":\"specialty_journals\",\"tenantterm\":\"specialty journals\",\"frontiersdefaultterm\":\"specialty journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":33,\"key\":\"manuscript\",\"tenantterm\":\"manuscript\",\"frontiersdefaultterm\":\"manuscript\",\"category\":\"core\"},{\"sequencenumber\":34,\"key\":\"manuscripts\",\"tenantterm\":\"manuscripts\",\"frontiersdefaultterm\":\"manuscripts\",\"category\":\"core\"},{\"sequencenumber\":35,\"key\":\"article\",\"tenantterm\":\"article\",\"frontiersdefaultterm\":\"article\",\"category\":\"core\"},{\"sequencenumber\":36,\"key\":\"articles\",\"tenantterm\":\"articles\",\"frontiersdefaultterm\":\"articles\",\"category\":\"core\"},{\"sequencenumber\":37,\"key\":\"article_type\",\"tenantterm\":\"article type\",\"frontiersdefaultterm\":\"article type\",\"category\":\"core\"},{\"sequencenumber\":38,\"key\":\"article_types\",\"tenantterm\":\"article types\",\"frontiersdefaultterm\":\"article types\",\"category\":\"core\"},{\"sequencenumber\":39,\"key\":\"author\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":40,\"key\":\"authors\",\"tenantterm\":\"authors\",\"frontiersdefaultterm\":\"authors\",\"category\":\"label (role)\"},{\"sequencenumber\":41,\"key\":\"authoring\",\"tenantterm\":\"authoring\",\"frontiersdefaultterm\":\"authoring\",\"category\":\"core\"},{\"sequencenumber\":42,\"key\":\"authored\",\"tenantterm\":\"authored\",\"frontiersdefaultterm\":\"authored\",\"category\":\"core\"},{\"sequencenumber\":43,\"key\":\"accept\",\"tenantterm\":\"accept\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":44,\"key\":\"accepted\",\"tenantterm\":\"accepted\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":45,\"key\":\"assistant_field_chief_editor\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"description\":\"an editorial role on a field journal that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":46,\"key\":\"assistant_specialty_chief_editor\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":47,\"key\":\"assistant_specialty_chief_editors\",\"tenantterm\":\"assistant specialty chief editors\",\"frontiersdefaultterm\":\"assistant specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":48,\"key\":\"associate_editor\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":49,\"key\":\"specialty_chief_editor\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":50,\"key\":\"specialty_chief_editors\",\"tenantterm\":\"specialty chief editors\",\"frontiersdefaultterm\":\"specialty chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":51,\"key\":\"chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":52,\"key\":\"chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":53,\"key\":\"call_for_participation\",\"tenantterm\":\"call for participation\",\"frontiersdefaultterm\":\"call for participation\",\"category\":\"process\"},{\"sequencenumber\":54,\"key\":\"citation\",\"tenantterm\":\"citation\",\"frontiersdefaultterm\":\"citation\",\"category\":\"misc.\"},{\"sequencenumber\":55,\"key\":\"citations\",\"tenantterm\":\"citations\",\"frontiersdefaultterm\":\"citations\",\"category\":\"misc.\"},{\"sequencenumber\":56,\"key\":\"contributor\",\"tenantterm\":\"contributor\",\"frontiersdefaultterm\":\"contributor\",\"category\":\"label (role)\"},{\"sequencenumber\":57,\"key\":\"contributors\",\"tenantterm\":\"contributors\",\"frontiersdefaultterm\":\"contributors\",\"category\":\"label (role)\"},{\"sequencenumber\":58,\"key\":\"corresponding_author\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":59,\"key\":\"corresponding_authors\",\"tenantterm\":\"corresponding authors\",\"frontiersdefaultterm\":\"corresponding authors\",\"category\":\"label (role)\"},{\"sequencenumber\":60,\"key\":\"decline\",\"tenantterm\":\"decline\",\"frontiersdefaultterm\":\"decline\",\"category\":\"process\"},{\"sequencenumber\":61,\"key\":\"declined\",\"tenantterm\":\"declined\",\"frontiersdefaultterm\":\"declined\",\"category\":\"process\"},{\"sequencenumber\":62,\"key\":\"reject\",\"tenantterm\":\"reject\",\"frontiersdefaultterm\":\"reject\",\"category\":\"process\"},{\"sequencenumber\":63,\"key\":\"rejected\",\"tenantterm\":\"rejected\",\"frontiersdefaultterm\":\"rejected\",\"category\":\"process\"},{\"sequencenumber\":64,\"key\":\"publish\",\"tenantterm\":\"publish\",\"frontiersdefaultterm\":\"publish\",\"category\":\"core\"},{\"sequencenumber\":65,\"key\":\"published\",\"tenantterm\":\"published\",\"frontiersdefaultterm\":\"published\",\"category\":\"core\"},{\"sequencenumber\":66,\"key\":\"publication\",\"tenantterm\":\"publication\",\"frontiersdefaultterm\":\"publication\",\"category\":\"core\"},{\"sequencenumber\":67,\"key\":\"peer_review\",\"tenantterm\":\"peer review\",\"frontiersdefaultterm\":\"peer review\",\"category\":\"peer review process\"},{\"sequencenumber\":68,\"key\":\"peer_reviewed\",\"tenantterm\":\"peer reviewed\",\"frontiersdefaultterm\":\"peer reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":69,\"key\":\"initial_validation\",\"tenantterm\":\"initial validation\",\"frontiersdefaultterm\":\"initial validation\",\"category\":\"peer review process\"},{\"sequencenumber\":70,\"key\":\"editorial_assignment\",\"tenantterm\":\"editorial assignment\",\"frontiersdefaultterm\":\"editorial assignment\",\"category\":\"peer review process\"},{\"sequencenumber\":71,\"key\":\"independent_review\",\"tenantterm\":\"independent review\",\"frontiersdefaultterm\":\"independent review\",\"category\":\"peer review process\"},{\"sequencenumber\":72,\"key\":\"interactive_review\",\"tenantterm\":\"interactive review\",\"frontiersdefaultterm\":\"interactive review\",\"category\":\"peer review process\"},{\"sequencenumber\":73,\"key\":\"review\",\"tenantterm\":\"review\",\"frontiersdefaultterm\":\"review\",\"category\":\"peer review process\"},{\"sequencenumber\":74,\"key\":\"reviewing\",\"tenantterm\":\"reviewing\",\"frontiersdefaultterm\":\"reviewing\",\"category\":\"peer review process\"},{\"sequencenumber\":75,\"key\":\"reviewer\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":76,\"key\":\"reviewers\",\"tenantterm\":\"reviewers\",\"frontiersdefaultterm\":\"reviewers\",\"category\":\"label (role)\"},{\"sequencenumber\":77,\"key\":\"review_finalized\",\"tenantterm\":\"review finalized\",\"frontiersdefaultterm\":\"review finalized\",\"category\":\"peer review process\"},{\"sequencenumber\":78,\"key\":\"final_decision\",\"tenantterm\":\"final decision\",\"frontiersdefaultterm\":\"final decision\",\"category\":\"peer review process\"},{\"sequencenumber\":79,\"key\":\"final_validation\",\"tenantterm\":\"final validation\",\"frontiersdefaultterm\":\"final validation\",\"category\":\"peer review process\"},{\"sequencenumber\":80,\"key\":\"ae_accept_manuscript\",\"tenantterm\":\"recommend to accept manuscript\",\"frontiersdefaultterm\":\"accept manuscript\",\"category\":\"process\"},{\"sequencenumber\":81,\"key\":\"fee\",\"tenantterm\":\"fee\",\"frontiersdefaultterm\":\"fee\",\"category\":\"accounting\"},{\"sequencenumber\":82,\"key\":\"fees\",\"tenantterm\":\"fees\",\"frontiersdefaultterm\":\"fees\",\"category\":\"accounting\"},{\"sequencenumber\":83,\"key\":\"guest_associate_editor\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":84,\"key\":\"guest_associate_editors\",\"tenantterm\":\"guest associate editors\",\"frontiersdefaultterm\":\"guest associate editors\",\"category\":\"label (role)\"},{\"sequencenumber\":85,\"key\":\"in_review\",\"tenantterm\":\"in review\",\"frontiersdefaultterm\":\"in review\",\"category\":\"peer review process\"},{\"sequencenumber\":86,\"key\":\"institutional_member\",\"tenantterm\":\"institutional partner\",\"frontiersdefaultterm\":\"institutional partner\",\"category\":\"accounting\"},{\"sequencenumber\":87,\"key\":\"institutional_membership\",\"tenantterm\":\"institutional partnership\",\"frontiersdefaultterm\":\"institutional partnership\",\"category\":\"accounting\"},{\"sequencenumber\":88,\"key\":\"article_processing_charge\",\"tenantterm\":\"article processing charge\",\"frontiersdefaultterm\":\"article processing charge\",\"category\":\"accounting\"},{\"sequencenumber\":89,\"key\":\"article_processing_charges\",\"tenantterm\":\"article processing charges\",\"frontiersdefaultterm\":\"article processing charges\",\"category\":\"accounting\"},{\"sequencenumber\":90,\"key\":\"apcs\",\"tenantterm\":\"apcs\",\"frontiersdefaultterm\":\"apcs\",\"category\":\"accounting\"},{\"sequencenumber\":91,\"key\":\"apc\",\"tenantterm\":\"apc\",\"frontiersdefaultterm\":\"apc\",\"category\":\"accounting\"},{\"sequencenumber\":92,\"key\":\"received\",\"tenantterm\":\"received\",\"frontiersdefaultterm\":\"received\",\"description\":\"date manuscript was received on.\",\"category\":\"core\"},{\"sequencenumber\":93,\"key\":\"transferred\",\"tenantterm\":\"transferred\",\"frontiersdefaultterm\":\"transferred\",\"category\":\"core\"},{\"sequencenumber\":94,\"key\":\"transfer\",\"tenantterm\":\"transfer\",\"frontiersdefaultterm\":\"transfer\",\"category\":\"core\"},{\"sequencenumber\":95,\"key\":\"research_topic\",\"tenantterm\":\"research topic\",\"frontiersdefaultterm\":\"research topic\",\"category\":\"core\"},{\"sequencenumber\":96,\"key\":\"research_topics\",\"tenantterm\":\"research topics\",\"frontiersdefaultterm\":\"research topics\",\"category\":\"core\"},{\"sequencenumber\":97,\"key\":\"topic_editor\",\"tenantterm\":\"topic editor\",\"frontiersdefaultterm\":\"topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":98,\"key\":\"review_editor\",\"tenantterm\":\"community reviewer\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":99,\"key\":\"title\",\"tenantterm\":\"title\",\"frontiersdefaultterm\":\"title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":100,\"key\":\"running_title\",\"tenantterm\":\"running title\",\"frontiersdefaultterm\":\"running title\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":101,\"key\":\"submit\",\"tenantterm\":\"submit\",\"frontiersdefaultterm\":\"submit\",\"category\":\"process\"},{\"sequencenumber\":102,\"key\":\"submitted\",\"tenantterm\":\"submitted\",\"frontiersdefaultterm\":\"submitted\",\"category\":\"process\"},{\"sequencenumber\":103,\"key\":\"submitting\",\"tenantterm\":\"submitting\",\"frontiersdefaultterm\":\"submitting\",\"category\":\"process\"},{\"sequencenumber\":104,\"key\":\"t_e\",\"tenantterm\":\"te\",\"frontiersdefaultterm\":\"te\",\"category\":\"label (role)\"},{\"sequencenumber\":105,\"key\":\"topic\",\"tenantterm\":\"topic\",\"frontiersdefaultterm\":\"topic\",\"category\":\"process\"},{\"sequencenumber\":106,\"key\":\"topic_summary\",\"tenantterm\":\"topic summary\",\"frontiersdefaultterm\":\"topic summary\",\"category\":\"process\"},{\"sequencenumber\":107,\"key\":\"figure\",\"tenantterm\":\"figure\",\"frontiersdefaultterm\":\"figure\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":108,\"key\":\"figures\",\"tenantterm\":\"figures\",\"frontiersdefaultterm\":\"figures\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":109,\"key\":\"editorial_file\",\"tenantterm\":\"editorial file\",\"frontiersdefaultterm\":\"editorial file\",\"category\":\"core\"},{\"sequencenumber\":110,\"key\":\"editorial_files\",\"tenantterm\":\"editorial files\",\"frontiersdefaultterm\":\"editorial files\",\"category\":\"core\"},{\"sequencenumber\":111,\"key\":\"e_book\",\"tenantterm\":\"e-book\",\"frontiersdefaultterm\":\"e-book\",\"category\":\"core\"},{\"sequencenumber\":112,\"key\":\"organization\",\"tenantterm\":\"organization\",\"frontiersdefaultterm\":\"organization\",\"category\":\"core\"},{\"sequencenumber\":113,\"key\":\"institution\",\"tenantterm\":\"institution\",\"frontiersdefaultterm\":\"institution\",\"category\":\"core\"},{\"sequencenumber\":114,\"key\":\"reference\",\"tenantterm\":\"reference\",\"frontiersdefaultterm\":\"reference\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":115,\"key\":\"references\",\"tenantterm\":\"references\",\"frontiersdefaultterm\":\"references\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":116,\"key\":\"sce\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"description\":\"abbreviation for specialty chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":117,\"key\":\"submission\",\"tenantterm\":\"submission\",\"frontiersdefaultterm\":\"submission\",\"category\":\"process\"},{\"sequencenumber\":118,\"key\":\"submissions\",\"tenantterm\":\"submissions\",\"frontiersdefaultterm\":\"submissions\",\"category\":\"process\"},{\"sequencenumber\":119,\"key\":\"editing\",\"tenantterm\":\"editing\",\"frontiersdefaultterm\":\"editing\",\"category\":\"process\"},{\"sequencenumber\":120,\"key\":\"in_preparation\",\"tenantterm\":\"in preparation\",\"frontiersdefaultterm\":\"in preparation\",\"category\":\"process\"},{\"sequencenumber\":121,\"key\":\"country_region\",\"tenantterm\":\"country/region\",\"frontiersdefaultterm\":\"country/region\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":122,\"key\":\"countries_regions\",\"tenantterm\":\"countries/regions\",\"frontiersdefaultterm\":\"countries/regions\",\"description\":\"because of political issues, some of the country listings are actually classified as `regions` and we need to include this. however other clients may not want to do this.\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":123,\"key\":\"specialty\",\"tenantterm\":\"specialty\",\"frontiersdefaultterm\":\"specialty\",\"category\":\"core\"},{\"sequencenumber\":124,\"key\":\"specialties\",\"tenantterm\":\"specialties\",\"frontiersdefaultterm\":\"specialties\",\"category\":\"core\"},{\"sequencenumber\":125,\"key\":\"associate_editors\",\"tenantterm\":\"associate editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"an editorial role on a specialty that a registered user may hold. this gives them rights to different functionality and parts of the platform\",\"category\":\"label (role)\"},{\"sequencenumber\":126,\"key\":\"reviewed\",\"tenantterm\":\"reviewed\",\"frontiersdefaultterm\":\"reviewed\",\"category\":\"peer review process\"},{\"sequencenumber\":127,\"key\":\"institutional_members\",\"tenantterm\":\"institutional partners\",\"frontiersdefaultterm\":\"institutional partners\",\"category\":\"accounting\"},{\"sequencenumber\":128,\"key\":\"institutional_memberships\",\"tenantterm\":\"institutional partnerships\",\"frontiersdefaultterm\":\"institutional partnerships\",\"category\":\"accounting\"},{\"sequencenumber\":129,\"key\":\"assistant_field_chief_editors\",\"tenantterm\":\"assistant field chief editors\",\"frontiersdefaultterm\":\"assistant field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":130,\"key\":\"publications\",\"tenantterm\":\"publications\",\"frontiersdefaultterm\":\"publications\",\"category\":\"process\"},{\"sequencenumber\":131,\"key\":\"ae_accepted\",\"tenantterm\":\"recommended acceptance\",\"frontiersdefaultterm\":\"accepted\",\"category\":\"process\"},{\"sequencenumber\":132,\"key\":\"field_journal\",\"tenantterm\":\"field journal\",\"frontiersdefaultterm\":\"field journal\",\"category\":\"taxonomy\"},{\"sequencenumber\":133,\"key\":\"field_journals\",\"tenantterm\":\"field journals\",\"frontiersdefaultterm\":\"field journals\",\"category\":\"taxonomy\"},{\"sequencenumber\":134,\"key\":\"program_manager\",\"tenantterm\":\"program manager\",\"frontiersdefaultterm\":\"program manager\",\"category\":\"label (role)\"},{\"sequencenumber\":135,\"key\":\"journal_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":136,\"key\":\"journal_specialist\",\"tenantterm\":\"journal specialist\",\"frontiersdefaultterm\":\"journal specialist\",\"category\":\"label (role)\"},{\"sequencenumber\":137,\"key\":\"program_managers\",\"tenantterm\":\"program managers\",\"frontiersdefaultterm\":\"program managers\",\"category\":\"label (role)\"},{\"sequencenumber\":138,\"key\":\"journal_managers\",\"tenantterm\":\"journal managers\",\"frontiersdefaultterm\":\"journal managers\",\"category\":\"label (role)\"},{\"sequencenumber\":139,\"key\":\"journal_specialists\",\"tenantterm\":\"journal specialists\",\"frontiersdefaultterm\":\"journal specialists\",\"category\":\"label (role)\"},{\"sequencenumber\":140,\"key\":\"cover_letter\",\"tenantterm\":\"manuscript contribution to the field\",\"frontiersdefaultterm\":\"manuscript contribution to the field\",\"category\":\"process\"},{\"sequencenumber\":141,\"key\":\"ae_accepted_manuscript\",\"tenantterm\":\"recommended to accept manuscript\",\"frontiersdefaultterm\":\"accepted manuscript\",\"category\":\"process\"},{\"sequencenumber\":142,\"key\":\"recommend_for_rejection\",\"tenantterm\":\"recommend for rejection\",\"frontiersdefaultterm\":\"recommend for rejection\",\"category\":\"process\"},{\"sequencenumber\":143,\"key\":\"recommended_for_rejection\",\"tenantterm\":\"recommended for rejection\",\"frontiersdefaultterm\":\"recommended for rejection\",\"category\":\"process\"},{\"sequencenumber\":144,\"key\":\"ae\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"description\":\"associate editor - board member\",\"category\":\"label (role)\"},{\"sequencenumber\":145,\"key\":\"re\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"description\":\"review editor\",\"category\":\"label (role)\"},{\"sequencenumber\":146,\"key\":\"rev\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"description\":\"reviewer\",\"category\":\"label (role)\"},{\"sequencenumber\":147,\"key\":\"aut\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"description\":\"author\",\"category\":\"label (role)\"},{\"sequencenumber\":148,\"key\":\"coraut\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"description\":\"corresponding author\",\"category\":\"label (role)\"},{\"sequencenumber\":149,\"key\":\"saut\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"description\":\"submitting author\",\"category\":\"label (role)\"},{\"sequencenumber\":150,\"key\":\"coaut\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"description\":\"co-author\",\"category\":\"label (role)\"},{\"sequencenumber\":151,\"key\":\"tsof\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"description\":\"typesetter\",\"category\":\"label (role)\"},{\"sequencenumber\":152,\"key\":\"typesetting_office\",\"tenantterm\":\"typesetting office\",\"frontiersdefaultterm\":\"typesetting office\",\"category\":\"product\"},{\"sequencenumber\":153,\"key\":\"config\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"description\":\"configuration office role\",\"category\":\"label (role)\"},{\"sequencenumber\":154,\"key\":\"jm\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"description\":\"journal manager\",\"category\":\"label (role)\"},{\"sequencenumber\":155,\"key\":\"rte\",\"tenantterm\":\"rte\",\"frontiersdefaultterm\":\"rte\",\"description\":\"research topic editor\",\"category\":\"label (role)\"},{\"sequencenumber\":156,\"key\":\"organizations\",\"tenantterm\":\"organizations\",\"frontiersdefaultterm\":\"organizations\",\"category\":\"core\"},{\"sequencenumber\":157,\"key\":\"publishing\",\"tenantterm\":\"publishing\",\"frontiersdefaultterm\":\"publishing\",\"category\":\"core\"},{\"sequencenumber\":158,\"key\":\"acceptance\",\"tenantterm\":\"acceptance\",\"frontiersdefaultterm\":\"acceptance\",\"category\":\"process\"},{\"sequencenumber\":159,\"key\":\"preferred_associate_editor\",\"tenantterm\":\"preferred associate editor\",\"frontiersdefaultterm\":\"preferred associate editor\",\"category\":\"label (role)\"},{\"sequencenumber\":160,\"key\":\"topic_editors\",\"tenantterm\":\"topic editors\",\"frontiersdefaultterm\":\"topic editors\",\"category\":\"label (role)\"},{\"sequencenumber\":161,\"key\":\"institutions\",\"tenantterm\":\"institutions\",\"frontiersdefaultterm\":\"institutions\",\"category\":\"core\"},{\"sequencenumber\":162,\"key\":\"author(s)\",\"tenantterm\":\"author(s)\",\"frontiersdefaultterm\":\"author(s)\",\"category\":\"label (role)\"},{\"sequencenumber\":163,\"key\":\"figure(s)\",\"tenantterm\":\"figure(s)\",\"frontiersdefaultterm\":\"figure(s)\",\"category\":\"manuscript metadata\"},{\"sequencenumber\":164,\"key\":\"co-authors\",\"tenantterm\":\"co-authors\",\"frontiersdefaultterm\":\"co-authors\",\"description\":\"co-authors\",\"category\":\"label (role)\"},{\"sequencenumber\":165,\"key\":\"editorial_board_members\",\"tenantterm\":\"editorial board members\",\"frontiersdefaultterm\":\"editorial board members\",\"description\":\"editorial board members\",\"category\":\"label (role)\"},{\"sequencenumber\":166,\"key\":\"editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"editorial board\",\"category\":\"product\"},{\"sequencenumber\":167,\"key\":\"co-authorship\",\"tenantterm\":\"co-authorship\",\"frontiersdefaultterm\":\"co-authorship\",\"description\":\"co-authorship\",\"category\":\"misc.\"},{\"sequencenumber\":168,\"key\":\"role_id_1\",\"tenantterm\":\"registration office\",\"frontiersdefaultterm\":\"registration office\",\"category\":\"user role\"},{\"sequencenumber\":169,\"key\":\"role_id_2\",\"tenantterm\":\"editorial office\",\"frontiersdefaultterm\":\"editorial office\",\"category\":\"user role\"},{\"sequencenumber\":170,\"key\":\"role_id_7\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":171,\"key\":\"role_id_8\",\"tenantterm\":\"assistant field chief editor\",\"frontiersdefaultterm\":\"assistant field chief editor\",\"category\":\"user role\"},{\"sequencenumber\":172,\"key\":\"role_id_9\",\"tenantterm\":\"specialty chief editor\",\"frontiersdefaultterm\":\"specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":173,\"key\":\"role_id_10\",\"tenantterm\":\"assistant specialty chief editor\",\"frontiersdefaultterm\":\"assistant specialty chief editor\",\"category\":\"user role\"},{\"sequencenumber\":174,\"key\":\"role_id_11\",\"tenantterm\":\"associate editor\",\"frontiersdefaultterm\":\"associate editor\",\"category\":\"user role\"},{\"sequencenumber\":175,\"key\":\"role_id_12\",\"tenantterm\":\"guest associate editor\",\"frontiersdefaultterm\":\"guest associate editor\",\"category\":\"user role\"},{\"sequencenumber\":176,\"key\":\"role_id_13\",\"tenantterm\":\"review editor\",\"frontiersdefaultterm\":\"review editor\",\"category\":\"user role\"},{\"sequencenumber\":177,\"key\":\"role_id_14\",\"tenantterm\":\"reviewer\",\"frontiersdefaultterm\":\"reviewer\",\"category\":\"user role\"},{\"sequencenumber\":178,\"key\":\"role_id_15\",\"tenantterm\":\"author\",\"frontiersdefaultterm\":\"author\",\"category\":\"user role\"},{\"sequencenumber\":179,\"key\":\"role_id_16\",\"tenantterm\":\"corresponding author\",\"frontiersdefaultterm\":\"corresponding author\",\"category\":\"user role\"},{\"sequencenumber\":180,\"key\":\"role_id_17\",\"tenantterm\":\"submitting author\",\"frontiersdefaultterm\":\"submitting author\",\"category\":\"user role\"},{\"sequencenumber\":181,\"key\":\"role_id_18\",\"tenantterm\":\"co-author\",\"frontiersdefaultterm\":\"co-author\",\"category\":\"user role\"},{\"sequencenumber\":182,\"key\":\"role_id_20\",\"tenantterm\":\"production office\",\"frontiersdefaultterm\":\"production office\",\"category\":\"user role\"},{\"sequencenumber\":183,\"key\":\"role_id_22\",\"tenantterm\":\"typesetting office (typesetter)\",\"frontiersdefaultterm\":\"typesetting office (typesetter)\",\"category\":\"user role\"},{\"sequencenumber\":184,\"key\":\"role_id_24\",\"tenantterm\":\"registered user\",\"frontiersdefaultterm\":\"registered user\",\"category\":\"user role\"},{\"sequencenumber\":185,\"key\":\"role_id_35\",\"tenantterm\":\"job office\",\"frontiersdefaultterm\":\"job office\",\"category\":\"user role\"},{\"sequencenumber\":186,\"key\":\"role_id_41\",\"tenantterm\":\"special event administrator\",\"frontiersdefaultterm\":\"special event administrator\",\"category\":\"user role\"},{\"sequencenumber\":187,\"key\":\"role_id_42\",\"tenantterm\":\"special event reviewer\",\"frontiersdefaultterm\":\"special event reviewer\",\"category\":\"user role\"},{\"sequencenumber\":188,\"key\":\"role_id_43\",\"tenantterm\":\"submit abstract\",\"frontiersdefaultterm\":\"submit abstract\",\"category\":\"user role\"},{\"sequencenumber\":189,\"key\":\"role_id_52\",\"tenantterm\":\"events office\",\"frontiersdefaultterm\":\"events office\",\"category\":\"user role\"},{\"sequencenumber\":190,\"key\":\"role_id_53\",\"tenantterm\":\"event administrator\",\"frontiersdefaultterm\":\"event administrator\",\"category\":\"user role\"},{\"sequencenumber\":191,\"key\":\"role_id_89\",\"tenantterm\":\"content management office\",\"frontiersdefaultterm\":\"content management office\",\"category\":\"user role\"},{\"sequencenumber\":192,\"key\":\"role_id_98\",\"tenantterm\":\"accounting office\",\"frontiersdefaultterm\":\"accounting office\",\"category\":\"user role\"},{\"sequencenumber\":193,\"key\":\"role_id_99\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":194,\"key\":\"role_id_103\",\"tenantterm\":\"configuration office\",\"frontiersdefaultterm\":\"configuration office\",\"category\":\"user role\"},{\"sequencenumber\":195,\"key\":\"role_id_104\",\"tenantterm\":\"beta user\",\"frontiersdefaultterm\":\"beta user\",\"category\":\"user role\"},{\"sequencenumber\":196,\"key\":\"role_id_106\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":197,\"key\":\"role_id_107\",\"tenantterm\":\"rt management beta user\",\"frontiersdefaultterm\":\"rt management beta user\",\"category\":\"user role\"},{\"sequencenumber\":198,\"key\":\"role_id_108\",\"tenantterm\":\"deo beta user\",\"frontiersdefaultterm\":\"deo beta user\",\"category\":\"user role\"},{\"sequencenumber\":199,\"key\":\"role_id_109\",\"tenantterm\":\"search beta user\",\"frontiersdefaultterm\":\"search beta user\",\"category\":\"user role\"},{\"sequencenumber\":200,\"key\":\"role_id_110\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"journal manager\",\"category\":\"user role\"},{\"sequencenumber\":201,\"key\":\"role_id_111\",\"tenantterm\":\"myfrontiers beta user\",\"frontiersdefaultterm\":\"myfrontiers beta user\",\"category\":\"user role\"},{\"sequencenumber\":202,\"key\":\"role_id_21\",\"tenantterm\":\"copy editor\",\"frontiersdefaultterm\":\"copy editor\",\"category\":\"user role\"},{\"sequencenumber\":203,\"key\":\"role_id_1_abr\",\"tenantterm\":\"rof\",\"frontiersdefaultterm\":\"rof\",\"category\":\"user role\"},{\"sequencenumber\":204,\"key\":\"role_id_2_abr\",\"tenantterm\":\"eof\",\"frontiersdefaultterm\":\"eof\",\"category\":\"user role\"},{\"sequencenumber\":205,\"key\":\"role_id_7_abr\",\"tenantterm\":\"fce\",\"frontiersdefaultterm\":\"fce\",\"category\":\"user role\"},{\"sequencenumber\":206,\"key\":\"role_id_8_abr\",\"tenantterm\":\"afce\",\"frontiersdefaultterm\":\"afce\",\"category\":\"user role\"},{\"sequencenumber\":207,\"key\":\"role_id_9_abr\",\"tenantterm\":\"sce\",\"frontiersdefaultterm\":\"sce\",\"category\":\"user role\"},{\"sequencenumber\":208,\"key\":\"role_id_10_abr\",\"tenantterm\":\"asce\",\"frontiersdefaultterm\":\"asce\",\"category\":\"user role\"},{\"sequencenumber\":209,\"key\":\"role_id_11_abr\",\"tenantterm\":\"ae\",\"frontiersdefaultterm\":\"ae\",\"category\":\"user role\"},{\"sequencenumber\":210,\"key\":\"role_id_12_abr\",\"tenantterm\":\"gae\",\"frontiersdefaultterm\":\"gae\",\"category\":\"user role\"},{\"sequencenumber\":211,\"key\":\"role_id_13_abr\",\"tenantterm\":\"re\",\"frontiersdefaultterm\":\"re\",\"category\":\"user role\"},{\"sequencenumber\":212,\"key\":\"role_id_14_abr\",\"tenantterm\":\"rev\",\"frontiersdefaultterm\":\"rev\",\"category\":\"user role\"},{\"sequencenumber\":213,\"key\":\"role_id_15_abr\",\"tenantterm\":\"aut\",\"frontiersdefaultterm\":\"aut\",\"category\":\"user role\"},{\"sequencenumber\":214,\"key\":\"role_id_16_abr\",\"tenantterm\":\"coraut\",\"frontiersdefaultterm\":\"coraut\",\"category\":\"user role\"},{\"sequencenumber\":215,\"key\":\"role_id_17_abr\",\"tenantterm\":\"saut\",\"frontiersdefaultterm\":\"saut\",\"category\":\"user role\"},{\"sequencenumber\":216,\"key\":\"role_id_18_abr\",\"tenantterm\":\"coaut\",\"frontiersdefaultterm\":\"coaut\",\"category\":\"user role\"},{\"sequencenumber\":217,\"key\":\"role_id_20_abr\",\"tenantterm\":\"pof\",\"frontiersdefaultterm\":\"pof\",\"category\":\"user role\"},{\"sequencenumber\":218,\"key\":\"role_id_22_abr\",\"tenantterm\":\"tsof\",\"frontiersdefaultterm\":\"tsof\",\"category\":\"user role\"},{\"sequencenumber\":219,\"key\":\"role_id_24_abr\",\"tenantterm\":\"ru\",\"frontiersdefaultterm\":\"ru\",\"category\":\"user role\"},{\"sequencenumber\":220,\"key\":\"role_id_35_abr\",\"tenantterm\":\"jof\",\"frontiersdefaultterm\":\"jof\",\"category\":\"user role\"},{\"sequencenumber\":221,\"key\":\"role_id_41_abr\",\"tenantterm\":\"se-adm\",\"frontiersdefaultterm\":\"se-adm\",\"category\":\"user role\"},{\"sequencenumber\":222,\"key\":\"role_id_42_abr\",\"tenantterm\":\"se-rev\",\"frontiersdefaultterm\":\"se-rev\",\"category\":\"user role\"},{\"sequencenumber\":223,\"key\":\"role_id_43_abr\",\"tenantterm\":\"se-aut\",\"frontiersdefaultterm\":\"se-aut\",\"category\":\"user role\"},{\"sequencenumber\":224,\"key\":\"role_id_52_abr\",\"tenantterm\":\"evof\",\"frontiersdefaultterm\":\"evof\",\"category\":\"user role\"},{\"sequencenumber\":225,\"key\":\"role_id_53_abr\",\"tenantterm\":\"ev-adm\",\"frontiersdefaultterm\":\"ev-adm\",\"category\":\"user role\"},{\"sequencenumber\":226,\"key\":\"role_id_89_abr\",\"tenantterm\":\"comof\",\"frontiersdefaultterm\":\"comof\",\"category\":\"user role\"},{\"sequencenumber\":227,\"key\":\"role_id_98_abr\",\"tenantterm\":\"aof\",\"frontiersdefaultterm\":\"aof\",\"category\":\"user role\"},{\"sequencenumber\":228,\"key\":\"role_id_99_abr\",\"tenantterm\":\"projects\",\"frontiersdefaultterm\":\"projects\",\"category\":\"user role\"},{\"sequencenumber\":229,\"key\":\"role_id_103_abr\",\"tenantterm\":\"config\",\"frontiersdefaultterm\":\"config\",\"category\":\"user role\"},{\"sequencenumber\":230,\"key\":\"role_id_104_abr\",\"tenantterm\":\"beta\",\"frontiersdefaultterm\":\"beta\",\"category\":\"user role\"},{\"sequencenumber\":231,\"key\":\"role_id_106_abr\",\"tenantterm\":\"wfconf\",\"frontiersdefaultterm\":\"wfconf\",\"category\":\"user role\"},{\"sequencenumber\":232,\"key\":\"role_id_107_abr\",\"tenantterm\":\"rtbeta\",\"frontiersdefaultterm\":\"rtbeta\",\"category\":\"user role\"},{\"sequencenumber\":233,\"key\":\"role_id_108_abr\",\"tenantterm\":\"deobeta\",\"frontiersdefaultterm\":\"deobeta\",\"category\":\"user role\"},{\"sequencenumber\":234,\"key\":\"role_id_109_abr\",\"tenantterm\":\"searchbeta\",\"frontiersdefaultterm\":\"searchbeta\",\"category\":\"user role\"},{\"sequencenumber\":235,\"key\":\"role_id_110_abr\",\"tenantterm\":\"jm\",\"frontiersdefaultterm\":\"jm\",\"category\":\"user role\"},{\"sequencenumber\":236,\"key\":\"role_id_111_abr\",\"tenantterm\":\"mfbeta\",\"frontiersdefaultterm\":\"mfbeta\",\"category\":\"user role\"},{\"sequencenumber\":237,\"key\":\"role_id_21_abr\",\"tenantterm\":\"coped\",\"frontiersdefaultterm\":\"coped\",\"category\":\"user role\"},{\"sequencenumber\":238,\"key\":\"reviewer_editorial_board\",\"tenantterm\":\"editorial board\",\"frontiersdefaultterm\":\"editorial board\",\"description\":\"this is the label for the review editorial board\",\"category\":\"label\"},{\"sequencenumber\":239,\"key\":\"field_chief_editor\",\"tenantterm\":\"field chief editor\",\"frontiersdefaultterm\":\"field chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":240,\"key\":\"field_chief_editors\",\"tenantterm\":\"field chief editors\",\"frontiersdefaultterm\":\"field chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":241,\"key\":\"editor\",\"tenantterm\":\"editor\",\"frontiersdefaultterm\":\"editor\",\"category\":\"label (role)\"},{\"sequencenumber\":242,\"key\":\"editors\",\"tenantterm\":\"editors\",\"frontiersdefaultterm\":\"editors\",\"category\":\"label (role)\"},{\"sequencenumber\":243,\"key\":\"board\",\"tenantterm\":\"board\",\"frontiersdefaultterm\":\"board\",\"category\":\"label\"},{\"sequencenumber\":244,\"key\":\"boards\",\"tenantterm\":\"boards\",\"frontiersdefaultterm\":\"boards\",\"category\":\"label\"},{\"sequencenumber\":245,\"key\":\"article_collection\",\"tenantterm\":\"article collection\",\"frontiersdefaultterm\":\"article collection\",\"category\":\"label\"},{\"sequencenumber\":246,\"key\":\"article_collections\",\"tenantterm\":\"article collections\",\"frontiersdefaultterm\":\"article collections\",\"category\":\"label\"},{\"sequencenumber\":247,\"key\":\"handling_editor\",\"tenantterm\":\"handling editor\",\"frontiersdefaultterm\":\"associate editor\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":248,\"key\":\"handling_editors\",\"tenantterm\":\"handling editors\",\"frontiersdefaultterm\":\"associate editors\",\"description\":\"this terminology key is for the person assigned to edit a manuscript. it is a label for the temporary handling editor assignment.\",\"category\":\"label (role)\"},{\"sequencenumber\":249,\"key\":\"ae_accept\",\"tenantterm\":\"recommend acceptance\",\"frontiersdefaultterm\":\"accept\",\"category\":\"process\"},{\"sequencenumber\":250,\"key\":\"rtm\",\"tenantterm\":\"rtm\",\"frontiersdefaultterm\":\"rtm\",\"category\":\"product\"},{\"sequencenumber\":251,\"key\":\"frontiers_media_sa\",\"tenantterm\":\"frontiers media s.a\",\"frontiersdefaultterm\":\"frontiers media s.a\",\"category\":\"customer\"},{\"sequencenumber\":252,\"key\":\"review_editors\",\"tenantterm\":\"community reviewers\",\"frontiersdefaultterm\":\"review editors\",\"category\":\"label (role)\"},{\"sequencenumber\":253,\"key\":\"journal_card_chief_editor\",\"tenantterm\":\"chief editor\",\"frontiersdefaultterm\":\"chief editor\",\"category\":\"label (role)\"},{\"sequencenumber\":254,\"key\":\"journal_card_chief_editors\",\"tenantterm\":\"chief editors\",\"frontiersdefaultterm\":\"chief editors\",\"category\":\"label (role)\"},{\"sequencenumber\":255,\"key\":\"call_for_papers\",\"tenantterm\":\"call for papers\",\"frontiersdefaultterm\":\"call for papers\",\"category\":\"label\"},{\"sequencenumber\":256,\"key\":\"calls_for_papers\",\"tenantterm\":\"calls for papers\",\"frontiersdefaultterm\":\"calls for papers\",\"category\":\"label\"},{\"sequencenumber\":257,\"key\":\"supervising_editor\",\"tenantterm\":\"supervising editor\",\"frontiersdefaultterm\":\"supervising editor\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editor\"},{\"sequencenumber\":258,\"key\":\"supervising_editors\",\"tenantterm\":\"supervising editors\",\"frontiersdefaultterm\":\"supervising editors\",\"description\":\"a chief or assistant chief editor who is assigned to a manuscript to supervise.\",\"category\":\"role\",\"externalkey\":\"supervising_editors\"},{\"sequencenumber\":259,\"key\":\"reviewer_endorse\",\"tenantterm\":\"endorse\",\"frontiersdefaultterm\":\"endorse\",\"category\":\"label\"},{\"sequencenumber\":260,\"key\":\"reviewer_endorsed\",\"tenantterm\":\"endorsed\",\"frontiersdefaultterm\":\"endorsed\",\"category\":\"label\"},{\"sequencenumber\":261,\"key\":\"reviewer_endorse_publication\",\"tenantterm\":\"endorse publication\",\"frontiersdefaultterm\":\"endorse publication\",\"category\":\"label\"},{\"sequencenumber\":262,\"key\":\"reviewer_endorsed_publication\",\"tenantterm\":\"endorsed publication\",\"frontiersdefaultterm\":\"endorsed publication\",\"category\":\"label\"},{\"sequencenumber\":263,\"key\":\"editor_role\",\"tenantterm\":\"editor role\",\"frontiersdefaultterm\":\"editor role\",\"category\":\"label\"},{\"sequencenumber\":264,\"key\":\"editor_roles\",\"tenantterm\":\"editor roles\",\"frontiersdefaultterm\":\"editor roles\",\"category\":\"label\"},{\"sequencenumber\":265,\"key\":\"editorial_role\",\"tenantterm\":\"editorial role\",\"frontiersdefaultterm\":\"editorial role\",\"category\":\"label\"},{\"sequencenumber\":266,\"key\":\"editorial_roles\",\"tenantterm\":\"editorial roles\",\"frontiersdefaultterm\":\"editorial roles\",\"category\":\"label\"},{\"sequencenumber\":267,\"key\":\"call_for_paper\",\"tenantterm\":\"call for paper\",\"frontiersdefaultterm\":\"call for paper\",\"category\":\"label\"},{\"sequencenumber\":268,\"key\":\"research_topic_abstract\",\"tenantterm\":\"manuscript summary\",\"frontiersdefaultterm\":\"manuscript summary\",\"category\":\"process\"},{\"sequencenumber\":269,\"key\":\"research_topic_abstracts\",\"tenantterm\":\"manuscript summaries\",\"frontiersdefaultterm\":\"manuscript summaries\",\"category\":\"process\"},{\"sequencenumber\":270,\"key\":\"submissions_team_manager\",\"tenantterm\":\"journal manager\",\"frontiersdefaultterm\":\"content manager\",\"category\":\"process\"},{\"sequencenumber\":271,\"key\":\"submissions_team\",\"tenantterm\":\"journal team\",\"frontiersdefaultterm\":\"content team\",\"category\":\"process\"},{\"sequencenumber\":272,\"key\":\"topic_coordinator\",\"tenantterm\":\"topic coordinator\",\"frontiersdefaultterm\":\"topic coordinator\",\"category\":\"process\"},{\"sequencenumber\":273,\"key\":\"topic_coordinators\",\"tenantterm\":\"topic coordinators\",\"frontiersdefaultterm\":\"topic coordinators\",\"category\":\"process\"},{\"sequencenumber\":274,\"key\":\"frontiers_journal_team\",\"tenantterm\":\"frontiers journal team\",\"frontiersdefaultterm\":\"frontiers journal team\",\"category\":\"label (role)\"},{\"sequencenumber\":275,\"key\":\"research_topic_ic_submission\",\"tenantterm\":\"rt:ic submission\",\"frontiersdefaultterm\":\"rt:ic submission\",\"category\":\"label (role)\"},{\"sequencenumber\":276,\"key\":\"research_topic_ic_submission_participant\",\"tenantterm\":\"rt:ic submission participant\",\"frontiersdefaultterm\":\"rt:ic submission participant\",\"category\":\"label (role)\"}]}'\n",impactgtmid:"gtm-njf2ml9b",impactgtmauth:"fyo-7nodm9w37qgfms03sa",impactgtmpreview:"env-1",impactgooglemapsapikey:"aizasyctehx2eu8pwfi86gw9fi00ftcykk6ifr8",qualtricsv4tov3:"'{\"enabled\":true,\"interceptid\":\"si_er0e2ze69oz8yn4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricsumux:"'{\"enabled\":false,\"interceptid\":\"si_89fphy3etxqbwtu\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",qualtricscontinuousbrand:"'{\"enabled\":true,\"interceptid\":\"si_9zut94ut81fcrh4\",\"projectid\":\"zn_cloy77jhkpc8gai\",\"brandid\":\"frontiersin\"}'\n",defaultarticletemplate:"v3"},app:{baseurl:"/",buildid:"f2d5b6d8-d01c-4534-90b9-d659f10f17ca",buildassetsdir:"ap-2024/_nuxt",cdnurl:""}}## Scraping Notes- Successfully scraped from DOI.org